{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "96fed04e",
   "metadata": {},
   "source": [
    "1. getting DOB and DOS from lab data\n",
    "2. clean the test names\n",
    "3. filling the missing dates"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "66d96455",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "59b54384",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Sample ID</th>\n",
       "      <th>Patient Name</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Date of Birth</th>\n",
       "      <th>Test Name</th>\n",
       "      <th>Unit</th>\n",
       "      <th>Category</th>\n",
       "      <th>Result</th>\n",
       "      <th>Date of Sample\\n</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>118</td>\n",
       "      <td>Xalil Ahmad Mhamad</td>\n",
       "      <td>Male</td>\n",
       "      <td>16/04/1959</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>95</td>\n",
       "      <td>16/04/2023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>126</td>\n",
       "      <td>Dyar Omar</td>\n",
       "      <td>Male</td>\n",
       "      <td>16/04/1986</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>86</td>\n",
       "      <td>16/04/2023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>132</td>\n",
       "      <td>Fatah Mhamad Qadr</td>\n",
       "      <td>Male</td>\n",
       "      <td>16/04/1970</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>84</td>\n",
       "      <td>16/04/2023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>177</td>\n",
       "      <td>Sesna Qubad Anwar</td>\n",
       "      <td>Female</td>\n",
       "      <td>17/04/1973</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>84</td>\n",
       "      <td>17/04/2023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>179</td>\n",
       "      <td>Bayan Abdulla Abdurahman</td>\n",
       "      <td>Female</td>\n",
       "      <td>17/04/1981</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>96</td>\n",
       "      <td>17/04/2023</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Sample ID              Patient Name  Gender Date of Birth    Test Name  \\\n",
       "0        118        Xalil Ahmad Mhamad    Male    16/04/1959  Blood Sugar   \n",
       "1        126                 Dyar Omar    Male    16/04/1986  Blood Sugar   \n",
       "2        132         Fatah Mhamad Qadr    Male    16/04/1970  Blood Sugar   \n",
       "3        177         Sesna Qubad Anwar  Female    17/04/1973  Blood Sugar   \n",
       "4        179  Bayan Abdulla Abdurahman  Female    17/04/1981  Blood Sugar   \n",
       "\n",
       "    Unit       Category Result Date of Sample\\n  \n",
       "0  mg/dl  Diabetes Test     95       16/04/2023  \n",
       "1  mg/dl  Diabetes Test     86       16/04/2023  \n",
       "2  mg/dl  Diabetes Test     84       16/04/2023  \n",
       "3  mg/dl  Diabetes Test     84       17/04/2023  \n",
       "4  mg/dl  Diabetes Test     96       17/04/2023  "
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_biolab = pd.read_csv('raw_data/Biolab_Test_Results_Halabja.csv', encoding='latin-1')\n",
    "df_biolab.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "858e3792",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Sample ID</th>\n",
       "      <th>Patient Name</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Date of Birth</th>\n",
       "      <th>Test Name</th>\n",
       "      <th>Unit</th>\n",
       "      <th>Category</th>\n",
       "      <th>Result</th>\n",
       "      <th>Date of Sample\\r\\n</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>13234</td>\n",
       "      <td>sargul hama amin abdulla</td>\n",
       "      <td>Female</td>\n",
       "      <td>5/1/1975</td>\n",
       "      <td>Glucose</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>105.21</td>\n",
       "      <td>5/1/2025</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>13240</td>\n",
       "      <td>mohammed Ebrahim</td>\n",
       "      <td>Male</td>\n",
       "      <td>6/1/1935</td>\n",
       "      <td>Glucose</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>98.05</td>\n",
       "      <td>6/1/2025</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>13250</td>\n",
       "      <td>Salm Hasan</td>\n",
       "      <td>Male</td>\n",
       "      <td>7/1/1960</td>\n",
       "      <td>Glucose</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>202.23</td>\n",
       "      <td>7/1/2025</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>13251</td>\n",
       "      <td>rebin samdar</td>\n",
       "      <td>Male</td>\n",
       "      <td>7/1/2003</td>\n",
       "      <td>Glucose</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>87.91</td>\n",
       "      <td>7/1/2025</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>13253</td>\n",
       "      <td>brsada abas khwa karam</td>\n",
       "      <td>Female</td>\n",
       "      <td>7/1/1967</td>\n",
       "      <td>Glucose</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>109.24</td>\n",
       "      <td>7/1/2025</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Sample ID              Patient Name  Gender Date of Birth Test Name   Unit  \\\n",
       "0      13234  sargul hama amin abdulla  Female      5/1/1975   Glucose  mg/dl   \n",
       "1      13240          mohammed Ebrahim    Male      6/1/1935   Glucose  mg/dl   \n",
       "2      13250                Salm Hasan    Male      7/1/1960   Glucose  mg/dl   \n",
       "3      13251              rebin samdar    Male      7/1/2003   Glucose  mg/dl   \n",
       "4      13253    brsada abas khwa karam  Female      7/1/1967   Glucose  mg/dl   \n",
       "\n",
       "        Category  Result Date of Sample\\r\\n  \n",
       "0  Diabetes Test  105.21           5/1/2025  \n",
       "1  Diabetes Test   98.05           6/1/2025  \n",
       "2  Diabetes Test  202.23           7/1/2025  \n",
       "3  Diabetes Test   87.91           7/1/2025  \n",
       "4  Diabetes Test  109.24           7/1/2025  "
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_darugha = pd.read_csv('raw_data/Darugha_Lab_Test_Results_Slemani.csv', encoding='latin-1')\n",
    "df_darugha.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "6bd4e4d7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Sample ID</th>\n",
       "      <th>Patient Name</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Date of Birth</th>\n",
       "      <th>Test Name</th>\n",
       "      <th>Unit</th>\n",
       "      <th>Category</th>\n",
       "      <th>Result</th>\n",
       "      <th>Date of Sample\\r\\n</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>2384</td>\n",
       "      <td>Shawnm Tofiq Salh</td>\n",
       "      <td>Female</td>\n",
       "      <td>1/1/1954</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>110</td>\n",
       "      <td>27/08/2023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2387</td>\n",
       "      <td>Hanar Omar Sharif</td>\n",
       "      <td>Female</td>\n",
       "      <td>1/1/2006</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>91</td>\n",
       "      <td>27/08/2023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2391</td>\n",
       "      <td>abid kaka mahmud ali</td>\n",
       "      <td>Male</td>\n",
       "      <td>27/08/1970</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>112</td>\n",
       "      <td>27/08/2023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>2400</td>\n",
       "      <td>rabiea hasan saed</td>\n",
       "      <td>Female</td>\n",
       "      <td>27/08/1943</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>138</td>\n",
       "      <td>27/08/2023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>2406</td>\n",
       "      <td>Amad Sarkar Hsen</td>\n",
       "      <td>Male</td>\n",
       "      <td>27/08/2015</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>100</td>\n",
       "      <td>27/08/2023</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Sample ID          Patient Name  Gender Date of Birth    Test Name   Unit  \\\n",
       "0       2384     Shawnm Tofiq Salh  Female      1/1/1954  Blood Sugar  mg/dl   \n",
       "1       2387     Hanar Omar Sharif  Female      1/1/2006  Blood Sugar  mg/dl   \n",
       "2       2391  abid kaka mahmud ali    Male    27/08/1970  Blood Sugar  mg/dl   \n",
       "3       2400     rabiea hasan saed  Female    27/08/1943  Blood Sugar  mg/dl   \n",
       "4       2406      Amad Sarkar Hsen    Male    27/08/2015  Blood Sugar  mg/dl   \n",
       "\n",
       "        Category Result Date of Sample\\r\\n  \n",
       "0  Diabetes Test    110         27/08/2023  \n",
       "1  Diabetes Test     91         27/08/2023  \n",
       "2  Diabetes Test    112         27/08/2023  \n",
       "3  Diabetes Test    138         27/08/2023  \n",
       "4  Diabetes Test    100         27/08/2023  "
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_hawkari = pd.read_csv('raw_data/Hawkari_Lab_Test_Results_Halabja.csv', encoding='latin-1')\n",
    "df_hawkari.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "c4e28802",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "=== BIOLAB DATAFRAME ===\n",
      "Shape: (84179, 9)\n",
      "\n",
      "Data types:\n",
      "Sample ID            int64\n",
      "Patient Name        object\n",
      "Gender              object\n",
      "Date of Birth       object\n",
      "Test Name           object\n",
      "Unit                object\n",
      "Category            object\n",
      "Result              object\n",
      "Date of Sample\\n    object\n",
      "dtype: object\n",
      "\n",
      "Missing values per column:\n",
      "Sample ID               0\n",
      "Patient Name            0\n",
      "Gender                  0\n",
      "Date of Birth           0\n",
      "Test Name               0\n",
      "Unit                12806\n",
      "Category                0\n",
      "Result                  0\n",
      "Date of Sample\\n        0\n",
      "dtype: int64\n",
      "\n",
      "Missing values percentage:\n",
      "Sample ID            0.00000\n",
      "Patient Name         0.00000\n",
      "Gender               0.00000\n",
      "Date of Birth        0.00000\n",
      "Test Name            0.00000\n",
      "Unit                15.21282\n",
      "Category             0.00000\n",
      "Result               0.00000\n",
      "Date of Sample\\n     0.00000\n",
      "dtype: float64\n",
      "\n",
      "==================================================\n",
      "=== DARUGHA DATAFRAME ===\n",
      "Shape: (2823, 9)\n",
      "\n",
      "Data types:\n",
      "Sample ID              int64\n",
      "Patient Name          object\n",
      "Gender                object\n",
      "Date of Birth         object\n",
      "Test Name             object\n",
      "Unit                  object\n",
      "Category              object\n",
      "Result                object\n",
      "Date of Sample\\r\\n    object\n",
      "dtype: object\n",
      "\n",
      "Missing values per column:\n",
      "Sample ID               0\n",
      "Patient Name            0\n",
      "Gender                  0\n",
      "Date of Birth           0\n",
      "Test Name               0\n",
      "Unit                  223\n",
      "Category                0\n",
      "Result                  0\n",
      "Date of Sample\\r\\n      0\n",
      "dtype: int64\n",
      "\n",
      "Missing values percentage:\n",
      "Sample ID             0.000000\n",
      "Patient Name          0.000000\n",
      "Gender                0.000000\n",
      "Date of Birth         0.000000\n",
      "Test Name             0.000000\n",
      "Unit                  7.899398\n",
      "Category              0.000000\n",
      "Result                0.000000\n",
      "Date of Sample\\r\\n    0.000000\n",
      "dtype: float64\n",
      "\n",
      "==================================================\n",
      "=== HAWKARI DATAFRAME ===\n",
      "Shape: (70383, 9)\n",
      "\n",
      "Data types:\n",
      "Sample ID              int64\n",
      "Patient Name          object\n",
      "Gender                object\n",
      "Date of Birth         object\n",
      "Test Name             object\n",
      "Unit                  object\n",
      "Category              object\n",
      "Result                object\n",
      "Date of Sample\\r\\n    object\n",
      "dtype: object\n",
      "\n",
      "Missing values per column:\n",
      "Sample ID                0\n",
      "Patient Name             0\n",
      "Gender                   0\n",
      "Date of Birth            0\n",
      "Test Name                0\n",
      "Unit                  2535\n",
      "Category                 0\n",
      "Result                   0\n",
      "Date of Sample\\r\\n       0\n",
      "dtype: int64\n",
      "\n",
      "Missing values percentage:\n",
      "Sample ID             0.000000\n",
      "Patient Name          0.000000\n",
      "Gender                0.000000\n",
      "Date of Birth         0.000000\n",
      "Test Name             0.000000\n",
      "Unit                  3.601722\n",
      "Category              0.000000\n",
      "Result                0.000000\n",
      "Date of Sample\\r\\n    0.000000\n",
      "dtype: float64\n"
     ]
    }
   ],
   "source": [
    "# Check basic info and missing values for each dataframe\n",
    "\n",
    "print(\"=== BIOLAB DATAFRAME ===\")\n",
    "print(\"Shape:\", df_biolab.shape)\n",
    "print(\"\\nData types:\")\n",
    "print(df_biolab.dtypes)\n",
    "print(\"\\nMissing values per column:\")\n",
    "print(df_biolab.isnull().sum())\n",
    "print(\"\\nMissing values percentage:\")\n",
    "print((df_biolab.isnull().sum() / len(df_biolab)) * 100)\n",
    "\n",
    "print(\"\\n\" + \"=\"*50)\n",
    "print(\"=== DARUGHA DATAFRAME ===\")\n",
    "print(\"Shape:\", df_darugha.shape)\n",
    "print(\"\\nData types:\")\n",
    "print(df_darugha.dtypes)\n",
    "print(\"\\nMissing values per column:\")\n",
    "print(df_darugha.isnull().sum())\n",
    "print(\"\\nMissing values percentage:\")\n",
    "print((df_darugha.isnull().sum() / len(df_darugha)) * 100)\n",
    "\n",
    "print(\"\\n\" + \"=\"*50)\n",
    "print(\"=== HAWKARI DATAFRAME ===\")\n",
    "print(\"Shape:\", df_hawkari.shape)\n",
    "print(\"\\nData types:\")\n",
    "print(df_hawkari.dtypes)\n",
    "print(\"\\nMissing values per column:\")\n",
    "print(df_hawkari.isnull().sum())\n",
    "print(\"\\nMissing values percentage:\")\n",
    "print((df_hawkari.isnull().sum() / len(df_hawkari)) * 100)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "1f83e9b2",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "=== BIOLAB RESULT COLUMN ANALYSIS ===\n",
      "Total records: 84179\n",
      "Unique result values: 8638\n",
      "Numeric values: 71495 (84.9%)\n",
      "String/Text values: 12684 (15.1%)\n",
      "\n",
      "Sample numeric values:\n",
      "['95', '86', '84', '84', '96', '157', '106', '88', '86', '95']\n",
      "\n",
      "Sample string values:\n",
      "Result\n",
      "Attached         2886\n",
      "attached         1865\n",
      "Negative  -Ve    1005\n",
      "attach            982\n",
      "Negative -Ve      645\n",
      "Negative          586\n",
      "<0.1              434\n",
      "<3                361\n",
      "Negative -ve      291\n",
      "Positive  +Ve     275\n",
      "Name: count, dtype: int64\n",
      "\n",
      "============================================================\n",
      "=== DARUGHA RESULT COLUMN ANALYSIS ===\n",
      "Total records: 2823\n",
      "Unique result values: 1896\n",
      "Numeric values: 2600 (92.1%)\n",
      "String/Text values: 223 (7.9%)\n",
      "\n",
      "Sample numeric values:\n",
      "['105.21', '98.05', '202.23', '87.91', '109.24', '92.54', '254.36', '442.4', '125.02', '94.61']\n",
      "\n",
      "Sample string values:\n",
      "Result\n",
      "Negative            180\n",
      "Negative (-ve)        7\n",
      "Positive              6\n",
      "negative              6\n",
      ">100.0                2\n",
      "Positive (+ve)        2\n",
      "O (positive) +ve      2\n",
      "A positive            2\n",
      "A (Positive) +ve      2\n",
      "O (Negative) -ve      2\n",
      "Name: count, dtype: int64\n",
      "\n",
      "============================================================\n",
      "=== HAWKARI RESULT COLUMN ANALYSIS ===\n",
      "Total records: 70383\n",
      "Unique result values: 4347\n",
      "Numeric values: 67035 (95.2%)\n",
      "String/Text values: 3348 (4.8%)\n",
      "\n",
      "Sample numeric values:\n",
      "['110', '91', '112', '138', '100', '100', '101', '272', '88', '106']\n",
      "\n",
      "Sample string values:\n",
      "Result\n",
      "Negative - ve    607\n",
      "< 0.1            431\n",
      "Negative -ve     303\n",
      "< 3              220\n",
      "2:00             101\n",
      "Positive + ve     98\n",
      "< 3.0             88\n",
      "O + ve            87\n",
      "A + ve            81\n",
      "Positive +ve      73\n",
      "Name: count, dtype: int64\n"
     ]
    }
   ],
   "source": [
    "# Analyze the Result column in each dataframe to understand numeric vs string values\n",
    "\n",
    "print(\"=== BIOLAB RESULT COLUMN ANALYSIS ===\")\n",
    "print(f\"Total records: {len(df_biolab)}\")\n",
    "print(f\"Unique result values: {df_biolab['Result'].nunique()}\")\n",
    "\n",
    "# Check data types in Result column\n",
    "biolab_numeric = pd.to_numeric(df_biolab['Result'], errors='coerce')\n",
    "biolab_numeric_count = biolab_numeric.notna().sum()\n",
    "biolab_string_count = len(df_biolab) - biolab_numeric_count\n",
    "\n",
    "print(f\"Numeric values: {biolab_numeric_count} ({biolab_numeric_count/len(df_biolab)*100:.1f}%)\")\n",
    "print(f\"String/Text values: {biolab_string_count} ({biolab_string_count/len(df_biolab)*100:.1f}%)\")\n",
    "\n",
    "print(\"\\nSample numeric values:\")\n",
    "print(df_biolab[biolab_numeric.notna()]['Result'].head(10).tolist())\n",
    "print(\"\\nSample string values:\")\n",
    "print(df_biolab[biolab_numeric.isna()]['Result'].value_counts().head(10))\n",
    "\n",
    "print(\"\\n\" + \"=\"*60)\n",
    "print(\"=== DARUGHA RESULT COLUMN ANALYSIS ===\")\n",
    "print(f\"Total records: {len(df_darugha)}\")\n",
    "print(f\"Unique result values: {df_darugha['Result'].nunique()}\")\n",
    "\n",
    "darugha_numeric = pd.to_numeric(df_darugha['Result'], errors='coerce')\n",
    "darugha_numeric_count = darugha_numeric.notna().sum()\n",
    "darugha_string_count = len(df_darugha) - darugha_numeric_count\n",
    "\n",
    "print(f\"Numeric values: {darugha_numeric_count} ({darugha_numeric_count/len(df_darugha)*100:.1f}%)\")\n",
    "print(f\"String/Text values: {darugha_string_count} ({darugha_string_count/len(df_darugha)*100:.1f}%)\")\n",
    "\n",
    "print(\"\\nSample numeric values:\")\n",
    "print(df_darugha[darugha_numeric.notna()]['Result'].head(10).tolist())\n",
    "print(\"\\nSample string values:\")\n",
    "print(df_darugha[darugha_numeric.isna()]['Result'].value_counts().head(10))\n",
    "\n",
    "print(\"\\n\" + \"=\"*60)\n",
    "print(\"=== HAWKARI RESULT COLUMN ANALYSIS ===\")\n",
    "print(f\"Total records: {len(df_hawkari)}\")\n",
    "print(f\"Unique result values: {df_hawkari['Result'].nunique()}\")\n",
    "\n",
    "hawkari_numeric = pd.to_numeric(df_hawkari['Result'], errors='coerce')\n",
    "hawkari_numeric_count = hawkari_numeric.notna().sum()\n",
    "hawkari_string_count = len(df_hawkari) - hawkari_numeric_count\n",
    "\n",
    "print(f\"Numeric values: {hawkari_numeric_count} ({hawkari_numeric_count/len(df_hawkari)*100:.1f}%)\")\n",
    "print(f\"String/Text values: {hawkari_string_count} ({hawkari_string_count/len(df_hawkari)*100:.1f}%)\")\n",
    "\n",
    "print(\"\\nSample numeric values:\")\n",
    "print(df_hawkari[hawkari_numeric.notna()]['Result'].head(10).tolist())\n",
    "print(\"\\nSample string values:\")\n",
    "print(df_hawkari[hawkari_numeric.isna()]['Result'].value_counts().head(10))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "75a231c0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Creating unique test groups for each dataframe...\n",
      "=== BIOLAB UNIQUE GROUPS ===\n",
      "Total unique combinations: 181\n",
      "            Test Name   Unit       Category     Lab\n",
      "0         Blood Sugar  mg/dl  Diabetes Test  Biolab\n",
      "1               HBA1C      %  Diabetes Test  Biolab\n",
      "2             Insulin  IU/Ml  Diabetes Test  Biolab\n",
      "3  Fastin Blood Sugar  mg/dl           OGTT  Biolab\n",
      "4                1 hr  mg/dl           OGTT  Biolab\n",
      "5                2 hr  mg/dl           OGTT  Biolab\n",
      "6         Typhoid IgG    NaN  Serology Test  Biolab\n",
      "7         Typhoid IgM    NaN  Serology Test  Biolab\n",
      "8                 CRP    NaN  Serology Test  Biolab\n",
      "9         H.Pylori Ab    NaN  Serology Test  Biolab\n",
      "\n",
      "=== DARUGHA UNIQUE GROUPS ===\n",
      "Total unique combinations: 39\n",
      "          Test Name    Unit               Category      Lab\n",
      "0           Glucose   mg/dl          Diabetes Test  Darugha\n",
      "1             HBA1C       %          Diabetes Test  Darugha\n",
      "2       Typhoid IgG     NaN          Serology Test  Darugha\n",
      "3       Typhoid IgM     NaN          Serology Test  Darugha\n",
      "4               ASO     NaN          Serology Test  Darugha\n",
      "5                RF     NaN          Serology Test  Darugha\n",
      "6               TSH  µIU/ML  Thyroid Function Test  Darugha\n",
      "7   Free T3 ( FT3 )  pmol/L  Thyroid Function Test  Darugha\n",
      "8   Free T4 ( FT4 )  pmol/L  Thyroid Function Test  Darugha\n",
      "9  Total Cholestrol   mg/dl         Lipid Profile   Darugha\n",
      "\n",
      "=== HAWKARI UNIQUE GROUPS ===\n",
      "Total unique combinations: 161\n",
      "               Test Name   Unit       Category      Lab\n",
      "0            Blood Sugar  mg/dl  Diabetes Test  Hawkari\n",
      "1                  HBA1C      %  Diabetes Test  Hawkari\n",
      "2                   1 hr   mg/l           OGTT  Hawkari\n",
      "3                   2 hr  mg/dl           OGTT  Hawkari\n",
      "4            Typhoid IgG    NaN  Serology Test  Hawkari\n",
      "5            Typhoid IgM    NaN  Serology Test  Hawkari\n",
      "6               Brucella    NaN  Serology Test  Hawkari\n",
      "7                    ASO    NaN  Serology Test  Hawkari\n",
      "8                     RF    NaN  Serology Test  Hawkari\n",
      "9  Pregnancy Test (BHCG)    NaN  Serology Test  Hawkari\n",
      "\n",
      "=== ALL LABS COMBINED UNIQUE GROUPS ===\n",
      "Total unique combinations across all labs: 381\n",
      "Global unique combinations (no duplicates): 271\n",
      "\n",
      "Sample of all unique groups:\n",
      "                Test Name   Unit       Category     Lab\n",
      "0             Blood Sugar  mg/dl  Diabetes Test  Biolab\n",
      "1                   HBA1C      %  Diabetes Test  Biolab\n",
      "2                 Insulin  IU/Ml  Diabetes Test  Biolab\n",
      "3      Fastin Blood Sugar  mg/dl           OGTT  Biolab\n",
      "4                    1 hr  mg/dl           OGTT  Biolab\n",
      "5                    2 hr  mg/dl           OGTT  Biolab\n",
      "6             Typhoid IgG    NaN  Serology Test  Biolab\n",
      "7             Typhoid IgM    NaN  Serology Test  Biolab\n",
      "8                     CRP    NaN  Serology Test  Biolab\n",
      "9             H.Pylori Ab    NaN  Serology Test  Biolab\n",
      "10               Brucella    NaN  Serology Test  Biolab\n",
      "11                    ASO    NaN  Serology Test  Biolab\n",
      "12                     RA    NaN  Serology Test  Biolab\n",
      "13                     RF    NaN  Serology Test  Biolab\n",
      "14  Pregnancy Test (BHCG)    NaN  Serology Test  Biolab\n",
      "\n",
      "=== STATISTICS ===\n",
      "Biolab unique test-unit-category combinations: 181\n",
      "Darugha unique test-unit-category combinations: 39\n",
      "Hawkari unique test-unit-category combinations: 161\n",
      "Total when combined: 381\n",
      "Global unique (deduplicated): 271\n"
     ]
    }
   ],
   "source": [
    "# Get unique combinations of Test Name, Unit, and Category for each dataframe\n",
    "print(\"Creating unique test groups for each dataframe...\")\n",
    "\n",
    "# Biolab unique groups\n",
    "biolab_unique_groups = df_biolab[['Test Name', 'Unit', 'Category']].drop_duplicates().reset_index(drop=True)\n",
    "biolab_unique_groups['Lab'] = 'Biolab'\n",
    "\n",
    "# Darugha unique groups\n",
    "darugha_unique_groups = df_darugha[['Test Name', 'Unit', 'Category']].drop_duplicates().reset_index(drop=True)\n",
    "darugha_unique_groups['Lab'] = 'Darugha'\n",
    "\n",
    "# Hawkari unique groups\n",
    "hawkari_unique_groups = df_hawkari[['Test Name', 'Unit', 'Category']].drop_duplicates().reset_index(drop=True)\n",
    "hawkari_unique_groups['Lab'] = 'Hawkari'\n",
    "\n",
    "print(\"=== BIOLAB UNIQUE GROUPS ===\")\n",
    "print(f\"Total unique combinations: {len(biolab_unique_groups)}\")\n",
    "print(biolab_unique_groups.head(10))\n",
    "\n",
    "print(\"\\n=== DARUGHA UNIQUE GROUPS ===\")\n",
    "print(f\"Total unique combinations: {len(darugha_unique_groups)}\")\n",
    "print(darugha_unique_groups.head(10))\n",
    "\n",
    "print(\"\\n=== HAWKARI UNIQUE GROUPS ===\")\n",
    "print(f\"Total unique combinations: {len(hawkari_unique_groups)}\")\n",
    "print(hawkari_unique_groups.head(10))\n",
    "\n",
    "# Combine all unique groups into one dataframe\n",
    "all_unique_groups = pd.concat([biolab_unique_groups, darugha_unique_groups, hawkari_unique_groups], \n",
    "                              ignore_index=True)\n",
    "\n",
    "print(f\"\\n=== ALL LABS COMBINED UNIQUE GROUPS ===\")\n",
    "print(f\"Total unique combinations across all labs: {len(all_unique_groups)}\")\n",
    "\n",
    "# Get truly unique combinations across all labs (removing duplicates)\n",
    "global_unique_groups = all_unique_groups[['Test Name', 'Unit', 'Category']].drop_duplicates().reset_index(drop=True)\n",
    "print(f\"Global unique combinations (no duplicates): {len(global_unique_groups)}\")\n",
    "\n",
    "# Show sample of combined data\n",
    "print(\"\\nSample of all unique groups:\")\n",
    "print(all_unique_groups.head(15))\n",
    "\n",
    "# Show some statistics\n",
    "print(f\"\\n=== STATISTICS ===\")\n",
    "print(f\"Biolab unique test-unit-category combinations: {len(biolab_unique_groups)}\")\n",
    "print(f\"Darugha unique test-unit-category combinations: {len(darugha_unique_groups)}\")\n",
    "print(f\"Hawkari unique test-unit-category combinations: {len(hawkari_unique_groups)}\")\n",
    "print(f\"Total when combined: {len(all_unique_groups)}\")\n",
    "print(f\"Global unique (deduplicated): {len(global_unique_groups)}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "e3e21a77",
   "metadata": {},
   "outputs": [],
   "source": [
    "all_unique_groups.to_csv('processed_data/all_unique_test_unit_category_combinations.csv', index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "3c97aac5",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total Unique Test Names before standardizing test names:\n",
      "231\n",
      "Total Unique Test Names in standard names file USING CHATGPT:\n",
      "215\n"
     ]
    }
   ],
   "source": [
    "df_std_test_names_chatgpt = pd.read_csv('processed_data/tests_with_standard_names_chatgpt.csv', encoding='latin-1')\n",
    "print(f\"Total Unique Test Names before standardizing test names:\")\n",
    "print(df_std_test_names_chatgpt['Test Name'].nunique())\n",
    "\n",
    "print(f\"Total Unique Test Names in standard names file USING CHATGPT:\")\n",
    "print(df_std_test_names_chatgpt['Standard Test Name'].nunique())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "8088163f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total Unique Test Names before standardizing test names:\n",
      "231\n",
      "Total Unique Test Names in standard names file USING DEEPSEEK:\n",
      "213\n"
     ]
    }
   ],
   "source": [
    "df_std_test_names_deepseek = pd.read_csv('processed_data/tests_with_standard_names_deepseek.csv', encoding='latin-1')\n",
    "print(f\"Total Unique Test Names before standardizing test names:\")\n",
    "print(df_std_test_names_deepseek['Test Name'].nunique())\n",
    "\n",
    "print(f\"Total Unique Test Names in standard names file USING DEEPSEEK:\")\n",
    "print(df_std_test_names_deepseek['Standard Test Name'].nunique())"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "46314d5a",
   "metadata": {},
   "source": [
    "**WE GO WITH DEEPSEEK**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "161ce3b0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Created mapping dictionary with 381 entries\n",
      "Adding Standard Test Name column to Biolab dataframe...\n",
      "Adding Standard Test Name column to Darugha dataframe...\n",
      "Adding Standard Test Name column to Hawkari dataframe...\n",
      "Standard Test Name columns added successfully!\n",
      "\n",
      "=== BIOLAB STANDARDIZATION RESULTS ===\n",
      "Total records: 84179\n",
      "Unique original test names: 168\n",
      "Unique standard test names: 173\n",
      "Reduction: -5 test names\n",
      "\n",
      "=== DARUGHA STANDARDIZATION RESULTS ===\n",
      "Total records: 2823\n",
      "Unique original test names: 39\n",
      "Unique standard test names: 39\n",
      "Reduction: 0 test names\n",
      "\n",
      "=== HAWKARI STANDARDIZATION RESULTS ===\n",
      "Total records: 70383\n",
      "Unique original test names: 156\n",
      "Unique standard test names: 157\n",
      "Reduction: -1 test names\n",
      "\n",
      "=== SAMPLE STANDARDIZATION RESULTS ===\n",
      "Biolab sample:\n",
      "     Test Name Standard Test Name       Category   Unit\n",
      "0  Blood Sugar        Blood Sugar  Diabetes Test  mg/dl\n",
      "1  Blood Sugar        Blood Sugar  Diabetes Test  mg/dl\n",
      "2  Blood Sugar        Blood Sugar  Diabetes Test  mg/dl\n",
      "3  Blood Sugar        Blood Sugar  Diabetes Test  mg/dl\n",
      "4  Blood Sugar        Blood Sugar  Diabetes Test  mg/dl\n",
      "\n",
      "Darugha sample:\n",
      "  Test Name Standard Test Name       Category   Unit\n",
      "0   Glucose            Glucose  Diabetes Test  mg/dl\n",
      "1   Glucose            Glucose  Diabetes Test  mg/dl\n",
      "2   Glucose            Glucose  Diabetes Test  mg/dl\n",
      "3   Glucose            Glucose  Diabetes Test  mg/dl\n",
      "4   Glucose            Glucose  Diabetes Test  mg/dl\n",
      "\n",
      "Hawkari sample:\n",
      "     Test Name Standard Test Name       Category   Unit\n",
      "0  Blood Sugar      Blood Glucose  Diabetes Test  mg/dl\n",
      "1  Blood Sugar      Blood Glucose  Diabetes Test  mg/dl\n",
      "2  Blood Sugar      Blood Glucose  Diabetes Test  mg/dl\n",
      "3  Blood Sugar      Blood Glucose  Diabetes Test  mg/dl\n",
      "4  Blood Sugar      Blood Glucose  Diabetes Test  mg/dl\n"
     ]
    }
   ],
   "source": [
    "# Create a mapping dictionary from df_std_test_names_deepseek\n",
    "mapping_dict = {}\n",
    "for _, row in df_std_test_names_deepseek.iterrows():\n",
    "    key = (row['Test Name'], row['Unit'] if pd.notna(row['Unit']) else None, row['Category'], row['Lab'])\n",
    "    mapping_dict[key] = row['Standard Test Name']\n",
    "\n",
    "print(f\"Created mapping dictionary with {len(mapping_dict)} entries\")\n",
    "\n",
    "# Function to get standard test name\n",
    "def get_standard_test_name(row, lab_name):\n",
    "    key = (row['Test Name'], row['Unit'] if pd.notna(row['Unit']) else None, row['Category'], lab_name)\n",
    "    return mapping_dict.get(key, row['Test Name'])  # Return original if no match found\n",
    "\n",
    "# Add Standard Test Name column to each dataframe\n",
    "print(\"Adding Standard Test Name column to Biolab dataframe...\")\n",
    "df_biolab['Standard Test Name'] = df_biolab.apply(lambda row: get_standard_test_name(row, 'Biolab'), axis=1)\n",
    "\n",
    "print(\"Adding Standard Test Name column to Darugha dataframe...\")\n",
    "df_darugha['Standard Test Name'] = df_darugha.apply(lambda row: get_standard_test_name(row, 'Darugha'), axis=1)\n",
    "\n",
    "print(\"Adding Standard Test Name column to Hawkari dataframe...\")\n",
    "df_hawkari['Standard Test Name'] = df_hawkari.apply(lambda row: get_standard_test_name(row, 'Hawkari'), axis=1)\n",
    "\n",
    "print(\"Standard Test Name columns added successfully!\")\n",
    "\n",
    "# Show statistics\n",
    "print(f\"\\n=== BIOLAB STANDARDIZATION RESULTS ===\")\n",
    "print(f\"Total records: {len(df_biolab)}\")\n",
    "print(f\"Unique original test names: {df_biolab['Test Name'].nunique()}\")\n",
    "print(f\"Unique standard test names: {df_biolab['Standard Test Name'].nunique()}\")\n",
    "reduction_biolab = df_biolab['Test Name'].nunique() - df_biolab['Standard Test Name'].nunique()\n",
    "print(f\"Reduction: {reduction_biolab} test names\")\n",
    "\n",
    "print(f\"\\n=== DARUGHA STANDARDIZATION RESULTS ===\")\n",
    "print(f\"Total records: {len(df_darugha)}\")\n",
    "print(f\"Unique original test names: {df_darugha['Test Name'].nunique()}\")\n",
    "print(f\"Unique standard test names: {df_darugha['Standard Test Name'].nunique()}\")\n",
    "reduction_darugha = df_darugha['Test Name'].nunique() - df_darugha['Standard Test Name'].nunique()\n",
    "print(f\"Reduction: {reduction_darugha} test names\")\n",
    "\n",
    "print(f\"\\n=== HAWKARI STANDARDIZATION RESULTS ===\")\n",
    "print(f\"Total records: {len(df_hawkari)}\")\n",
    "print(f\"Unique original test names: {df_hawkari['Test Name'].nunique()}\")\n",
    "print(f\"Unique standard test names: {df_hawkari['Standard Test Name'].nunique()}\")\n",
    "reduction_hawkari = df_hawkari['Test Name'].nunique() - df_hawkari['Standard Test Name'].nunique()\n",
    "print(f\"Reduction: {reduction_hawkari} test names\")\n",
    "\n",
    "# Show sample results\n",
    "print(\"\\n=== SAMPLE STANDARDIZATION RESULTS ===\")\n",
    "print(\"Biolab sample:\")\n",
    "print(df_biolab[['Test Name', 'Standard Test Name', 'Category', 'Unit']].head())\n",
    "print(\"\\nDarugha sample:\")\n",
    "print(df_darugha[['Test Name', 'Standard Test Name', 'Category', 'Unit']].head())\n",
    "print(\"\\nHawkari sample:\")\n",
    "print(df_hawkari[['Test Name', 'Standard Test Name', 'Category', 'Unit']].head())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "id": "9b6c9117",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Column names after renaming:\n",
      "Biolab columns: ['Sample ID', 'Patient Name', 'Gender', 'DOB', 'Test Name', 'Unit', 'Category', 'Result', 'DOS', 'Standard Test Name']\n",
      "Darugha columns: ['Sample ID', 'Patient Name', 'Gender', 'DOB', 'Test Name', 'Unit', 'Category', 'Result', 'DOS', 'Standard Test Name']\n",
      "Hawkari columns: ['Sample ID', 'Patient Name', 'Gender', 'DOB', 'Test Name', 'Unit', 'Category', 'Result', 'DOS', 'Standard Test Name']\n",
      "Combined dataframe shape: (157385, 11)\n",
      "Total records: 157,385\n",
      "\n",
      "Records by lab:\n",
      "Lab\n",
      "Biolab     84179\n",
      "Hawkari    70383\n",
      "Darugha     2823\n",
      "Name: count, dtype: int64\n",
      "\n",
      "Columns in combined dataframe:\n",
      "['Sample ID', 'Patient Name', 'Gender', 'DOB', 'Test Name', 'Unit', 'Category', 'Result', 'DOS', 'Standard Test Name', 'Lab']\n",
      "\n",
      "Sample of combined data:\n",
      "   Sample ID              Patient Name  Gender         DOB    Test Name  \\\n",
      "0        118        Xalil Ahmad Mhamad    Male  16/04/1959  Blood Sugar   \n",
      "1        126                 Dyar Omar    Male  16/04/1986  Blood Sugar   \n",
      "2        132         Fatah Mhamad Qadr    Male  16/04/1970  Blood Sugar   \n",
      "3        177         Sesna Qubad Anwar  Female  17/04/1973  Blood Sugar   \n",
      "4        179  Bayan Abdulla Abdurahman  Female  17/04/1981  Blood Sugar   \n",
      "\n",
      "    Unit       Category Result         DOS Standard Test Name     Lab  \n",
      "0  mg/dl  Diabetes Test     95  16/04/2023        Blood Sugar  Biolab  \n",
      "1  mg/dl  Diabetes Test     86  16/04/2023        Blood Sugar  Biolab  \n",
      "2  mg/dl  Diabetes Test     84  16/04/2023        Blood Sugar  Biolab  \n",
      "3  mg/dl  Diabetes Test     84  17/04/2023        Blood Sugar  Biolab  \n",
      "4  mg/dl  Diabetes Test     96  17/04/2023        Blood Sugar  Biolab  \n"
     ]
    }
   ],
   "source": [
    "# Drop the Outcome and Outcome_original columns from each dataframe\n",
    "df_biolab_clean = df_biolab.drop(['Outcome', 'Outcome_original'], axis=1)\n",
    "df_darugha_clean = df_darugha.drop(['Outcome', 'Outcome_original'], axis=1)\n",
    "df_hawkari_clean = df_hawkari.drop(['Outcome', 'Outcome_original'], axis=1)\n",
    "# Rename columns: Date of Sample\\n to DOS and Date of Birth to DOB\n",
    "df_biolab_clean = df_biolab_clean.rename(columns={\n",
    "    'Date of Sample\\n': 'DOS',\n",
    "    'Date of Birth': 'DOB'\n",
    "})\n",
    "\n",
    "df_darugha_clean = df_darugha_clean.rename(columns={\n",
    "    'Date of Sample\\r\\n': 'DOS',\n",
    "    'Date of Birth': 'DOB'\n",
    "})\n",
    "\n",
    "df_hawkari_clean = df_hawkari_clean.rename(columns={\n",
    "    'Date of Sample\\r\\n': 'DOS',\n",
    "    'Date of Birth': 'DOB'\n",
    "})\n",
    "\n",
    "print(\"Column names after renaming:\")\n",
    "print(f\"Biolab columns: {df_biolab_clean.columns.tolist()}\")\n",
    "print(f\"Darugha columns: {df_darugha_clean.columns.tolist()}\")\n",
    "print(f\"Hawkari columns: {df_hawkari_clean.columns.tolist()}\")\n",
    "\n",
    "# Add a source lab column to identify which lab each record came from\n",
    "df_biolab_clean['Lab'] = 'Biolab'\n",
    "df_darugha_clean['Lab'] = 'Darugha'\n",
    "df_hawkari_clean['Lab'] = 'Hawkari'\n",
    "\n",
    "# Combine all three dataframes into one\n",
    "df_combined = pd.concat([df_biolab_clean, df_darugha_clean, df_hawkari_clean], \n",
    "                       ignore_index=True)\n",
    "\n",
    "print(f\"Combined dataframe shape: {df_combined.shape}\")\n",
    "print(f\"Total records: {len(df_combined):,}\")\n",
    "print(f\"\\nRecords by lab:\")\n",
    "print(df_combined['Lab'].value_counts())\n",
    "print(f\"\\nColumns in combined dataframe:\")\n",
    "print(df_combined.columns.tolist())\n",
    "print(f\"\\nSample of combined data:\")\n",
    "print(df_combined.head())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "id": "119ff6c1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Sample ID</th>\n",
       "      <th>Patient Name</th>\n",
       "      <th>Gender</th>\n",
       "      <th>DOB</th>\n",
       "      <th>Test Name</th>\n",
       "      <th>Unit</th>\n",
       "      <th>Category</th>\n",
       "      <th>Result</th>\n",
       "      <th>DOS</th>\n",
       "      <th>Standard Test Name</th>\n",
       "      <th>Lab</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>118</td>\n",
       "      <td>Xalil Ahmad Mhamad</td>\n",
       "      <td>Male</td>\n",
       "      <td>16/04/1959</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>95</td>\n",
       "      <td>16/04/2023</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>Biolab</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>126</td>\n",
       "      <td>Dyar Omar</td>\n",
       "      <td>Male</td>\n",
       "      <td>16/04/1986</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>86</td>\n",
       "      <td>16/04/2023</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>Biolab</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>132</td>\n",
       "      <td>Fatah Mhamad Qadr</td>\n",
       "      <td>Male</td>\n",
       "      <td>16/04/1970</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>84</td>\n",
       "      <td>16/04/2023</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>Biolab</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>177</td>\n",
       "      <td>Sesna Qubad Anwar</td>\n",
       "      <td>Female</td>\n",
       "      <td>17/04/1973</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>84</td>\n",
       "      <td>17/04/2023</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>Biolab</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>179</td>\n",
       "      <td>Bayan Abdulla Abdurahman</td>\n",
       "      <td>Female</td>\n",
       "      <td>17/04/1981</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>96</td>\n",
       "      <td>17/04/2023</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>Biolab</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Sample ID              Patient Name  Gender         DOB    Test Name  \\\n",
       "0        118        Xalil Ahmad Mhamad    Male  16/04/1959  Blood Sugar   \n",
       "1        126                 Dyar Omar    Male  16/04/1986  Blood Sugar   \n",
       "2        132         Fatah Mhamad Qadr    Male  16/04/1970  Blood Sugar   \n",
       "3        177         Sesna Qubad Anwar  Female  17/04/1973  Blood Sugar   \n",
       "4        179  Bayan Abdulla Abdurahman  Female  17/04/1981  Blood Sugar   \n",
       "\n",
       "    Unit       Category Result         DOS Standard Test Name     Lab  \n",
       "0  mg/dl  Diabetes Test     95  16/04/2023        Blood Sugar  Biolab  \n",
       "1  mg/dl  Diabetes Test     86  16/04/2023        Blood Sugar  Biolab  \n",
       "2  mg/dl  Diabetes Test     84  16/04/2023        Blood Sugar  Biolab  \n",
       "3  mg/dl  Diabetes Test     84  17/04/2023        Blood Sugar  Biolab  \n",
       "4  mg/dl  Diabetes Test     96  17/04/2023        Blood Sugar  Biolab  "
      ]
     },
     "execution_count": 57,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_combined.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "id": "94853193",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "================================================================================\n",
      "COMPREHENSIVE DATA INSIGHTS FOR df_combined\n",
      "================================================================================\n",
      "\n",
      "1. BASIC INFORMATION\n",
      "   Shape: (157385, 11)\n",
      "   Total records: 157,385\n",
      "   Total columns: 11\n",
      "\n",
      "2. MEMORY USAGE\n",
      "   Memory usage: 89.61 MB\n",
      "\n",
      "3. DATA TYPES\n",
      "Sample ID              int64\n",
      "Patient Name          object\n",
      "Gender                object\n",
      "DOB                   object\n",
      "Test Name             object\n",
      "Unit                  object\n",
      "Category              object\n",
      "Result                object\n",
      "DOS                   object\n",
      "Standard Test Name    object\n",
      "Lab                   object\n",
      "dtype: object\n",
      "\n",
      "4. NULL VALUES ANALYSIS\n",
      "            Column  Null_Count  Null_Percentage  Non_Null_Count\n",
      "         Sample ID           0         0.000000          157385\n",
      "      Patient Name           0         0.000000          157385\n",
      "            Gender           0         0.000000          157385\n",
      "               DOB           0         0.000000          157385\n",
      "         Test Name           0         0.000000          157385\n",
      "              Unit       15564         9.889125          141821\n",
      "          Category           0         0.000000          157385\n",
      "            Result           0         0.000000          157385\n",
      "               DOS           0         0.000000          157385\n",
      "Standard Test Name           0         0.000000          157385\n",
      "               Lab           0         0.000000          157385\n",
      "\n",
      "5. RECORDS BY LAB\n",
      "   Biolab: 84,179 records (53.5%)\n",
      "   Hawkari: 70,383 records (44.7%)\n",
      "   Darugha: 2,823 records (1.8%)\n",
      "\n",
      "6. GENDER DISTRIBUTION\n",
      "   Female: 99,584 records (63.3%)\n",
      "   Male: 57,777 records (36.7%)\n",
      "   Child: 24 records (0.0%)\n",
      "\n",
      "7. TEST CATEGORIES ANALYSIS\n",
      "   Total unique categories: 50\n",
      "   Top 10 categories:\n",
      "    1. Lipid Profile : 17,609 (11.2%)\n",
      "    2. Diabetes Test: 17,580 (11.2%)\n",
      "    3. Viral Test: 15,035 (9.6%)\n",
      "    4. Thyroid Function Test: 14,930 (9.5%)\n",
      "    5. Renal Function Test: 13,865 (8.8%)\n",
      "    6. Liver Function Test: 12,266 (7.8%)\n",
      "    7. Heamatology Test: 11,100 (7.1%)\n",
      "    8. Vitamins Test: 8,261 (5.2%)\n",
      "    9. Biochemical Test: 8,155 (5.2%)\n",
      "   10. Iron Profile: 6,392 (4.1%)\n",
      "\n",
      "8. TEST NAMES ANALYSIS\n",
      "   Original test names: 231\n",
      "   Standard test names: 216\n",
      "   Standardization reduced by: 15 test names\n",
      "\n",
      "9. UNITS ANALYSIS\n",
      "   Total unique units: 37\n",
      "   Records with missing units: 15,564 (9.9%)\n",
      "   Top 10 units:\n",
      "    1. mg/dl: 53,011 (33.7%)\n",
      "    2. COI: 14,913 (9.5%)\n",
      "    3. ng/ml: 14,519 (9.2%)\n",
      "    4. µIU/ML: 12,468 (7.9%)\n",
      "    5. %: 9,136 (5.8%)\n",
      "    6. mg/l: 6,479 (4.1%)\n",
      "    7. U/L: 4,063 (2.6%)\n",
      "    8. µg/dl: 3,764 (2.4%)\n",
      "    9. mIU/ml: 3,542 (2.3%)\n",
      "   10. mm/1hr: 3,283 (2.1%)\n",
      "\n",
      "10. RESULTS ANALYSIS\n",
      "    Numeric results: 141,130 (89.7%)\n",
      "    Text/String results: 16,255 (10.3%)\n",
      "\n",
      "    Sample text results (top 10):\n",
      "    'Attached': 2,887\n",
      "    'attached': 1,865\n",
      "    'Negative  -Ve': 1,005\n",
      "    'attach': 982\n",
      "    'Negative': 781\n",
      "    '< 0.1': 653\n",
      "    'Negative -Ve': 648\n",
      "    'Negative - ve': 607\n",
      "    'Negative -ve': 594\n",
      "    '<0.1': 451\n",
      "\n",
      "11. DATE ANALYSIS\n",
      "    DOB (Date of Birth) - Sample values:\n",
      "    ['16/04/1959', '16/04/1986', '16/04/1970', '17/04/1973', '17/04/1981']\n",
      "    DOS (Date of Sample) - Sample values:\n",
      "    ['16/04/2023', '16/04/2023', '16/04/2023', '17/04/2023', '17/04/2023']\n",
      "\n",
      "12. SAMPLE ID ANALYSIS\n",
      "    Unique sample IDs: 35,383\n",
      "    Total records: 157,385\n",
      "    Average tests per sample: 4.4\n",
      "\n",
      "13. DUPLICATE ANALYSIS\n",
      "    Complete duplicate rows: 1\n",
      "    Potential duplicates (same Sample ID, Test Name, DOS): 2\n",
      "\n",
      "14. TOP 15 STANDARD TEST NAMES\n",
      "     1. TSH: 12,468 (7.9%)\n",
      "     2. Serum Creatinine: 9,276 (5.9%)\n",
      "     3. Blood Glucose: 8,983 (5.7%)\n",
      "     4. Vitamin D3: 6,847 (4.4%)\n",
      "     5. Complete Blood Count: 6,165 (3.9%)\n",
      "     6. C-Reactive Protein Titer: 6,024 (3.8%)\n",
      "     7. HbA1c: 5,093 (3.2%)\n",
      "     8. Total Serum Bilirubin: 5,029 (3.2%)\n",
      "     9. Hepatitis B Surface Antigen: 5,028 (3.2%)\n",
      "    10. Hepatitis C Antibody: 5,010 (3.2%)\n",
      "    11. HIV Antibody: 5,003 (3.2%)\n",
      "    12. Blood Urea Nitrogen: 3,882 (2.5%)\n",
      "    13. Packed Cell Volume: 3,866 (2.5%)\n",
      "    14. Serum Triglycerides: 3,670 (2.3%)\n",
      "    15. Serum Ferritin: 3,574 (2.3%)\n",
      "\n",
      "15. DATA QUALITY SUMMARY\n",
      "    ✓ No missing values in: Sample ID, Patient Name, Gender, DOB, Test Name, Category, Result, DOS, Standard Test Name, Lab\n",
      "    ⚠ Missing values in: Unit (15,564 records, 9.9%)\n",
      "    ✓ All labs represented: Biolab, Darugha, Hawkari\n",
      "    ✓ Both genders represented: Male, Female, Child\n",
      "    ✓ Wide variety of tests: 216 standardized test types\n",
      "\n",
      "================================================================================\n",
      "ANALYSIS COMPLETE\n",
      "================================================================================\n"
     ]
    }
   ],
   "source": [
    "# Comprehensive data insights for df_combined dataframe\n",
    "print(\"=\"*80)\n",
    "print(\"COMPREHENSIVE DATA INSIGHTS FOR df_combined\")\n",
    "print(\"=\"*80)\n",
    "\n",
    "# Basic information\n",
    "print(f\"\\n1. BASIC INFORMATION\")\n",
    "print(f\"   Shape: {df_combined.shape}\")\n",
    "print(f\"   Total records: {len(df_combined):,}\")\n",
    "print(f\"   Total columns: {len(df_combined.columns)}\")\n",
    "\n",
    "# Memory usage\n",
    "print(f\"\\n2. MEMORY USAGE\")\n",
    "print(f\"   Memory usage: {df_combined.memory_usage(deep=True).sum() / 1024**2:.2f} MB\")\n",
    "\n",
    "# Data types\n",
    "print(f\"\\n3. DATA TYPES\")\n",
    "print(df_combined.dtypes)\n",
    "\n",
    "# Null values analysis\n",
    "print(f\"\\n4. NULL VALUES ANALYSIS\")\n",
    "null_counts = df_combined.isnull().sum()\n",
    "null_percentages = (null_counts / len(df_combined)) * 100\n",
    "\n",
    "null_analysis = pd.DataFrame({\n",
    "    'Column': df_combined.columns,\n",
    "    'Null_Count': null_counts.values,\n",
    "    'Null_Percentage': null_percentages.values,\n",
    "    'Non_Null_Count': len(df_combined) - null_counts.values\n",
    "})\n",
    "\n",
    "print(null_analysis.to_string(index=False))\n",
    "\n",
    "# Records by lab distribution\n",
    "print(f\"\\n5. RECORDS BY LAB\")\n",
    "lab_distribution = df_combined['Lab'].value_counts()\n",
    "lab_percentages = (lab_distribution / len(df_combined)) * 100\n",
    "\n",
    "for lab, count in lab_distribution.items():\n",
    "    percentage = lab_percentages[lab]\n",
    "    print(f\"   {lab}: {count:,} records ({percentage:.1f}%)\")\n",
    "\n",
    "# Gender distribution\n",
    "print(f\"\\n6. GENDER DISTRIBUTION\")\n",
    "gender_distribution = df_combined['Gender'].value_counts()\n",
    "gender_percentages = (gender_distribution / len(df_combined)) * 100\n",
    "\n",
    "for gender, count in gender_distribution.items():\n",
    "    percentage = gender_percentages[gender]\n",
    "    print(f\"   {gender}: {count:,} records ({percentage:.1f}%)\")\n",
    "\n",
    "# Categories analysis\n",
    "print(f\"\\n7. TEST CATEGORIES ANALYSIS\")\n",
    "category_distribution = df_combined['Category'].value_counts()\n",
    "print(f\"   Total unique categories: {df_combined['Category'].nunique()}\")\n",
    "print(f\"   Top 10 categories:\")\n",
    "for i, (category, count) in enumerate(category_distribution.head(10).items(), 1):\n",
    "    percentage = (count / len(df_combined)) * 100\n",
    "    print(f\"   {i:2d}. {category}: {count:,} ({percentage:.1f}%)\")\n",
    "\n",
    "# Test names analysis\n",
    "print(f\"\\n8. TEST NAMES ANALYSIS\")\n",
    "print(f\"   Original test names: {df_combined['Test Name'].nunique():,}\")\n",
    "print(f\"   Standard test names: {df_combined['Standard Test Name'].nunique():,}\")\n",
    "test_reduction = df_combined['Test Name'].nunique() - df_combined['Standard Test Name'].nunique()\n",
    "print(f\"   Standardization reduced by: {test_reduction} test names\")\n",
    "\n",
    "# Units analysis\n",
    "print(f\"\\n9. UNITS ANALYSIS\")\n",
    "print(f\"   Total unique units: {df_combined['Unit'].nunique()}\")\n",
    "print(f\"   Records with missing units: {df_combined['Unit'].isnull().sum():,} ({(df_combined['Unit'].isnull().sum()/len(df_combined)*100):.1f}%)\")\n",
    "\n",
    "unit_distribution = df_combined['Unit'].value_counts()\n",
    "print(f\"   Top 10 units:\")\n",
    "for i, (unit, count) in enumerate(unit_distribution.head(10).items(), 1):\n",
    "    percentage = (count / len(df_combined)) * 100\n",
    "    print(f\"   {i:2d}. {unit}: {count:,} ({percentage:.1f}%)\")\n",
    "\n",
    "# Results analysis - numeric vs text\n",
    "print(f\"\\n10. RESULTS ANALYSIS\")\n",
    "# Try to convert results to numeric\n",
    "numeric_results = pd.to_numeric(df_combined['Result'], errors='coerce')\n",
    "numeric_count = numeric_results.notna().sum()\n",
    "text_count = len(df_combined) - numeric_count\n",
    "\n",
    "print(f\"    Numeric results: {numeric_count:,} ({numeric_count/len(df_combined)*100:.1f}%)\")\n",
    "print(f\"    Text/String results: {text_count:,} ({text_count/len(df_combined)*100:.1f}%)\")\n",
    "\n",
    "# Sample text results\n",
    "print(f\"\\n    Sample text results (top 10):\")\n",
    "text_results = df_combined[numeric_results.isna()]['Result'].value_counts().head(10)\n",
    "for result, count in text_results.items():\n",
    "    print(f\"    '{result}': {count:,}\")\n",
    "\n",
    "# Date analysis\n",
    "print(f\"\\n11. DATE ANALYSIS\")\n",
    "print(f\"    DOB (Date of Birth) - Sample values:\")\n",
    "print(f\"    {df_combined['DOB'].head().tolist()}\")\n",
    "print(f\"    DOS (Date of Sample) - Sample values:\")\n",
    "print(f\"    {df_combined['DOS'].head().tolist()}\")\n",
    "\n",
    "# Sample ID analysis\n",
    "print(f\"\\n12. SAMPLE ID ANALYSIS\")\n",
    "print(f\"    Unique sample IDs: {df_combined['Sample ID'].nunique():,}\")\n",
    "print(f\"    Total records: {len(df_combined):,}\")\n",
    "print(f\"    Average tests per sample: {len(df_combined) / df_combined['Sample ID'].nunique():.1f}\")\n",
    "\n",
    "# Check for duplicates\n",
    "print(f\"\\n13. DUPLICATE ANALYSIS\")\n",
    "duplicate_rows = df_combined.duplicated().sum()\n",
    "print(f\"    Complete duplicate rows: {duplicate_rows:,}\")\n",
    "\n",
    "# Check for potential duplicates based on key columns\n",
    "potential_duplicates = df_combined.duplicated(subset=['Sample ID', 'Test Name', 'DOS']).sum()\n",
    "print(f\"    Potential duplicates (same Sample ID, Test Name, DOS): {potential_duplicates:,}\")\n",
    "\n",
    "# Standard test names distribution\n",
    "print(f\"\\n14. TOP 15 STANDARD TEST NAMES\")\n",
    "std_test_distribution = df_combined['Standard Test Name'].value_counts().head(15)\n",
    "for i, (test, count) in enumerate(std_test_distribution.items(), 1):\n",
    "    percentage = (count / len(df_combined)) * 100\n",
    "    print(f\"    {i:2d}. {test}: {count:,} ({percentage:.1f}%)\")\n",
    "\n",
    "# Data quality summary\n",
    "print(f\"\\n15. DATA QUALITY SUMMARY\")\n",
    "print(f\"    ✓ No missing values in: Sample ID, Patient Name, Gender, DOB, Test Name, Category, Result, DOS, Standard Test Name, Lab\")\n",
    "print(f\"    ⚠ Missing values in: Unit ({df_combined['Unit'].isnull().sum():,} records, {(df_combined['Unit'].isnull().sum()/len(df_combined)*100):.1f}%)\")\n",
    "print(f\"    ✓ All labs represented: {', '.join(df_combined['Lab'].unique())}\")\n",
    "print(f\"    ✓ Both genders represented: {', '.join(df_combined['Gender'].unique())}\")\n",
    "print(f\"    ✓ Wide variety of tests: {df_combined['Standard Test Name'].nunique():,} standardized test types\")\n",
    "\n",
    "print(f\"\\n\" + \"=\"*80)\n",
    "print(\"ANALYSIS COMPLETE\")\n",
    "print(\"=\"*80)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "7fbfdc0b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Removing records with Gender = 'Child'\n",
      "Original shape: (157385, 11)\n",
      "Updated shape: (157361, 11)\n",
      "Updated gender distribution:\n",
      "Gender\n",
      "Female    99584\n",
      "Male      57777\n",
      "Name: count, dtype: int64\n"
     ]
    }
   ],
   "source": [
    "# Removing Gender = 'Child'\n",
    "\n",
    "print(\"Removing records with Gender = 'Child'\")\n",
    "print(f\"Original shape: {df_combined.shape}\")\n",
    "df_combined = df_combined[df_combined['Gender'] != 'Child'].copy()\n",
    "\n",
    "# Display the updated dataframe information\n",
    "print(f\"Updated shape: {df_combined.shape}\")\n",
    "print(\"Updated gender distribution:\")\n",
    "print(df_combined['Gender'].value_counts())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "id": "2fa76476",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting date components from DOB and DOS...\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1800x1200 with 6 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== DATE ANALYSIS SUMMARY (Sample of 10000 records) ===\n",
      "\n",
      "DATE OF BIRTH (DOB) ANALYSIS:\n",
      "Valid DOB extractions: 9999/10000 (100.0%)\n",
      "DOB Year range: 1928 - 2046\n",
      "Most common DOB month: 5.0\n",
      "Most common DOB day: 24.0\n",
      "\n",
      "DATE OF SAMPLE (DOS) ANALYSIS:\n",
      "Valid DOS extractions: 10000/10000 (100.0%)\n",
      "DOS Year range: 2023 - 2025\n",
      "Most common DOS month: 7\n",
      "Most common DOS day: 24\n",
      "\n",
      "=== SAMPLE OF EXTRACTED DATES ===\n",
      "          DOB         DOS  DOB_Year  DOB_Month  DOB_Day  DOS_Year  DOS_Month  \\\n",
      "0  16/04/1959  16/04/2023    1959.0        4.0     16.0      2023          4   \n",
      "1  16/04/1986  16/04/2023    1986.0        4.0     16.0      2023          4   \n",
      "2  16/04/1970  16/04/2023    1970.0        4.0     16.0      2023          4   \n",
      "3  17/04/1973  17/04/2023    1973.0        4.0     17.0      2023          4   \n",
      "4  17/04/1981  17/04/2023    1981.0        4.0     17.0      2023          4   \n",
      "5  17/04/1966  17/04/2023    1966.0        4.0     17.0      2023          4   \n",
      "6  17/04/1969  17/04/2023    1969.0        4.0     17.0      2023          4   \n",
      "7  17/04/1967  17/04/2023    1967.0        4.0     17.0      2023          4   \n",
      "8  17/04/1983  17/04/2023    1983.0        4.0     17.0      2023          4   \n",
      "9  17/04/1980  17/04/2023    1980.0        4.0     17.0      2023          4   \n",
      "\n",
      "   DOS_Day  \n",
      "0       16  \n",
      "1       16  \n",
      "2       16  \n",
      "3       17  \n",
      "4       17  \n",
      "5       17  \n",
      "6       17  \n",
      "7       17  \n",
      "8       17  \n",
      "9       17  \n"
     ]
    }
   ],
   "source": [
    "# Extract year, month, and day from DOB and DOS columns for histogram analysis\n",
    "\n",
    "def extract_date_components(date_string):\n",
    "    \"\"\"Extract year, month, day from various date formats\"\"\"\n",
    "    if pd.isna(date_string):\n",
    "        return None, None, None\n",
    "    \n",
    "    date_str = str(date_string).strip()\n",
    "    \n",
    "    # Try splitting by '/' first (most common format)\n",
    "    if '/' in date_str:\n",
    "        parts = date_str.split('/')\n",
    "        if len(parts) == 3:\n",
    "            try:\n",
    "                day = int(parts[0])\n",
    "                month = int(parts[1])\n",
    "                year = int(parts[2])\n",
    "                \n",
    "                # Convert 2-digit years to 4-digit\n",
    "                if year < 100:\n",
    "                    if year > 50:  # Assume 1950-1999\n",
    "                        year += 1900\n",
    "                    else:  # Assume 2000-2050\n",
    "                        year += 2000\n",
    "                \n",
    "                # Validate ranges\n",
    "                if 1 <= day <= 31 and 1 <= month <= 12 and 1900 <= year <= 2100:\n",
    "                    return year, month, day\n",
    "            except ValueError:\n",
    "                pass\n",
    "    \n",
    "    # Try splitting by '-' as fallback\n",
    "    if '-' in date_str:\n",
    "        parts = date_str.split('-')\n",
    "        if len(parts) == 3:\n",
    "            try:\n",
    "                # Try dd-mm-yyyy format first\n",
    "                day = int(parts[0])\n",
    "                month = int(parts[1])\n",
    "                year = int(parts[2])\n",
    "                \n",
    "                # Convert 2-digit years to 4-digit\n",
    "                if year < 100:\n",
    "                    if year > 50:\n",
    "                        year += 1900\n",
    "                    else:\n",
    "                        year += 2000\n",
    "                \n",
    "                if 1 <= day <= 31 and 1 <= month <= 12 and 1900 <= year <= 2100:\n",
    "                    return year, month, day\n",
    "                    \n",
    "                # Try yyyy-mm-dd format if dd-mm-yyyy fails\n",
    "                year = int(parts[0])\n",
    "                month = int(parts[1])\n",
    "                day = int(parts[2])\n",
    "                \n",
    "                if 1900 <= year <= 2100 and 1 <= month <= 12 and 1 <= day <= 31:\n",
    "                    return year, month, day\n",
    "            except ValueError:\n",
    "                pass\n",
    "    \n",
    "    return None, None, None\n",
    "\n",
    "# Extract date components for both DOB and DOS\n",
    "print(\"Extracting date components from DOB and DOS...\")\n",
    "\n",
    "# Sample a subset for processing (you can remove this to process all data)\n",
    "sample_size = min(10000, len(df_combined))  # Process first 10k records for speed\n",
    "df_sample = df_combined.head(sample_size).copy()\n",
    "\n",
    "# Extract DOB components\n",
    "dob_components = df_sample['DOB'].apply(extract_date_components)\n",
    "df_sample['DOB_Year'] = [comp[0] for comp in dob_components]\n",
    "df_sample['DOB_Month'] = [comp[1] for comp in dob_components]\n",
    "df_sample['DOB_Day'] = [comp[2] for comp in dob_components]\n",
    "\n",
    "# Extract DOS components\n",
    "dos_components = df_sample['DOS'].apply(extract_date_components)\n",
    "df_sample['DOS_Year'] = [comp[0] for comp in dos_components]\n",
    "df_sample['DOS_Month'] = [comp[1] for comp in dos_components]\n",
    "df_sample['DOS_Day'] = [comp[2] for comp in dos_components]\n",
    "\n",
    "# Create histograms\n",
    "fig, axes = plt.subplots(2, 3, figsize=(18, 12))\n",
    "fig.suptitle('Date Component Histograms: DOB and DOS Analysis', fontsize=16, fontweight='bold')\n",
    "\n",
    "# DOB Year histogram\n",
    "axes[0, 0].hist(df_sample['DOB_Year'].dropna(), bins=30, alpha=0.7, color='skyblue', edgecolor='black')\n",
    "axes[0, 0].set_title('Date of Birth - Years Distribution')\n",
    "axes[0, 0].set_xlabel('Year')\n",
    "axes[0, 0].set_ylabel('Frequency')\n",
    "axes[0, 0].grid(True, alpha=0.3)\n",
    "\n",
    "# DOB Month histogram\n",
    "axes[0, 1].hist(df_sample['DOB_Month'].dropna(), bins=12, alpha=0.7, color='lightgreen', edgecolor='black')\n",
    "axes[0, 1].set_title('Date of Birth - Months Distribution')\n",
    "axes[0, 1].set_xlabel('Month')\n",
    "axes[0, 1].set_ylabel('Frequency')\n",
    "axes[0, 1].set_xticks(range(1, 13))\n",
    "axes[0, 1].grid(True, alpha=0.3)\n",
    "\n",
    "# DOB Day histogram\n",
    "axes[0, 2].hist(df_sample['DOB_Day'].dropna(), bins=31, alpha=0.7, color='lightcoral', edgecolor='black')\n",
    "axes[0, 2].set_title('Date of Birth - Days Distribution')\n",
    "axes[0, 2].set_xlabel('Day')\n",
    "axes[0, 2].set_ylabel('Frequency')\n",
    "axes[0, 2].grid(True, alpha=0.3)\n",
    "\n",
    "# DOS Year histogram\n",
    "axes[1, 0].hist(df_sample['DOS_Year'].dropna(), bins=20, alpha=0.7, color='gold', edgecolor='black')\n",
    "axes[1, 0].set_title('Date of Sample - Years Distribution')\n",
    "axes[1, 0].set_xlabel('Year')\n",
    "axes[1, 0].set_ylabel('Frequency')\n",
    "axes[1, 0].grid(True, alpha=0.3)\n",
    "\n",
    "# DOS Month histogram\n",
    "axes[1, 1].hist(df_sample['DOS_Month'].dropna(), bins=12, alpha=0.7, color='plum', edgecolor='black')\n",
    "axes[1, 1].set_title('Date of Sample - Months Distribution')\n",
    "axes[1, 1].set_xlabel('Month')\n",
    "axes[1, 1].set_ylabel('Frequency')\n",
    "axes[1, 1].set_xticks(range(1, 13))\n",
    "axes[1, 1].grid(True, alpha=0.3)\n",
    "\n",
    "# DOS Day histogram\n",
    "axes[1, 2].hist(df_sample['DOS_Day'].dropna(), bins=31, alpha=0.7, color='orange', edgecolor='black')\n",
    "axes[1, 2].set_title('Date of Sample - Days Distribution')\n",
    "axes[1, 2].set_xlabel('Day')\n",
    "axes[1, 2].set_ylabel('Frequency')\n",
    "axes[1, 2].grid(True, alpha=0.3)\n",
    "\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# Print summary statistics\n",
    "print(f\"\\n=== DATE ANALYSIS SUMMARY (Sample of {sample_size} records) ===\")\n",
    "print(f\"\\nDATE OF BIRTH (DOB) ANALYSIS:\")\n",
    "print(f\"Valid DOB extractions: {df_sample['DOB_Year'].notna().sum()}/{len(df_sample)} ({df_sample['DOB_Year'].notna().sum()/len(df_sample)*100:.1f}%)\")\n",
    "print(f\"DOB Year range: {df_sample['DOB_Year'].min():.0f} - {df_sample['DOB_Year'].max():.0f}\")\n",
    "print(f\"Most common DOB month: {df_sample['DOB_Month'].mode().iloc[0] if len(df_sample['DOB_Month'].mode()) > 0 else 'N/A'}\")\n",
    "print(f\"Most common DOB day: {df_sample['DOB_Day'].mode().iloc[0] if len(df_sample['DOB_Day'].mode()) > 0 else 'N/A'}\")\n",
    "\n",
    "print(f\"\\nDATE OF SAMPLE (DOS) ANALYSIS:\")\n",
    "print(f\"Valid DOS extractions: {df_sample['DOS_Year'].notna().sum()}/{len(df_sample)} ({df_sample['DOS_Year'].notna().sum()/len(df_sample)*100:.1f}%)\")\n",
    "print(f\"DOS Year range: {df_sample['DOS_Year'].min():.0f} - {df_sample['DOS_Year'].max():.0f}\")\n",
    "print(f\"Most common DOS month: {df_sample['DOS_Month'].mode().iloc[0] if len(df_sample['DOS_Month'].mode()) > 0 else 'N/A'}\")\n",
    "print(f\"Most common DOS day: {df_sample['DOS_Day'].mode().iloc[0] if len(df_sample['DOS_Day'].mode()) > 0 else 'N/A'}\")\n",
    "\n",
    "# Show sample of extracted dates\n",
    "print(f\"\\n=== SAMPLE OF EXTRACTED DATES ===\")\n",
    "sample_dates = df_sample[['DOB', 'DOS', 'DOB_Year', 'DOB_Month', 'DOB_Day', 'DOS_Year', 'DOS_Month', 'DOS_Day']].head(10)\n",
    "print(sample_dates)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "82b9632f",
   "metadata": {},
   "source": [
    "**NORMAL DISTRIBUTION OBSERVED OF YEAR, MONTH, AND DAY IN DOS AND DOS**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "id": "96e2fae1",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Calculating age using extracted date components...\n",
      "\n",
      "=== AGE CALCULATION RESULTS ===\n",
      "Successfully calculated age for: 157,321 records (100.0%)\n",
      "Failed to calculate age for: 40 records (0.0%)\n",
      "\n",
      "=== AGE STATISTICS ===\n",
      "Minimum age: -69 years\n",
      "Maximum age: 106 years\n",
      "Mean age: 39.0 years\n",
      "Median age: 39.0 years\n",
      "\n",
      "=== SAMPLE DATA WITH AGES ===\n",
      "   Sample ID              Patient Name  Gender         DOB         DOS   Age  \\\n",
      "0        118        Xalil Ahmad Mhamad    Male  16/04/1959  16/04/2023  64.0   \n",
      "1        126                 Dyar Omar    Male  16/04/1986  16/04/2023  37.0   \n",
      "2        132         Fatah Mhamad Qadr    Male  16/04/1970  16/04/2023  53.0   \n",
      "3        177         Sesna Qubad Anwar  Female  17/04/1973  17/04/2023  50.0   \n",
      "4        179  Bayan Abdulla Abdurahman  Female  17/04/1981  17/04/2023  42.0   \n",
      "5        182         Xarman Ali Mhamad  Female  17/04/1966  17/04/2023  57.0   \n",
      "6        185         Bahar Ali Shawaes  Female  17/04/1969  17/04/2023  54.0   \n",
      "7        192        Ahoo Aziz Kakamand  Female  17/04/1967  17/04/2023  56.0   \n",
      "8        200  Hataw Nasraden Hamatofeq  Female  17/04/1983  17/04/2023  40.0   \n",
      "9        201      Halmat Shawkat Karem    Male  17/04/1980  17/04/2023  43.0   \n",
      "\n",
      "      Lab  \n",
      "0  Biolab  \n",
      "1  Biolab  \n",
      "2  Biolab  \n",
      "3  Biolab  \n",
      "4  Biolab  \n",
      "5  Biolab  \n",
      "6  Biolab  \n",
      "7  Biolab  \n",
      "8  Biolab  \n",
      "9  Biolab  \n",
      "\n",
      "=== AGE DISTRIBUTION CHECKS ===\n",
      "Ages below 0: 79\n",
      "Ages above 120: 0\n",
      "Ages 0-1 years: 6509\n",
      "Ages 1-18 years: 17060\n",
      "Ages 18-65 years: 115856\n",
      "Ages above 65 years: 17817\n",
      "\n",
      "=== UPDATED DATAFRAME INFO ===\n",
      "Shape: (157361, 12)\n",
      "New column added: Age\n"
     ]
    }
   ],
   "source": [
    "# Function to convert date string to datetime\n",
    "def parse_date(date_str):\n",
    "    \"\"\"Parse date string in dd/mm/yyyy format to datetime\"\"\"\n",
    "    if pd.isna(date_str):\n",
    "        return pd.NaT\n",
    "    \n",
    "    date_str = str(date_str).strip()\n",
    "    \n",
    "    # Try different date formats for dd/mm/yyyy\n",
    "    formats = ['%d/%m/%Y', '%d/%m/%y', '%d-%m-%Y', '%d-%m-%y']\n",
    "    \n",
    "    for fmt in formats:\n",
    "        try:\n",
    "            parsed_date = pd.to_datetime(date_str, format=fmt)\n",
    "            # Convert 2-digit years to appropriate 4-digit years\n",
    "            if parsed_date.year < 1950:\n",
    "                parsed_date = parsed_date.replace(year=parsed_date.year + 100)\n",
    "            return parsed_date\n",
    "        except ValueError:\n",
    "            continue\n",
    "    \n",
    "    # If all formats fail, try pandas automatic parsing with dayfirst=True\n",
    "    try:\n",
    "        return pd.to_datetime(date_str, dayfirst=True)\n",
    "    except:\n",
    "        return pd.NaT\n",
    "\n",
    "# Calculate age using the extracted date components (more reliable than datetime parsing)\n",
    "print(\"Calculating age using extracted date components...\")\n",
    "\n",
    "def calculate_age_from_components(dob_str, dos_str):\n",
    "    \"\"\"Calculate age using date components without datetime conversion\"\"\"\n",
    "    dob_year, dob_month, dob_day = extract_date_components(dob_str)\n",
    "    dos_year, dos_month, dos_day = extract_date_components(dos_str)\n",
    "    \n",
    "    if any(x is None for x in [dob_year, dob_month, dob_day, dos_year, dos_month, dos_day]):\n",
    "        return None\n",
    "    \n",
    "    # Calculate age in years\n",
    "    age = dos_year - dob_year\n",
    "    \n",
    "    # Adjust if birthday hasn't occurred yet this year\n",
    "    if dos_month < dob_month or (dos_month == dob_month and dos_day < dob_day):\n",
    "        age -= 1\n",
    "    \n",
    "    return age\n",
    "\n",
    "# Apply age calculation to the combined dataframe\n",
    "df_combined['Age'] = df_combined.apply(\n",
    "    lambda row: calculate_age_from_components(row['DOB'], row['DOS']), \n",
    "    axis=1\n",
    ")\n",
    "\n",
    "# Display statistics\n",
    "print(f\"\\n=== AGE CALCULATION RESULTS ===\")\n",
    "print(f\"Successfully calculated age for: {df_combined['Age'].notna().sum():,} records ({df_combined['Age'].notna().sum()/len(df_combined)*100:.1f}%)\")\n",
    "print(f\"Failed to calculate age for: {df_combined['Age'].isna().sum():,} records ({df_combined['Age'].isna().sum()/len(df_combined)*100:.1f}%)\")\n",
    "\n",
    "# Age statistics\n",
    "print(f\"\\n=== AGE STATISTICS ===\")\n",
    "print(f\"Minimum age: {df_combined['Age'].min():.0f} years\")\n",
    "print(f\"Maximum age: {df_combined['Age'].max():.0f} years\")\n",
    "print(f\"Mean age: {df_combined['Age'].mean():.1f} years\")\n",
    "print(f\"Median age: {df_combined['Age'].median():.1f} years\")\n",
    "\n",
    "# Show sample with calculated ages\n",
    "print(f\"\\n=== SAMPLE DATA WITH AGES ===\")\n",
    "sample_cols = ['Sample ID', 'Patient Name', 'Gender', 'DOB', 'DOS', 'Age', 'Lab']\n",
    "print(df_combined[sample_cols].head(10))\n",
    "\n",
    "# Check for any unusual ages\n",
    "print(f\"\\n=== AGE DISTRIBUTION CHECKS ===\")\n",
    "print(f\"Ages below 0: {(df_combined['Age'] < 0).sum()}\")\n",
    "print(f\"Ages above 120: {(df_combined['Age'] > 120).sum()}\")\n",
    "print(f\"Ages 0-1 years: {((df_combined['Age'] >= 0) & (df_combined['Age'] <= 1)).sum()}\")\n",
    "print(f\"Ages 1-18 years: {((df_combined['Age'] > 1) & (df_combined['Age'] <= 18)).sum()}\")\n",
    "print(f\"Ages 18-65 years: {((df_combined['Age'] > 18) & (df_combined['Age'] <= 65)).sum()}\")\n",
    "print(f\"Ages above 65 years: {(df_combined['Age'] > 65).sum()}\")\n",
    "\n",
    "# Show updated dataframe info\n",
    "print(f\"\\n=== UPDATED DATAFRAME INFO ===\")\n",
    "print(f\"Shape: {df_combined.shape}\")\n",
    "print(f\"New column added: Age\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "id": "d8a12bd5",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "=== DETAILED AGE ANALYSIS FOR STRANGE PATTERNS ===\n",
      "Total records with calculated ages: 157,321\n",
      "Records without ages: 40\n",
      "\n",
      "1. NEGATIVE AGES (Born after sample date): 79 records\n",
      "Sample negative age records:\n",
      "       Sample ID                   Patient Name         DOB         DOS   Age  \\\n",
      "450         6147           Mhamad Qadr Hamaamin    1/8/2037    1/8/2023 -14.0   \n",
      "3868       17923                ozra Abid Habib  13/04/2041  13/04/2024 -17.0   \n",
      "6259        6147           Mhamad Qadr Hamaamin    1/8/2037    1/8/2023 -14.0   \n",
      "6600        6147           Mhamad Qadr Hamaamin    1/8/2037    1/8/2023 -14.0   \n",
      "8770        6147           Mhamad Qadr Hamaamin    1/8/2037    1/8/2023 -14.0   \n",
      "9784         388            Abdulla Mstafa Marf  20/04/2046  20/04/2023 -23.0   \n",
      "10329       3742                Taliha Salh Ali  20/06/2045  20/06/2023 -22.0   \n",
      "10655       5813  Abdurahman Mahmood Abdurahman  25/07/2041  25/07/2023 -18.0   \n",
      "10714       6147           Mhamad Qadr Hamaamin    1/8/2037    1/8/2023 -14.0   \n",
      "11028       8140                      Atya Amin    6/9/2037    6/9/2023 -14.0   \n",
      "\n",
      "          Lab  \n",
      "450    Biolab  \n",
      "3868   Biolab  \n",
      "6259   Biolab  \n",
      "6600   Biolab  \n",
      "8770   Biolab  \n",
      "9784   Biolab  \n",
      "10329  Biolab  \n",
      "10655  Biolab  \n",
      "10714  Biolab  \n",
      "11028  Biolab  \n",
      "Age range: -69.0 to -1.0 years\n",
      "\n",
      "2. ZERO AGES (Same birth and sample year): 4,746 records\n",
      "Sample zero age records:\n",
      "    Sample ID          Patient Name         DOB         DOS  Age     Lab\n",
      "15        261  Darawan Bayar Saefwr  18/04/2023  18/04/2023  0.0  Biolab\n",
      "20        267     sozan hady mhamad  18/04/2023  18/04/2023  0.0  Biolab\n",
      "26        314           Suham Xalaf  19/04/2023  19/04/2023  0.0  Biolab\n",
      "36        350      Runak Mhamad Ali  19/04/2023  19/04/2023  0.0  Biolab\n",
      "37        351            Atya Karim  19/04/2023  19/04/2023  0.0  Biolab\n",
      "\n",
      "3. VERY OLD AGES (>100 years): 10 records\n",
      "Sample very old age records:\n",
      "       Sample ID           Patient Name         DOB         DOS    Age     Lab\n",
      "30475      38072  Amina Muhamad Mahmood  23/03/1919  23/03/2025  106.0  Biolab\n",
      "33184      38072  Amina Muhamad Mahmood  23/03/1919  23/03/2025  106.0  Biolab\n",
      "39379      26699      Fatma Ali Muhamad    4/9/1923    4/9/2024  101.0  Biolab\n",
      "50857      38072  Amina Muhamad Mahmood  23/03/1919  23/03/2025  106.0  Biolab\n",
      "53343      38072  Amina Muhamad Mahmood  23/03/1919  23/03/2025  106.0  Biolab\n",
      "55823      38072  Amina Muhamad Mahmood  23/03/1919  23/03/2025  106.0  Biolab\n",
      "65908      38072  Amina Muhamad Mahmood  23/03/1919  23/03/2025  106.0  Biolab\n",
      "68435      26699      Fatma Ali Muhamad    4/9/1923    4/9/2024  101.0  Biolab\n",
      "78977      26699      Fatma Ali Muhamad    4/9/1923    4/9/2024  101.0  Biolab\n",
      "80802      38072  Amina Muhamad Mahmood  23/03/1919  23/03/2025  106.0  Biolab\n",
      "Age range: 101.0 to 106.0 years\n",
      "\n",
      "4. SUSPICIOUSLY ROUND AGES (multiples of 5): 29,934 records (19.0%)\n",
      "\n",
      "5. VERY ELDERLY (>90 years): 450 records\n",
      "Sample very elderly records:\n",
      "      Sample ID            Patient Name         DOB         DOS   Age     Lab\n",
      "187        2291  Mahmood Abdulkarem Ali  27/05/1929  27/05/2023  94.0  Biolab\n",
      "2390      31484    Mhabat Asaad Mahmood  27/11/1931  27/11/2024  93.0  Biolab\n",
      "3223       6698        Raena Saeed Bawa   11/1/1928   11/8/2023  95.0  Biolab\n",
      "3398      10669      Aesha Mhamad Ahmad  31/10/1930  31/10/2023  93.0  Biolab\n",
      "4952      33702            Rostam Faraj    7/1/1930    7/1/2025  95.0  Biolab\n",
      "\n",
      "6. NEWBORNS AND INFANTS (0-2 years): 7,785 records\n",
      "Sample newborn/infant records:\n",
      "    Sample ID          Patient Name         DOB         DOS  Age     Lab\n",
      "15        261  Darawan Bayar Saefwr  18/04/2023  18/04/2023  0.0  Biolab\n",
      "20        267     sozan hady mhamad  18/04/2023  18/04/2023  0.0  Biolab\n",
      "26        314           Suham Xalaf  19/04/2023  19/04/2023  0.0  Biolab\n",
      "36        350      Runak Mhamad Ali  19/04/2023  19/04/2023  0.0  Biolab\n",
      "37        351            Atya Karim  19/04/2023  19/04/2023  0.0  Biolab\n",
      "\n",
      "7. AGE STATISTICS BY LAB:\n",
      "Biolab:\n",
      "  Count: 84,169\n",
      "  Mean: 37.3 years\n",
      "  Median: 37.0 years\n",
      "  Min: -69.0 years\n",
      "  Max: 106.0 years\n",
      "  Negative ages: 58\n",
      "Darugha:\n",
      "  Count: 2,820\n",
      "  Mean: 48.8 years\n",
      "  Median: 51.0 years\n",
      "  Min: 0.0 years\n",
      "  Max: 91.0 years\n",
      "  Negative ages: 0\n",
      "Hawkari:\n",
      "  Count: 70,332\n",
      "  Mean: 40.7 years\n",
      "  Median: 41.0 years\n",
      "  Min: -25.0 years\n",
      "  Max: 97.0 years\n",
      "  Negative ages: 21\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 2000x1200 with 6 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== ADDITIONAL STRANGE INSIGHTS ===\n",
      "Future sample dates (beyond 2025): 0\n",
      "People born in 2023-2025: 5449\n",
      "\n",
      "Age gap analysis:\n",
      "Most common age: 0 years (4746 people)\n",
      "Age with no records: Looking for gaps...\n",
      "Ages with no records: [-68, -67, -66, -65, -64, -63, -62, -61, -60, -59]...\n",
      "\n",
      "=== GENDER DISTRIBUTION BY AGE GROUPS ===\n",
      "Children/Teens (0-18): 22,003 people\n",
      "  Female: 11,784 (53.6%)\n",
      "  Male: 10,219 (46.4%)\n",
      "Young Adults (18-35): 40,884 people\n",
      "  Female: 29,239 (71.5%)\n",
      "  Male: 11,645 (28.5%)\n",
      "Middle-aged (35-50): 49,060 people\n",
      "  Female: 31,967 (65.2%)\n",
      "  Male: 17,093 (34.8%)\n",
      "Pre-elderly (50-65): 26,306 people\n",
      "  Female: 15,651 (59.5%)\n",
      "  Male: 10,655 (40.5%)\n",
      "Elderly (65-100): 18,978 people\n",
      "  Female: 10,879 (57.3%)\n",
      "  Male: 8,099 (42.7%)\n",
      "Very Elderly (100-150): 11 people\n",
      "  Female: 11 (100.0%)\n"
     ]
    }
   ],
   "source": [
    "# Analyze strange age patterns in detail\n",
    "print(\"=== DETAILED AGE ANALYSIS FOR STRANGE PATTERNS ===\")\n",
    "\n",
    "# Filter for records with calculated ages\n",
    "age_data = df_combined[df_combined['Age'].notna()].copy()\n",
    "\n",
    "print(f\"Total records with calculated ages: {len(age_data):,}\")\n",
    "print(f\"Records without ages: {df_combined['Age'].isna().sum():,}\")\n",
    "\n",
    "# 1. Negative ages (people born after sample date)\n",
    "negative_ages = age_data[age_data['Age'] < 0]\n",
    "print(f\"\\n1. NEGATIVE AGES (Born after sample date): {len(negative_ages):,} records\")\n",
    "if len(negative_ages) > 0:\n",
    "    print(\"Sample negative age records:\")\n",
    "    print(negative_ages[['Sample ID', 'Patient Name', 'DOB', 'DOS', 'Age', 'Lab']].head(10))\n",
    "    print(f\"Age range: {negative_ages['Age'].min():.1f} to {negative_ages['Age'].max():.1f} years\")\n",
    "\n",
    "# 2. Zero ages (born same year as sample)\n",
    "zero_ages = age_data[age_data['Age'] == 0]\n",
    "print(f\"\\n2. ZERO AGES (Same birth and sample year): {len(zero_ages):,} records\")\n",
    "if len(zero_ages) > 0:\n",
    "    print(\"Sample zero age records:\")\n",
    "    print(zero_ages[['Sample ID', 'Patient Name', 'DOB', 'DOS', 'Age', 'Lab']].head(5))\n",
    "\n",
    "# 3. Very old ages (potentially data entry errors)\n",
    "very_old = age_data[age_data['Age'] > 100]\n",
    "print(f\"\\n3. VERY OLD AGES (>100 years): {len(very_old):,} records\")\n",
    "if len(very_old) > 0:\n",
    "    print(\"Sample very old age records:\")\n",
    "    print(very_old[['Sample ID', 'Patient Name', 'DOB', 'DOS', 'Age', 'Lab']].head(10))\n",
    "    print(f\"Age range: {very_old['Age'].min():.1f} to {very_old['Age'].max():.1f} years\")\n",
    "\n",
    "# 4. Suspiciously round ages (might indicate approximations)\n",
    "round_ages = age_data[age_data['Age'].isin([25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100])]\n",
    "print(f\"\\n4. SUSPICIOUSLY ROUND AGES (multiples of 5): {len(round_ages):,} records ({len(round_ages)/len(age_data)*100:.1f}%)\")\n",
    "\n",
    "# 5. People over 90 years old\n",
    "very_elderly = age_data[age_data['Age'] > 90]\n",
    "print(f\"\\n5. VERY ELDERLY (>90 years): {len(very_elderly):,} records\")\n",
    "if len(very_elderly) > 0:\n",
    "    print(\"Sample very elderly records:\")\n",
    "    print(very_elderly[['Sample ID', 'Patient Name', 'DOB', 'DOS', 'Age', 'Lab']].head(5))\n",
    "\n",
    "# 6. Newborns and infants (0-2 years)\n",
    "newborns = age_data[(age_data['Age'] >= 0) & (age_data['Age'] <= 2)]\n",
    "print(f\"\\n6. NEWBORNS AND INFANTS (0-2 years): {len(newborns):,} records\")\n",
    "if len(newborns) > 0:\n",
    "    print(\"Sample newborn/infant records:\")\n",
    "    print(newborns[['Sample ID', 'Patient Name', 'DOB', 'DOS', 'Age', 'Lab']].head(5))\n",
    "\n",
    "# 7. Age distribution by lab\n",
    "print(f\"\\n7. AGE STATISTICS BY LAB:\")\n",
    "for lab in df_combined['Lab'].unique():\n",
    "    lab_ages = age_data[age_data['Lab'] == lab]['Age']\n",
    "    print(f\"{lab}:\")\n",
    "    print(f\"  Count: {len(lab_ages):,}\")\n",
    "    print(f\"  Mean: {lab_ages.mean():.1f} years\")\n",
    "    print(f\"  Median: {lab_ages.median():.1f} years\")\n",
    "    print(f\"  Min: {lab_ages.min():.1f} years\")\n",
    "    print(f\"  Max: {lab_ages.max():.1f} years\")\n",
    "    print(f\"  Negative ages: {(lab_ages < 0).sum()}\")\n",
    "\n",
    "# Create comprehensive age histograms\n",
    "fig, axes = plt.subplots(2, 3, figsize=(20, 12))\n",
    "fig.suptitle('Age Distribution Analysis: Strange Patterns and Insights', fontsize=16, fontweight='bold')\n",
    "\n",
    "# 1. Overall age distribution\n",
    "axes[0, 0].hist(age_data['Age'], bins=50, alpha=0.7, color='skyblue', edgecolor='black')\n",
    "axes[0, 0].set_title('Overall Age Distribution\\n(All Records)')\n",
    "axes[0, 0].set_xlabel('Age (years)')\n",
    "axes[0, 0].set_ylabel('Frequency')\n",
    "axes[0, 0].grid(True, alpha=0.3)\n",
    "axes[0, 0].axvline(0, color='red', linestyle='--', alpha=0.7, label='Age 0')\n",
    "axes[0, 0].axvline(100, color='orange', linestyle='--', alpha=0.7, label='Age 100')\n",
    "axes[0, 0].legend()\n",
    "\n",
    "# 2. Age distribution by lab\n",
    "for i, lab in enumerate(['Biolab', 'Darugha', 'Hawkari']):\n",
    "    lab_ages = age_data[age_data['Lab'] == lab]['Age']\n",
    "    if i == 0:\n",
    "        axes[0, 1].hist(lab_ages, bins=30, alpha=0.7, label=lab, color='lightcoral')\n",
    "    elif i == 1:\n",
    "        axes[0, 1].hist(lab_ages, bins=30, alpha=0.7, label=lab, color='lightgreen')\n",
    "    else:\n",
    "        axes[0, 1].hist(lab_ages, bins=30, alpha=0.7, label=lab, color='gold')\n",
    "\n",
    "axes[0, 1].set_title('Age Distribution by Lab')\n",
    "axes[0, 1].set_xlabel('Age (years)')\n",
    "axes[0, 1].set_ylabel('Frequency')\n",
    "axes[0, 1].legend()\n",
    "axes[0, 1].grid(True, alpha=0.3)\n",
    "\n",
    "# 3. Focus on strange ages (-10 to 120 years)\n",
    "strange_ages = age_data[(age_data['Age'] >= -10) & (age_data['Age'] <= 120)]\n",
    "axes[0, 2].hist(strange_ages['Age'], bins=60, alpha=0.7, color='lightpink', edgecolor='black')\n",
    "axes[0, 2].set_title('Strange Ages Focus\\n(-10 to 120 years)')\n",
    "axes[0, 2].set_xlabel('Age (years)')\n",
    "axes[0, 2].set_ylabel('Frequency')\n",
    "axes[0, 2].grid(True, alpha=0.3)\n",
    "axes[0, 2].axvline(0, color='red', linestyle='--', alpha=0.7, label='Age 0')\n",
    "axes[0, 2].axvline(100, color='orange', linestyle='--', alpha=0.7, label='Age 100')\n",
    "axes[0, 2].legend()\n",
    "\n",
    "# 4. Age distribution for children and young adults (0-25 years)\n",
    "young_ages = age_data[(age_data['Age'] >= 0) & (age_data['Age'] <= 25)]\n",
    "axes[1, 0].hist(young_ages['Age'], bins=25, alpha=0.7, color='lightgreen', edgecolor='black')\n",
    "axes[1, 0].set_title('Children and Young Adults\\n(0-25 years)')\n",
    "axes[1, 0].set_xlabel('Age (years)')\n",
    "axes[1, 0].set_ylabel('Frequency')\n",
    "axes[1, 0].grid(True, alpha=0.3)\n",
    "\n",
    "# 5. Age distribution for elderly (65+ years)\n",
    "elderly_ages = age_data[age_data['Age'] >= 65]\n",
    "axes[1, 1].hist(elderly_ages['Age'], bins=30, alpha=0.7, color='orange', edgecolor='black')\n",
    "axes[1, 1].set_title('Elderly Population\\n(65+ years)')\n",
    "axes[1, 1].set_xlabel('Age (years)')\n",
    "axes[1, 1].set_ylabel('Frequency')\n",
    "axes[1, 1].grid(True, alpha=0.3)\n",
    "\n",
    "# 6. Box plot showing age distribution and outliers\n",
    "age_data.boxplot(column='Age', by='Lab', ax=axes[1, 2])\n",
    "axes[1, 2].set_title('Age Distribution Box Plot by Lab\\n(Shows Outliers)')\n",
    "axes[1, 2].set_xlabel('Lab')\n",
    "axes[1, 2].set_ylabel('Age (years)')\n",
    "axes[1, 2].grid(True, alpha=0.3)\n",
    "\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# Additional insights\n",
    "print(f\"\\n=== ADDITIONAL STRANGE INSIGHTS ===\")\n",
    "\n",
    "# Check for impossible dates (future dates)\n",
    "current_year = 2025  # Based on the data, samples go up to 2025\n",
    "future_samples = age_data[age_data['DOS'].str.contains('2026|2027|2028', na=False)]\n",
    "print(f\"Future sample dates (beyond 2025): {len(future_samples)}\")\n",
    "\n",
    "# Check for people born in very recent years but with tests\n",
    "recent_births = age_data[age_data['DOB'].str.contains('2023|2024|2025', na=False)]\n",
    "print(f\"People born in 2023-2025: {len(recent_births)}\")\n",
    "\n",
    "# Age gaps analysis\n",
    "print(f\"\\nAge gap analysis:\")\n",
    "print(f\"Most common age: {age_data['Age'].mode().iloc[0]:.0f} years ({(age_data['Age'] == age_data['Age'].mode().iloc[0]).sum()} people)\")\n",
    "print(f\"Age with no records: Looking for gaps...\")\n",
    "\n",
    "# Find age gaps\n",
    "all_possible_ages = set(range(int(age_data['Age'].min()), int(age_data['Age'].max()) + 1))\n",
    "actual_ages = set(age_data['Age'].round().astype(int))\n",
    "missing_ages = sorted(all_possible_ages - actual_ages)\n",
    "if missing_ages:\n",
    "    print(f\"Ages with no records: {missing_ages[:10]}...\" if len(missing_ages) > 10 else f\"Ages with no records: {missing_ages}\")\n",
    "\n",
    "# Gender distribution by age groups\n",
    "print(f\"\\n=== GENDER DISTRIBUTION BY AGE GROUPS ===\")\n",
    "age_groups = [\n",
    "    (0, 18, \"Children/Teens\"),\n",
    "    (18, 35, \"Young Adults\"),\n",
    "    (35, 50, \"Middle-aged\"),\n",
    "    (50, 65, \"Pre-elderly\"),\n",
    "    (65, 100, \"Elderly\"),\n",
    "    (100, 150, \"Very Elderly\")\n",
    "]\n",
    "\n",
    "for min_age, max_age, group_name in age_groups:\n",
    "    group_data = age_data[(age_data['Age'] >= min_age) & (age_data['Age'] < max_age)]\n",
    "    if len(group_data) > 0:\n",
    "        gender_dist = group_data['Gender'].value_counts()\n",
    "        print(f\"{group_name} ({min_age}-{max_age}): {len(group_data):,} people\")\n",
    "        for gender, count in gender_dist.items():\n",
    "            print(f\"  {gender}: {count:,} ({count/len(group_data)*100:.1f}%)\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "643350da",
   "metadata": {},
   "source": [
    "***We are not focusing on Age so we keep the*** **outliers** ***for now***"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "id": "31ab7045",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Sample ID</th>\n",
       "      <th>Patient Name</th>\n",
       "      <th>Gender</th>\n",
       "      <th>DOB</th>\n",
       "      <th>Test Name</th>\n",
       "      <th>Unit</th>\n",
       "      <th>Category</th>\n",
       "      <th>Result</th>\n",
       "      <th>DOS</th>\n",
       "      <th>Standard Test Name</th>\n",
       "      <th>Lab</th>\n",
       "      <th>Age</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>118</td>\n",
       "      <td>Xalil Ahmad Mhamad</td>\n",
       "      <td>Male</td>\n",
       "      <td>16/04/1959</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>95</td>\n",
       "      <td>16/04/2023</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>Biolab</td>\n",
       "      <td>64.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>126</td>\n",
       "      <td>Dyar Omar</td>\n",
       "      <td>Male</td>\n",
       "      <td>16/04/1986</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>86</td>\n",
       "      <td>16/04/2023</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>Biolab</td>\n",
       "      <td>37.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>132</td>\n",
       "      <td>Fatah Mhamad Qadr</td>\n",
       "      <td>Male</td>\n",
       "      <td>16/04/1970</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>84</td>\n",
       "      <td>16/04/2023</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>Biolab</td>\n",
       "      <td>53.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>177</td>\n",
       "      <td>Sesna Qubad Anwar</td>\n",
       "      <td>Female</td>\n",
       "      <td>17/04/1973</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>84</td>\n",
       "      <td>17/04/2023</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>Biolab</td>\n",
       "      <td>50.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>179</td>\n",
       "      <td>Bayan Abdulla Abdurahman</td>\n",
       "      <td>Female</td>\n",
       "      <td>17/04/1981</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>96</td>\n",
       "      <td>17/04/2023</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>Biolab</td>\n",
       "      <td>42.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Sample ID              Patient Name  Gender         DOB    Test Name  \\\n",
       "0        118        Xalil Ahmad Mhamad    Male  16/04/1959  Blood Sugar   \n",
       "1        126                 Dyar Omar    Male  16/04/1986  Blood Sugar   \n",
       "2        132         Fatah Mhamad Qadr    Male  16/04/1970  Blood Sugar   \n",
       "3        177         Sesna Qubad Anwar  Female  17/04/1973  Blood Sugar   \n",
       "4        179  Bayan Abdulla Abdurahman  Female  17/04/1981  Blood Sugar   \n",
       "\n",
       "    Unit       Category Result         DOS Standard Test Name     Lab   Age  \n",
       "0  mg/dl  Diabetes Test     95  16/04/2023        Blood Sugar  Biolab  64.0  \n",
       "1  mg/dl  Diabetes Test     86  16/04/2023        Blood Sugar  Biolab  37.0  \n",
       "2  mg/dl  Diabetes Test     84  16/04/2023        Blood Sugar  Biolab  53.0  \n",
       "3  mg/dl  Diabetes Test     84  17/04/2023        Blood Sugar  Biolab  50.0  \n",
       "4  mg/dl  Diabetes Test     96  17/04/2023        Blood Sugar  Biolab  42.0  "
      ]
     },
     "execution_count": 67,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_combined.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "id": "874f9ce5",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Blood Sugar\n",
      "HbA1c\n",
      "Insulin\n",
      "Fasting Blood Sugar\n",
      "1-Hour Glucose\n",
      "2-Hour Glucose\n",
      "Typhoid IgG\n",
      "Typhoid IgM\n",
      "C-Reactive Protein\n",
      "Helicobacter pylori Antibody\n",
      "Brucella\n",
      "Anti-Streptolysin O\n",
      "Rheumatoid Arthritis\n",
      "Rheumatoid Factor\n",
      "Pregnancy Test (Beta-hCG)\n",
      "CA 125\n",
      "CA 19-9\n",
      "Alpha-Fetoprotein\n",
      "Carcinoembryonic Antigen\n",
      "Prostate-Specific Antigen\n",
      "CA 15-3\n",
      "Immunoglobulin E\n",
      "Triiodothyronine (T3)\n",
      "Thyroxine (T4)\n",
      "TSH\n",
      "Free T3\n",
      "Free T4\n",
      "Anti-Thyroid Peroxidase Antibody\n",
      "Anti-Thyroglobulin Antibody\n",
      "Tissue Transglutaminase IgA\n",
      "Tissue Transglutaminase IgG\n",
      "Anti-Endomysial Antibody IgG\n",
      "Anti-Endomysial Antibody IgA\n",
      "Anti-Gliadin Antibody IgA\n",
      "Anti-Gliadin Antibody IgG\n",
      "Serum Amylase\n",
      "Serum Lipase\n",
      "Serum Cholesterol\n",
      "Serum Triglycerides\n",
      "Serum HDL Cholesterol\n",
      "Serum LDL Cholesterol\n",
      "Blood Urea Nitrogen\n",
      "Serum Creatinine\n",
      "Serum Uric Acid\n",
      "Aspartate Aminotransferase (AST)\n",
      "Alanine Aminotransferase (ALT)\n",
      "Alkaline Phosphatase\n",
      "Total Serum Bilirubin\n",
      "Direct Bilirubin\n",
      "Indirect Bilirubin\n",
      "Serum Albumin\n",
      "Total Serum Protein\n",
      "S.Iron\n",
      "Serum Ferritin\n",
      "TIBC\n",
      "Vitamin B12\n",
      "Folate\n",
      "Vitamin D3\n",
      "Prothrombin Time\n",
      "International Normalized Ratio\n",
      "Partial Thromboplastin Time\n",
      "Clotting Time\n",
      "Bleeding Time\n",
      "Direct Coombs Test\n",
      "D-Dimer\n",
      "Lupus Anticoagulant\n",
      "Urea Breath Test\n",
      "Helicobacter pylori IgG\n",
      "Brucella IgG\n",
      "Brucella IgM\n",
      "Cytomegalovirus IgG\n",
      "Cytomegalovirus IgM\n",
      "Toxoplasma IgG\n",
      "Toxoplasma IgM\n",
      "Rubella IgG\n",
      "Rubella IgM\n",
      "Hepatitis B Surface Antigen\n",
      "Hepatitis C Antibody\n",
      "HIV Antibody\n",
      "Lactate Dehydrogenase\n",
      "Creatine Phosphokinase\n",
      "High-Sensitivity Troponin T\n",
      "Antinuclear Antibody\n",
      "Anti-Cyclic Citrullinated Peptide\n",
      "Anti-dsDNA IgG\n",
      "Anti-dsDNA IgM\n",
      "Rheumatoid Factor Titer\n",
      "Anti-SSA/Ro Antibody\n",
      "Fecal Calprotectein\n",
      "Sodium\n",
      "Potassium\n",
      "Chloride\n",
      "Serum Calcium\n",
      "COVID-19 Antigen\n",
      "COVID-19 IgG\n",
      "COVID-19 IgM\n",
      "COVID-19 Antigen Titer\n",
      "COVID-19 IgG Spike\n",
      "COVID-19 IgM Spike\n",
      "Packed Cell Volume\n",
      "White Blood Cell Count\n",
      "Erythrocyte Sedimentation Rate\n",
      "Blood Glucose\n",
      "Blood Group and Rh Factor\n",
      "Reticulocyte Count\n",
      "C-Reactive Protein Titer\n",
      "S.Zinc\n",
      "Serum Phosphorus\n",
      "Gamma-Glutamyl Transferase\n",
      "Anti-Streptolysin O Titer\n",
      "TSH Receptor Antibody\n",
      "Anti-Beta-2 Glycoprotein IgG\n",
      "Anti-Beta-2 Glycoprotein IgM\n",
      "Anti-Cardiolipin IgG\n",
      "Anti-Cardiolipin IgM\n",
      "Anti-Phospholipid IgG\n",
      "Anti-Phospholipid IgM\n",
      "Luteinizing Hormone\n",
      "Follicle-Stimulating Hormone\n",
      "Prolactin\n",
      "Beta-hCG Titer\n",
      "Anti-MÃ¼llerian Hormone\n",
      "Adrenocorticotropic Hormone\n",
      "Cortisol\n",
      "Estradiol (E2)\n",
      "Progesterone\n",
      "Testosterone\n",
      "DHEA - S\n",
      "Free Testosterone\n",
      "Insulin-like Growth Factor 1\n",
      "Parathyroid Hormone\n",
      "Potassium Hydroxide Test\n",
      "Glucose-6-Phosphate Dehydrogenase\n",
      "Procalcitonin\n",
      "Helicobacter pylori Antigen\n",
      "Complete Blood Count\n",
      "S.Copper ( Cu )\n",
      "Ceruloplasmin\n",
      "Fecal Occult Blood\n",
      "COVID-19 IgG Rapid Test\n",
      "COVID-19 IgM Rapid Test\n",
      "Urine Culture\n",
      "Serum Magnesium\n",
      "Serum VLDL Cholesterol\n",
      "Immunochemical Fecal Occult Blood\n",
      "Helicobacter pylori Antigen Titer\n",
      "Helicobacter pylori Antibody Titer\n",
      "Growth Hormone (Stimulation Test)\n",
      "Growth Hormone (Basal Level)\n",
      "Fecal Occult Blood Titer\n",
      "Fecal Calprotectein Titer\n",
      "Anti-Myeloperoxidase Antibody (p-ANCA)\n",
      "Anti-Proteinase 3 Antibody (c-ANCA)\n",
      "Urine Albumin (Spot)\n",
      "Urine Creatinine (Spot)\n",
      "Albumin-to-Creatinine Ratio\n",
      "Cytomegalovirus IgG Rapid Test\n",
      "Cytomegalovirus IgM Rapid Test\n",
      "Toxoplasma IgG Rapid Test\n",
      "Toxoplasma IgM Rapid Test\n",
      "Rubella IgG Rapid Test\n",
      "Rubella IgM Rapid Test\n",
      "Herpes Simplex Virus I IgG\n",
      "Herpes Simplex Virus I IgM\n",
      "24-Hour Urine Protein\n",
      "Urine Beta-hCG\n",
      "2-Hour Postprandial Glucose\n",
      "N-Terminal Pro-B-Type Natriuretic Peptide\n",
      "24-Hour Urine Calcium\n",
      "Gastrin\n",
      "IFOB Titer ( FIT )\n",
      "Transferrin Saturation\n",
      "UIBC\n",
      "Glucose\n",
      "Total Cholesterol\n",
      "Triglycerides\n",
      "HDL Cholesterol\n",
      "LDL Cholesterol\n",
      "Creatinine\n",
      "Helicobacter pylori Antigen Stool Test\n",
      "Helicobacter pylori Antibody Test\n",
      "Rose Bengal Test\n",
      "Immunoglobulin A\n",
      "Iron ( Total )\n",
      "Anti-SSB/La Antibody\n",
      "S.Zink\n",
      "Helicobacter pylori Antigen Stool Titer\n",
      "Stool For Calprotectin titer\n",
      "24-Hour Urine Volume\n",
      "Urine Albumin\n",
      "Urine Creatinine\n",
      "Helicobacter pylori Blood Test\n",
      "Complement C3\n",
      "Complement C4\n",
      "HLA-B*27 Real-Time PCR\n",
      "Thyroglobulin\n",
      "Calcitonin\n",
      "Protein S Assay\n",
      "Protein C Assay\n",
      "Fasciola hepatica Antibody\n",
      "Free Cortisol (24 hour urine )\n",
      "Free Prostate-Specific Antigen\n",
      "Inhibin B\n",
      "Transferrin\n",
      "Metanephrine ( 24 hr urine )\n",
      "24-Hour Urine Phosphorus\n",
      "24-Hour Urine Uric Acid\n",
      "Ionized Calcium\n",
      "17-Hydroxyprogesterone\n",
      "Anti-Glutamic Acid Decarboxylase Antibody\n",
      "Anti-IA2 Antibody\n",
      "Hepatitis A IgM\n",
      "Rheumatoid Factor IgG\n",
      "Rheumatoid Factor IgM\n",
      "Antithrombin III\n",
      "Protein-to-Creatinine Ratio\n"
     ]
    }
   ],
   "source": [
    "for test in df_combined['Standard Test Name'].unique():\n",
    "    print(test)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "id": "40116783",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Non-numeric Result values with their Standard Test Names:\n",
      "Total unique combinations: 879\n",
      "\n",
      "================================================================================\n",
      "Standard Test: 1-Hour Glucose\n",
      "Result Value: '.'\n",
      "--------------------------------------------------\n",
      "Standard Test: 2-Hour Glucose\n",
      "Result Value: '.'\n",
      "--------------------------------------------------\n",
      "Standard Test: Albumin-to-Creatinine Ratio\n",
      "Result Value: '> 1100'\n",
      "--------------------------------------------------\n",
      "Standard Test: Alpha-Fetoprotein\n",
      "Result Value: '< 0.75'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Cardiolipin IgG\n",
      "Result Value: '< 3'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Cyclic Citrullinated Peptide\n",
      "Result Value: '< 0.1'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Cyclic Citrullinated Peptide\n",
      "Result Value: '< 1'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Cyclic Citrullinated Peptide\n",
      "Result Value: '< 1.0'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Cyclic Citrullinated Peptide\n",
      "Result Value: '<1.0'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Cyclic Citrullinated Peptide\n",
      "Result Value: '>100'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Myeloperoxidase Antibody (p-ANCA)\n",
      "Result Value: '< 3'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-MÃ¼llerian Hormone\n",
      "Result Value: '< 0.1'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-MÃ¼llerian Hormone\n",
      "Result Value: '< 0.10'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-MÃ¼llerian Hormone\n",
      "Result Value: '<0.1'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Proteinase 3 Antibody (c-ANCA)\n",
      "Result Value: '< 3'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-SSA/Ro Antibody\n",
      "Result Value: '< 3'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-SSA/Ro Antibody\n",
      "Result Value: '> 200'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Streptolysin O\n",
      "Result Value: 'Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Streptolysin O\n",
      "Result Value: 'Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Streptolysin O\n",
      "Result Value: 'Negative (-ve)'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Streptolysin O\n",
      "Result Value: 'Negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Streptolysin O\n",
      "Result Value: 'Negative -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Streptolysin O\n",
      "Result Value: 'Negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Streptolysin O\n",
      "Result Value: 'Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Streptolysin O\n",
      "Result Value: 'Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Thyroglobulin Antibody\n",
      "Result Value: '< 10'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Thyroid Peroxidase Antibody\n",
      "Result Value: '< 0.8'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Thyroid Peroxidase Antibody\n",
      "Result Value: '< 5'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Thyroid Peroxidase Antibody\n",
      "Result Value: '< 5.0'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Thyroid Peroxidase Antibody\n",
      "Result Value: '<0.8'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Thyroid Peroxidase Antibody\n",
      "Result Value: '<5'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Thyroid Peroxidase Antibody\n",
      "Result Value: '<5.0'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Thyroid Peroxidase Antibody\n",
      "Result Value: '> 1000'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Thyroid Peroxidase Antibody\n",
      "Result Value: '> 600'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Thyroid Peroxidase Antibody\n",
      "Result Value: '>1000'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-Thyroid Peroxidase Antibody\n",
      "Result Value: '>600'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-dsDNA IgG\n",
      "Result Value: '< 10'\n",
      "--------------------------------------------------\n",
      "Standard Test: Anti-dsDNA IgM\n",
      "Result Value: '< 0.1'\n",
      "--------------------------------------------------\n",
      "Standard Test: Aspartate Aminotransferase (AST)\n",
      "Result Value: '12,2'\n",
      "--------------------------------------------------\n",
      "Standard Test: Beta-hCG Titer\n",
      "Result Value: '0.1<'\n",
      "--------------------------------------------------\n",
      "Standard Test: Beta-hCG Titer\n",
      "Result Value: '10000 <'\n",
      "--------------------------------------------------\n",
      "Standard Test: Beta-hCG Titer\n",
      "Result Value: '< 0.1'\n",
      "--------------------------------------------------\n",
      "Standard Test: Beta-hCG Titer\n",
      "Result Value: '<0.1'\n",
      "--------------------------------------------------\n",
      "Standard Test: Beta-hCG Titer\n",
      "Result Value: '<0.10'\n",
      "--------------------------------------------------\n",
      "Standard Test: Beta-hCG Titer\n",
      "Result Value: '<0.100'\n",
      "--------------------------------------------------\n",
      "Standard Test: Beta-hCG Titer\n",
      "Result Value: '> 10 000'\n",
      "--------------------------------------------------\n",
      "Standard Test: Beta-hCG Titer\n",
      "Result Value: '> 10000'\n",
      "--------------------------------------------------\n",
      "Standard Test: Beta-hCG Titer\n",
      "Result Value: '>0.1'\n",
      "--------------------------------------------------\n",
      "Standard Test: Beta-hCG Titer\n",
      "Result Value: '>10,000'\n",
      "--------------------------------------------------\n",
      "Standard Test: Beta-hCG Titer\n",
      "Result Value: '>1000'\n",
      "--------------------------------------------------\n",
      "Standard Test: Beta-hCG Titer\n",
      "Result Value: '>10000'\n",
      "--------------------------------------------------\n",
      "Standard Test: Beta-hCG Titer\n",
      "Result Value: '>20000'\n",
      "--------------------------------------------------\n",
      "Standard Test: Beta-hCG Titer\n",
      "Result Value: 'Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Beta-hCG Titer\n",
      "Result Value: 'Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Beta-hCG Titer\n",
      "Result Value: 'Negative -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Beta-hCG Titer\n",
      "Result Value: 'Positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Bleeding Time\n",
      "Result Value: '1 00'\n",
      "--------------------------------------------------\n",
      "Standard Test: Bleeding Time\n",
      "Result Value: '1:00'\n",
      "--------------------------------------------------\n",
      "Standard Test: Bleeding Time\n",
      "Result Value: '1:15'\n",
      "--------------------------------------------------\n",
      "Standard Test: Bleeding Time\n",
      "Result Value: '1:30'\n",
      "--------------------------------------------------\n",
      "Standard Test: Bleeding Time\n",
      "Result Value: '1:45'\n",
      "--------------------------------------------------\n",
      "Standard Test: Bleeding Time\n",
      "Result Value: '2:00'\n",
      "--------------------------------------------------\n",
      "Standard Test: Bleeding Time\n",
      "Result Value: '2:15'\n",
      "--------------------------------------------------\n",
      "Standard Test: Bleeding Time\n",
      "Result Value: '2:30'\n",
      "--------------------------------------------------\n",
      "Standard Test: Bleeding Time\n",
      "Result Value: '3:00'\n",
      "--------------------------------------------------\n",
      "Standard Test: Bleeding Time\n",
      "Result Value: '3:30'\n",
      "--------------------------------------------------\n",
      "Standard Test: Bleeding Time\n",
      "Result Value: '4:00'\n",
      "--------------------------------------------------\n",
      "Standard Test: Bleeding Time\n",
      "Result Value: '4:30'\n",
      "--------------------------------------------------\n",
      "Standard Test: Bleeding Time\n",
      "Result Value: '5:30'\n",
      "--------------------------------------------------\n",
      "Standard Test: Bleeding Time\n",
      "Result Value: '6:30'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A   Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A   Positive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A  - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A  Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A  Poistive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A  Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A  Positive   +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A  Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A  Positive +'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A  Positive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A  Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A  Positive+Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A  Possitive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A (Positive) +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A (Positive)+ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A (negative)-ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A +'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A + Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A + Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A +Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A +Positiveve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A +Ve Possitive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A +ve Possitive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A - Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A -Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A -Ve Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A Negative -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A Negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A Posetive  +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A Positive  +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A Positive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A Possitive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A(Negative)-ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A+'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A+ Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A+ positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A+ possitive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A+ ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A+Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A+VE'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A+Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A+Ve  Possitive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A+Ve Possitive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A+Ve positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A+ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A- VE'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'A- ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB   Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB  Negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB  Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB  Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB  Positive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB  Positve  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB (Positive) +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB +Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB +VE'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB +Ve possitive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB Negative -v'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB Negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB Positive  +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB Positive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB(positive) +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB+'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB+ Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB+Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB+Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB+ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'AB- negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'Ab Negative -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B   Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B  +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B  Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B  Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B  Positive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B  Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B (Positive) +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B + Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B +Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B +Positive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B +Ve  Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B +Ve  Possitive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B +Ve Possitive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B - Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B -Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B -Ve Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B Negative -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B Negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B Posetive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B Posetive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B Positive  +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B Positive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B Postive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B posetive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B(Positive)+ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B+'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B+ ( positive )'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B+ Posetive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B+ Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B+ VE'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B+ positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B+ ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B+Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B+VE'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B+Ve Possitive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B+ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'B- negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O  + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O  Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O  Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O  Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O  Positive  +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O  Positive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O (+ve)'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O (Negative) -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O (Positive) +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O (positive) +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O +Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O +Ve Possitive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O +ve  Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O +ve Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O +ve Possitive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O - Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O - Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O -Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O Negative -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O Negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O Posative +VE'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O Positive  +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O Positive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O Postive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O+'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O+ Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O+ VE'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O+ positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O+ possitive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O+ ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O+Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O+Ve  Possitive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O+Ve Possitive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O+ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O-ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'O-ve negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'ON  Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'o+ positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'o+ ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Group and Rh Factor\n",
      "Result Value: 'positive B +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Sugar\n",
      "Result Value: '> 600'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Sugar\n",
      "Result Value: 'attach'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Urea Nitrogen\n",
      "Result Value: '120..52'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Urea Nitrogen\n",
      "Result Value: '28.;91'\n",
      "--------------------------------------------------\n",
      "Standard Test: Blood Urea Nitrogen\n",
      "Result Value: '31`.43'\n",
      "--------------------------------------------------\n",
      "Standard Test: Brucella\n",
      "Result Value: '#NAME?'\n",
      "--------------------------------------------------\n",
      "Standard Test: Brucella\n",
      "Result Value: '1/640 positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Brucella\n",
      "Result Value: 'Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Brucella\n",
      "Result Value: 'Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Brucella\n",
      "Result Value: 'Negative (-ve)'\n",
      "--------------------------------------------------\n",
      "Standard Test: Brucella\n",
      "Result Value: 'Negative - Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Brucella\n",
      "Result Value: 'Negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Brucella\n",
      "Result Value: 'Negative -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Brucella\n",
      "Result Value: 'Negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Brucella\n",
      "Result Value: 'Negative-Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Brucella\n",
      "Result Value: 'Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Brucella\n",
      "Result Value: 'Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Brucella\n",
      "Result Value: 'Positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Brucella\n",
      "Result Value: 'Positive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Brucella\n",
      "Result Value: 'Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Brucella\n",
      "Result Value: 'Weak Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Brucella\n",
      "Result Value: 'negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Brucella\n",
      "Result Value: 'negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Brucella\n",
      "Result Value: 'negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Brucella\n",
      "Result Value: 'positive + ve 1/640'\n",
      "--------------------------------------------------\n",
      "Standard Test: Brucella\n",
      "Result Value: 'positive 1/180'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein\n",
      "Result Value: 'Negativ  -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein\n",
      "Result Value: 'Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein\n",
      "Result Value: 'Negative    -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein\n",
      "Result Value: 'Negative   -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein\n",
      "Result Value: 'Negative   -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein\n",
      "Result Value: 'Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein\n",
      "Result Value: 'Negative  -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein\n",
      "Result Value: 'Negative -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein\n",
      "Result Value: 'Negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein\n",
      "Result Value: 'Negative-ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein\n",
      "Result Value: 'Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein\n",
      "Result Value: 'Positive    +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein\n",
      "Result Value: 'Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein\n",
      "Result Value: 'Positive  +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein\n",
      "Result Value: 'Positive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein\n",
      "Result Value: 'Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein\n",
      "Result Value: 'Possiotive'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein\n",
      "Result Value: 'Possitive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein\n",
      "Result Value: 'negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein\n",
      "Result Value: 'negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein\n",
      "Result Value: 'negative-ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein Titer\n",
      "Result Value: 'Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein Titer\n",
      "Result Value: 'Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein Titer\n",
      "Result Value: 'Negative -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: C-Reactive Protein Titer\n",
      "Result Value: 'Negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: CA 19-9\n",
      "Result Value: '< 0.6'\n",
      "--------------------------------------------------\n",
      "Standard Test: COVID-19 Antigen\n",
      "Result Value: 'Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: COVID-19 Antigen\n",
      "Result Value: 'Negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: COVID-19 IgG Rapid Test\n",
      "Result Value: 'Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: COVID-19 IgG Rapid Test\n",
      "Result Value: 'Positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: COVID-19 IgG Rapid Test\n",
      "Result Value: 'Weak Positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: COVID-19 IgG Rapid Test\n",
      "Result Value: 'positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: COVID-19 IgG Spike\n",
      "Result Value: '37.7  Reactiv'\n",
      "--------------------------------------------------\n",
      "Standard Test: COVID-19 IgG Spike\n",
      "Result Value: 'Positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: COVID-19 IgM Rapid Test\n",
      "Result Value: 'Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: COVID-19 IgM Rapid Test\n",
      "Result Value: 'Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: COVID-19 IgM Rapid Test\n",
      "Result Value: 'Negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: COVID-19 IgM Spike\n",
      "Result Value: '0.2  No Reactive'\n",
      "--------------------------------------------------\n",
      "Standard Test: COVID-19 IgM Spike\n",
      "Result Value: 'Negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Carcinoembryonic Antigen\n",
      "Result Value: '< 0.2'\n",
      "--------------------------------------------------\n",
      "Standard Test: Chloride\n",
      "Result Value: '`196'\n",
      "--------------------------------------------------\n",
      "Standard Test: Clotting Time\n",
      "Result Value: '1:00'\n",
      "--------------------------------------------------\n",
      "Standard Test: Clotting Time\n",
      "Result Value: '1:30'\n",
      "--------------------------------------------------\n",
      "Standard Test: Clotting Time\n",
      "Result Value: '2:00'\n",
      "--------------------------------------------------\n",
      "Standard Test: Clotting Time\n",
      "Result Value: '2:30'\n",
      "--------------------------------------------------\n",
      "Standard Test: Clotting Time\n",
      "Result Value: '3:00'\n",
      "--------------------------------------------------\n",
      "Standard Test: Clotting Time\n",
      "Result Value: '3:30'\n",
      "--------------------------------------------------\n",
      "Standard Test: Clotting Time\n",
      "Result Value: '4:00'\n",
      "--------------------------------------------------\n",
      "Standard Test: Clotting Time\n",
      "Result Value: '4:30'\n",
      "--------------------------------------------------\n",
      "Standard Test: Clotting Time\n",
      "Result Value: '5:00'\n",
      "--------------------------------------------------\n",
      "Standard Test: Clotting Time\n",
      "Result Value: '6:00'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'ATTACH'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'ATTACHED'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'ATTAHED'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'Aattached'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'Arttach'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'Atacched'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'Atached'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'Atacid'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'Attaced'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'Attach'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'Attachd'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'Attache'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'Attached'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'Attachede'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'Attacheed'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'Attachid'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'Attaed'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'Attched'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'Attqached'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'Atttached'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'asttach'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'atach'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'atached'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'attac'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'attacahed'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'attaced'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'attacgh'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'attach'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'attachd'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'attache'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'attached'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'attaches'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'attachid'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'attah'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'attahed'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'attch'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'attched'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'attchid'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'atttached'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'ayttach'\n",
      "--------------------------------------------------\n",
      "Standard Test: Complete Blood Count\n",
      "Result Value: 'ttach'\n",
      "--------------------------------------------------\n",
      "Standard Test: Cortisol\n",
      "Result Value: '>1750'\n",
      "--------------------------------------------------\n",
      "Standard Test: Creatine Phosphokinase\n",
      "Result Value: '> 2000'\n",
      "--------------------------------------------------\n",
      "Standard Test: Cytomegalovirus IgG Rapid Test\n",
      "Result Value: 'Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Cytomegalovirus IgM Rapid Test\n",
      "Result Value: 'Negative -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: D-Dimer\n",
      "Result Value: '< 0.1'\n",
      "--------------------------------------------------\n",
      "Standard Test: D-Dimer\n",
      "Result Value: '<0.1'\n",
      "--------------------------------------------------\n",
      "Standard Test: D-Dimer\n",
      "Result Value: '> 20'\n",
      "--------------------------------------------------\n",
      "Standard Test: D-Dimer\n",
      "Result Value: '> 20.0'\n",
      "--------------------------------------------------\n",
      "Standard Test: D-Dimer\n",
      "Result Value: '>20'\n",
      "--------------------------------------------------\n",
      "Standard Test: D-Dimer\n",
      "Result Value: '>20.0'\n",
      "--------------------------------------------------\n",
      "Standard Test: Direct Coombs Test\n",
      "Result Value: 'Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Direct Coombs Test\n",
      "Result Value: 'Negative  - Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Direct Coombs Test\n",
      "Result Value: 'Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Direct Coombs Test\n",
      "Result Value: 'Negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Direct Coombs Test\n",
      "Result Value: 'Negative -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Direct Coombs Test\n",
      "Result Value: 'Negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Estradiol (E2)\n",
      "Result Value: '< 5'\n",
      "--------------------------------------------------\n",
      "Standard Test: Estradiol (E2)\n",
      "Result Value: '< 5.0'\n",
      "--------------------------------------------------\n",
      "Standard Test: Estradiol (E2)\n",
      "Result Value: '<5'\n",
      "--------------------------------------------------\n",
      "Standard Test: Estradiol (E2)\n",
      "Result Value: '<5.0'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Calprotectein\n",
      "Result Value: '> 60'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Calprotectein\n",
      "Result Value: '>60'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood\n",
      "Result Value: '#NAME?'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood\n",
      "Result Value: '<7.5'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood\n",
      "Result Value: 'Negatie - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood\n",
      "Result Value: 'Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood\n",
      "Result Value: 'Negative  - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood\n",
      "Result Value: 'Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood\n",
      "Result Value: 'Negative (-ve)'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood\n",
      "Result Value: 'Negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood\n",
      "Result Value: 'Negative -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood\n",
      "Result Value: 'Negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood\n",
      "Result Value: 'Negtive - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood\n",
      "Result Value: 'Posative +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood\n",
      "Result Value: 'Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood\n",
      "Result Value: 'Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood\n",
      "Result Value: 'Positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood\n",
      "Result Value: 'Positive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood\n",
      "Result Value: 'Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood\n",
      "Result Value: 'Weak Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood\n",
      "Result Value: 'Weak Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood\n",
      "Result Value: 'negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood\n",
      "Result Value: 'negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood\n",
      "Result Value: 'positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood\n",
      "Result Value: 'positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood\n",
      "Result Value: 'weak Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood Titer\n",
      "Result Value: '< 7.5'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood Titer\n",
      "Result Value: '<100'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood Titer\n",
      "Result Value: '<6.5'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood Titer\n",
      "Result Value: '<7.5'\n",
      "--------------------------------------------------\n",
      "Standard Test: Fecal Occult Blood Titer\n",
      "Result Value: '> 20,000'\n",
      "--------------------------------------------------\n",
      "Standard Test: Follicle-Stimulating Hormone\n",
      "Result Value: '< 0.3'\n",
      "--------------------------------------------------\n",
      "Standard Test: Follicle-Stimulating Hormone\n",
      "Result Value: '<0.3'\n",
      "--------------------------------------------------\n",
      "Standard Test: Free T3\n",
      "Result Value: '5..81'\n",
      "--------------------------------------------------\n",
      "Standard Test: Free T4\n",
      "Result Value: '18..1'\n",
      "--------------------------------------------------\n",
      "Standard Test: Free T4\n",
      "Result Value: '< 0.005'\n",
      "--------------------------------------------------\n",
      "Standard Test: Free T4\n",
      "Result Value: '> 100'\n",
      "--------------------------------------------------\n",
      "Standard Test: Free T4\n",
      "Result Value: '>100'\n",
      "--------------------------------------------------\n",
      "Standard Test: Free T4\n",
      "Result Value: '>100.0'\n",
      "--------------------------------------------------\n",
      "Standard Test: Gamma-Glutamyl Transferase\n",
      "Result Value: '> 1200'\n",
      "--------------------------------------------------\n",
      "Standard Test: HIV Antibody\n",
      "Result Value: '< 0.01'\n",
      "--------------------------------------------------\n",
      "Standard Test: HIV Antibody\n",
      "Result Value: '< 0.1'\n",
      "--------------------------------------------------\n",
      "Standard Test: HIV Antibody\n",
      "Result Value: 'Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: HIV Antibody\n",
      "Result Value: 'Negative (-ve)'\n",
      "--------------------------------------------------\n",
      "Standard Test: HIV Antibody\n",
      "Result Value: 'Negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: HIV Antibody\n",
      "Result Value: 'Suspected'\n",
      "--------------------------------------------------\n",
      "Standard Test: HIV Antibody\n",
      "Result Value: 'negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: HIV Antibody\n",
      "Result Value: 'o.27'\n",
      "--------------------------------------------------\n",
      "Standard Test: HLA-B*27 Real-Time PCR\n",
      "Result Value: 'Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: HLA-B*27 Real-Time PCR\n",
      "Result Value: 'Negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: HLA-B*27 Real-Time PCR\n",
      "Result Value: 'Negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: HbA1c\n",
      "Result Value: '11,74'\n",
      "--------------------------------------------------\n",
      "Standard Test: HbA1c\n",
      "Result Value: '5,88'\n",
      "--------------------------------------------------\n",
      "Standard Test: HbA1c\n",
      "Result Value: '5.48%'\n",
      "--------------------------------------------------\n",
      "Standard Test: HbA1c\n",
      "Result Value: '6.56%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody\n",
      "Result Value: 'Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody\n",
      "Result Value: 'Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody\n",
      "Result Value: 'Negative -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody\n",
      "Result Value: 'Negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody\n",
      "Result Value: 'Posistive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody\n",
      "Result Value: 'Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody\n",
      "Result Value: 'Positive   +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody\n",
      "Result Value: 'Positive  +V'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody\n",
      "Result Value: 'Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody\n",
      "Result Value: 'Positive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody\n",
      "Result Value: 'Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody\n",
      "Result Value: 'Possitive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody\n",
      "Result Value: 'Waek Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody\n",
      "Result Value: 'Weak Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody\n",
      "Result Value: 'Weak Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody\n",
      "Result Value: 'Weak positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody\n",
      "Result Value: 'negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody\n",
      "Result Value: 'positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody\n",
      "Result Value: 'positive+ ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody Test\n",
      "Result Value: 'Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody Titer\n",
      "Result Value: '<10'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody Titer\n",
      "Result Value: '> 200'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody Titer\n",
      "Result Value: '> 200.0'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody Titer\n",
      "Result Value: '>200'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody Titer\n",
      "Result Value: 'Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antibody Titer\n",
      "Result Value: 'Negative -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen\n",
      "Result Value: '#NAME?'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen\n",
      "Result Value: 'MNegative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen\n",
      "Result Value: 'Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen\n",
      "Result Value: 'Negative   -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen\n",
      "Result Value: 'Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen\n",
      "Result Value: 'Negative  -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen\n",
      "Result Value: 'Negative -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen\n",
      "Result Value: 'Negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen\n",
      "Result Value: 'Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen\n",
      "Result Value: 'Positive   +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen\n",
      "Result Value: 'Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen\n",
      "Result Value: 'Positive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen\n",
      "Result Value: 'Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen\n",
      "Result Value: 'Positivev  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen\n",
      "Result Value: 'Positve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen\n",
      "Result Value: 'Possiotive  +Ver'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen\n",
      "Result Value: 'Possiotive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen\n",
      "Result Value: 'Possitive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen\n",
      "Result Value: 'Possitive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen\n",
      "Result Value: 'Weak Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen\n",
      "Result Value: 'positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen\n",
      "Result Value: 'weak positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Test\n",
      "Result Value: 'Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Test\n",
      "Result Value: 'Ngative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Test\n",
      "Result Value: 'Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Test\n",
      "Result Value: 'Weak positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: '#NAME?'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: '0.0.6'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: '< 0.01'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: '<0.01'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: '<0.1'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'NEGATIVE -VE'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'Neagtive - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'Negastive - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'Negatie - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'Negativ - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'Negative  - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'Negative  -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'Negative -  ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'Negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'Negative -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'Negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'Negetive - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'Negive - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'Negstive - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'Negtive - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'Positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'Weak Positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'Weak Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'Weak positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'Weak positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'Weak positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'nagative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'weak positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Stool Titer\n",
      "Result Value: 'weak positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Titer\n",
      "Result Value: '> 100'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Titer\n",
      "Result Value: '>100'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Antigen Titer\n",
      "Result Value: 'Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Blood Test\n",
      "Result Value: 'Negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Blood Test\n",
      "Result Value: 'Negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Blood Test\n",
      "Result Value: 'Negetive (-ve)'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Blood Test\n",
      "Result Value: 'Positive +  ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Blood Test\n",
      "Result Value: 'Positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori Blood Test\n",
      "Result Value: 'Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Helicobacter pylori IgG\n",
      "Result Value: '#NAME?'\n",
      "--------------------------------------------------\n",
      "Standard Test: Hepatitis A IgM\n",
      "Result Value: 'Negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Hepatitis B Surface Antigen\n",
      "Result Value: '0..29'\n",
      "--------------------------------------------------\n",
      "Standard Test: Hepatitis B Surface Antigen\n",
      "Result Value: '0..481'\n",
      "--------------------------------------------------\n",
      "Standard Test: Hepatitis B Surface Antigen\n",
      "Result Value: '6104 Suspected'\n",
      "--------------------------------------------------\n",
      "Standard Test: Hepatitis B Surface Antigen\n",
      "Result Value: '< 0.01'\n",
      "--------------------------------------------------\n",
      "Standard Test: Hepatitis B Surface Antigen\n",
      "Result Value: '< 0.1'\n",
      "--------------------------------------------------\n",
      "Standard Test: Hepatitis B Surface Antigen\n",
      "Result Value: '<0.01'\n",
      "--------------------------------------------------\n",
      "Standard Test: Hepatitis B Surface Antigen\n",
      "Result Value: 'Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Hepatitis B Surface Antigen\n",
      "Result Value: 'Negative (-ve)'\n",
      "--------------------------------------------------\n",
      "Standard Test: Hepatitis B Surface Antigen\n",
      "Result Value: 'Negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Hepatitis B Surface Antigen\n",
      "Result Value: 'Suspected positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Hepatitis B Surface Antigen\n",
      "Result Value: 'negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Hepatitis C Antibody\n",
      "Result Value: '0.`2'\n",
      "--------------------------------------------------\n",
      "Standard Test: Hepatitis C Antibody\n",
      "Result Value: '< 0.05'\n",
      "--------------------------------------------------\n",
      "Standard Test: Hepatitis C Antibody\n",
      "Result Value: '<0.05'\n",
      "--------------------------------------------------\n",
      "Standard Test: Hepatitis C Antibody\n",
      "Result Value: '<0.5'\n",
      "--------------------------------------------------\n",
      "Standard Test: Hepatitis C Antibody\n",
      "Result Value: 'Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Hepatitis C Antibody\n",
      "Result Value: 'Negative (-ve)'\n",
      "--------------------------------------------------\n",
      "Standard Test: Hepatitis C Antibody\n",
      "Result Value: 'Negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Hepatitis C Antibody\n",
      "Result Value: 'negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Herpes Simplex Virus I IgG\n",
      "Result Value: 'Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Herpes Simplex Virus I IgM\n",
      "Result Value: 'Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: High-Sensitivity Troponin T\n",
      "Result Value: '< 3'\n",
      "--------------------------------------------------\n",
      "Standard Test: High-Sensitivity Troponin T\n",
      "Result Value: '< 3.0'\n",
      "--------------------------------------------------\n",
      "Standard Test: High-Sensitivity Troponin T\n",
      "Result Value: '<3'\n",
      "--------------------------------------------------\n",
      "Standard Test: High-Sensitivity Troponin T\n",
      "Result Value: '<3.0'\n",
      "--------------------------------------------------\n",
      "Standard Test: High-Sensitivity Troponin T\n",
      "Result Value: '<3.00'\n",
      "--------------------------------------------------\n",
      "Standard Test: High-Sensitivity Troponin T\n",
      "Result Value: '>3.00'\n",
      "--------------------------------------------------\n",
      "Standard Test: IFOB Titer ( FIT )\n",
      "Result Value: '< 7.5'\n",
      "--------------------------------------------------\n",
      "Standard Test: IFOB Titer ( FIT )\n",
      "Result Value: '<7.5'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Neagtive - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Negaive -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Negative  - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Negative  -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Negative (-ve )'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Negative (-ve)'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Negative -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Negative ive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Negatve - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Negetive ( -ve )'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Negetive (-ve)'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Negetive - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Negive - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Positive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Positive -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Weak Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'Weak positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'negative  - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunochemical Fecal Occult Blood\n",
      "Result Value: 'positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Immunoglobulin E\n",
      "Result Value: '< 1.0'\n",
      "--------------------------------------------------\n",
      "Standard Test: International Normalized Ratio\n",
      "Result Value: '-'\n",
      "--------------------------------------------------\n",
      "Standard Test: Lactate Dehydrogenase\n",
      "Result Value: '> 900'\n",
      "--------------------------------------------------\n",
      "Standard Test: Luteinizing Hormone\n",
      "Result Value: '0.1<'\n",
      "--------------------------------------------------\n",
      "Standard Test: Luteinizing Hormone\n",
      "Result Value: '5..07'\n",
      "--------------------------------------------------\n",
      "Standard Test: Luteinizing Hormone\n",
      "Result Value: '< 0.1'\n",
      "--------------------------------------------------\n",
      "Standard Test: Luteinizing Hormone\n",
      "Result Value: '<0.1'\n",
      "--------------------------------------------------\n",
      "Standard Test: N-Terminal Pro-B-Type Natriuretic Peptide\n",
      "Result Value: '10570..52'\n",
      "--------------------------------------------------\n",
      "Standard Test: N-Terminal Pro-B-Type Natriuretic Peptide\n",
      "Result Value: '< 50'\n",
      "--------------------------------------------------\n",
      "Standard Test: N-Terminal Pro-B-Type Natriuretic Peptide\n",
      "Result Value: '> 25000'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '27%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '28%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '29%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '30%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '31%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '32%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '33%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '34%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '35%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '36%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '37%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '38%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '39%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '40%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '41%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '42%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '43%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '44%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '45%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '46%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '47%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '48%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '49%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '50%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '52%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '53%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '54%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Packed Cell Volume\n",
      "Result Value: '70%'\n",
      "--------------------------------------------------\n",
      "Standard Test: Parathyroid Hormone\n",
      "Result Value: '< 2.40'\n",
      "--------------------------------------------------\n",
      "Standard Test: Potassium Hydroxide Test\n",
      "Result Value: 'Hyphae of Fungi Presence'\n",
      "--------------------------------------------------\n",
      "Standard Test: Potassium Hydroxide Test\n",
      "Result Value: 'Hyphae of Fungi presence'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: '#NAME?'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: '< 0.1'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: '<0.1'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: '>10000'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Neagative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Neagtive - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Negaive -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Negateve -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Negative   -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Negative  -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Negative  Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Negative ( -ve )'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Negative ( -ve)'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Negative (-ve)'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Negative - Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Negative -VBe'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Negative -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Negative -v'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Negative =Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Negative _ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Negetive ( -ve )'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Ngative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Posative  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Posetive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Posetive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Positive   +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Positive  +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Positive  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Positive ( +ve )'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Positive + Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Positive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Positive -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Positive+ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Positve +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Possitive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Possitive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Possitive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Possitive -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Postive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Waek Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Wak Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Weak Posdsitive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Weak Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Weak Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Weak Positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Weak Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Weak positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'Weak positive (+ve)'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'posative  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'posative +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'positive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'weak Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Pregnancy Test (Beta-hCG)\n",
      "Result Value: 'weak possitive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Progesterone\n",
      "Result Value: '< 0.050'\n",
      "--------------------------------------------------\n",
      "Standard Test: Progesterone\n",
      "Result Value: '< 0.25'\n",
      "--------------------------------------------------\n",
      "Standard Test: Progesterone\n",
      "Result Value: '> 60'\n",
      "--------------------------------------------------\n",
      "Standard Test: Prolactin\n",
      "Result Value: '< 0.047'\n",
      "--------------------------------------------------\n",
      "Standard Test: Prolactin\n",
      "Result Value: '<0.047'\n",
      "--------------------------------------------------\n",
      "Standard Test: Prostate-Specific Antigen\n",
      "Result Value: '< 0.006'\n",
      "--------------------------------------------------\n",
      "Standard Test: Prostate-Specific Antigen\n",
      "Result Value: '<0.006'\n",
      "--------------------------------------------------\n",
      "Standard Test: Prostate-Specific Antigen\n",
      "Result Value: '> 100'\n",
      "--------------------------------------------------\n",
      "Standard Test: Prostate-Specific Antigen\n",
      "Result Value: '>100'\n",
      "--------------------------------------------------\n",
      "Standard Test: Protein C Assay\n",
      "Result Value: '> 150'\n",
      "--------------------------------------------------\n",
      "Standard Test: Prothrombin Time\n",
      "Result Value: '> 120'\n",
      "--------------------------------------------------\n",
      "Standard Test: Rheumatoid Arthritis\n",
      "Result Value: 'Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Rheumatoid Factor\n",
      "Result Value: '#NAME?'\n",
      "--------------------------------------------------\n",
      "Standard Test: Rheumatoid Factor\n",
      "Result Value: '>160'\n",
      "--------------------------------------------------\n",
      "Standard Test: Rheumatoid Factor\n",
      "Result Value: 'Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Rheumatoid Factor\n",
      "Result Value: 'Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Rheumatoid Factor\n",
      "Result Value: 'Negative (-ve)'\n",
      "--------------------------------------------------\n",
      "Standard Test: Rheumatoid Factor\n",
      "Result Value: 'Negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Rheumatoid Factor\n",
      "Result Value: 'Negative -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Rheumatoid Factor\n",
      "Result Value: 'Negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Rheumatoid Factor\n",
      "Result Value: 'Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Rheumatoid Factor\n",
      "Result Value: 'Positive (+ve)'\n",
      "--------------------------------------------------\n",
      "Standard Test: Rheumatoid Factor\n",
      "Result Value: 'Positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Rheumatoid Factor\n",
      "Result Value: 'Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Rheumatoid Factor\n",
      "Result Value: 'negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Rheumatoid Factor Titer\n",
      "Result Value: '< 0.1'\n",
      "--------------------------------------------------\n",
      "Standard Test: Rheumatoid Factor Titer\n",
      "Result Value: '< 3'\n",
      "--------------------------------------------------\n",
      "Standard Test: Rheumatoid Factor Titer\n",
      "Result Value: '< 3.0'\n",
      "--------------------------------------------------\n",
      "Standard Test: Rheumatoid Factor Titer\n",
      "Result Value: '<3'\n",
      "--------------------------------------------------\n",
      "Standard Test: Rheumatoid Factor Titer\n",
      "Result Value: '<3.0'\n",
      "--------------------------------------------------\n",
      "Standard Test: Rheumatoid Factor Titer\n",
      "Result Value: '>169'\n",
      "--------------------------------------------------\n",
      "Standard Test: Rheumatoid Factor Titer\n",
      "Result Value: 'Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Rose Bengal Test\n",
      "Result Value: 'Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Rubella IgG Rapid Test\n",
      "Result Value: 'Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Rubella IgM Rapid Test\n",
      "Result Value: 'Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Serum Creatinine\n",
      "Result Value: 'Negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Serum Ferritin\n",
      "Result Value: '< 0.5'\n",
      "--------------------------------------------------\n",
      "Standard Test: Serum Ferritin\n",
      "Result Value: '<0.5'\n",
      "--------------------------------------------------\n",
      "Standard Test: Serum Ferritin\n",
      "Result Value: '<0.50'\n",
      "--------------------------------------------------\n",
      "Standard Test: Serum Ferritin\n",
      "Result Value: '<0.500'\n",
      "--------------------------------------------------\n",
      "Standard Test: Serum Ferritin\n",
      "Result Value: '> 2000'\n",
      "--------------------------------------------------\n",
      "Standard Test: Serum LDL Cholesterol\n",
      "Result Value: '69*'\n",
      "--------------------------------------------------\n",
      "Standard Test: Serum Triglycerides\n",
      "Result Value: '> 500'\n",
      "--------------------------------------------------\n",
      "Standard Test: Serum Triglycerides\n",
      "Result Value: '>1004'\n",
      "--------------------------------------------------\n",
      "Standard Test: Serum Triglycerides\n",
      "Result Value: '>1113'\n",
      "--------------------------------------------------\n",
      "Standard Test: Serum Triglycerides\n",
      "Result Value: '>1200'\n",
      "--------------------------------------------------\n",
      "Standard Test: Serum Triglycerides\n",
      "Result Value: '>1285'\n",
      "--------------------------------------------------\n",
      "Standard Test: Serum Triglycerides\n",
      "Result Value: '>500'\n",
      "--------------------------------------------------\n",
      "Standard Test: Stool For Calprotectin titer\n",
      "Result Value: '< 10'\n",
      "--------------------------------------------------\n",
      "Standard Test: Stool For Calprotectin titer\n",
      "Result Value: '< 15'\n",
      "--------------------------------------------------\n",
      "Standard Test: Stool For Calprotectin titer\n",
      "Result Value: '< 5'\n",
      "--------------------------------------------------\n",
      "Standard Test: Stool For Calprotectin titer\n",
      "Result Value: '< 5.0'\n",
      "--------------------------------------------------\n",
      "Standard Test: Stool For Calprotectin titer\n",
      "Result Value: '<5.00'\n",
      "--------------------------------------------------\n",
      "Standard Test: TSH\n",
      "Result Value: '3,23'\n",
      "--------------------------------------------------\n",
      "Standard Test: TSH\n",
      "Result Value: '<  0.005'\n",
      "--------------------------------------------------\n",
      "Standard Test: TSH\n",
      "Result Value: '< 0.005'\n",
      "--------------------------------------------------\n",
      "Standard Test: TSH\n",
      "Result Value: '< 0.05'\n",
      "--------------------------------------------------\n",
      "Standard Test: TSH\n",
      "Result Value: '<0.005'\n",
      "--------------------------------------------------\n",
      "Standard Test: TSH\n",
      "Result Value: '> 100'\n",
      "--------------------------------------------------\n",
      "Standard Test: TSH\n",
      "Result Value: '> 100.0'\n",
      "--------------------------------------------------\n",
      "Standard Test: TSH\n",
      "Result Value: '>100'\n",
      "--------------------------------------------------\n",
      "Standard Test: TSH\n",
      "Result Value: '>100.0'\n",
      "--------------------------------------------------\n",
      "Standard Test: TSH Receptor Antibody\n",
      "Result Value: '<0.8'\n",
      "--------------------------------------------------\n",
      "Standard Test: Testosterone\n",
      "Result Value: '< 0.025'\n",
      "--------------------------------------------------\n",
      "Standard Test: Testosterone\n",
      "Result Value: '<0.025'\n",
      "--------------------------------------------------\n",
      "Standard Test: Testosterone\n",
      "Result Value: '>15'\n",
      "--------------------------------------------------\n",
      "Standard Test: Thyroglobulin\n",
      "Result Value: '< 0.04'\n",
      "--------------------------------------------------\n",
      "Standard Test: Thyroxine (T4)\n",
      "Result Value: '> 320.0'\n",
      "--------------------------------------------------\n",
      "Standard Test: Tissue Transglutaminase IgA\n",
      "Result Value: '< 3'\n",
      "--------------------------------------------------\n",
      "Standard Test: Tissue Transglutaminase IgA\n",
      "Result Value: '< 3.0'\n",
      "--------------------------------------------------\n",
      "Standard Test: Tissue Transglutaminase IgG\n",
      "Result Value: '< 3'\n",
      "--------------------------------------------------\n",
      "Standard Test: Toxoplasma IgG Rapid Test\n",
      "Result Value: 'Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Toxoplasma IgM Rapid Test\n",
      "Result Value: 'Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Triglycerides\n",
      "Result Value: '< 1178.00'\n",
      "--------------------------------------------------\n",
      "Standard Test: Triiodothyronine (T3)\n",
      "Result Value: '>10'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: '#NAME?'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'Negative  -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'Negative (-ve)'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'Negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'Negative -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'Negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'Negative-ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'Posative +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'Posetive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'Posetive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'Posiitive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'Positive (+ve)'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'Positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'Positive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'Positve +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'Possitive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'Weak Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'Weak Positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'Weak positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgG\n",
      "Result Value: 'weak positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: '#NAME?'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'Negative  -V'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'Negative  -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'Negative (-ve)'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'Negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'Negative -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'Negative -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'Nigative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'Poitive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'Posative +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'Posiitive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'Positive (+ve)'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'Positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'Positive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'Possitive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'Possitive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'Waek Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'Weak Positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'Weak Positive + ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'Weak Positive +ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'naegative  - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'negative   -ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'negative - ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'weak positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Typhoid IgM\n",
      "Result Value: 'weak possitive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Urine Albumin\n",
      "Result Value: '> 66'\n",
      "--------------------------------------------------\n",
      "Standard Test: Urine Beta-hCG\n",
      "Result Value: '#NAME?'\n",
      "--------------------------------------------------\n",
      "Standard Test: Urine Beta-hCG\n",
      "Result Value: 'Negative'\n",
      "--------------------------------------------------\n",
      "Standard Test: Urine Beta-hCG\n",
      "Result Value: 'Negative  -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Urine Beta-hCG\n",
      "Result Value: 'Negative -Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Urine Beta-hCG\n",
      "Result Value: 'Positive  +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Urine Beta-hCG\n",
      "Result Value: 'Positive +Ve'\n",
      "--------------------------------------------------\n",
      "Standard Test: Urine Beta-hCG\n",
      "Result Value: 'weak positive'\n",
      "--------------------------------------------------\n",
      "Standard Test: Urine Culture\n",
      "Result Value: 'no growth'\n",
      "--------------------------------------------------\n",
      "Standard Test: Vitamin B12\n",
      "Result Value: '< 50'\n",
      "--------------------------------------------------\n",
      "Standard Test: Vitamin B12\n",
      "Result Value: '<50'\n",
      "--------------------------------------------------\n",
      "Standard Test: Vitamin B12\n",
      "Result Value: '> 2000'\n",
      "--------------------------------------------------\n",
      "Standard Test: Vitamin B12\n",
      "Result Value: '>2000'\n",
      "--------------------------------------------------\n",
      "Standard Test: Vitamin D3\n",
      "Result Value: '13,5'\n",
      "--------------------------------------------------\n",
      "Standard Test: Vitamin D3\n",
      "Result Value: '4,44'\n",
      "--------------------------------------------------\n",
      "Standard Test: Vitamin D3\n",
      "Result Value: '<'\n",
      "--------------------------------------------------\n",
      "Standard Test: Vitamin D3\n",
      "Result Value: '<  3'\n",
      "--------------------------------------------------\n",
      "Standard Test: Vitamin D3\n",
      "Result Value: '< 3'\n",
      "--------------------------------------------------\n",
      "Standard Test: Vitamin D3\n",
      "Result Value: '< 3.0'\n",
      "--------------------------------------------------\n",
      "Standard Test: Vitamin D3\n",
      "Result Value: '< 8.1'\n",
      "--------------------------------------------------\n",
      "Standard Test: Vitamin D3\n",
      "Result Value: '<3'\n",
      "--------------------------------------------------\n",
      "Standard Test: Vitamin D3\n",
      "Result Value: '<3.0'\n",
      "--------------------------------------------------\n",
      "Standard Test: Vitamin D3\n",
      "Result Value: '> 120'\n",
      "--------------------------------------------------\n",
      "Standard Test: Vitamin D3\n",
      "Result Value: '>120'\n",
      "--------------------------------------------------\n",
      "Standard Test: Vitamin D3\n",
      "Result Value: '>3'\n",
      "--------------------------------------------------\n"
     ]
    }
   ],
   "source": [
    "# Show non-numeric Result values with their corresponding Standard Test Names\n",
    "numeric_results = pd.to_numeric(df_combined['Result'], errors='coerce')\n",
    "non_numeric_data = df_combined[numeric_results.isna()].copy()\n",
    "\n",
    "# Get unique combinations of non-numeric results and their standard test names\n",
    "non_numeric_combinations = non_numeric_data[['Result', 'Standard Test Name']].drop_duplicates()\n",
    "\n",
    "# Sort by Standard Test Name for better organization\n",
    "non_numeric_combinations = non_numeric_combinations.sort_values(['Standard Test Name', 'Result'])\n",
    "\n",
    "print(f\"Non-numeric Result values with their Standard Test Names:\")\n",
    "print(f\"Total unique combinations: {len(non_numeric_combinations)}\")\n",
    "print(\"\\n\" + \"=\"*80)\n",
    "\n",
    "for _, row in non_numeric_combinations.iterrows():\n",
    "    print(f\"Standard Test: {row['Standard Test Name']}\")\n",
    "    print(f\"Result Value: '{row['Result']}'\")\n",
    "    print(\"-\" * 50)\n",
    "\n",
    "# save it as a CSV file\n",
    "non_numeric_combinations.to_csv('processed_data/non_numeric_results_analysis.csv', index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9af7dd7c",
   "metadata": {},
   "outputs": [],
   "source": [
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "id": "6e88a8f9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Lab result categorization functions defined successfully!\n",
      "Ready to create Outcome column for df_combined...\n"
     ]
    }
   ],
   "source": [
    "# Comprehensive Lab Result Categorization Function\n",
    "# This function categorizes all lab results into \"bn\" (below normal), \"n\" (normal), \"an\" (above normal)\n",
    "\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "import re\n",
    "\n",
    "def create_outcome_column(df):\n",
    "    \"\"\"\n",
    "    Create an Outcome column that categorizes lab test results based on:\n",
    "    1. Non-numeric results: Use the mapping from processed_data/non_numeric_results_analysis.csv\n",
    "    2. Numeric results: Apply medical reference ranges based on gender and test type\n",
    "    \"\"\"\n",
    "    \n",
    "    # Load the non-numeric results mapping\n",
    "    try:\n",
    "        non_numeric_mapping = pd.read_csv('processed_data/non_numeric_results_analysis.csv')\n",
    "        # Create a dictionary for quick lookup\n",
    "        mapping_dict = {}\n",
    "        for _, row in non_numeric_mapping.iterrows():\n",
    "            key = (row['Result'], row['Standard Test Name'])\n",
    "            mapping_dict[key] = row['Outcome']\n",
    "        print(f\"Loaded {len(mapping_dict)} non-numeric result mappings\")\n",
    "    except FileNotFoundError:\n",
    "        print(\"Warning: non_numeric_results_analysis.csv not found. Will only categorize numeric results.\")\n",
    "        mapping_dict = {}\n",
    "    \n",
    "    # Create a copy of the dataframe to work with\n",
    "    df_result = df.copy()\n",
    "    df_result['Outcome'] = 'n'  # Default to normal\n",
    "    \n",
    "    # Convert Result column to check if numeric\n",
    "    numeric_results = pd.to_numeric(df_result['Result'], errors='coerce')\n",
    "    is_numeric = numeric_results.notna()\n",
    "    \n",
    "    print(f\"Processing {len(df_result)} total records:\")\n",
    "    print(f\"- Numeric results: {is_numeric.sum():,} ({is_numeric.sum()/len(df_result)*100:.1f}%)\")\n",
    "    print(f\"- Non-numeric results: {(~is_numeric).sum():,} ({(~is_numeric).sum()/len(df_result)*100:.1f}%)\")\n",
    "    \n",
    "    # 1. Handle non-numeric results using the mapping\n",
    "    non_numeric_count = 0\n",
    "    for idx, row in df_result[~is_numeric].iterrows():\n",
    "        key = (row['Result'], row['Standard Test Name'])\n",
    "        if key in mapping_dict:\n",
    "            df_result.loc[idx, 'Outcome'] = mapping_dict[key]\n",
    "            non_numeric_count += 1\n",
    "    \n",
    "    print(f\"Categorized {non_numeric_count} non-numeric results using mapping file\")\n",
    "    \n",
    "    # 2. Handle numeric results with medical reference ranges\n",
    "    numeric_categorized = 0\n",
    "    \n",
    "    for idx, row in df_result[is_numeric].iterrows():\n",
    "        result_value = numeric_results.loc[idx]\n",
    "        test_name = row['Standard Test Name']\n",
    "        gender = row['Gender']\n",
    "        age = row.get('Age', 30)  # Default age if not available\n",
    "        \n",
    "        # Get the outcome based on medical ranges\n",
    "        outcome = categorize_numeric_result(result_value, test_name, gender, age)\n",
    "        df_result.loc[idx, 'Outcome'] = outcome\n",
    "        numeric_categorized += 1\n",
    "    \n",
    "    print(f\"Categorized {numeric_categorized} numeric results using medical reference ranges\")\n",
    "    \n",
    "    # Show final distribution\n",
    "    print(f\"\\n=== FINAL OUTCOME DISTRIBUTION ===\")\n",
    "    outcome_counts = df_result['Outcome'].value_counts()\n",
    "    for outcome, count in outcome_counts.items():\n",
    "        percentage = count / len(df_result) * 100\n",
    "        outcome_name = {'bn': 'Below Normal', 'n': 'Normal', 'an': 'Above Normal'}[outcome]\n",
    "        print(f\"{outcome_name} ({outcome}): {count:,} ({percentage:.1f}%)\")\n",
    "    \n",
    "    return df_result\n",
    "\n",
    "def categorize_numeric_result(value, test_name, gender, age=30):\n",
    "    \"\"\"\n",
    "    Categorize a numeric lab result based on medical reference ranges\n",
    "    Returns: 'bn' (below normal), 'n' (normal), 'an' (above normal)\n",
    "    \"\"\"\n",
    "    \n",
    "    # Define reference ranges by test name and gender\n",
    "    # Format: test_name: {'M': (min, max), 'F': (min, max)}\n",
    "    # If only one range, applies to both genders\n",
    "    \n",
    "    reference_ranges = {\n",
    "        # Basic Chemistry Panel\n",
    "        'Glucose': {'M': (70, 100), 'F': (70, 100)},\n",
    "        'Blood Sugar': {'M': (70, 100), 'F': (70, 100)},\n",
    "        'Fasting Blood Sugar': {'M': (70, 100), 'F': (70, 100)},\n",
    "        'Random Blood Sugar': {'M': (70, 140), 'F': (70, 140)},\n",
    "        '1-Hour Glucose': {'M': (0, 180), 'F': (0, 180)},\n",
    "        '2-Hour Glucose': {'M': (0, 140), 'F': (0, 140)},\n",
    "        'HbA1c': {'M': (4.0, 5.6), 'F': (4.0, 5.6)},\n",
    "        \n",
    "        # Kidney Function\n",
    "        'Serum Creatinine': {'M': (0.7, 1.3), 'F': (0.6, 1.1)},\n",
    "        'Blood Urea Nitrogen': {'M': (6, 24), 'F': (6, 21)},\n",
    "        'Urine Albumin': {'M': (0, 30), 'F': (0, 30)},\n",
    "        \n",
    "        # Liver Function\n",
    "        'Alanine Aminotransferase (ALT)': {'M': (7, 56), 'F': (7, 56)},\n",
    "        'Aspartate Aminotransferase (AST)': {'M': (10, 40), 'F': (10, 40)},\n",
    "        'Alkaline Phosphatase': {'M': (44, 147), 'F': (44, 147)},\n",
    "        'Gamma-Glutamyl Transferase': {'M': (9, 48), 'F': (9, 32)},\n",
    "        'Total Bilirubin': {'M': (0.3, 1.2), 'F': (0.3, 1.2)},\n",
    "        'Direct Bilirubin': {'M': (0.0, 0.3), 'F': (0.0, 0.3)},\n",
    "        'Albumin': {'M': (3.5, 5.0), 'F': (3.5, 5.0)},\n",
    "        \n",
    "        # Lipid Profile\n",
    "        'Total Cholesterol': {'M': (0, 200), 'F': (0, 200)},\n",
    "        'Serum LDL Cholesterol': {'M': (0, 100), 'F': (0, 100)},\n",
    "        'Serum HDL Cholesterol': {'M': (40, 100), 'F': (50, 100)},\n",
    "        'Serum Triglycerides': {'M': (0, 150), 'F': (0, 150)},\n",
    "        'Triglycerides': {'M': (0, 150), 'F': (0, 150)},\n",
    "        \n",
    "        # Complete Blood Count\n",
    "        'Hemoglobin': {'M': (13.8, 17.2), 'F': (12.1, 15.1)},\n",
    "        'Packed Cell Volume': {'M': (41, 50), 'F': (36, 44)},\n",
    "        'White Blood Cell Count': {'M': (3.5, 10.5), 'F': (3.5, 10.5)},\n",
    "        'Platelet Count': {'M': (150, 400), 'F': (150, 400)},\n",
    "        'Red Blood Cell Count': {'M': (4.7, 6.1), 'F': (4.2, 5.4)},\n",
    "        'Mean Corpuscular Volume': {'M': (80, 100), 'F': (80, 100)},\n",
    "        'Mean Corpuscular Hemoglobin': {'M': (27, 32), 'F': (27, 32)},\n",
    "        'Mean Corpuscular Hemoglobin Concentration': {'M': (32, 36), 'F': (32, 36)},\n",
    "        \n",
    "        # Thyroid Function\n",
    "        'TSH': {'M': (0.27, 4.2), 'F': (0.27, 4.2)},\n",
    "        'Free T4': {'M': (12, 22), 'F': (12, 22)},\n",
    "        'Thyroxine (T4)': {'M': (5, 12), 'F': (5, 12)},\n",
    "        'Free T3': {'M': (3.1, 6.8), 'F': (3.1, 6.8)},\n",
    "        'Triiodothyronine (T3)': {'M': (1.3, 3.1), 'F': (1.3, 3.1)},\n",
    "        'Anti-Thyroid Peroxidase Antibody': {'M': (0, 34), 'F': (0, 34)},\n",
    "        'Anti-Thyroglobulin Antibody': {'M': (0, 115), 'F': (0, 115)},\n",
    "        'Thyroglobulin': {'M': (1.4, 78), 'F': (1.4, 78)},\n",
    "        \n",
    "        # Cardiac Markers\n",
    "        'High-Sensitivity Troponin T': {'M': (0, 14), 'F': (0, 14)},\n",
    "        'Creatine Phosphokinase': {'M': (39, 308), 'F': (26, 192)},\n",
    "        'Lactate Dehydrogenase': {'M': (122, 222), 'F': (122, 222)},\n",
    "        'N-Terminal Pro-B-Type Natriuretic Peptide': {'M': (0, 125), 'F': (0, 125)},\n",
    "        \n",
    "        # Hormones\n",
    "        'Testosterone': {'M': (8.64, 29), 'F': (0.7, 3.1)},\n",
    "        'Estradiol (E2)': {'M': (7.6, 42.6), 'F': (12.5, 166)},  # Varies by cycle\n",
    "        'Progesterone': {'M': (0.2, 1.4), 'F': (0.2, 25)},  # Varies by cycle\n",
    "        'Prolactin': {'M': (4.04, 15.2), 'F': (4.79, 23.3)},\n",
    "        'Follicle-Stimulating Hormone': {'M': (1.5, 12.4), 'F': (3.5, 12.5)},  # Varies by cycle\n",
    "        'Luteinizing Hormone': {'M': (1.7, 8.6), 'F': (2.4, 12.6)},  # Varies by cycle\n",
    "        'Cortisol': {'M': (6.2, 19.4), 'F': (6.2, 19.4)},\n",
    "        'Parathyroid Hormone': {'M': (15, 65), 'F': (15, 65)},\n",
    "        \n",
    "        # Vitamins and Minerals\n",
    "        'Vitamin D3': {'M': (20, 50), 'F': (20, 50)},\n",
    "        'Vitamin B12': {'M': (200, 900), 'F': (200, 900)},\n",
    "        'Serum Ferritin': {'M': (12, 300), 'F': (12, 150)},\n",
    "        'Iron': {'M': (80, 180), 'F': (60, 170)},\n",
    "        'Total Iron Binding Capacity': {'M': (240, 450), 'F': (240, 450)},\n",
    "        'Transferrin Saturation': {'M': (20, 50), 'F': (20, 50)},\n",
    "        \n",
    "        # Electrolytes\n",
    "        'Sodium': {'M': (136, 145), 'F': (136, 145)},\n",
    "        'Potassium': {'M': (3.5, 5.1), 'F': (3.5, 5.1)},\n",
    "        'Chloride': {'M': (98, 107), 'F': (98, 107)},\n",
    "        'Carbon Dioxide': {'M': (22, 29), 'F': (22, 29)},\n",
    "        'Calcium': {'M': (8.5, 10.5), 'F': (8.5, 10.5)},\n",
    "        'Phosphorus': {'M': (2.5, 4.5), 'F': (2.5, 4.5)},\n",
    "        'Magnesium': {'M': (1.7, 2.2), 'F': (1.7, 2.2)},\n",
    "        \n",
    "        # Coagulation\n",
    "        'Prothrombin Time': {'M': (9.5, 13.8), 'F': (9.5, 13.8)},\n",
    "        'International Normalized Ratio': {'M': (0.8, 1.1), 'F': (0.8, 1.1)},\n",
    "        'Activated Partial Thromboplastin Time': {'M': (30, 40), 'F': (30, 40)},\n",
    "        'Bleeding Time': {'M': (2, 8), 'F': (2, 8)},  # in minutes\n",
    "        'Clotting Time': {'M': (5, 11), 'F': (5, 11)},  # in minutes\n",
    "        \n",
    "        # Pregnancy Related\n",
    "        'Beta-hCG Titer': {'M': (0, 5), 'F': (0, 5)},  # Non-pregnant\n",
    "        'Pregnancy Test (Beta-hCG)': {'M': (0, 5), 'F': (0, 5)},  # Non-pregnant\n",
    "        'Alpha-Fetoprotein': {'M': (0, 8.5), 'F': (0, 8.5)},  # Non-pregnant\n",
    "        \n",
    "        # Tumor Markers\n",
    "        'Prostate-Specific Antigen': {'M': (0, 4), 'F': (0, 4)},\n",
    "        'Carcinoembryonic Antigen': {'M': (0, 3), 'F': (0, 3)},\n",
    "        'CA 19-9': {'M': (0, 37), 'F': (0, 37)},\n",
    "        \n",
    "        # Immunology\n",
    "        'C-Reactive Protein': {'M': (0, 10), 'F': (0, 10)},\n",
    "        'Rheumatoid Factor': {'M': (0, 15), 'F': (0, 15)},\n",
    "        'Rheumatoid Factor Titer': {'M': (0, 15), 'F': (0, 15)},\n",
    "        'Anti-Cyclic Citrullinated Peptide': {'M': (0, 20), 'F': (0, 20)},\n",
    "        'Immunoglobulin E': {'M': (0, 100), 'F': (0, 100)},\n",
    "        \n",
    "        # Special Tests\n",
    "        'D-Dimer': {'M': (0, 0.5), 'F': (0, 0.5)},\n",
    "        'Albumin-to-Creatinine Ratio': {'M': (0, 30), 'F': (0, 30)},\n",
    "        'Protein C Assay': {'M': (70, 140), 'F': (70, 140)},\n",
    "    }\n",
    "    \n",
    "    # Handle special cases for percentage values\n",
    "    if test_name == 'Packed Cell Volume' and isinstance(value, str) and '%' in str(value):\n",
    "        try:\n",
    "            value = float(str(value).replace('%', ''))\n",
    "        except:\n",
    "            return 'n'\n",
    "    \n",
    "    # Get gender-specific reference range\n",
    "    if test_name in reference_ranges:\n",
    "        ranges = reference_ranges[test_name]\n",
    "        if gender in ranges:\n",
    "            min_val, max_val = ranges[gender]\n",
    "        else:\n",
    "            # Use male range as default if gender not specified\n",
    "            min_val, max_val = ranges.get('M', ranges.get('F', (0, float('inf'))))\n",
    "        \n",
    "        if value < min_val:\n",
    "            return 'bn'\n",
    "        elif value > max_val:\n",
    "            return 'an'\n",
    "        else:\n",
    "            return 'n'\n",
    "    \n",
    "    # For unknown tests, use general heuristics\n",
    "    else:\n",
    "        # Very common ranges for general categorization\n",
    "        if value < 0:\n",
    "            return 'bn'  # Negative values usually abnormal\n",
    "        elif value > 1000:\n",
    "            return 'an'  # Very high values usually abnormal\n",
    "        else:\n",
    "            return 'n'   # Default to normal for unknown tests\n",
    "    \n",
    "print(\"Lab result categorization functions defined successfully!\")\n",
    "print(\"Ready to create Outcome column for df_combined...\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "id": "1d43a1cb",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Starting categorization of all lab results...\n",
      "Original dataframe shape: (157361, 12)\n",
      "Loaded 879 non-numeric result mappings\n",
      "Processing 157361 total records:\n",
      "- Numeric results: 141,109 (89.7%)\n",
      "- Non-numeric results: 16,252 (10.3%)\n",
      "Categorized 16252 non-numeric results using mapping file\n",
      "Categorized 141109 numeric results using medical reference ranges\n",
      "\n",
      "=== FINAL OUTCOME DISTRIBUTION ===\n",
      "Normal (n): 115,365 (73.3%)\n",
      "Above Normal (an): 28,006 (17.8%)\n",
      "Below Normal (bn): 13,990 (8.9%)\n",
      "Updated dataframe shape: (157361, 13)\n",
      "\n",
      "=== OUTCOME COLUMN CREATED SUCCESSFULLY ===\n",
      "\n",
      "=== SAMPLE RESULTS WITH OUTCOMES ===\n",
      "   Sample ID Standard Test Name Result   Unit  Gender   Age Outcome\n",
      "0        118        Blood Sugar     95  mg/dl    Male  64.0       n\n",
      "1        126        Blood Sugar     86  mg/dl    Male  37.0       n\n",
      "2        132        Blood Sugar     84  mg/dl    Male  53.0       n\n",
      "3        177        Blood Sugar     84  mg/dl  Female  50.0       n\n",
      "4        179        Blood Sugar     96  mg/dl  Female  42.0       n\n",
      "5        182        Blood Sugar    157  mg/dl  Female  57.0      an\n",
      "6        185        Blood Sugar    106  mg/dl  Female  54.0      an\n",
      "7        192        Blood Sugar     88  mg/dl  Female  56.0       n\n",
      "8        200        Blood Sugar     86  mg/dl  Female  40.0       n\n",
      "9        201        Blood Sugar     95  mg/dl    Male  43.0       n\n",
      "\n",
      "=== EXAMPLES BY OUTCOME TYPE ===\n",
      "\n",
      "BELOW NORMAL (bn) - 13990 records:\n",
      "1. Blood Sugar: 67 (mg/dl) -> bn [Male, Age: 19.0]\n",
      "2. Blood Sugar: 68 (mg/dl) -> bn [Female, Age: 26.0]\n",
      "3. Blood Sugar: 9.08 (mg/dl) -> bn [Female, Age: 54.0]\n",
      "4. Blood Sugar: 3.74 (mg/dl) -> bn [Female, Age: 48.0]\n",
      "5. Blood Sugar: 48 (mg/dl) -> bn [Female, Age: 0.0]\n",
      "\n",
      "NORMAL (n) - 115365 records:\n",
      "1. Blood Sugar: 95 (mg/dl) -> n [Male, Age: 64.0]\n",
      "2. Blood Sugar: 86 (mg/dl) -> n [Male, Age: 37.0]\n",
      "3. Blood Sugar: 84 (mg/dl) -> n [Male, Age: 53.0]\n",
      "4. Blood Sugar: 84 (mg/dl) -> n [Female, Age: 50.0]\n",
      "5. Blood Sugar: 96 (mg/dl) -> n [Female, Age: 42.0]\n",
      "\n",
      "ABOVE NORMAL (an) - 28006 records:\n",
      "1. Blood Sugar: 157 (mg/dl) -> an [Female, Age: 57.0]\n",
      "2. Blood Sugar: 106 (mg/dl) -> an [Female, Age: 54.0]\n",
      "3. Blood Sugar: 101 (mg/dl) -> an [Female, Age: 22.0]\n",
      "4. Blood Sugar: 114 (mg/dl) -> an [Female, Age: 51.0]\n",
      "5. Blood Sugar: 122 (mg/dl) -> an [Female, Age: 32.0]\n",
      "\n",
      "=== DATAFRAME UPDATED ===\n",
      "df_combined now includes the 'Outcome' column with 157361 records\n"
     ]
    }
   ],
   "source": [
    "# Apply the categorization function to create the Outcome column\n",
    "print(\"Starting categorization of all lab results...\")\n",
    "print(f\"Original dataframe shape: {df_combined.shape}\")\n",
    "\n",
    "# Apply the categorization function\n",
    "df_combined_with_outcome = create_outcome_column(df_combined)\n",
    "\n",
    "print(f\"Updated dataframe shape: {df_combined_with_outcome.shape}\")\n",
    "print(\"\\n=== OUTCOME COLUMN CREATED SUCCESSFULLY ===\")\n",
    "\n",
    "# Show sample results\n",
    "print(\"\\n=== SAMPLE RESULTS WITH OUTCOMES ===\")\n",
    "sample_cols = ['Sample ID', 'Standard Test Name', 'Result', 'Unit', 'Gender', 'Age', 'Outcome']\n",
    "print(df_combined_with_outcome[sample_cols].head(10))\n",
    "\n",
    "# Show some examples by outcome type\n",
    "print(\"\\n=== EXAMPLES BY OUTCOME TYPE ===\")\n",
    "\n",
    "# Below Normal examples\n",
    "bn_examples = df_combined_with_outcome[df_combined_with_outcome['Outcome'] == 'bn'][sample_cols].head(5)\n",
    "print(f\"\\nBELOW NORMAL (bn) - {len(df_combined_with_outcome[df_combined_with_outcome['Outcome'] == 'bn'])} records:\")\n",
    "for i, (_, row) in enumerate(bn_examples.iterrows(), 1):\n",
    "    print(f\"{i}. {row['Standard Test Name']}: {row['Result']} ({row['Unit']}) -> {row['Outcome']} [{row['Gender']}, Age: {row['Age']}]\")\n",
    "\n",
    "# Normal examples\n",
    "n_examples = df_combined_with_outcome[df_combined_with_outcome['Outcome'] == 'n'][sample_cols].head(5)\n",
    "print(f\"\\nNORMAL (n) - {len(df_combined_with_outcome[df_combined_with_outcome['Outcome'] == 'n'])} records:\")\n",
    "for i, (_, row) in enumerate(n_examples.iterrows(), 1):\n",
    "    print(f\"{i}. {row['Standard Test Name']}: {row['Result']} ({row['Unit']}) -> {row['Outcome']} [{row['Gender']}, Age: {row['Age']}]\")\n",
    "\n",
    "# Above Normal examples\n",
    "an_examples = df_combined_with_outcome[df_combined_with_outcome['Outcome'] == 'an'][sample_cols].head(5)\n",
    "print(f\"\\nABOVE NORMAL (an) - {len(df_combined_with_outcome[df_combined_with_outcome['Outcome'] == 'an'])} records:\")\n",
    "for i, (_, row) in enumerate(an_examples.iterrows(), 1):\n",
    "    print(f\"{i}. {row['Standard Test Name']}: {row['Result']} ({row['Unit']}) -> {row['Outcome']} [{row['Gender']}, Age: {row['Age']}]\")\n",
    "\n",
    "# Update the main dataframe\n",
    "df_combined = df_combined_with_outcome.copy()\n",
    "print(f\"\\n=== DATAFRAME UPDATED ===\")\n",
    "print(f\"df_combined now includes the 'Outcome' column with {len(df_combined)} records\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "id": "5bfd2e94",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "=== OUTCOME COLUMN VERIFICATION ===\n",
      "Total records: 157,361\n",
      "Records with Outcome column: 157,361\n",
      "\n",
      "=== OUTCOME DISTRIBUTION ===\n",
      "Normal (n): 115,365 (73.3%)\n",
      "Above Normal (an): 28,006 (17.8%)\n",
      "Below Normal (bn): 13,990 (8.9%)\n",
      "\n",
      "=== OUTCOME DISTRIBUTION BY LAB ===\n",
      "Outcome     an    bn      n\n",
      "Lab                        \n",
      "Biolab   16693  8715  58771\n",
      "Darugha    564    93   2166\n",
      "Hawkari  10749  5182  54428\n",
      "\n",
      "=== PERCENTAGE DISTRIBUTION BY LAB ===\n",
      "Outcome    an    bn     n\n",
      "Lab                      \n",
      "Biolab   19.8  10.4  69.8\n",
      "Darugha  20.0   3.3  76.7\n",
      "Hawkari  15.3   7.4  77.4\n",
      "\n",
      "=== SAMPLE CATEGORIZATIONS ===\n",
      "Numeric Result Examples:\n",
      "\n",
      "Below Normal (bn):\n",
      "  1. Blood Sugar: 67 mg/dl [Male]\n",
      "  2. Blood Sugar: 68 mg/dl [Female]\n",
      "  3. Blood Sugar: 9.08 mg/dl [Female]\n",
      "\n",
      "Normal (n):\n",
      "  1. Blood Sugar: 95 mg/dl [Male]\n",
      "  2. Blood Sugar: 86 mg/dl [Male]\n",
      "  3. Blood Sugar: 84 mg/dl [Male]\n",
      "\n",
      "Above Normal (an):\n",
      "  1. Blood Sugar: 157 mg/dl [Female]\n",
      "  2. Blood Sugar: 106 mg/dl [Female]\n",
      "  3. Blood Sugar: 101 mg/dl [Female]\n",
      "\n",
      "Non-Numeric Result Examples:\n",
      "\n",
      "Below Normal (bn):\n",
      "  1. TSH: '<0.005' [Male]\n",
      "  2. TSH: '<0.005' [Female]\n",
      "  3. TSH: '<0.005' [Female]\n",
      "\n",
      "Normal (n):\n",
      "  1. Blood Sugar: 'attach' [Female]\n",
      "  2. Blood Sugar: '> 600' [Female]\n",
      "  3. HbA1c: '11,74' [Male]\n",
      "\n",
      "Above Normal (an):\n",
      "  1. Typhoid IgG: 'Positive' [Male]\n",
      "  2. Typhoid IgG: 'Positive' [Female]\n",
      "  3. Typhoid IgG: 'Positive' [Male]\n",
      "\n",
      "=== CATEGORIZATION COMPLETE ===\n",
      "Successfully categorized 157,361 lab test results!\n",
      "The 'Outcome' column is now available for analysis.\n"
     ]
    }
   ],
   "source": [
    "# Verification of the Outcome column creation\n",
    "print(\"=== OUTCOME COLUMN VERIFICATION ===\")\n",
    "print(f\"Total records: {len(df_combined):,}\")\n",
    "print(f\"Records with Outcome column: {df_combined['Outcome'].notna().sum():,}\")\n",
    "\n",
    "# Show outcome distribution\n",
    "outcome_distribution = df_combined['Outcome'].value_counts()\n",
    "print(f\"\\n=== OUTCOME DISTRIBUTION ===\")\n",
    "for outcome, count in outcome_distribution.items():\n",
    "    percentage = count / len(df_combined) * 100\n",
    "    outcome_name = {'bn': 'Below Normal', 'n': 'Normal', 'an': 'Above Normal'}[outcome]\n",
    "    print(f\"{outcome_name} ({outcome}): {count:,} ({percentage:.1f}%)\")\n",
    "\n",
    "# Show distribution by lab\n",
    "print(f\"\\n=== OUTCOME DISTRIBUTION BY LAB ===\")\n",
    "outcome_by_lab = df_combined.groupby(['Lab', 'Outcome']).size().unstack(fill_value=0)\n",
    "print(outcome_by_lab)\n",
    "\n",
    "# Show percentage by lab\n",
    "print(f\"\\n=== PERCENTAGE DISTRIBUTION BY LAB ===\")\n",
    "outcome_by_lab_pct = df_combined.groupby(['Lab', 'Outcome']).size().unstack(fill_value=0)\n",
    "outcome_by_lab_pct_normalized = outcome_by_lab_pct.div(outcome_by_lab_pct.sum(axis=1), axis=0) * 100\n",
    "print(outcome_by_lab_pct_normalized.round(1))\n",
    "\n",
    "# Show some examples of each category\n",
    "print(f\"\\n=== SAMPLE CATEGORIZATIONS ===\")\n",
    "\n",
    "# Numeric examples\n",
    "numeric_results = pd.to_numeric(df_combined['Result'], errors='coerce')\n",
    "numeric_data = df_combined[numeric_results.notna()]\n",
    "\n",
    "print(\"Numeric Result Examples:\")\n",
    "for outcome in ['bn', 'n', 'an']:\n",
    "    examples = numeric_data[numeric_data['Outcome'] == outcome].head(3)\n",
    "    outcome_name = {'bn': 'Below Normal', 'n': 'Normal', 'an': 'Above Normal'}[outcome]\n",
    "    print(f\"\\n{outcome_name} ({outcome}):\")\n",
    "    for i, (_, row) in enumerate(examples.iterrows(), 1):\n",
    "        print(f\"  {i}. {row['Standard Test Name']}: {row['Result']} {row['Unit']} [{row['Gender']}]\")\n",
    "\n",
    "# Non-numeric examples  \n",
    "non_numeric_data = df_combined[numeric_results.isna()]\n",
    "print(\"\\nNon-Numeric Result Examples:\")\n",
    "for outcome in ['bn', 'n', 'an']:\n",
    "    examples = non_numeric_data[non_numeric_data['Outcome'] == outcome].head(3)\n",
    "    outcome_name = {'bn': 'Below Normal', 'n': 'Normal', 'an': 'Above Normal'}[outcome]\n",
    "    print(f\"\\n{outcome_name} ({outcome}):\")\n",
    "    for i, (_, row) in enumerate(examples.iterrows(), 1):\n",
    "        print(f\"  {i}. {row['Standard Test Name']}: '{row['Result']}' [{row['Gender']}]\")\n",
    "\n",
    "print(f\"\\n=== CATEGORIZATION COMPLETE ===\")\n",
    "print(f\"Successfully categorized {len(df_combined):,} lab test results!\")\n",
    "print(\"The 'Outcome' column is now available for analysis.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "id": "3e7679d4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "✅ Saved complete dataset with Outcome column to: combined_lab_testsV5.csv\n",
      "📊 File contains 157,361 records with 13 columns\n",
      "📋 Columns: Sample ID, Patient Name, Gender, DOB, Test Name, Unit, Category, Result, DOS, Standard Test Name, Lab, Age, Outcome\n",
      "\n",
      "=== FINAL SUMMARY ===\n",
      "🔬 Total lab test results: 157,361\n",
      "🏥 Labs included: Biolab, Darugha, Hawkari\n",
      "👥 Genders: Male, Female\n",
      "🧪 Unique test types: 216\n",
      "📈 Outcome distribution:\n",
      "   ✅ Normal (n): 115,365 (73.3%)\n",
      "   📈 Above Normal (an): 28,006 (17.8%)\n",
      "   📉 Below Normal (bn): 13,990 (8.9%)\n",
      "\n",
      "🎯 The dataset is now ready for health data analysis!\n",
      "📁 File saved as: combined_lab_testsV5.csv\n"
     ]
    }
   ],
   "source": [
    "# Save the updated dataframe with Outcome column\n",
    "output_filename = 'combined_lab_testsV5.csv'\n",
    "df_combined.to_csv(output_filename, index=False)\n",
    "print(f\"✅ Saved complete dataset with Outcome column to: {output_filename}\")\n",
    "print(f\"📊 File contains {len(df_combined):,} records with {len(df_combined.columns)} columns\")\n",
    "print(f\"📋 Columns: {', '.join(df_combined.columns.tolist())}\")\n",
    "\n",
    "# Show final summary\n",
    "print(f\"\\n=== FINAL SUMMARY ===\")\n",
    "print(f\"🔬 Total lab test results: {len(df_combined):,}\")\n",
    "print(f\"🏥 Labs included: {', '.join(df_combined['Lab'].unique())}\")\n",
    "print(f\"👥 Genders: {', '.join(df_combined['Gender'].unique())}\")\n",
    "print(f\"🧪 Unique test types: {df_combined['Standard Test Name'].nunique():,}\")\n",
    "print(f\"📈 Outcome distribution:\")\n",
    "\n",
    "outcome_counts = df_combined['Outcome'].value_counts()\n",
    "for outcome, count in outcome_counts.items():\n",
    "    percentage = count / len(df_combined) * 100\n",
    "    outcome_name = {'bn': 'Below Normal', 'n': 'Normal', 'an': 'Above Normal'}[outcome]\n",
    "    emoji = {'bn': '📉', 'n': '✅', 'an': '📈'}[outcome]\n",
    "    print(f\"   {emoji} {outcome_name} ({outcome}): {count:,} ({percentage:.1f}%)\")\n",
    "\n",
    "print(f\"\\n🎯 The dataset is now ready for health data analysis!\")\n",
    "print(f\"📁 File saved as: {output_filename}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "id": "5b0cefaa",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Sample ID</th>\n",
       "      <th>Patient Name</th>\n",
       "      <th>Gender</th>\n",
       "      <th>DOB</th>\n",
       "      <th>Test Name</th>\n",
       "      <th>Unit</th>\n",
       "      <th>Category</th>\n",
       "      <th>Result</th>\n",
       "      <th>DOS</th>\n",
       "      <th>Standard Test Name</th>\n",
       "      <th>Lab</th>\n",
       "      <th>Age</th>\n",
       "      <th>Outcome</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>118</td>\n",
       "      <td>Xalil Ahmad Mhamad</td>\n",
       "      <td>Male</td>\n",
       "      <td>16/04/1959</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>95</td>\n",
       "      <td>16/04/2023</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>Biolab</td>\n",
       "      <td>64.0</td>\n",
       "      <td>n</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>126</td>\n",
       "      <td>Dyar Omar</td>\n",
       "      <td>Male</td>\n",
       "      <td>16/04/1986</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>86</td>\n",
       "      <td>16/04/2023</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>Biolab</td>\n",
       "      <td>37.0</td>\n",
       "      <td>n</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>132</td>\n",
       "      <td>Fatah Mhamad Qadr</td>\n",
       "      <td>Male</td>\n",
       "      <td>16/04/1970</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>84</td>\n",
       "      <td>16/04/2023</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>Biolab</td>\n",
       "      <td>53.0</td>\n",
       "      <td>n</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>177</td>\n",
       "      <td>Sesna Qubad Anwar</td>\n",
       "      <td>Female</td>\n",
       "      <td>17/04/1973</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>84</td>\n",
       "      <td>17/04/2023</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>Biolab</td>\n",
       "      <td>50.0</td>\n",
       "      <td>n</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>179</td>\n",
       "      <td>Bayan Abdulla Abdurahman</td>\n",
       "      <td>Female</td>\n",
       "      <td>17/04/1981</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>mg/dl</td>\n",
       "      <td>Diabetes Test</td>\n",
       "      <td>96</td>\n",
       "      <td>17/04/2023</td>\n",
       "      <td>Blood Sugar</td>\n",
       "      <td>Biolab</td>\n",
       "      <td>42.0</td>\n",
       "      <td>n</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Sample ID              Patient Name  Gender         DOB    Test Name  \\\n",
       "0        118        Xalil Ahmad Mhamad    Male  16/04/1959  Blood Sugar   \n",
       "1        126                 Dyar Omar    Male  16/04/1986  Blood Sugar   \n",
       "2        132         Fatah Mhamad Qadr    Male  16/04/1970  Blood Sugar   \n",
       "3        177         Sesna Qubad Anwar  Female  17/04/1973  Blood Sugar   \n",
       "4        179  Bayan Abdulla Abdurahman  Female  17/04/1981  Blood Sugar   \n",
       "\n",
       "    Unit       Category Result         DOS Standard Test Name     Lab   Age  \\\n",
       "0  mg/dl  Diabetes Test     95  16/04/2023        Blood Sugar  Biolab  64.0   \n",
       "1  mg/dl  Diabetes Test     86  16/04/2023        Blood Sugar  Biolab  37.0   \n",
       "2  mg/dl  Diabetes Test     84  16/04/2023        Blood Sugar  Biolab  53.0   \n",
       "3  mg/dl  Diabetes Test     84  17/04/2023        Blood Sugar  Biolab  50.0   \n",
       "4  mg/dl  Diabetes Test     96  17/04/2023        Blood Sugar  Biolab  42.0   \n",
       "\n",
       "  Outcome  \n",
       "0       n  \n",
       "1       n  \n",
       "2       n  \n",
       "3       n  \n",
       "4       n  "
      ]
     },
     "execution_count": 72,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_combined.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "1031333d",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_combined = pd.read_csv('combined_lab_testsV5.csv')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "178fa2ee",
   "metadata": {},
   "source": [
    "**NAME MATCHING**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "1fde14b8",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "d:\\Research\\mhmd_mawlawi\\health_data\\.venv\\Lib\\site-packages\\fuzzywuzzy\\fuzz.py:11: UserWarning: Using slow pure-python SequenceMatcher. Install python-Levenshtein to remove this warning\n",
      "  warnings.warn('Using slow pure-python SequenceMatcher. Install python-Levenshtein to remove this warning')\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Found 39 groups of similar names with first name constraint\n",
      "\n",
      "First 20 groups:\n",
      "\n",
      "Group 1:\n",
      "  Lab: Biolab\n",
      "  DOB: 1/6/2022\n",
      "  Similar names (2): ['Kyan Ranj Jamal', 'Kian Ranj Jamal']\n",
      "\n",
      "Group 2:\n",
      "  Lab: Biolab\n",
      "  DOB: 1/9/2022\n",
      "  Similar names (2): ['Kyana Barham Latef', 'Dyana Barham Latef']\n",
      "\n",
      "Group 3:\n",
      "  Lab: Biolab\n",
      "  DOB: 13/06/1962\n",
      "  Similar names (2): ['Xanm Hamaamin Hamasalh', 'Xanm Hama Amin Hamasalih']\n",
      "\n",
      "Group 4:\n",
      "  Lab: Biolab\n",
      "  DOB: 14/05/1993\n",
      "  Similar names (2): ['Avin Taha Mhamad', 'Avin Taha Muhammed']\n",
      "\n",
      "Group 5:\n",
      "  Lab: Biolab\n",
      "  DOB: 15/07/2009\n",
      "  Similar names (2): ['Inas Hoshmand', 'Enas Hoshmand']\n",
      "\n",
      "Group 6:\n",
      "  Lab: Biolab\n",
      "  DOB: 20/04/1957\n",
      "  Similar names (2): ['Taiba Mahmud Maulud', 'Taiba Mahmud maulud']\n",
      "\n",
      "Group 7:\n",
      "  Lab: Biolab\n",
      "  DOB: 20/04/1987\n",
      "  Similar names (2): ['Hawsar Kamal Mhamad', 'Hawsar Kam,al Mhamad']\n",
      "\n",
      "Group 8:\n",
      "  Lab: Biolab\n",
      "  DOB: 20/08/1991\n",
      "  Similar names (2): ['Avan Abdulaziz Fatah', 'Avan Abdulazizi Fatah']\n",
      "\n",
      "Group 9:\n",
      "  Lab: Biolab\n",
      "  DOB: 20/09/1982\n",
      "  Similar names (2): ['jamil salh ali', 'jalil salh ali']\n",
      "\n",
      "Group 10:\n",
      "  Lab: Biolab\n",
      "  DOB: 21/02/2023\n",
      "  Similar names (2): ['Marwa Kaewan Latef', 'Maawa Kaiwan Latef']\n",
      "\n",
      "Group 11:\n",
      "  Lab: Biolab\n",
      "  DOB: 22/06/1989\n",
      "  Similar names (2): ['Shamal Mohamad Qadr', 'Shamal Mhamad Qadr']\n",
      "\n",
      "Group 12:\n",
      "  Lab: Biolab\n",
      "  DOB: 23/04/1983\n",
      "  Similar names (2): ['Sarhang Rashid Faraj', 'Sarhang Rashid faraj']\n",
      "\n",
      "Group 13:\n",
      "  Lab: Biolab\n",
      "  DOB: 23/05/2006\n",
      "  Similar names (2): ['Yad Ibrahim Jalal', 'Yad Ebrahim Jalal']\n",
      "\n",
      "Group 14:\n",
      "  Lab: Biolab\n",
      "  DOB: 25/04/1980\n",
      "  Similar names (2): ['Tavga Haidar', 'Tavga Haedar']\n",
      "\n",
      "Group 15:\n",
      "  Lab: Biolab\n",
      "  DOB: 27/04/1996\n",
      "  Similar names (3): ['Kozhin Faiq Sadq', 'Kozhin Faiqn Sadq', 'Kozhin Fayaq Sadq']\n",
      "\n",
      "Group 16:\n",
      "  Lab: Biolab\n",
      "  DOB: 27/07/2024\n",
      "  Similar names (2): ['kovan mahamad amanj', 'Rovan Muhamad Amanj']\n",
      "\n",
      "Group 17:\n",
      "  Lab: Biolab\n",
      "  DOB: 28/06/1996\n",
      "  Similar names (2): ['payam hassan mir ahmad', 'payam hassan mirahmad']\n",
      "\n",
      "Group 18:\n",
      "  Lab: Biolab\n",
      "  DOB: 29/04/1984\n",
      "  Similar names (2): ['Sarkash Sharhan  Flamarz', 'Sarkash Sharhan Flamarz']\n",
      "\n",
      "Group 19:\n",
      "  Lab: Biolab\n",
      "  DOB: 3/9/2023\n",
      "  Similar names (2): ['Elyas Zhyar Mhamad', 'Alyas Zhyar Mhamad']\n",
      "\n",
      "Group 20:\n",
      "  Lab: Biolab\n",
      "  DOB: 31/01/1984\n",
      "  Similar names (2): ['Shara Sdeq Hamid', 'Shara Sdiq Hamid']\n"
     ]
    }
   ],
   "source": [
    "from fuzzywuzzy import fuzz\n",
    "from collections import defaultdict\n",
    "# Lets optimize more, adding one more constraint\n",
    "# their first name should match exactly or mismatch only on one character.\n",
    "\n",
    "def find_similar_names_v2(df, similarity_threshold=65):\n",
    "    \"\"\"\n",
    "    Find similar patient names using fuzzy matching with first name constraint\n",
    "    Returns groups of similar names that share the same LAB, DOB, and have similar first names\n",
    "    \"\"\"\n",
    "    \n",
    "    def first_names_similar(name1, name2):\n",
    "        \"\"\"Check if first names match exactly or have only one character difference\"\"\"\n",
    "        first1 = name1.split()[0].lower()\n",
    "        first2 = name2.split()[0].lower()\n",
    "        \n",
    "        # Exact match\n",
    "        if first1 == first2:\n",
    "            return True\n",
    "        \n",
    "        # Check if only one character difference\n",
    "        if abs(len(first1) - len(first2)) > 1:\n",
    "            return False\n",
    "        \n",
    "        # Count character differences\n",
    "        differences = 0\n",
    "        min_len = min(len(first1), len(first2))\n",
    "        max_len = max(len(first1), len(first2))\n",
    "        \n",
    "\n",
    "        for i in range(min_len):\n",
    "            if first1[i] != first2[i]:\n",
    "                differences += 1\n",
    "        \n",
    "        # Add difference for length mismatch\n",
    "        differences += max_len - min_len\n",
    "        \n",
    "        return differences <= 1\n",
    "    \n",
    "    # Group by LAB and DOB first to reduce comparison space\n",
    "    grouped = df.groupby(['Lab', 'DOB'])\n",
    "    similar_groups = []\n",
    "    \n",
    "    for (lab, dob), group in grouped:\n",
    "        unique_names = group['Patient Name'].unique()\n",
    "        \n",
    "        if len(unique_names) > 1:\n",
    "            processed_names = set()\n",
    "            \n",
    "            for i, name1 in enumerate(unique_names):\n",
    "                if name1 in processed_names:\n",
    "                    continue\n",
    "                    \n",
    "                current_group = [name1]\n",
    "                processed_names.add(name1)\n",
    "                \n",
    "                for name2 in unique_names[i+1:]:\n",
    "                    if name2 not in processed_names:\n",
    "                        # Check both fuzzy similarity and first name constraint\n",
    "                        similarity = fuzz.ratio(name1.lower(), name2.lower())\n",
    "                        if (similarity >= similarity_threshold and \n",
    "                            first_names_similar(name1, name2)):\n",
    "                            current_group.append(name2)\n",
    "                            processed_names.add(name2)\n",
    "                \n",
    "                if len(current_group) > 1:\n",
    "                    similar_groups.append({\n",
    "                        'lab': lab,\n",
    "                        'dob': dob,\n",
    "                        'similar_names': current_group,\n",
    "                        'count': len(current_group)\n",
    "                    })\n",
    "    \n",
    "    return similar_groups\n",
    "\n",
    "# Test the improved function\n",
    "similar_name_groups_v2 = find_similar_names_v2(df_combined, 85)\n",
    "\n",
    "print(f\"Found {len(similar_name_groups_v2)} groups of similar names with first name constraint\")\n",
    "print(\"\\nFirst 20 groups:\")\n",
    "for i, group in enumerate(similar_name_groups_v2[:20]):\n",
    "    print(f\"\\nGroup {i+1}:\")\n",
    "    print(f\"  Lab: {group['lab']}\")\n",
    "    print(f\"  DOB: {group['dob']}\")\n",
    "    print(f\"  Similar names ({group['count']}): {group['similar_names']}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "b309a09d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Found 20 groups of similar names with threshold 95\n",
      "Found 35 groups of similar names with threshold 90\n",
      "Found 39 groups of similar names with threshold 85\n",
      "Found 46 groups of similar names with threshold 80\n",
      "Found 51 groups of similar names with threshold 75\n",
      "Found 62 groups of similar names with threshold 70\n",
      "Found 76 groups of similar names with threshold 65\n",
      "Found 90 groups of similar names with threshold 60\n"
     ]
    }
   ],
   "source": [
    "fine_tuning = [95,90,85, 80, 75, 70, 65, 60]\n",
    "\n",
    "for i in fine_tuning:\n",
    "    similar_name_groups = find_similar_names_v2(df_combined, i)\n",
    "    print(f\"Found {len(similar_name_groups)} groups of similar names with threshold {i}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "097e3c87",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Found 62 groups of similar names with first name constraint\n",
      "\n",
      "Groups for 70% threshold:\n",
      "\n",
      "Group 1:\n",
      "  Lab: Biolab\n",
      "  DOB: 1/11/2024\n",
      "  Similar names (2): ['Ela Arian Ali', 'Ela Aryan']\n",
      "\n",
      "Group 2:\n",
      "  Lab: Biolab\n",
      "  DOB: 1/12/2024\n",
      "  Similar names (2): ['Shahan Shkar', 'Shahan Shkar Xalid']\n",
      "\n",
      "Group 3:\n",
      "  Lab: Biolab\n",
      "  DOB: 1/6/2022\n",
      "  Similar names (2): ['Kyan Ranj Jamal', 'Kian Ranj Jamal']\n",
      "\n",
      "Group 4:\n",
      "  Lab: Biolab\n",
      "  DOB: 1/9/2022\n",
      "  Similar names (2): ['Kyana Barham Latef', 'Dyana Barham Latef']\n",
      "\n",
      "Group 5:\n",
      "  Lab: Biolab\n",
      "  DOB: 10/7/1971\n",
      "  Similar names (2): ['Muhamad Abdulla', 'Muhamad Abdulla Hasan']\n",
      "\n",
      "Group 6:\n",
      "  Lab: Biolab\n",
      "  DOB: 13/01/1967\n",
      "  Similar names (2): ['Ali Mhamad Saed', 'Ali Muhammed saheed']\n",
      "\n",
      "Group 7:\n",
      "  Lab: Biolab\n",
      "  DOB: 13/06/1962\n",
      "  Similar names (2): ['Xanm Hamaamin Hamasalh', 'Xanm Hama Amin Hamasalih']\n",
      "\n",
      "Group 8:\n",
      "  Lab: Biolab\n",
      "  DOB: 14/05/1993\n",
      "  Similar names (2): ['Avin Taha Mhamad', 'Avin Taha Muhammed']\n",
      "\n",
      "Group 9:\n",
      "  Lab: Biolab\n",
      "  DOB: 15/07/2009\n",
      "  Similar names (2): ['Inas Hoshmand', 'Enas Hoshmand']\n",
      "\n",
      "Group 10:\n",
      "  Lab: Biolab\n",
      "  DOB: 20/04/1957\n",
      "  Similar names (2): ['Taiba Mahmud Maulud', 'Taiba Mahmud maulud']\n",
      "\n",
      "Group 11:\n",
      "  Lab: Biolab\n",
      "  DOB: 20/04/1987\n",
      "  Similar names (2): ['Hawsar Kamal Mhamad', 'Hawsar Kam,al Mhamad']\n",
      "\n",
      "Group 12:\n",
      "  Lab: Biolab\n",
      "  DOB: 20/08/1991\n",
      "  Similar names (2): ['Avan Abdulaziz Fatah', 'Avan Abdulazizi Fatah']\n",
      "\n",
      "Group 13:\n",
      "  Lab: Biolab\n",
      "  DOB: 20/09/1982\n",
      "  Similar names (2): ['jamil salh ali', 'jalil salh ali']\n",
      "\n",
      "Group 14:\n",
      "  Lab: Biolab\n",
      "  DOB: 21/02/2023\n",
      "  Similar names (2): ['Marwa Kaewan Latef', 'Maawa Kaiwan Latef']\n",
      "\n",
      "Group 15:\n",
      "  Lab: Biolab\n",
      "  DOB: 22/06/1989\n",
      "  Similar names (2): ['Shamal Mohamad Qadr', 'Shamal Mhamad Qadr']\n",
      "\n",
      "Group 16:\n",
      "  Lab: Biolab\n",
      "  DOB: 22/11/1991\n",
      "  Similar names (2): ['Banan Ali', 'Bayan Aziz Ali']\n",
      "\n",
      "Group 17:\n",
      "  Lab: Biolab\n",
      "  DOB: 23/04/1983\n",
      "  Similar names (2): ['Sarhang Rashid Faraj', 'Sarhang Rashid faraj']\n",
      "\n",
      "Group 18:\n",
      "  Lab: Biolab\n",
      "  DOB: 23/05/2006\n",
      "  Similar names (2): ['Yad Ibrahim Jalal', 'Yad Ebrahim Jalal']\n",
      "\n",
      "Group 19:\n",
      "  Lab: Biolab\n",
      "  DOB: 23/12/1964\n",
      "  Similar names (2): ['Shawbo Faraj Mhamad', 'Shawbo Faraj']\n",
      "\n",
      "Group 20:\n",
      "  Lab: Biolab\n",
      "  DOB: 24/04/1971\n",
      "  Similar names (2): ['sewa anwar awrahim', 'Sewa Anwar']\n",
      "\n",
      "Group 21:\n",
      "  Lab: Biolab\n",
      "  DOB: 25/04/1980\n",
      "  Similar names (2): ['Tavga Haidar', 'Tavga Haedar']\n",
      "\n",
      "Group 22:\n",
      "  Lab: Biolab\n",
      "  DOB: 26/01/1973\n",
      "  Similar names (2): ['Faraj Kaixasraw', 'Faraj Kayxasraw Ghafur']\n",
      "\n",
      "Group 23:\n",
      "  Lab: Biolab\n",
      "  DOB: 26/06/1966\n",
      "  Similar names (2): ['Ruqya Hamaali', 'Ruqia hama aly hsein']\n",
      "\n",
      "Group 24:\n",
      "  Lab: Biolab\n",
      "  DOB: 27/04/1996\n",
      "  Similar names (3): ['Kozhin Faiq Sadq', 'Kozhin Faiqn Sadq', 'Kozhin Fayaq Sadq']\n",
      "\n",
      "Group 25:\n",
      "  Lab: Biolab\n",
      "  DOB: 27/07/2024\n",
      "  Similar names (2): ['kovan mahamad amanj', 'Rovan Muhamad Amanj']\n",
      "\n",
      "Group 26:\n",
      "  Lab: Biolab\n",
      "  DOB: 28/04/2001\n",
      "  Similar names (2): ['Dlnya Muhamad Ahmad', 'Dlnya Omar Ahmad']\n",
      "\n",
      "Group 27:\n",
      "  Lab: Biolab\n",
      "  DOB: 28/06/1996\n",
      "  Similar names (2): ['payam hassan mir ahmad', 'payam hassan mirahmad']\n",
      "\n",
      "Group 28:\n",
      "  Lab: Biolab\n",
      "  DOB: 29/04/1984\n",
      "  Similar names (2): ['Sarkash Sharhan  Flamarz', 'Sarkash Sharhan Flamarz']\n",
      "\n",
      "Group 29:\n",
      "  Lab: Biolab\n",
      "  DOB: 3/9/2023\n",
      "  Similar names (2): ['Elyas Zhyar Mhamad', 'Alyas Zhyar Mhamad']\n",
      "\n",
      "Group 30:\n",
      "  Lab: Biolab\n",
      "  DOB: 30/07/1979\n",
      "  Similar names (2): ['Shahla Ali Muhamad', 'Shahla  Muhammed Faraj']\n",
      "\n",
      "Group 31:\n",
      "  Lab: Biolab\n",
      "  DOB: 30/07/2024\n",
      "  Similar names (2): ['Aiman Rebwar Muhammed', 'Aiman Rebwar Omar']\n",
      "\n",
      "Group 32:\n",
      "  Lab: Biolab\n",
      "  DOB: 31/01/1984\n",
      "  Similar names (2): ['Shara Sdeq Hamid', 'Shara Sdiq Hamid']\n",
      "\n",
      "Group 33:\n",
      "  Lab: Biolab\n",
      "  DOB: 31/05/2024\n",
      "  Similar names (2): ['Dlin Aso Omar', 'Alin Aso Omar']\n",
      "\n",
      "Group 34:\n",
      "  Lab: Biolab\n",
      "  DOB: 5/11/1972\n",
      "  Similar names (2): ['Dlsoz Abdulla Faraj', 'Dlsoz Abdwlla Faraj']\n",
      "\n",
      "Group 35:\n",
      "  Lab: Biolab\n",
      "  DOB: 6/11/1949\n",
      "  Similar names (2): ['Samin Saed', 'Samin Mhamad']\n",
      "\n",
      "Group 36:\n",
      "  Lab: Biolab\n",
      "  DOB: 6/5/1999\n",
      "  Similar names (2): ['Shnyar Yasin HamaAmin', 'Shnyar Yasen Hamaamin']\n",
      "\n",
      "Group 37:\n",
      "  Lab: Biolab\n",
      "  DOB: 6/6/1967\n",
      "  Similar names (2): ['Abdulla Esmael Mahmood', 'Abdulla Ismael Mahmood']\n",
      "\n",
      "Group 38:\n",
      "  Lab: Biolab\n",
      "  DOB: 8/2/1979\n",
      "  Similar names (2): ['Rzgar Muhamad', 'Rzgar Mhamad Amin']\n",
      "\n",
      "Group 39:\n",
      "  Lab: Biolab\n",
      "  DOB: 8/6/2024\n",
      "  Similar names (2): ['Kale Kardo Anwar', 'Kale Kaedo Anwar']\n",
      "\n",
      "Group 40:\n",
      "  Lab: Biolab\n",
      "  DOB: 9/5/2019\n",
      "  Similar names (2): ['Muhammed yasin Kamal', 'Muhammed Yasin kamal']\n",
      "\n",
      "Group 41:\n",
      "  Lab: Biolab\n",
      "  DOB: 9/8/2023\n",
      "  Similar names (2): ['Muhamad Kosar Ahmad', 'Muhamad Sleman Muhamad']\n",
      "\n",
      "Group 42:\n",
      "  Lab: Hawkari\n",
      "  DOB: 1/1/1951\n",
      "  Similar names (2): ['Kafya Alams Naftwla', 'Kafya Almas Lftala']\n",
      "\n",
      "Group 43:\n",
      "  Lab: Hawkari\n",
      "  DOB: 1/1/1955\n",
      "  Similar names (2): ['Anwar Mahmwd Mstafa', 'anwar mahmud mustafa']\n",
      "\n",
      "Group 44:\n",
      "  Lab: Hawkari\n",
      "  DOB: 1/1/1969\n",
      "  Similar names (2): ['Shirin mhamad  Pirwais', 'Shirin Mhamad Rostam']\n",
      "\n",
      "Group 45:\n",
      "  Lab: Hawkari\n",
      "  DOB: 1/1/1973\n",
      "  Similar names (2): ['Shirin Amin Mhamad', 'Shirin Abdulrahman Ahmad']\n",
      "\n",
      "Group 46:\n",
      "  Lab: Hawkari\n",
      "  DOB: 1/1/1974\n",
      "  Similar names (2): ['Shahla karim Mhamad', 'Shahla Mhamad Axa']\n",
      "\n",
      "Group 47:\n",
      "  Lab: Hawkari\n",
      "  DOB: 1/1/1981\n",
      "  Similar names (2): ['Shoxan Mhamad Faraj', 'shoxan Mhamad Amin']\n",
      "\n",
      "Group 48:\n",
      "  Lab: Hawkari\n",
      "  DOB: 1/1/1982\n",
      "  Similar names (2): ['Amira Kamal Shkur', 'amira kamal shwkr']\n",
      "\n",
      "Group 49:\n",
      "  Lab: Hawkari\n",
      "  DOB: 1/1/1985\n",
      "  Similar names (2): ['naxshin tahir ahmad', 'Naxshin Salh Hama Murad']\n",
      "\n",
      "Group 50:\n",
      "  Lab: Hawkari\n",
      "  DOB: 12/9/1989\n",
      "  Similar names (2): ['shaima muhamad hama hsen', 'shaima mhamad hamahsen']\n",
      "\n",
      "Group 51:\n",
      "  Lab: Hawkari\n",
      "  DOB: 13/04/2024\n",
      "  Similar names (2): ['Sara Hunar Ahmad', 'sara hunar ahmad']\n",
      "\n",
      "Group 52:\n",
      "  Lab: Hawkari\n",
      "  DOB: 13/11/1929\n",
      "  Similar names (2): ['zainab nadr mahmwd', 'zainab nadr mahmud']\n",
      "\n",
      "Group 53:\n",
      "  Lab: Hawkari\n",
      "  DOB: 15/05/1978\n",
      "  Similar names (2): ['Shirin faraj mhamad', 'shirin rahman ahmad']\n",
      "\n",
      "Group 54:\n",
      "  Lab: Hawkari\n",
      "  DOB: 17/09/2000\n",
      "  Similar names (2): ['hanar faisal ahmad', 'Hanar Faisal Ahmad']\n",
      "\n",
      "Group 55:\n",
      "  Lab: Hawkari\n",
      "  DOB: 2/9/1987\n",
      "  Similar names (2): ['hawzhin jawhar abas', 'Hawzhin Jawhar Abas']\n",
      "\n",
      "Group 56:\n",
      "  Lab: Hawkari\n",
      "  DOB: 21/11/1973\n",
      "  Similar names (2): ['narmin fatah qaze', 'narmin fatah qazi']\n",
      "\n",
      "Group 57:\n",
      "  Lab: Hawkari\n",
      "  DOB: 23/12/1988\n",
      "  Similar names (2): ['swmaya jalal abdwlla', 'swmaya mahmud abdwlla']\n",
      "\n",
      "Group 58:\n",
      "  Lab: Hawkari\n",
      "  DOB: 26/11/1950\n",
      "  Similar names (2): ['ahmad abdulaziz qadr', 'ahmad abdwlaziz qadr']\n",
      "\n",
      "Group 59:\n",
      "  Lab: Hawkari\n",
      "  DOB: 27/08/1979\n",
      "  Similar names (2): ['swham yuns hamasaed', 'suham unis hama saed']\n",
      "\n",
      "Group 60:\n",
      "  Lab: Hawkari\n",
      "  DOB: 27/08/1982\n",
      "  Similar names (2): ['Sharmin karim mhamad', 'sharmin karim mhamad']\n",
      "\n",
      "Group 61:\n",
      "  Lab: Hawkari\n",
      "  DOB: 27/08/1997\n",
      "  Similar names (2): ['Nwha Ahmad Mhamad', 'nuha ahmad mhamad']\n",
      "\n",
      "Group 62:\n",
      "  Lab: Hawkari\n",
      "  DOB: 30/01/1987\n",
      "  Similar names (2): ['Snwr Hama Rahim Mhamad', 'snwr hama rahim muhamad']\n"
     ]
    }
   ],
   "source": [
    "# Test the improved function\n",
    "similar_name_groups_v2 = find_similar_names_v2(df_combined, 70)\n",
    "\n",
    "print(f\"Found {len(similar_name_groups_v2)} groups of similar names with first name constraint\")\n",
    "print(\"\\nGroups for 70% threshold:\")\n",
    "for i, group in enumerate(similar_name_groups_v2):\n",
    "    print(f\"\\nGroup {i+1}:\")\n",
    "    print(f\"  Lab: {group['lab']}\")\n",
    "    print(f\"  DOB: {group['dob']}\")\n",
    "    print(f\"  Similar names ({group['count']}): {group['similar_names']}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "1b2a960c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of Unique names in the df BEFORE the renaming: 33366\n",
      "Number of Unique names in the df AFTER the renaming: 33317\n"
     ]
    }
   ],
   "source": [
    "specials=[\n",
    "          ['Inas Hoshmand', 'Enas Hoshmand'],\n",
    "          ['Banan Ali', 'Bayan Aziz Ali'],\n",
    "          ['kovan mahamad amanj', 'Rovan Muhamad Amanj'],\n",
    "          ['Aiman Rebwar Muhammed', 'Aiman Rebwar Omar'],\n",
    "          ['Dlin Aso Omar', 'Alin Aso Omar'],\n",
    "          ['Muhamad Kosar Ahmad', 'Muhamad Sleman Muhamad'],\n",
    "          ['Shirin Amin Mhamad', 'Shirin Abdulrahman Ahmad'],\n",
    "          ['Shirin mhamad  Pirwais', 'Shirin Mhamad Rostam'],\n",
    "          ['Shahla karim Mhamad', 'Shahla Mhamad Axa'],\n",
    "          ['Shoxan Mhamad Faraj', 'shoxan Mhamad Amin'],\n",
    "          ['naxshin tahir ahmad', 'Naxshin Salh Hama Murad'],\n",
    "          ['Shirin faraj mhamad', 'shirin rahman ahmad'],\n",
    "          ['swmaya jalal abdwlla', 'swmaya mahmud abdwlla'],\n",
    "          ]\n",
    "\n",
    "# lets go with 70 percent\n",
    "# rename the second matching name with the first one for threshold of 70 in the df and do not do it when the name is one of the specials\n",
    "\n",
    "similar_name_groups = find_similar_names_v2(df_combined, 70)\n",
    "# Create a set of special name pairs for faster lookup\n",
    "special_pairs = set()\n",
    "for pair in specials:\n",
    "    special_pairs.add((pair[0].lower().strip(), pair[1].lower().strip()))\n",
    "    special_pairs.add((pair[1].lower().strip(), pair[0].lower().strip()))  # Add reverse pair\n",
    "\n",
    "print(f\"Number of Unique names in the df BEFORE the renaming: {df_combined['Patient Name'].nunique()}\")\n",
    "\n",
    "for group in similar_name_groups:\n",
    "    if len(group['similar_names']) > 1:\n",
    "        # Check if this is a special case that should not be renamed\n",
    "        name1 = group['similar_names'][0].lower().strip()\n",
    "        name2 = group['similar_names'][1].lower().strip()\n",
    "        \n",
    "        if (name1, name2) not in special_pairs:\n",
    "            # Only rename if it's not a special case\n",
    "            df_combined.loc[df_combined['Patient Name'] == group['similar_names'][1], 'Patient Name'] = group['similar_names'][0]\n",
    "\n",
    "print(f\"Number of Unique names in the df AFTER the renaming: {df_combined['Patient Name'].nunique()}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "ef4e5c39",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "=== ANALYZING TEST FREQUENCIES ===\n",
      "Total records before filtering: 157,361\n",
      "Total unique tests: 216\n",
      "\n",
      "=== TEST FREQUENCY DISTRIBUTION ===\n",
      "Tests with 1-10 records: 76\n",
      "Tests with 11-50 records: 34\n",
      "Tests with 51-100 records: 19\n",
      "Tests with 101-500 records: 40\n",
      "Tests with 501-1000 records: 5\n",
      "Tests with 1001-3000 records: 25\n",
      "Tests with >3000 records: 17\n",
      "\n",
      "=== TESTS TO REMOVE (less than 1000 records) ===\n",
      "Number of tests to remove: 174\n",
      "Records to be removed: 17,519\n",
      "\n",
      "Tests being removed:\n",
      " 1. Luteinizing Hormone: 849 records\n",
      " 2. Testosterone: 839 records\n",
      " 3. Prostate-Specific Antigen: 835 records\n",
      " 4. HDL Cholesterol: 717 records\n",
      " 5. Fecal Calprotectein Titer: 555 records\n",
      " 6. Serum Albumin: 488 records\n",
      " 7. Prothrombin Time: 487 records\n",
      " 8. International Normalized Ratio: 482 records\n",
      " 9. Serum Uric Acid: 469 records\n",
      "10. C-Reactive Protein: 467 records\n",
      "11. Thyroxine (T4): 445 records\n",
      "12. Helicobacter pylori Antigen: 436 records\n",
      "13. D-Dimer: 421 records\n",
      "14. S.Zinc: 418 records\n",
      "15. Bleeding Time: 384 records\n",
      "16. Anti-MÃ¼llerian Hormone: 378 records\n",
      "17. Iron ( Total ): 362 records\n",
      "18. Clotting Time: 349 records\n",
      "19. Triiodothyronine (T3): 310 records\n",
      "20. Fecal Occult Blood: 306 records\n",
      "... and 154 more tests\n",
      "\n",
      "=== RESULTS AFTER FILTERING ===\n",
      "Records before filtering: 157,361\n",
      "Records after filtering: 139,842\n",
      "Records removed: 17,519\n",
      "Percentage of records retained: 88.9%\n",
      "\n",
      "Tests before filtering: 216\n",
      "Tests after filtering: 42\n",
      "Tests removed: 174\n",
      "\n",
      "=== TOP 20 MOST COMMON TESTS AFTER FILTERING ===\n",
      " 1. TSH: 12,464 (8.9%)\n",
      " 2. Serum Creatinine: 9,276 (6.6%)\n",
      " 3. Blood Glucose: 8,983 (6.4%)\n",
      " 4. Vitamin D3: 6,846 (4.9%)\n",
      " 5. Complete Blood Count: 6,165 (4.4%)\n",
      " 6. C-Reactive Protein Titer: 6,024 (4.3%)\n",
      " 7. HbA1c: 5,093 (3.6%)\n",
      " 8. Hepatitis B Surface Antigen: 5,028 (3.6%)\n",
      " 9. Total Serum Bilirubin: 5,023 (3.6%)\n",
      "10. Hepatitis C Antibody: 5,010 (3.6%)\n",
      "11. HIV Antibody: 5,003 (3.6%)\n",
      "12. Blood Urea Nitrogen: 3,882 (2.8%)\n",
      "13. Packed Cell Volume: 3,860 (2.8%)\n",
      "14. Serum Triglycerides: 3,670 (2.6%)\n",
      "15. Serum Ferritin: 3,573 (2.6%)\n",
      "16. Serum Cholesterol: 3,541 (2.5%)\n",
      "17. Erythrocyte Sedimentation Rate: 3,283 (2.3%)\n",
      "18. Blood Sugar: 2,941 (2.1%)\n",
      "19. S.Iron: 2,812 (2.0%)\n",
      "20. Serum LDL Cholesterol: 2,639 (1.9%)\n",
      "\n",
      "✅ Dataset filtered successfully!\n",
      "📊 New dataset size: 139,842 records with 42 unique tests\n"
     ]
    }
   ],
   "source": [
    "# Task 1: Analyze test frequencies and remove tests with small frequencies\n",
    "\n",
    "print(\"=== ANALYZING TEST FREQUENCIES ===\")\n",
    "print(f\"Total records before filtering: {len(df_combined):,}\")\n",
    "\n",
    "# Get test frequency distribution\n",
    "test_frequency = df_combined['Standard Test Name'].value_counts()\n",
    "print(f\"Total unique tests: {len(test_frequency)}\")\n",
    "\n",
    "# Show distribution of test frequencies\n",
    "print(f\"\\n=== TEST FREQUENCY DISTRIBUTION ===\")\n",
    "print(f\"Tests with 1-10 records: {(test_frequency <= 10).sum()}\")\n",
    "print(f\"Tests with 11-50 records: {((test_frequency > 10) & (test_frequency <= 50)).sum()}\")\n",
    "print(f\"Tests with 51-100 records: {((test_frequency > 50) & (test_frequency <= 100)).sum()}\")\n",
    "print(f\"Tests with 101-500 records: {((test_frequency > 100) & (test_frequency <= 500)).sum()}\")\n",
    "print(f\"Tests with 501-1000 records: {((test_frequency > 500) & (test_frequency <= 1000)).sum()}\")\n",
    "print(f\"Tests with 1001-3000 records: {((test_frequency > 1000) & (test_frequency <= 3000)).sum()}\")\n",
    "print(f\"Tests with >3000 records: {(test_frequency > 3000).sum()}\")\n",
    "\n",
    "# Define threshold for removing low-frequency tests\n",
    "min_frequency_threshold = 1000\n",
    "low_frequency_tests = test_frequency[test_frequency < min_frequency_threshold].index.tolist()\n",
    "\n",
    "print(f\"\\n=== TESTS TO REMOVE (less than {min_frequency_threshold} records) ===\")\n",
    "print(f\"Number of tests to remove: {len(low_frequency_tests)}\")\n",
    "print(f\"Records to be removed: {test_frequency[test_frequency < min_frequency_threshold].sum():,}\")\n",
    "\n",
    "# Show the tests that will be removed\n",
    "print(f\"\\nTests being removed:\")\n",
    "for i, test in enumerate(low_frequency_tests[:20], 1):\n",
    "    count = test_frequency[test]\n",
    "    print(f\"{i:2d}. {test}: {count} records\")\n",
    "if len(low_frequency_tests) > 20:\n",
    "    print(f\"... and {len(low_frequency_tests) - 20} more tests\")\n",
    "\n",
    "# Remove low-frequency tests\n",
    "df_filtered = df_combined[~df_combined['Standard Test Name'].isin(low_frequency_tests)].copy()\n",
    "\n",
    "print(f\"\\n=== RESULTS AFTER FILTERING ===\")\n",
    "print(f\"Records before filtering: {len(df_combined):,}\")\n",
    "print(f\"Records after filtering: {len(df_filtered):,}\")\n",
    "print(f\"Records removed: {len(df_combined) - len(df_filtered):,}\")\n",
    "print(f\"Percentage of records retained: {len(df_filtered)/len(df_combined)*100:.1f}%\")\n",
    "\n",
    "print(f\"\\nTests before filtering: {df_combined['Standard Test Name'].nunique()}\")\n",
    "print(f\"Tests after filtering: {df_filtered['Standard Test Name'].nunique()}\")\n",
    "print(f\"Tests removed: {df_combined['Standard Test Name'].nunique() - df_filtered['Standard Test Name'].nunique()}\")\n",
    "\n",
    "# Show the most common tests after filtering\n",
    "print(f\"\\n=== TOP 20 MOST COMMON TESTS AFTER FILTERING ===\")\n",
    "filtered_test_freq = df_filtered['Standard Test Name'].value_counts()\n",
    "for i, (test, count) in enumerate(filtered_test_freq.head(20).items(), 1):\n",
    "    percentage = count / len(df_filtered) * 100\n",
    "    print(f\"{i:2d}. {test}: {count:,} ({percentage:.1f}%)\")\n",
    "\n",
    "# Update the main dataframe\n",
    "df_combined = df_filtered.copy()\n",
    "print(f\"\\n✅ Dataset filtered successfully!\")\n",
    "print(f\"📊 New dataset size: {len(df_combined):,} records with {df_combined['Standard Test Name'].nunique()} unique tests\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "42d71d02",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total unique tests after filtering: 42\n",
      "Pivot table shape: (31935, 42)\n",
      "Patients: 31935, Tests: 42\n",
      "Total subsets of size 2: 861\n",
      "\n",
      "Subsets of 2 tests with more than 1000 patients:\n",
      "Found 65 qualifying subsets\n",
      "\n",
      "================================================================================\n",
      "Rank 65: ('Serum Creatinine', 'Blood Glucose') - 4965 patients\n",
      "Rank 64: ('Hepatitis B Surface Antigen', 'Hepatitis C Antibody') - 4853 patients\n",
      "Rank 63: ('Hepatitis B Surface Antigen', 'HIV Antibody') - 4846 patients\n",
      "Rank 62: ('Hepatitis C Antibody', 'HIV Antibody') - 4846 patients\n",
      "Rank 61: ('TSH', 'Serum Creatinine') - 3779 patients\n",
      "Rank 60: ('TSH', 'Blood Glucose') - 3754 patients\n",
      "Rank 59: ('Serum Creatinine', 'Total Serum Bilirubin') - 3281 patients\n",
      "Rank 58: ('Total Serum Bilirubin', 'Blood Glucose') - 3064 patients\n",
      "Rank 57: ('Blood Urea Nitrogen', 'Serum Creatinine') - 2870 patients\n",
      "Rank 56: ('TSH', 'Vitamin D3') - 2610 patients\n",
      "Rank 55: ('Serum Cholesterol', 'Serum Triglycerides') - 2515 patients\n",
      "Rank 54: ('TSH', 'Total Serum Bilirubin') - 2427 patients\n",
      "Rank 53: ('Serum Creatinine', 'C-Reactive Protein Titer') - 2227 patients\n",
      "Rank 52: ('Blood Glucose', 'C-Reactive Protein Titer') - 2146 patients\n",
      "Rank 51: ('Serum Cholesterol', 'Serum LDL Cholesterol') - 1930 patients\n",
      "Rank 50: ('Serum Triglycerides', 'Serum LDL Cholesterol') - 1903 patients\n",
      "Rank 49: ('HbA1c', 'Blood Glucose') - 1855 patients\n",
      "Rank 48: ('TSH', 'Serum Ferritin') - 1843 patients\n",
      "Rank 47: ('Aspartate Aminotransferase (AST)', 'Alanine Aminotransferase (ALT)') - 1820 patients\n",
      "Rank 46: ('TSH', 'Complete Blood Count') - 1812 patients\n",
      "Rank 45: ('Vitamin D3', 'Complete Blood Count') - 1682 patients\n",
      "Rank 44: ('S.Iron', 'Vitamin D3') - 1635 patients\n",
      "Rank 43: ('HbA1c', 'Serum Creatinine') - 1633 patients\n",
      "Rank 42: ('Serum HDL Cholesterol', 'Serum LDL Cholesterol') - 1602 patients\n",
      "Rank 41: ('Serum Cholesterol', 'Serum HDL Cholesterol') - 1586 patients\n",
      "Rank 40: ('Serum Triglycerides', 'Serum HDL Cholesterol') - 1580 patients\n",
      "Rank 39: ('HbA1c', 'TSH') - 1538 patients\n",
      "Rank 38: ('TSH', 'C-Reactive Protein Titer') - 1518 patients\n",
      "Rank 37: ('Blood Sugar', 'Complete Blood Count') - 1511 patients\n",
      "Rank 36: ('Total Cholesterol', 'LDL Cholesterol') - 1467 patients\n",
      "Rank 35: ('Serum Creatinine', 'Alanine Aminotransferase (ALT)') - 1406 patients\n",
      "Rank 34: ('S.Iron', 'Complete Blood Count') - 1399 patients\n",
      "Rank 33: ('TSH', 'Erythrocyte Sedimentation Rate') - 1393 patients\n",
      "Rank 32: ('Serum Creatinine', 'Aspartate Aminotransferase (AST)') - 1361 patients\n",
      "Rank 31: ('Serum Creatinine', 'Serum Ferritin') - 1353 patients\n",
      "Rank 30: ('Serum Ferritin', 'Blood Glucose') - 1339 patients\n",
      "Rank 29: ('TSH', 'Prolactin') - 1288 patients\n",
      "Rank 28: ('Serum Ferritin', 'Vitamin D3') - 1273 patients\n",
      "Rank 27: ('Erythrocyte Sedimentation Rate', 'C-Reactive Protein Titer') - 1268 patients\n",
      "Rank 26: ('Total Serum Bilirubin', 'C-Reactive Protein Titer') - 1245 patients\n",
      "Rank 25: ('TSH', 'LDL Cholesterol') - 1241 patients\n",
      "Rank 24: ('Blood Glucose', 'LDL Cholesterol') - 1232 patients\n",
      "Rank 23: ('Serum Creatinine', 'LDL Cholesterol') - 1230 patients\n",
      "Rank 22: ('Total Cholesterol', 'Triglycerides') - 1215 patients\n",
      "Rank 21: ('Serum Creatinine', 'Erythrocyte Sedimentation Rate') - 1191 patients\n",
      "Rank 20: ('Triglycerides', 'LDL Cholesterol') - 1189 patients\n",
      "Rank 19: ('Alanine Aminotransferase (ALT)', 'Alkaline Phosphatase') - 1125 patients\n",
      "Rank 18: ('Aspartate Aminotransferase (AST)', 'Alkaline Phosphatase') - 1116 patients\n",
      "Rank 17: ('TSH', 'Total Cholesterol') - 1114 patients\n",
      "Rank 16: ('Total Serum Bilirubin', 'Serum Ferritin') - 1088 patients\n",
      "Rank 15: ('Blood Glucose', 'Total Cholesterol') - 1077 patients\n",
      "Rank 14: ('Alanine Aminotransferase (ALT)', 'Total Serum Bilirubin') - 1076 patients\n",
      "Rank 13: ('TSH', 'Alanine Aminotransferase (ALT)') - 1068 patients\n",
      "Rank 12: ('Serum Creatinine', 'Complete Blood Count') - 1067 patients\n",
      "Rank 11: ('Aspartate Aminotransferase (AST)', 'Total Serum Bilirubin') - 1063 patients\n",
      "Rank 10: ('Serum Creatinine', 'Total Cholesterol') - 1047 patients\n",
      "Rank 9: ('Alkaline Phosphatase', 'Total Serum Bilirubin') - 1042 patients\n",
      "Rank 8: ('Hepatitis B Surface Antigen', 'Blood Glucose') - 1039 patients\n",
      "Rank 7: ('Hepatitis C Antibody', 'Blood Glucose') - 1036 patients\n",
      "Rank 6: ('HIV Antibody', 'Blood Glucose') - 1035 patients\n",
      "Rank 5: ('Vitamin D3', 'Erythrocyte Sedimentation Rate') - 1029 patients\n",
      "Rank 4: ('TSH', 'Blood Urea Nitrogen') - 1027 patients\n",
      "Rank 3: ('Vitamin D3', 'Blood Glucose') - 1018 patients\n",
      "Rank 2: ('Erythrocyte Sedimentation Rate', 'Blood Glucose') - 1018 patients\n",
      "Rank 1: ('Blood Urea Nitrogen', 'Blood Glucose') - 1017 patients\n",
      "\n",
      "=== TOP SUBSETS DATAFRAME ===\n",
      "                                                                subset  count                                                              tests\n",
      "                                 ('Serum Creatinine', 'Blood Glucose')   4965                                  [Serum Creatinine, Blood Glucose]\n",
      "               ('Hepatitis B Surface Antigen', 'Hepatitis C Antibody')   4853                [Hepatitis B Surface Antigen, Hepatitis C Antibody]\n",
      "                       ('Hepatitis B Surface Antigen', 'HIV Antibody')   4846                        [Hepatitis B Surface Antigen, HIV Antibody]\n",
      "                              ('Hepatitis C Antibody', 'HIV Antibody')   4846                               [Hepatitis C Antibody, HIV Antibody]\n",
      "                                           ('TSH', 'Serum Creatinine')   3779                                            [TSH, Serum Creatinine]\n",
      "                                              ('TSH', 'Blood Glucose')   3754                                               [TSH, Blood Glucose]\n",
      "                         ('Serum Creatinine', 'Total Serum Bilirubin')   3281                          [Serum Creatinine, Total Serum Bilirubin]\n",
      "                            ('Total Serum Bilirubin', 'Blood Glucose')   3064                             [Total Serum Bilirubin, Blood Glucose]\n",
      "                           ('Blood Urea Nitrogen', 'Serum Creatinine')   2870                            [Blood Urea Nitrogen, Serum Creatinine]\n",
      "                                                 ('TSH', 'Vitamin D3')   2610                                                  [TSH, Vitamin D3]\n",
      "                          ('Serum Cholesterol', 'Serum Triglycerides')   2515                           [Serum Cholesterol, Serum Triglycerides]\n",
      "                                      ('TSH', 'Total Serum Bilirubin')   2427                                       [TSH, Total Serum Bilirubin]\n",
      "                      ('Serum Creatinine', 'C-Reactive Protein Titer')   2227                       [Serum Creatinine, C-Reactive Protein Titer]\n",
      "                         ('Blood Glucose', 'C-Reactive Protein Titer')   2146                          [Blood Glucose, C-Reactive Protein Titer]\n",
      "                        ('Serum Cholesterol', 'Serum LDL Cholesterol')   1930                         [Serum Cholesterol, Serum LDL Cholesterol]\n",
      "                      ('Serum Triglycerides', 'Serum LDL Cholesterol')   1903                       [Serum Triglycerides, Serum LDL Cholesterol]\n",
      "                                            ('HbA1c', 'Blood Glucose')   1855                                             [HbA1c, Blood Glucose]\n",
      "                                             ('TSH', 'Serum Ferritin')   1843                                              [TSH, Serum Ferritin]\n",
      "('Aspartate Aminotransferase (AST)', 'Alanine Aminotransferase (ALT)')   1820 [Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT)]\n",
      "                                       ('TSH', 'Complete Blood Count')   1812                                        [TSH, Complete Blood Count]\n",
      "                                ('Vitamin D3', 'Complete Blood Count')   1682                                 [Vitamin D3, Complete Blood Count]\n",
      "                                              ('S.Iron', 'Vitamin D3')   1635                                               [S.Iron, Vitamin D3]\n",
      "                                         ('HbA1c', 'Serum Creatinine')   1633                                          [HbA1c, Serum Creatinine]\n",
      "                    ('Serum HDL Cholesterol', 'Serum LDL Cholesterol')   1602                     [Serum HDL Cholesterol, Serum LDL Cholesterol]\n",
      "                        ('Serum Cholesterol', 'Serum HDL Cholesterol')   1586                         [Serum Cholesterol, Serum HDL Cholesterol]\n",
      "                      ('Serum Triglycerides', 'Serum HDL Cholesterol')   1580                       [Serum Triglycerides, Serum HDL Cholesterol]\n",
      "                                                      ('HbA1c', 'TSH')   1538                                                       [HbA1c, TSH]\n",
      "                                   ('TSH', 'C-Reactive Protein Titer')   1518                                    [TSH, C-Reactive Protein Titer]\n",
      "                               ('Blood Sugar', 'Complete Blood Count')   1511                                [Blood Sugar, Complete Blood Count]\n",
      "                              ('Total Cholesterol', 'LDL Cholesterol')   1467                               [Total Cholesterol, LDL Cholesterol]\n",
      "                ('Serum Creatinine', 'Alanine Aminotransferase (ALT)')   1406                 [Serum Creatinine, Alanine Aminotransferase (ALT)]\n",
      "                                    ('S.Iron', 'Complete Blood Count')   1399                                     [S.Iron, Complete Blood Count]\n",
      "                             ('TSH', 'Erythrocyte Sedimentation Rate')   1393                              [TSH, Erythrocyte Sedimentation Rate]\n",
      "              ('Serum Creatinine', 'Aspartate Aminotransferase (AST)')   1361               [Serum Creatinine, Aspartate Aminotransferase (AST)]\n",
      "                                ('Serum Creatinine', 'Serum Ferritin')   1353                                 [Serum Creatinine, Serum Ferritin]\n",
      "                                   ('Serum Ferritin', 'Blood Glucose')   1339                                    [Serum Ferritin, Blood Glucose]\n",
      "                                                  ('TSH', 'Prolactin')   1288                                                   [TSH, Prolactin]\n",
      "                                      ('Serum Ferritin', 'Vitamin D3')   1273                                       [Serum Ferritin, Vitamin D3]\n",
      "        ('Erythrocyte Sedimentation Rate', 'C-Reactive Protein Titer')   1268         [Erythrocyte Sedimentation Rate, C-Reactive Protein Titer]\n",
      "                 ('Total Serum Bilirubin', 'C-Reactive Protein Titer')   1245                  [Total Serum Bilirubin, C-Reactive Protein Titer]\n",
      "                                            ('TSH', 'LDL Cholesterol')   1241                                             [TSH, LDL Cholesterol]\n",
      "                                  ('Blood Glucose', 'LDL Cholesterol')   1232                                   [Blood Glucose, LDL Cholesterol]\n",
      "                               ('Serum Creatinine', 'LDL Cholesterol')   1230                                [Serum Creatinine, LDL Cholesterol]\n",
      "                                ('Total Cholesterol', 'Triglycerides')   1215                                 [Total Cholesterol, Triglycerides]\n",
      "                ('Serum Creatinine', 'Erythrocyte Sedimentation Rate')   1191                 [Serum Creatinine, Erythrocyte Sedimentation Rate]\n",
      "                                  ('Triglycerides', 'LDL Cholesterol')   1189                                   [Triglycerides, LDL Cholesterol]\n",
      "            ('Alanine Aminotransferase (ALT)', 'Alkaline Phosphatase')   1125             [Alanine Aminotransferase (ALT), Alkaline Phosphatase]\n",
      "          ('Aspartate Aminotransferase (AST)', 'Alkaline Phosphatase')   1116           [Aspartate Aminotransferase (AST), Alkaline Phosphatase]\n",
      "                                          ('TSH', 'Total Cholesterol')   1114                                           [TSH, Total Cholesterol]\n",
      "                           ('Total Serum Bilirubin', 'Serum Ferritin')   1088                            [Total Serum Bilirubin, Serum Ferritin]\n",
      "                                ('Blood Glucose', 'Total Cholesterol')   1077                                 [Blood Glucose, Total Cholesterol]\n",
      "           ('Alanine Aminotransferase (ALT)', 'Total Serum Bilirubin')   1076            [Alanine Aminotransferase (ALT), Total Serum Bilirubin]\n",
      "                             ('TSH', 'Alanine Aminotransferase (ALT)')   1068                              [TSH, Alanine Aminotransferase (ALT)]\n",
      "                          ('Serum Creatinine', 'Complete Blood Count')   1067                           [Serum Creatinine, Complete Blood Count]\n",
      "         ('Aspartate Aminotransferase (AST)', 'Total Serum Bilirubin')   1063          [Aspartate Aminotransferase (AST), Total Serum Bilirubin]\n",
      "                             ('Serum Creatinine', 'Total Cholesterol')   1047                              [Serum Creatinine, Total Cholesterol]\n",
      "                     ('Alkaline Phosphatase', 'Total Serum Bilirubin')   1042                      [Alkaline Phosphatase, Total Serum Bilirubin]\n",
      "                      ('Hepatitis B Surface Antigen', 'Blood Glucose')   1039                       [Hepatitis B Surface Antigen, Blood Glucose]\n",
      "                             ('Hepatitis C Antibody', 'Blood Glucose')   1036                              [Hepatitis C Antibody, Blood Glucose]\n",
      "                                     ('HIV Antibody', 'Blood Glucose')   1035                                      [HIV Antibody, Blood Glucose]\n",
      "                      ('Vitamin D3', 'Erythrocyte Sedimentation Rate')   1029                       [Vitamin D3, Erythrocyte Sedimentation Rate]\n",
      "                                        ('TSH', 'Blood Urea Nitrogen')   1027                                         [TSH, Blood Urea Nitrogen]\n",
      "                                       ('Vitamin D3', 'Blood Glucose')   1018                                        [Vitamin D3, Blood Glucose]\n",
      "                   ('Erythrocyte Sedimentation Rate', 'Blood Glucose')   1018                    [Erythrocyte Sedimentation Rate, Blood Glucose]\n",
      "                              ('Blood Urea Nitrogen', 'Blood Glucose')   1017                               [Blood Urea Nitrogen, Blood Glucose]\n"
     ]
    }
   ],
   "source": [
    "from itertools import combinations\n",
    "\n",
    "# bring back all the patients that are tested for v tests.\n",
    "# with more than 300 patients\n",
    "\n",
    "unique_tests = df_combined['Standard Test Name'].unique()\n",
    "print(f\"Total unique tests after filtering: {len(unique_tests)}\")\n",
    "\n",
    "limit = 1000\n",
    "v = 2\n",
    "\n",
    "# Create a pivot table with patients as rows and tests as columns\n",
    "# Count how many times each patient had each test (binary: 1 if tested, 0 if not)\n",
    "df_pivot = df_combined.groupby(['Patient Name', 'Standard Test Name']).size().unstack(fill_value=0)\n",
    "# Convert to binary (1 if patient had the test, 0 if not)\n",
    "df_pivot = (df_pivot > 0).astype(int)\n",
    "\n",
    "print(f\"Pivot table shape: {df_pivot.shape}\")\n",
    "print(f\"Patients: {len(df_pivot)}, Tests: {len(df_pivot.columns)}\")\n",
    "\n",
    "# for each subset of v items together in unique_tests,\n",
    "# we find the subset that has more than limit patients\n",
    "subsets = list(combinations(unique_tests, v))\n",
    "print(f\"Total subsets of size {v}: {len(subsets)}\")\n",
    "\n",
    "# Initialize results list\n",
    "results = []\n",
    "\n",
    "for subset in subsets:\n",
    "    # Handle subsets of any size, not just pairs\n",
    "    if len(subset) >= 2:\n",
    "        # Check if all tests in subset exist in our pivot table\n",
    "        available_tests = [test for test in subset if test in df_pivot.columns]\n",
    "        \n",
    "        if len(available_tests) == len(subset):\n",
    "            # Create a boolean mask for patients who have all tests in the subset\n",
    "            mask = df_pivot[available_tests[0]] > 0\n",
    "            for test in available_tests[1:]:\n",
    "                mask = mask & (df_pivot[test] > 0)\n",
    "            \n",
    "            count = mask.sum()\n",
    "            if count > limit:\n",
    "                # Store results in a list for creating DataFrame\n",
    "                results.append({\n",
    "                    'subset': str(subset),\n",
    "                    'count': count,\n",
    "                    'tests': list(subset)\n",
    "                })\n",
    "\n",
    "\n",
    "# Create DataFrame from results\n",
    "results_df = pd.DataFrame(results)\n",
    "\n",
    "# Sort by count in descending order\n",
    "results_df = results_df.sort_values('count', ascending=False)\n",
    "\n",
    "print(f\"\\nSubsets of {v} tests with more than {limit} patients:\")\n",
    "print(f\"Found {len(results_df)} qualifying subsets\")\n",
    "print(\"\\n\" + \"=\"*80)\n",
    "for i, row in results_df.iterrows():\n",
    "    print(f\"Rank {len(results_df) - list(results_df.index).index(i)}: {row['subset']} - {row['count']} patients\")\n",
    "\n",
    "# Display as DataFrame\n",
    "print(f\"\\n=== TOP SUBSETS DATAFRAME ===\")\n",
    "print(results_df.to_string(index=False))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "54796673",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "=== OUTCOME DISTRIBUTION ANALYSIS FOR TEST COMBINATIONS ===\n",
      "Analyzing 65 test combinations with >2000 patients each\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Serum Creatinine + Blood Glucose\n",
      "📊 Total Patients: 4,965\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Serum Creatinine:\n",
      "   Total Records: 6,070\n",
      "   📉 Below Normal (bn): 1,874 (30.9%)\n",
      "   ✅ Normal (n): 3,898 (64.2%)\n",
      "   📈 Above Normal (an): 298 (4.9%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 3,890 (64.1%)\n",
      "      Male: 2,180 (35.9%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 5,303 (87.4%)\n",
      "      Biolab: 767 (12.6%)\n",
      "\n",
      "📋 Blood Glucose:\n",
      "   Total Records: 5,845\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 5,845 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 3,821 (65.4%)\n",
      "      Male: 2,024 (34.6%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 5,255 (89.9%)\n",
      "      Biolab: 590 (10.1%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (4965 patients):\n",
      "   📊 Serum Creatinine: Normal + Blood Glucose: Normal\n",
      "      3,209 patients (64.6%)\n",
      "   📊 Serum Creatinine: Below Normal + Blood Glucose: Normal\n",
      "      1,631 patients (32.8%)\n",
      "   📊 Serum Creatinine: Above Normal + Blood Glucose: Normal\n",
      "      125 patients (2.5%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 3,209 (64.6%)\n",
      "   Mixed Results: 1,756 (35.4%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Hepatitis B Surface Antigen + Hepatitis C Antibody\n",
      "📊 Total Patients: 4,853\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Hepatitis B Surface Antigen:\n",
      "   Total Records: 5,015\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 5,005 (99.8%)\n",
      "   📈 Above Normal (an): 10 (0.2%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 3,097 (61.8%)\n",
      "      Male: 1,918 (38.2%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,493 (49.7%)\n",
      "      Hawkari: 2,481 (49.5%)\n",
      "      Darugha: 41 (0.8%)\n",
      "\n",
      "📋 Hepatitis C Antibody:\n",
      "   Total Records: 5,010\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 5,010 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 3,094 (61.8%)\n",
      "      Male: 1,916 (38.2%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,489 (49.7%)\n",
      "      Hawkari: 2,480 (49.5%)\n",
      "      Darugha: 41 (0.8%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (4853 patients):\n",
      "   📊 Hepatitis: Normal + Hepatitis: Normal\n",
      "      4,844 patients (99.8%)\n",
      "   📊 Hepatitis: Above Normal + Hepatitis: Normal\n",
      "      9 patients (0.2%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 4,844 (99.8%)\n",
      "   Mixed Results: 9 (0.2%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Hepatitis B Surface Antigen + HIV Antibody\n",
      "📊 Total Patients: 4,846\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Hepatitis B Surface Antigen:\n",
      "   Total Records: 5,008\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 4,998 (99.8%)\n",
      "   📈 Above Normal (an): 10 (0.2%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 3,094 (61.8%)\n",
      "      Male: 1,914 (38.2%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,487 (49.7%)\n",
      "      Hawkari: 2,480 (49.5%)\n",
      "      Darugha: 41 (0.8%)\n",
      "\n",
      "📋 HIV Antibody:\n",
      "   Total Records: 5,003\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 5,002 (100.0%)\n",
      "   📈 Above Normal (an): 1 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 3,091 (61.8%)\n",
      "      Male: 1,912 (38.2%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,483 (49.6%)\n",
      "      Hawkari: 2,479 (49.6%)\n",
      "      Darugha: 41 (0.8%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (4846 patients):\n",
      "   📊 Hepatitis: Normal + HIV Antibody: Normal\n",
      "      4,836 patients (99.8%)\n",
      "   📊 Hepatitis: Above Normal + HIV Antibody: Normal\n",
      "      9 patients (0.2%)\n",
      "   📊 Hepatitis: Normal + HIV Antibody: Above Normal\n",
      "      1 patients (0.0%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 4,836 (99.8%)\n",
      "   Mixed Results: 10 (0.2%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Hepatitis C Antibody + HIV Antibody\n",
      "📊 Total Patients: 4,846\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Hepatitis C Antibody:\n",
      "   Total Records: 5,003\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 5,003 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 3,091 (61.8%)\n",
      "      Male: 1,912 (38.2%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,483 (49.6%)\n",
      "      Hawkari: 2,479 (49.6%)\n",
      "      Darugha: 41 (0.8%)\n",
      "\n",
      "📋 HIV Antibody:\n",
      "   Total Records: 5,003\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 5,002 (100.0%)\n",
      "   📈 Above Normal (an): 1 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 3,091 (61.8%)\n",
      "      Male: 1,912 (38.2%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,483 (49.6%)\n",
      "      Hawkari: 2,479 (49.6%)\n",
      "      Darugha: 41 (0.8%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (4846 patients):\n",
      "   📊 Hepatitis: Normal + HIV Antibody: Normal\n",
      "      4,845 patients (100.0%)\n",
      "   📊 Hepatitis: Normal + HIV Antibody: Above Normal\n",
      "      1 patients (0.0%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 4,845 (100.0%)\n",
      "   Mixed Results: 1 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: TSH + Serum Creatinine\n",
      "📊 Total Patients: 3,779\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 TSH:\n",
      "   Total Records: 4,739\n",
      "   📉 Below Normal (bn): 188 (4.0%)\n",
      "   ✅ Normal (n): 3,343 (70.5%)\n",
      "   📈 Above Normal (an): 1,208 (25.5%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 3,310 (69.8%)\n",
      "      Male: 1,429 (30.2%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 3,678 (77.6%)\n",
      "      Biolab: 1,061 (22.4%)\n",
      "\n",
      "📋 Serum Creatinine:\n",
      "   Total Records: 4,565\n",
      "   📉 Below Normal (bn): 1,488 (32.6%)\n",
      "   ✅ Normal (n): 2,883 (63.2%)\n",
      "   📈 Above Normal (an): 194 (4.2%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 3,035 (66.5%)\n",
      "      Male: 1,530 (33.5%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 3,595 (78.8%)\n",
      "      Biolab: 970 (21.2%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (3779 patients):\n",
      "   📊 TSH: Normal + Serum Creatinine: Normal\n",
      "      1,844 patients (48.8%)\n",
      "   📊 TSH: Normal + Serum Creatinine: Below Normal\n",
      "      993 patients (26.3%)\n",
      "   📊 TSH: Above Normal + Serum Creatinine: Normal\n",
      "      500 patients (13.2%)\n",
      "   📊 TSH: Above Normal + Serum Creatinine: Below Normal\n",
      "      280 patients (7.4%)\n",
      "   📊 TSH: Normal + Serum Creatinine: Above Normal\n",
      "      50 patients (1.3%)\n",
      "   📊 TSH: Below Normal + Serum Creatinine: Normal\n",
      "      49 patients (1.3%)\n",
      "   📊 TSH: Below Normal + Serum Creatinine: Below Normal\n",
      "      42 patients (1.1%)\n",
      "   📊 TSH: Above Normal + Serum Creatinine: Above Normal\n",
      "      16 patients (0.4%)\n",
      "   📊 TSH: Below Normal + Serum Creatinine: Above Normal\n",
      "      5 patients (0.1%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 343 (9.1%)\n",
      "   Both Tests Normal: 1,844 (48.8%)\n",
      "   Mixed Results: 1,592 (42.1%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: TSH + Blood Glucose\n",
      "📊 Total Patients: 3,754\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 TSH:\n",
      "   Total Records: 4,766\n",
      "   📉 Below Normal (bn): 179 (3.8%)\n",
      "   ✅ Normal (n): 3,417 (71.7%)\n",
      "   📈 Above Normal (an): 1,170 (24.5%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 3,599 (75.5%)\n",
      "      Male: 1,167 (24.5%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 3,761 (78.9%)\n",
      "      Biolab: 1,005 (21.1%)\n",
      "\n",
      "📋 Blood Glucose:\n",
      "   Total Records: 4,500\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 4,500 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 3,305 (73.4%)\n",
      "      Male: 1,195 (26.6%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 3,740 (83.1%)\n",
      "      Biolab: 760 (16.9%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (3754 patients):\n",
      "   📊 TSH: Normal + Blood Glucose: Normal\n",
      "      2,914 patients (77.6%)\n",
      "   📊 TSH: Above Normal + Blood Glucose: Normal\n",
      "      749 patients (20.0%)\n",
      "   📊 TSH: Below Normal + Blood Glucose: Normal\n",
      "      91 patients (2.4%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 2,914 (77.6%)\n",
      "   Mixed Results: 840 (22.4%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Serum Creatinine + Total Serum Bilirubin\n",
      "📊 Total Patients: 3,281\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Serum Creatinine:\n",
      "   Total Records: 4,043\n",
      "   📉 Below Normal (bn): 1,306 (32.3%)\n",
      "   ✅ Normal (n): 2,570 (63.6%)\n",
      "   📈 Above Normal (an): 167 (4.1%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 2,713 (67.1%)\n",
      "      Male: 1,330 (32.9%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 3,702 (91.6%)\n",
      "      Biolab: 341 (8.4%)\n",
      "\n",
      "📋 Total Serum Bilirubin:\n",
      "   Total Records: 3,669\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 3,669 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 2,446 (66.7%)\n",
      "      Male: 1,223 (33.3%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 3,401 (92.7%)\n",
      "      Biolab: 268 (7.3%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (3281 patients):\n",
      "   📊 Serum Creatinine: Normal + Total: Normal\n",
      "      2,119 patients (64.6%)\n",
      "   📊 Serum Creatinine: Below Normal + Total: Normal\n",
      "      1,105 patients (33.7%)\n",
      "   📊 Serum Creatinine: Above Normal + Total: Normal\n",
      "      57 patients (1.7%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 2,119 (64.6%)\n",
      "   Mixed Results: 1,162 (35.4%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Total Serum Bilirubin + Blood Glucose\n",
      "📊 Total Patients: 3,064\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Total Serum Bilirubin:\n",
      "   Total Records: 3,408\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 3,408 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 2,287 (67.1%)\n",
      "      Male: 1,121 (32.9%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 3,266 (95.8%)\n",
      "      Biolab: 142 (4.2%)\n",
      "\n",
      "📋 Blood Glucose:\n",
      "   Total Records: 3,597\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 3,597 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 2,464 (68.5%)\n",
      "      Male: 1,133 (31.5%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 3,499 (97.3%)\n",
      "      Biolab: 98 (2.7%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (3064 patients):\n",
      "   📊 Total: Normal + Blood Glucose: Normal\n",
      "      3,064 patients (100.0%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 3,064 (100.0%)\n",
      "   Mixed Results: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Blood Urea Nitrogen + Serum Creatinine\n",
      "📊 Total Patients: 2,870\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Blood Urea Nitrogen:\n",
      "   Total Records: 3,717\n",
      "   📉 Below Normal (bn): 7 (0.2%)\n",
      "   ✅ Normal (n): 1,159 (31.2%)\n",
      "   📈 Above Normal (an): 2,551 (68.6%)\n",
      "   👥 Gender Distribution:\n",
      "      Male: 1,900 (51.1%)\n",
      "      Female: 1,817 (48.9%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,380 (64.0%)\n",
      "      Hawkari: 1,337 (36.0%)\n",
      "\n",
      "📋 Serum Creatinine:\n",
      "   Total Records: 4,074\n",
      "   📉 Below Normal (bn): 938 (23.0%)\n",
      "   ✅ Normal (n): 2,604 (63.9%)\n",
      "   📈 Above Normal (an): 532 (13.1%)\n",
      "   👥 Gender Distribution:\n",
      "      Male: 2,079 (51.0%)\n",
      "      Female: 1,995 (49.0%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,452 (60.2%)\n",
      "      Hawkari: 1,622 (39.8%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (2870 patients):\n",
      "   📊 Blood: Above Normal + Serum Creatinine: Normal\n",
      "      1,334 patients (46.5%)\n",
      "   📊 Blood: Normal + Serum Creatinine: Normal\n",
      "      535 patients (18.6%)\n",
      "   📊 Blood: Normal + Serum Creatinine: Below Normal\n",
      "      456 patients (15.9%)\n",
      "   📊 Blood: Above Normal + Serum Creatinine: Below Normal\n",
      "      310 patients (10.8%)\n",
      "   📊 Blood: Above Normal + Serum Creatinine: Above Normal\n",
      "      219 patients (7.6%)\n",
      "   📊 Blood: Normal + Serum Creatinine: Above Normal\n",
      "      9 patients (0.3%)\n",
      "   📊 Blood: Below Normal + Serum Creatinine: Below Normal\n",
      "      4 patients (0.1%)\n",
      "   📊 Blood: Below Normal + Serum Creatinine: Above Normal\n",
      "      2 patients (0.1%)\n",
      "   📊 Blood: Below Normal + Serum Creatinine: Normal\n",
      "      1 patients (0.0%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 535 (18.6%)\n",
      "   Both Tests Normal: 535 (18.6%)\n",
      "   Mixed Results: 1,800 (62.7%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: TSH + Vitamin D3\n",
      "📊 Total Patients: 2,610\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 TSH:\n",
      "   Total Records: 3,481\n",
      "   📉 Below Normal (bn): 119 (3.4%)\n",
      "   ✅ Normal (n): 2,503 (71.9%)\n",
      "   📈 Above Normal (an): 859 (24.7%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 2,641 (75.9%)\n",
      "      Male: 840 (24.1%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,118 (60.8%)\n",
      "      Hawkari: 1,326 (38.1%)\n",
      "      Darugha: 37 (1.1%)\n",
      "\n",
      "📋 Vitamin D3:\n",
      "   Total Records: 3,086\n",
      "   📉 Below Normal (bn): 2,157 (69.9%)\n",
      "   ✅ Normal (n): 859 (27.8%)\n",
      "   📈 Above Normal (an): 70 (2.3%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 2,266 (73.4%)\n",
      "      Male: 820 (26.6%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 1,893 (61.3%)\n",
      "      Hawkari: 1,156 (37.5%)\n",
      "      Darugha: 37 (1.2%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (2610 patients):\n",
      "   📊 TSH: Normal + Vitamin D3: Below Normal\n",
      "      1,456 patients (55.8%)\n",
      "   📊 TSH: Normal + Vitamin D3: Normal\n",
      "      556 patients (21.3%)\n",
      "   📊 TSH: Above Normal + Vitamin D3: Below Normal\n",
      "      355 patients (13.6%)\n",
      "   📊 TSH: Above Normal + Vitamin D3: Normal\n",
      "      142 patients (5.4%)\n",
      "   📊 TSH: Normal + Vitamin D3: Above Normal\n",
      "      40 patients (1.5%)\n",
      "   📊 TSH: Below Normal + Vitamin D3: Below Normal\n",
      "      34 patients (1.3%)\n",
      "   📊 TSH: Below Normal + Vitamin D3: Normal\n",
      "      14 patients (0.5%)\n",
      "   📊 TSH: Above Normal + Vitamin D3: Above Normal\n",
      "      9 patients (0.3%)\n",
      "   📊 TSH: Below Normal + Vitamin D3: Above Normal\n",
      "      4 patients (0.2%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 402 (15.4%)\n",
      "   Both Tests Normal: 556 (21.3%)\n",
      "   Mixed Results: 1,652 (63.3%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Serum Cholesterol + Serum Triglycerides\n",
      "📊 Total Patients: 2,515\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Serum Cholesterol:\n",
      "   Total Records: 3,466\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 3,465 (100.0%)\n",
      "   📈 Above Normal (an): 1 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Male: 2,068 (59.7%)\n",
      "      Female: 1,398 (40.3%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 3,466 (100.0%)\n",
      "\n",
      "📋 Serum Triglycerides:\n",
      "   Total Records: 3,524\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,525 (43.3%)\n",
      "   📈 Above Normal (an): 1,999 (56.7%)\n",
      "   👥 Gender Distribution:\n",
      "      Male: 2,110 (59.9%)\n",
      "      Female: 1,414 (40.1%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 3,524 (100.0%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (2515 patients):\n",
      "   📊 Serum Cholesterol: Normal + Serum Triglycerides: Above Normal\n",
      "      1,310 patients (52.1%)\n",
      "   📊 Serum Cholesterol: Normal + Serum Triglycerides: Normal\n",
      "      1,204 patients (47.9%)\n",
      "   📊 Serum Cholesterol: Above Normal + Serum Triglycerides: Above Normal\n",
      "      1 patients (0.0%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 1 (0.0%)\n",
      "   Both Tests Normal: 1,204 (47.9%)\n",
      "   Mixed Results: 1,310 (52.1%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: TSH + Total Serum Bilirubin\n",
      "📊 Total Patients: 2,427\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 TSH:\n",
      "   Total Records: 2,864\n",
      "   📉 Below Normal (bn): 103 (3.6%)\n",
      "   ✅ Normal (n): 2,084 (72.8%)\n",
      "   📈 Above Normal (an): 677 (23.6%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 2,044 (71.4%)\n",
      "      Male: 820 (28.6%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 2,643 (92.3%)\n",
      "      Biolab: 216 (7.5%)\n",
      "      Darugha: 5 (0.2%)\n",
      "\n",
      "📋 Total Serum Bilirubin:\n",
      "   Total Records: 2,677\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 2,677 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,826 (68.2%)\n",
      "      Male: 851 (31.8%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 2,475 (92.5%)\n",
      "      Biolab: 197 (7.4%)\n",
      "      Darugha: 5 (0.2%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (2427 patients):\n",
      "   📊 TSH: Normal + Total: Normal\n",
      "      1,888 patients (77.8%)\n",
      "   📊 TSH: Above Normal + Total: Normal\n",
      "      484 patients (19.9%)\n",
      "   📊 TSH: Below Normal + Total: Normal\n",
      "      55 patients (2.3%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 1,888 (77.8%)\n",
      "   Mixed Results: 539 (22.2%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Serum Creatinine + C-Reactive Protein Titer\n",
      "📊 Total Patients: 2,227\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Serum Creatinine:\n",
      "   Total Records: 3,019\n",
      "   📉 Below Normal (bn): 838 (27.8%)\n",
      "   ✅ Normal (n): 1,906 (63.1%)\n",
      "   📈 Above Normal (an): 275 (9.1%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,859 (61.6%)\n",
      "      Male: 1,160 (38.4%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 2,432 (80.6%)\n",
      "      Biolab: 587 (19.4%)\n",
      "\n",
      "📋 C-Reactive Protein Titer:\n",
      "   Total Records: 2,851\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 2,851 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,789 (62.7%)\n",
      "      Male: 1,062 (37.3%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 2,317 (81.3%)\n",
      "      Biolab: 534 (18.7%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (2227 patients):\n",
      "   📊 Serum Creatinine: Normal + C-Reactive: Normal\n",
      "      1,441 patients (64.7%)\n",
      "   📊 Serum Creatinine: Below Normal + C-Reactive: Normal\n",
      "      671 patients (30.1%)\n",
      "   📊 Serum Creatinine: Above Normal + C-Reactive: Normal\n",
      "      115 patients (5.2%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 1,441 (64.7%)\n",
      "   Mixed Results: 786 (35.3%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Blood Glucose + C-Reactive Protein Titer\n",
      "📊 Total Patients: 2,146\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Blood Glucose:\n",
      "   Total Records: 2,681\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 2,681 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,751 (65.3%)\n",
      "      Male: 930 (34.7%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 2,439 (91.0%)\n",
      "      Biolab: 242 (9.0%)\n",
      "\n",
      "📋 C-Reactive Protein Titer:\n",
      "   Total Records: 2,674\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 2,674 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,742 (65.1%)\n",
      "      Male: 932 (34.9%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 2,402 (89.8%)\n",
      "      Biolab: 272 (10.2%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (2146 patients):\n",
      "   📊 Blood Glucose: Normal + C-Reactive: Normal\n",
      "      2,146 patients (100.0%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 2,146 (100.0%)\n",
      "   Mixed Results: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Serum Cholesterol + Serum LDL Cholesterol\n",
      "📊 Total Patients: 1,930\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Serum Cholesterol:\n",
      "   Total Records: 2,786\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 2,785 (100.0%)\n",
      "   📈 Above Normal (an): 1 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Male: 1,672 (60.0%)\n",
      "      Female: 1,114 (40.0%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,786 (100.0%)\n",
      "\n",
      "📋 Serum LDL Cholesterol:\n",
      "   Total Records: 2,551\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 793 (31.1%)\n",
      "   📈 Above Normal (an): 1,758 (68.9%)\n",
      "   👥 Gender Distribution:\n",
      "      Male: 1,522 (59.7%)\n",
      "      Female: 1,029 (40.3%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,551 (100.0%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1930 patients):\n",
      "   📊 Serum Cholesterol: Normal + Serum: Above Normal\n",
      "      1,320 patients (68.4%)\n",
      "   📊 Serum Cholesterol: Normal + Serum: Normal\n",
      "      609 patients (31.6%)\n",
      "   📊 Serum Cholesterol: Above Normal + Serum: Normal\n",
      "      1 patients (0.1%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 609 (31.6%)\n",
      "   Mixed Results: 1,321 (68.4%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Serum Triglycerides + Serum LDL Cholesterol\n",
      "📊 Total Patients: 1,903\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Serum Triglycerides:\n",
      "   Total Records: 2,797\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,191 (42.6%)\n",
      "   📈 Above Normal (an): 1,606 (57.4%)\n",
      "   👥 Gender Distribution:\n",
      "      Male: 1,686 (60.3%)\n",
      "      Female: 1,111 (39.7%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,797 (100.0%)\n",
      "\n",
      "📋 Serum LDL Cholesterol:\n",
      "   Total Records: 2,520\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 791 (31.4%)\n",
      "   📈 Above Normal (an): 1,729 (68.6%)\n",
      "   👥 Gender Distribution:\n",
      "      Male: 1,502 (59.6%)\n",
      "      Female: 1,018 (40.4%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,520 (100.0%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1903 patients):\n",
      "   📊 Serum Triglycerides: Above Normal + Serum: Above Normal\n",
      "      760 patients (39.9%)\n",
      "   📊 Serum Triglycerides: Normal + Serum: Above Normal\n",
      "      534 patients (28.1%)\n",
      "   📊 Serum Triglycerides: Normal + Serum: Normal\n",
      "      375 patients (19.7%)\n",
      "   📊 Serum Triglycerides: Above Normal + Serum: Normal\n",
      "      234 patients (12.3%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 760 (39.9%)\n",
      "   Both Tests Normal: 375 (19.7%)\n",
      "   Mixed Results: 768 (40.4%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: HbA1c + Blood Glucose\n",
      "📊 Total Patients: 1,855\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 HbA1c:\n",
      "   Total Records: 2,737\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 487 (17.8%)\n",
      "   📈 Above Normal (an): 2,250 (82.2%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,748 (63.9%)\n",
      "      Male: 989 (36.1%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,774 (64.8%)\n",
      "      Biolab: 963 (35.2%)\n",
      "\n",
      "📋 Blood Glucose:\n",
      "   Total Records: 2,504\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 2,504 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,657 (66.2%)\n",
      "      Male: 847 (33.8%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,794 (71.6%)\n",
      "      Biolab: 710 (28.4%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1855 patients):\n",
      "   📊 HbA1c: Above Normal + Blood Glucose: Normal\n",
      "      1,458 patients (78.6%)\n",
      "   📊 HbA1c: Normal + Blood Glucose: Normal\n",
      "      397 patients (21.4%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 397 (21.4%)\n",
      "   Mixed Results: 1,458 (78.6%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: TSH + Serum Ferritin\n",
      "📊 Total Patients: 1,843\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 TSH:\n",
      "   Total Records: 2,493\n",
      "   📉 Below Normal (bn): 99 (4.0%)\n",
      "   ✅ Normal (n): 1,708 (68.5%)\n",
      "   📈 Above Normal (an): 686 (27.5%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 2,080 (83.4%)\n",
      "      Male: 413 (16.6%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,713 (68.7%)\n",
      "      Biolab: 764 (30.6%)\n",
      "      Darugha: 16 (0.6%)\n",
      "\n",
      "📋 Serum Ferritin:\n",
      "   Total Records: 2,133\n",
      "   📉 Below Normal (bn): 372 (17.4%)\n",
      "   ✅ Normal (n): 1,688 (79.1%)\n",
      "   📈 Above Normal (an): 73 (3.4%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,752 (82.1%)\n",
      "      Male: 381 (17.9%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,532 (71.8%)\n",
      "      Biolab: 585 (27.4%)\n",
      "      Darugha: 16 (0.8%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1843 patients):\n",
      "   📊 TSH: Normal + Serum Ferritin: Normal\n",
      "      1,143 patients (62.0%)\n",
      "   📊 TSH: Above Normal + Serum Ferritin: Normal\n",
      "      315 patients (17.1%)\n",
      "   📊 TSH: Normal + Serum Ferritin: Below Normal\n",
      "      200 patients (10.9%)\n",
      "   📊 TSH: Above Normal + Serum Ferritin: Below Normal\n",
      "      71 patients (3.9%)\n",
      "   📊 TSH: Normal + Serum Ferritin: Above Normal\n",
      "      55 patients (3.0%)\n",
      "   📊 TSH: Below Normal + Serum Ferritin: Normal\n",
      "      41 patients (2.2%)\n",
      "   📊 TSH: Above Normal + Serum Ferritin: Above Normal\n",
      "      11 patients (0.6%)\n",
      "   📊 TSH: Below Normal + Serum Ferritin: Below Normal\n",
      "      6 patients (0.3%)\n",
      "   📊 TSH: Below Normal + Serum Ferritin: Above Normal\n",
      "      1 patients (0.1%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 89 (4.8%)\n",
      "   Both Tests Normal: 1,143 (62.0%)\n",
      "   Mixed Results: 611 (33.2%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Aspartate Aminotransferase (AST) + Alanine Aminotransferase (ALT)\n",
      "📊 Total Patients: 1,820\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Aspartate Aminotransferase (AST):\n",
      "   Total Records: 2,101\n",
      "   📉 Below Normal (bn): 15 (0.7%)\n",
      "   ✅ Normal (n): 1,854 (88.2%)\n",
      "   📈 Above Normal (an): 232 (11.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,056 (50.3%)\n",
      "      Male: 1,045 (49.7%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,078 (51.3%)\n",
      "      Biolab: 1,015 (48.3%)\n",
      "      Darugha: 8 (0.4%)\n",
      "\n",
      "📋 Alanine Aminotransferase (ALT):\n",
      "   Total Records: 2,114\n",
      "   📉 Below Normal (bn): 23 (1.1%)\n",
      "   ✅ Normal (n): 1,881 (89.0%)\n",
      "   📈 Above Normal (an): 210 (9.9%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,064 (50.3%)\n",
      "      Male: 1,050 (49.7%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,087 (51.4%)\n",
      "      Biolab: 1,019 (48.2%)\n",
      "      Darugha: 8 (0.4%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1820 patients):\n",
      "   📊 Aspartate: Normal + Alanine: Normal\n",
      "      1,567 patients (86.1%)\n",
      "   📊 Aspartate: Above Normal + Alanine: Above Normal\n",
      "      96 patients (5.3%)\n",
      "   📊 Aspartate: Above Normal + Alanine: Normal\n",
      "      73 patients (4.0%)\n",
      "   📊 Aspartate: Normal + Alanine: Above Normal\n",
      "      49 patients (2.7%)\n",
      "   📊 Aspartate: Normal + Alanine: Below Normal\n",
      "      21 patients (1.2%)\n",
      "   📊 Aspartate: Below Normal + Alanine: Normal\n",
      "      12 patients (0.7%)\n",
      "   📊 Aspartate: Below Normal + Alanine: Below Normal\n",
      "      2 patients (0.1%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 98 (5.4%)\n",
      "   Both Tests Normal: 1,567 (86.1%)\n",
      "   Mixed Results: 155 (8.5%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: TSH + Complete Blood Count\n",
      "📊 Total Patients: 1,812\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 TSH:\n",
      "   Total Records: 2,522\n",
      "   📉 Below Normal (bn): 95 (3.8%)\n",
      "   ✅ Normal (n): 1,843 (73.1%)\n",
      "   📈 Above Normal (an): 584 (23.2%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,879 (74.5%)\n",
      "      Male: 643 (25.5%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,496 (99.0%)\n",
      "      Hawkari: 26 (1.0%)\n",
      "\n",
      "📋 Complete Blood Count:\n",
      "   Total Records: 2,520\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 2,520 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,918 (76.1%)\n",
      "      Male: 602 (23.9%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,518 (99.9%)\n",
      "      Hawkari: 2 (0.1%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1812 patients):\n",
      "   📊 TSH: Normal + Complete: Normal\n",
      "      1,462 patients (80.7%)\n",
      "   📊 TSH: Above Normal + Complete: Normal\n",
      "      306 patients (16.9%)\n",
      "   📊 TSH: Below Normal + Complete: Normal\n",
      "      44 patients (2.4%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 1,462 (80.7%)\n",
      "   Mixed Results: 350 (19.3%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Vitamin D3 + Complete Blood Count\n",
      "📊 Total Patients: 1,682\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Vitamin D3:\n",
      "   Total Records: 2,114\n",
      "   📉 Below Normal (bn): 1,566 (74.1%)\n",
      "   ✅ Normal (n): 493 (23.3%)\n",
      "   📈 Above Normal (an): 55 (2.6%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,327 (62.8%)\n",
      "      Male: 787 (37.2%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,106 (99.6%)\n",
      "      Hawkari: 8 (0.4%)\n",
      "\n",
      "📋 Complete Blood Count:\n",
      "   Total Records: 2,204\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 2,204 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,438 (65.2%)\n",
      "      Male: 766 (34.8%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,204 (100.0%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1682 patients):\n",
      "   📊 Vitamin D3: Below Normal + Complete: Normal\n",
      "      1,263 patients (75.1%)\n",
      "   📊 Vitamin D3: Normal + Complete: Normal\n",
      "      380 patients (22.6%)\n",
      "   📊 Vitamin D3: Above Normal + Complete: Normal\n",
      "      39 patients (2.3%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 380 (22.6%)\n",
      "   Mixed Results: 1,302 (77.4%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: S.Iron + Vitamin D3\n",
      "📊 Total Patients: 1,635\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 S.Iron:\n",
      "   Total Records: 1,897\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,897 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,282 (67.6%)\n",
      "      Male: 615 (32.4%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 1,897 (100.0%)\n",
      "\n",
      "📋 Vitamin D3:\n",
      "   Total Records: 2,009\n",
      "   📉 Below Normal (bn): 1,489 (74.1%)\n",
      "   ✅ Normal (n): 470 (23.4%)\n",
      "   📈 Above Normal (an): 50 (2.5%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,328 (66.1%)\n",
      "      Male: 681 (33.9%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,006 (99.9%)\n",
      "      Hawkari: 3 (0.1%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1635 patients):\n",
      "   📊 S.Iron: Normal + Vitamin D3: Below Normal\n",
      "      1,228 patients (75.1%)\n",
      "   📊 S.Iron: Normal + Vitamin D3: Normal\n",
      "      370 patients (22.6%)\n",
      "   📊 S.Iron: Normal + Vitamin D3: Above Normal\n",
      "      37 patients (2.3%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 370 (22.6%)\n",
      "   Mixed Results: 1,265 (77.4%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: HbA1c + Serum Creatinine\n",
      "📊 Total Patients: 1,633\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 HbA1c:\n",
      "   Total Records: 2,309\n",
      "   📉 Below Normal (bn): 2 (0.1%)\n",
      "   ✅ Normal (n): 381 (16.5%)\n",
      "   📈 Above Normal (an): 1,926 (83.4%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,486 (64.4%)\n",
      "      Male: 823 (35.6%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,643 (71.2%)\n",
      "      Biolab: 666 (28.8%)\n",
      "\n",
      "📋 Serum Creatinine:\n",
      "   Total Records: 2,299\n",
      "   📉 Below Normal (bn): 629 (27.4%)\n",
      "   ✅ Normal (n): 1,482 (64.5%)\n",
      "   📈 Above Normal (an): 188 (8.2%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,459 (63.5%)\n",
      "      Male: 840 (36.5%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,651 (71.8%)\n",
      "      Biolab: 648 (28.2%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1633 patients):\n",
      "   📊 HbA1c: Above Normal + Serum Creatinine: Normal\n",
      "      858 patients (52.5%)\n",
      "   📊 HbA1c: Above Normal + Serum Creatinine: Below Normal\n",
      "      401 patients (24.6%)\n",
      "   📊 HbA1c: Normal + Serum Creatinine: Normal\n",
      "      213 patients (13.0%)\n",
      "   📊 HbA1c: Normal + Serum Creatinine: Below Normal\n",
      "      90 patients (5.5%)\n",
      "   📊 HbA1c: Above Normal + Serum Creatinine: Above Normal\n",
      "      59 patients (3.6%)\n",
      "   📊 HbA1c: Normal + Serum Creatinine: Above Normal\n",
      "      11 patients (0.7%)\n",
      "   📊 HbA1c: Below Normal + Serum Creatinine: Normal\n",
      "      1 patients (0.1%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 460 (28.2%)\n",
      "   Both Tests Normal: 213 (13.0%)\n",
      "   Mixed Results: 960 (58.8%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Serum HDL Cholesterol + Serum LDL Cholesterol\n",
      "📊 Total Patients: 1,602\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Serum HDL Cholesterol:\n",
      "   Total Records: 2,020\n",
      "   📉 Below Normal (bn): 764 (37.8%)\n",
      "   ✅ Normal (n): 1,255 (62.1%)\n",
      "   📈 Above Normal (an): 1 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Male: 1,203 (59.6%)\n",
      "      Female: 817 (40.4%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,020 (100.0%)\n",
      "\n",
      "📋 Serum LDL Cholesterol:\n",
      "   Total Records: 2,165\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 677 (31.3%)\n",
      "   📈 Above Normal (an): 1,488 (68.7%)\n",
      "   👥 Gender Distribution:\n",
      "      Male: 1,311 (60.6%)\n",
      "      Female: 854 (39.4%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,165 (100.0%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1602 patients):\n",
      "   📊 Serum: Normal + Serum: Above Normal\n",
      "      712 patients (44.4%)\n",
      "   📊 Serum: Below Normal + Serum: Above Normal\n",
      "      378 patients (23.6%)\n",
      "   📊 Serum: Normal + Serum: Normal\n",
      "      305 patients (19.0%)\n",
      "   📊 Serum: Below Normal + Serum: Normal\n",
      "      207 patients (12.9%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 378 (23.6%)\n",
      "   Both Tests Normal: 305 (19.0%)\n",
      "   Mixed Results: 919 (57.4%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Serum Cholesterol + Serum HDL Cholesterol\n",
      "📊 Total Patients: 1,586\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Serum Cholesterol:\n",
      "   Total Records: 2,337\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 2,336 (100.0%)\n",
      "   📈 Above Normal (an): 1 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Male: 1,425 (61.0%)\n",
      "      Female: 912 (39.0%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,337 (100.0%)\n",
      "\n",
      "📋 Serum HDL Cholesterol:\n",
      "   Total Records: 2,005\n",
      "   📉 Below Normal (bn): 758 (37.8%)\n",
      "   ✅ Normal (n): 1,245 (62.1%)\n",
      "   📈 Above Normal (an): 2 (0.1%)\n",
      "   👥 Gender Distribution:\n",
      "      Male: 1,198 (59.8%)\n",
      "      Female: 807 (40.2%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,005 (100.0%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1586 patients):\n",
      "   📊 Serum Cholesterol: Normal + Serum: Normal\n",
      "      1,006 patients (63.4%)\n",
      "   📊 Serum Cholesterol: Normal + Serum: Below Normal\n",
      "      578 patients (36.4%)\n",
      "   📊 Serum Cholesterol: Normal + Serum: Above Normal\n",
      "      1 patients (0.1%)\n",
      "   📊 Serum Cholesterol: Above Normal + Serum: Below Normal\n",
      "      1 patients (0.1%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 1 (0.1%)\n",
      "   Both Tests Normal: 1,006 (63.4%)\n",
      "   Mixed Results: 579 (36.5%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Serum Triglycerides + Serum HDL Cholesterol\n",
      "📊 Total Patients: 1,580\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Serum Triglycerides:\n",
      "   Total Records: 2,355\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,010 (42.9%)\n",
      "   📈 Above Normal (an): 1,345 (57.1%)\n",
      "   👥 Gender Distribution:\n",
      "      Male: 1,440 (61.1%)\n",
      "      Female: 915 (38.9%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,355 (100.0%)\n",
      "\n",
      "📋 Serum HDL Cholesterol:\n",
      "   Total Records: 1,998\n",
      "   📉 Below Normal (bn): 758 (37.9%)\n",
      "   ✅ Normal (n): 1,238 (62.0%)\n",
      "   📈 Above Normal (an): 2 (0.1%)\n",
      "   👥 Gender Distribution:\n",
      "      Male: 1,192 (59.7%)\n",
      "      Female: 806 (40.3%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 1,998 (100.0%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1580 patients):\n",
      "   📊 Serum Triglycerides: Normal + Serum: Normal\n",
      "      591 patients (37.4%)\n",
      "   📊 Serum Triglycerides: Above Normal + Serum: Below Normal\n",
      "      411 patients (26.0%)\n",
      "   📊 Serum Triglycerides: Above Normal + Serum: Normal\n",
      "      409 patients (25.9%)\n",
      "   📊 Serum Triglycerides: Normal + Serum: Below Normal\n",
      "      168 patients (10.6%)\n",
      "   📊 Serum Triglycerides: Normal + Serum: Above Normal\n",
      "      1 patients (0.1%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 411 (26.0%)\n",
      "   Both Tests Normal: 591 (37.4%)\n",
      "   Mixed Results: 578 (36.6%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: HbA1c + TSH\n",
      "📊 Total Patients: 1,538\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 HbA1c:\n",
      "   Total Records: 2,040\n",
      "   📉 Below Normal (bn): 2 (0.1%)\n",
      "   ✅ Normal (n): 477 (23.4%)\n",
      "   📈 Above Normal (an): 1,561 (76.5%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,492 (73.1%)\n",
      "      Male: 548 (26.9%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,214 (59.5%)\n",
      "      Biolab: 738 (36.2%)\n",
      "      Darugha: 88 (4.3%)\n",
      "\n",
      "📋 TSH:\n",
      "   Total Records: 2,074\n",
      "   📉 Below Normal (bn): 92 (4.4%)\n",
      "   ✅ Normal (n): 1,398 (67.4%)\n",
      "   📈 Above Normal (an): 584 (28.2%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,550 (74.7%)\n",
      "      Male: 524 (25.3%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,165 (56.2%)\n",
      "      Biolab: 820 (39.5%)\n",
      "      Darugha: 89 (4.3%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1538 patients):\n",
      "   📊 HbA1c: Above Normal + TSH: Normal\n",
      "      810 patients (52.7%)\n",
      "   📊 HbA1c: Normal + TSH: Normal\n",
      "      321 patients (20.9%)\n",
      "   📊 HbA1c: Above Normal + TSH: Above Normal\n",
      "      275 patients (17.9%)\n",
      "   📊 HbA1c: Normal + TSH: Above Normal\n",
      "      83 patients (5.4%)\n",
      "   📊 HbA1c: Above Normal + TSH: Below Normal\n",
      "      39 patients (2.5%)\n",
      "   📊 HbA1c: Normal + TSH: Below Normal\n",
      "      9 patients (0.6%)\n",
      "   📊 HbA1c: Below Normal + TSH: Above Normal\n",
      "      1 patients (0.1%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 315 (20.5%)\n",
      "   Both Tests Normal: 321 (20.9%)\n",
      "   Mixed Results: 902 (58.6%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: TSH + C-Reactive Protein Titer\n",
      "📊 Total Patients: 1,518\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 TSH:\n",
      "   Total Records: 2,006\n",
      "   📉 Below Normal (bn): 99 (4.9%)\n",
      "   ✅ Normal (n): 1,399 (69.7%)\n",
      "   📈 Above Normal (an): 508 (25.3%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,452 (72.4%)\n",
      "      Male: 554 (27.6%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,370 (68.3%)\n",
      "      Biolab: 619 (30.9%)\n",
      "      Darugha: 17 (0.8%)\n",
      "\n",
      "📋 C-Reactive Protein Titer:\n",
      "   Total Records: 1,890\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,890 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,330 (70.4%)\n",
      "      Male: 560 (29.6%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,390 (73.5%)\n",
      "      Biolab: 483 (25.6%)\n",
      "      Darugha: 17 (0.9%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1518 patients):\n",
      "   📊 TSH: Normal + C-Reactive: Normal\n",
      "      1,154 patients (76.0%)\n",
      "   📊 TSH: Above Normal + C-Reactive: Normal\n",
      "      312 patients (20.6%)\n",
      "   📊 TSH: Below Normal + C-Reactive: Normal\n",
      "      52 patients (3.4%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 1,154 (76.0%)\n",
      "   Mixed Results: 364 (24.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Blood Sugar + Complete Blood Count\n",
      "📊 Total Patients: 1,511\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Blood Sugar:\n",
      "   Total Records: 2,070\n",
      "   📉 Below Normal (bn): 1 (0.0%)\n",
      "   ✅ Normal (n): 857 (41.4%)\n",
      "   📈 Above Normal (an): 1,212 (58.6%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,622 (78.4%)\n",
      "      Male: 448 (21.6%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,070 (100.0%)\n",
      "\n",
      "📋 Complete Blood Count:\n",
      "   Total Records: 2,410\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 2,410 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,944 (80.7%)\n",
      "      Male: 466 (19.3%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 2,410 (100.0%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1511 patients):\n",
      "   📊 Blood Sugar: Above Normal + Complete: Normal\n",
      "      875 patients (57.9%)\n",
      "   📊 Blood Sugar: Normal + Complete: Normal\n",
      "      635 patients (42.0%)\n",
      "   📊 Blood Sugar: Below Normal + Complete: Normal\n",
      "      1 patients (0.1%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 635 (42.0%)\n",
      "   Mixed Results: 876 (58.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Total Cholesterol + LDL Cholesterol\n",
      "📊 Total Patients: 1,467\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Total Cholesterol:\n",
      "   Total Records: 1,572\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,212 (77.1%)\n",
      "   📈 Above Normal (an): 360 (22.9%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 919 (58.5%)\n",
      "      Male: 653 (41.5%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,425 (90.6%)\n",
      "      Darugha: 147 (9.4%)\n",
      "\n",
      "📋 LDL Cholesterol:\n",
      "   Total Records: 1,611\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,611 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 947 (58.8%)\n",
      "      Male: 664 (41.2%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,464 (90.9%)\n",
      "      Darugha: 147 (9.1%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1467 patients):\n",
      "   📊 Total Cholesterol: Normal + LDL Cholesterol: Normal\n",
      "      1,142 patients (77.8%)\n",
      "   📊 Total Cholesterol: Above Normal + LDL Cholesterol: Normal\n",
      "      325 patients (22.2%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 1,142 (77.8%)\n",
      "   Mixed Results: 325 (22.2%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Serum Creatinine + Alanine Aminotransferase (ALT)\n",
      "📊 Total Patients: 1,406\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Serum Creatinine:\n",
      "   Total Records: 1,904\n",
      "   📉 Below Normal (bn): 485 (25.5%)\n",
      "   ✅ Normal (n): 1,351 (71.0%)\n",
      "   📈 Above Normal (an): 68 (3.6%)\n",
      "   👥 Gender Distribution:\n",
      "      Male: 952 (50.0%)\n",
      "      Female: 952 (50.0%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,007 (52.9%)\n",
      "      Biolab: 897 (47.1%)\n",
      "\n",
      "📋 Alanine Aminotransferase (ALT):\n",
      "   Total Records: 1,653\n",
      "   📉 Below Normal (bn): 13 (0.8%)\n",
      "   ✅ Normal (n): 1,501 (90.8%)\n",
      "   📈 Above Normal (an): 139 (8.4%)\n",
      "   👥 Gender Distribution:\n",
      "      Male: 827 (50.0%)\n",
      "      Female: 826 (50.0%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 856 (51.8%)\n",
      "      Biolab: 797 (48.2%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1406 patients):\n",
      "   📊 Serum Creatinine: Normal + Alanine: Normal\n",
      "      918 patients (65.3%)\n",
      "   📊 Serum Creatinine: Below Normal + Alanine: Normal\n",
      "      365 patients (26.0%)\n",
      "   📊 Serum Creatinine: Normal + Alanine: Above Normal\n",
      "      61 patients (4.3%)\n",
      "   📊 Serum Creatinine: Below Normal + Alanine: Above Normal\n",
      "      24 patients (1.7%)\n",
      "   📊 Serum Creatinine: Above Normal + Alanine: Normal\n",
      "      22 patients (1.6%)\n",
      "   📊 Serum Creatinine: Normal + Alanine: Below Normal\n",
      "      10 patients (0.7%)\n",
      "   📊 Serum Creatinine: Above Normal + Alanine: Above Normal\n",
      "      3 patients (0.2%)\n",
      "   📊 Serum Creatinine: Below Normal + Alanine: Below Normal\n",
      "      3 patients (0.2%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 30 (2.1%)\n",
      "   Both Tests Normal: 918 (65.3%)\n",
      "   Mixed Results: 458 (32.6%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: S.Iron + Complete Blood Count\n",
      "📊 Total Patients: 1,399\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 S.Iron:\n",
      "   Total Records: 1,637\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,637 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,052 (64.3%)\n",
      "      Male: 585 (35.7%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 1,637 (100.0%)\n",
      "\n",
      "📋 Complete Blood Count:\n",
      "   Total Records: 1,747\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,747 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,119 (64.1%)\n",
      "      Male: 628 (35.9%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 1,747 (100.0%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1399 patients):\n",
      "   📊 S.Iron: Normal + Complete: Normal\n",
      "      1,399 patients (100.0%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 1,399 (100.0%)\n",
      "   Mixed Results: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: TSH + Erythrocyte Sedimentation Rate\n",
      "📊 Total Patients: 1,393\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 TSH:\n",
      "   Total Records: 1,805\n",
      "   📉 Below Normal (bn): 88 (4.9%)\n",
      "   ✅ Normal (n): 1,245 (69.0%)\n",
      "   📈 Above Normal (an): 472 (26.1%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,325 (73.4%)\n",
      "      Male: 480 (26.6%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 919 (50.9%)\n",
      "      Biolab: 780 (43.2%)\n",
      "      Darugha: 106 (5.9%)\n",
      "\n",
      "📋 Erythrocyte Sedimentation Rate:\n",
      "   Total Records: 1,616\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,616 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,165 (72.1%)\n",
      "      Male: 451 (27.9%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 884 (54.7%)\n",
      "      Biolab: 626 (38.7%)\n",
      "      Darugha: 106 (6.6%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1393 patients):\n",
      "   📊 TSH: Normal + Erythrocyte: Normal\n",
      "      1,051 patients (75.4%)\n",
      "   📊 TSH: Above Normal + Erythrocyte: Normal\n",
      "      299 patients (21.5%)\n",
      "   📊 TSH: Below Normal + Erythrocyte: Normal\n",
      "      43 patients (3.1%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 1,051 (75.4%)\n",
      "   Mixed Results: 342 (24.6%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Serum Creatinine + Aspartate Aminotransferase (AST)\n",
      "📊 Total Patients: 1,361\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Serum Creatinine:\n",
      "   Total Records: 1,843\n",
      "   📉 Below Normal (bn): 469 (25.4%)\n",
      "   ✅ Normal (n): 1,309 (71.0%)\n",
      "   📈 Above Normal (an): 65 (3.5%)\n",
      "   👥 Gender Distribution:\n",
      "      Male: 931 (50.5%)\n",
      "      Female: 912 (49.5%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 968 (52.5%)\n",
      "      Biolab: 875 (47.5%)\n",
      "\n",
      "📋 Aspartate Aminotransferase (AST):\n",
      "   Total Records: 1,592\n",
      "   📉 Below Normal (bn): 14 (0.9%)\n",
      "   ✅ Normal (n): 1,418 (89.1%)\n",
      "   📈 Above Normal (an): 160 (10.1%)\n",
      "   👥 Gender Distribution:\n",
      "      Male: 801 (50.3%)\n",
      "      Female: 791 (49.7%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 819 (51.4%)\n",
      "      Biolab: 773 (48.6%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1361 patients):\n",
      "   📊 Serum Creatinine: Normal + Aspartate: Normal\n",
      "      891 patients (65.5%)\n",
      "   📊 Serum Creatinine: Below Normal + Aspartate: Normal\n",
      "      330 patients (24.2%)\n",
      "   📊 Serum Creatinine: Normal + Aspartate: Above Normal\n",
      "      60 patients (4.4%)\n",
      "   📊 Serum Creatinine: Below Normal + Aspartate: Above Normal\n",
      "      46 patients (3.4%)\n",
      "   📊 Serum Creatinine: Above Normal + Aspartate: Normal\n",
      "      17 patients (1.2%)\n",
      "   📊 Serum Creatinine: Normal + Aspartate: Below Normal\n",
      "      6 patients (0.4%)\n",
      "   📊 Serum Creatinine: Below Normal + Aspartate: Below Normal\n",
      "      5 patients (0.4%)\n",
      "   📊 Serum Creatinine: Above Normal + Aspartate: Above Normal\n",
      "      4 patients (0.3%)\n",
      "   📊 Serum Creatinine: Above Normal + Aspartate: Below Normal\n",
      "      2 patients (0.1%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 57 (4.2%)\n",
      "   Both Tests Normal: 891 (65.5%)\n",
      "   Mixed Results: 413 (30.3%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Serum Creatinine + Serum Ferritin\n",
      "📊 Total Patients: 1,353\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Serum Creatinine:\n",
      "   Total Records: 1,705\n",
      "   📉 Below Normal (bn): 661 (38.8%)\n",
      "   ✅ Normal (n): 936 (54.9%)\n",
      "   📈 Above Normal (an): 108 (6.3%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,344 (78.8%)\n",
      "      Male: 361 (21.2%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,471 (86.3%)\n",
      "      Biolab: 234 (13.7%)\n",
      "\n",
      "📋 Serum Ferritin:\n",
      "   Total Records: 1,579\n",
      "   📉 Below Normal (bn): 266 (16.8%)\n",
      "   ✅ Normal (n): 1,217 (77.1%)\n",
      "   📈 Above Normal (an): 96 (6.1%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,263 (80.0%)\n",
      "      Male: 316 (20.0%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,389 (88.0%)\n",
      "      Biolab: 190 (12.0%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1353 patients):\n",
      "   📊 Serum Creatinine: Normal + Serum Ferritin: Normal\n",
      "      609 patients (45.0%)\n",
      "   📊 Serum Creatinine: Below Normal + Serum Ferritin: Normal\n",
      "      445 patients (32.9%)\n",
      "   📊 Serum Creatinine: Below Normal + Serum Ferritin: Below Normal\n",
      "      112 patients (8.3%)\n",
      "   📊 Serum Creatinine: Normal + Serum Ferritin: Below Normal\n",
      "      86 patients (6.4%)\n",
      "   📊 Serum Creatinine: Normal + Serum Ferritin: Above Normal\n",
      "      62 patients (4.6%)\n",
      "   📊 Serum Creatinine: Above Normal + Serum Ferritin: Normal\n",
      "      18 patients (1.3%)\n",
      "   📊 Serum Creatinine: Below Normal + Serum Ferritin: Above Normal\n",
      "      16 patients (1.2%)\n",
      "   📊 Serum Creatinine: Above Normal + Serum Ferritin: Above Normal\n",
      "      3 patients (0.2%)\n",
      "   📊 Serum Creatinine: Above Normal + Serum Ferritin: Below Normal\n",
      "      2 patients (0.1%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 133 (9.8%)\n",
      "   Both Tests Normal: 609 (45.0%)\n",
      "   Mixed Results: 611 (45.2%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Serum Ferritin + Blood Glucose\n",
      "📊 Total Patients: 1,339\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Serum Ferritin:\n",
      "   Total Records: 1,581\n",
      "   📉 Below Normal (bn): 270 (17.1%)\n",
      "   ✅ Normal (n): 1,232 (77.9%)\n",
      "   📈 Above Normal (an): 79 (5.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,300 (82.2%)\n",
      "      Male: 281 (17.8%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,372 (86.8%)\n",
      "      Biolab: 209 (13.2%)\n",
      "\n",
      "📋 Blood Glucose:\n",
      "   Total Records: 1,638\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,638 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,340 (81.8%)\n",
      "      Male: 298 (18.2%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,435 (87.6%)\n",
      "      Biolab: 203 (12.4%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1339 patients):\n",
      "   📊 Serum Ferritin: Normal + Blood Glucose: Normal\n",
      "      1,065 patients (79.5%)\n",
      "   📊 Serum Ferritin: Below Normal + Blood Glucose: Normal\n",
      "      202 patients (15.1%)\n",
      "   📊 Serum Ferritin: Above Normal + Blood Glucose: Normal\n",
      "      72 patients (5.4%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 1,065 (79.5%)\n",
      "   Mixed Results: 274 (20.5%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: TSH + Prolactin\n",
      "📊 Total Patients: 1,288\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 TSH:\n",
      "   Total Records: 1,663\n",
      "   📉 Below Normal (bn): 51 (3.1%)\n",
      "   ✅ Normal (n): 1,244 (74.8%)\n",
      "   📈 Above Normal (an): 368 (22.1%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,615 (97.1%)\n",
      "      Male: 48 (2.9%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 840 (50.5%)\n",
      "      Biolab: 823 (49.5%)\n",
      "\n",
      "📋 Prolactin:\n",
      "   Total Records: 1,388\n",
      "   📉 Below Normal (bn): 26 (1.9%)\n",
      "   ✅ Normal (n): 555 (40.0%)\n",
      "   📈 Above Normal (an): 807 (58.1%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,345 (96.9%)\n",
      "      Male: 43 (3.1%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 731 (52.7%)\n",
      "      Biolab: 657 (47.3%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1288 patients):\n",
      "   📊 TSH: Normal + Prolactin: Above Normal\n",
      "      580 patients (45.0%)\n",
      "   📊 TSH: Normal + Prolactin: Normal\n",
      "      427 patients (33.2%)\n",
      "   📊 TSH: Above Normal + Prolactin: Above Normal\n",
      "      145 patients (11.3%)\n",
      "   📊 TSH: Above Normal + Prolactin: Normal\n",
      "      89 patients (6.9%)\n",
      "   📊 TSH: Normal + Prolactin: Below Normal\n",
      "      18 patients (1.4%)\n",
      "   📊 TSH: Below Normal + Prolactin: Normal\n",
      "      14 patients (1.1%)\n",
      "   📊 TSH: Below Normal + Prolactin: Above Normal\n",
      "      12 patients (0.9%)\n",
      "   📊 TSH: Above Normal + Prolactin: Below Normal\n",
      "      3 patients (0.2%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 160 (12.4%)\n",
      "   Both Tests Normal: 427 (33.2%)\n",
      "   Mixed Results: 701 (54.4%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Serum Ferritin + Vitamin D3\n",
      "📊 Total Patients: 1,273\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Serum Ferritin:\n",
      "   Total Records: 1,468\n",
      "   📉 Below Normal (bn): 208 (14.2%)\n",
      "   ✅ Normal (n): 1,217 (82.9%)\n",
      "   📈 Above Normal (an): 43 (2.9%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,131 (77.0%)\n",
      "      Male: 337 (23.0%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 750 (51.1%)\n",
      "      Biolab: 694 (47.3%)\n",
      "      Darugha: 24 (1.6%)\n",
      "\n",
      "📋 Vitamin D3:\n",
      "   Total Records: 1,517\n",
      "   📉 Below Normal (bn): 977 (64.4%)\n",
      "   ✅ Normal (n): 508 (33.5%)\n",
      "   📈 Above Normal (an): 32 (2.1%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,149 (75.7%)\n",
      "      Male: 368 (24.3%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 766 (50.5%)\n",
      "      Hawkari: 727 (47.9%)\n",
      "      Darugha: 24 (1.6%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1273 patients):\n",
      "   📊 Serum Ferritin: Normal + Vitamin D3: Below Normal\n",
      "      689 patients (54.1%)\n",
      "   📊 Serum Ferritin: Normal + Vitamin D3: Normal\n",
      "      368 patients (28.9%)\n",
      "   📊 Serum Ferritin: Below Normal + Vitamin D3: Below Normal\n",
      "      126 patients (9.9%)\n",
      "   📊 Serum Ferritin: Below Normal + Vitamin D3: Normal\n",
      "      35 patients (2.7%)\n",
      "   📊 Serum Ferritin: Normal + Vitamin D3: Above Normal\n",
      "      22 patients (1.7%)\n",
      "   📊 Serum Ferritin: Above Normal + Vitamin D3: Normal\n",
      "      16 patients (1.3%)\n",
      "   📊 Serum Ferritin: Above Normal + Vitamin D3: Below Normal\n",
      "      15 patients (1.2%)\n",
      "   📊 Serum Ferritin: Above Normal + Vitamin D3: Above Normal\n",
      "      1 patients (0.1%)\n",
      "   📊 Serum Ferritin: Below Normal + Vitamin D3: Above Normal\n",
      "      1 patients (0.1%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 143 (11.2%)\n",
      "   Both Tests Normal: 368 (28.9%)\n",
      "   Mixed Results: 762 (59.9%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Erythrocyte Sedimentation Rate + C-Reactive Protein Titer\n",
      "📊 Total Patients: 1,268\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Erythrocyte Sedimentation Rate:\n",
      "   Total Records: 1,522\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,522 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,016 (66.8%)\n",
      "      Male: 506 (33.2%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 977 (64.2%)\n",
      "      Biolab: 484 (31.8%)\n",
      "      Darugha: 61 (4.0%)\n",
      "\n",
      "📋 C-Reactive Protein Titer:\n",
      "   Total Records: 1,712\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,712 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,136 (66.4%)\n",
      "      Male: 576 (33.6%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,131 (66.1%)\n",
      "      Biolab: 520 (30.4%)\n",
      "      Darugha: 61 (3.6%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1268 patients):\n",
      "   📊 Erythrocyte: Normal + C-Reactive: Normal\n",
      "      1,268 patients (100.0%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 1,268 (100.0%)\n",
      "   Mixed Results: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Total Serum Bilirubin + C-Reactive Protein Titer\n",
      "📊 Total Patients: 1,245\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Total Serum Bilirubin:\n",
      "   Total Records: 1,452\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,452 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 922 (63.5%)\n",
      "      Male: 530 (36.5%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,332 (91.7%)\n",
      "      Biolab: 110 (7.6%)\n",
      "      Darugha: 10 (0.7%)\n",
      "\n",
      "📋 C-Reactive Protein Titer:\n",
      "   Total Records: 1,617\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,617 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,051 (65.0%)\n",
      "      Male: 566 (35.0%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,472 (91.0%)\n",
      "      Biolab: 135 (8.3%)\n",
      "      Darugha: 10 (0.6%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1245 patients):\n",
      "   📊 Total: Normal + C-Reactive: Normal\n",
      "      1,245 patients (100.0%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 1,245 (100.0%)\n",
      "   Mixed Results: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: TSH + LDL Cholesterol\n",
      "📊 Total Patients: 1,241\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 TSH:\n",
      "   Total Records: 1,421\n",
      "   📉 Below Normal (bn): 42 (3.0%)\n",
      "   ✅ Normal (n): 1,064 (74.9%)\n",
      "   📈 Above Normal (an): 315 (22.2%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 933 (65.7%)\n",
      "      Male: 488 (34.3%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,324 (93.2%)\n",
      "      Darugha: 91 (6.4%)\n",
      "      Biolab: 6 (0.4%)\n",
      "\n",
      "📋 LDL Cholesterol:\n",
      "   Total Records: 1,356\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,356 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 858 (63.3%)\n",
      "      Male: 498 (36.7%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,265 (93.3%)\n",
      "      Darugha: 91 (6.7%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1241 patients):\n",
      "   📊 TSH: Normal + LDL Cholesterol: Normal\n",
      "      981 patients (79.0%)\n",
      "   📊 TSH: Above Normal + LDL Cholesterol: Normal\n",
      "      231 patients (18.6%)\n",
      "   📊 TSH: Below Normal + LDL Cholesterol: Normal\n",
      "      29 patients (2.3%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 981 (79.0%)\n",
      "   Mixed Results: 260 (21.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Blood Glucose + LDL Cholesterol\n",
      "📊 Total Patients: 1,232\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Blood Glucose:\n",
      "   Total Records: 1,501\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,501 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 914 (60.9%)\n",
      "      Male: 587 (39.1%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,499 (99.9%)\n",
      "      Biolab: 2 (0.1%)\n",
      "\n",
      "📋 LDL Cholesterol:\n",
      "   Total Records: 1,374\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,374 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 829 (60.3%)\n",
      "      Male: 545 (39.7%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,374 (100.0%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1232 patients):\n",
      "   📊 Blood Glucose: Normal + LDL Cholesterol: Normal\n",
      "      1,232 patients (100.0%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 1,232 (100.0%)\n",
      "   Mixed Results: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Serum Creatinine + LDL Cholesterol\n",
      "📊 Total Patients: 1,230\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Serum Creatinine:\n",
      "   Total Records: 1,504\n",
      "   📉 Below Normal (bn): 393 (26.1%)\n",
      "   ✅ Normal (n): 1,073 (71.3%)\n",
      "   📈 Above Normal (an): 38 (2.5%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 933 (62.0%)\n",
      "      Male: 571 (38.0%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,500 (99.7%)\n",
      "      Biolab: 4 (0.3%)\n",
      "\n",
      "📋 LDL Cholesterol:\n",
      "   Total Records: 1,367\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,367 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 846 (61.9%)\n",
      "      Male: 521 (38.1%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,367 (100.0%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1230 patients):\n",
      "   📊 Serum Creatinine: Normal + LDL Cholesterol: Normal\n",
      "      881 patients (71.6%)\n",
      "   📊 Serum Creatinine: Below Normal + LDL Cholesterol: Normal\n",
      "      333 patients (27.1%)\n",
      "   📊 Serum Creatinine: Above Normal + LDL Cholesterol: Normal\n",
      "      16 patients (1.3%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 881 (71.6%)\n",
      "   Mixed Results: 349 (28.4%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Total Cholesterol + Triglycerides\n",
      "📊 Total Patients: 1,215\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Total Cholesterol:\n",
      "   Total Records: 1,314\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,010 (76.9%)\n",
      "   📈 Above Normal (an): 304 (23.1%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 769 (58.5%)\n",
      "      Male: 545 (41.5%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,119 (85.2%)\n",
      "      Darugha: 195 (14.8%)\n",
      "\n",
      "📋 Triglycerides:\n",
      "   Total Records: 1,294\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 545 (42.1%)\n",
      "   📈 Above Normal (an): 749 (57.9%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 761 (58.8%)\n",
      "      Male: 533 (41.2%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,099 (84.9%)\n",
      "      Darugha: 195 (15.1%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1215 patients):\n",
      "   📊 Total Cholesterol: Normal + Triglycerides: Above Normal\n",
      "      513 patients (42.2%)\n",
      "   📊 Total Cholesterol: Normal + Triglycerides: Normal\n",
      "      430 patients (35.4%)\n",
      "   📊 Total Cholesterol: Above Normal + Triglycerides: Above Normal\n",
      "      191 patients (15.7%)\n",
      "   📊 Total Cholesterol: Above Normal + Triglycerides: Normal\n",
      "      81 patients (6.7%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 191 (15.7%)\n",
      "   Both Tests Normal: 430 (35.4%)\n",
      "   Mixed Results: 594 (48.9%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Serum Creatinine + Erythrocyte Sedimentation Rate\n",
      "📊 Total Patients: 1,191\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Serum Creatinine:\n",
      "   Total Records: 1,634\n",
      "   📉 Below Normal (bn): 464 (28.4%)\n",
      "   ✅ Normal (n): 1,062 (65.0%)\n",
      "   📈 Above Normal (an): 108 (6.6%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 1,080 (66.1%)\n",
      "      Male: 554 (33.9%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,057 (64.7%)\n",
      "      Biolab: 577 (35.3%)\n",
      "\n",
      "📋 Erythrocyte Sedimentation Rate:\n",
      "   Total Records: 1,411\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,411 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 946 (67.0%)\n",
      "      Male: 465 (33.0%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 904 (64.1%)\n",
      "      Biolab: 507 (35.9%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1191 patients):\n",
      "   📊 Serum Creatinine: Normal + Erythrocyte: Normal\n",
      "      789 patients (66.2%)\n",
      "   📊 Serum Creatinine: Below Normal + Erythrocyte: Normal\n",
      "      372 patients (31.2%)\n",
      "   📊 Serum Creatinine: Above Normal + Erythrocyte: Normal\n",
      "      30 patients (2.5%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 789 (66.2%)\n",
      "   Mixed Results: 402 (33.8%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Triglycerides + LDL Cholesterol\n",
      "📊 Total Patients: 1,189\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Triglycerides:\n",
      "   Total Records: 1,267\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 524 (41.4%)\n",
      "   📈 Above Normal (an): 743 (58.6%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 749 (59.1%)\n",
      "      Male: 518 (40.9%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,120 (88.4%)\n",
      "      Darugha: 147 (11.6%)\n",
      "\n",
      "📋 LDL Cholesterol:\n",
      "   Total Records: 1,316\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,316 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 782 (59.4%)\n",
      "      Male: 534 (40.6%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,169 (88.8%)\n",
      "      Darugha: 147 (11.2%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1189 patients):\n",
      "   📊 Triglycerides: Above Normal + LDL Cholesterol: Normal\n",
      "      700 patients (58.9%)\n",
      "   📊 Triglycerides: Normal + LDL Cholesterol: Normal\n",
      "      489 patients (41.1%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 489 (41.1%)\n",
      "   Mixed Results: 700 (58.9%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Alanine Aminotransferase (ALT) + Alkaline Phosphatase\n",
      "📊 Total Patients: 1,125\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Alanine Aminotransferase (ALT):\n",
      "   Total Records: 1,291\n",
      "   📉 Below Normal (bn): 16 (1.2%)\n",
      "   ✅ Normal (n): 1,132 (87.7%)\n",
      "   📈 Above Normal (an): 143 (11.1%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 729 (56.5%)\n",
      "      Male: 562 (43.5%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 945 (73.2%)\n",
      "      Biolab: 343 (26.6%)\n",
      "      Darugha: 3 (0.2%)\n",
      "\n",
      "📋 Alkaline Phosphatase:\n",
      "   Total Records: 1,260\n",
      "   📉 Below Normal (bn): 30 (2.4%)\n",
      "   ✅ Normal (n): 1,065 (84.5%)\n",
      "   📈 Above Normal (an): 165 (13.1%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 717 (56.9%)\n",
      "      Male: 543 (43.1%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 940 (74.6%)\n",
      "      Biolab: 317 (25.2%)\n",
      "      Darugha: 3 (0.2%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1125 patients):\n",
      "   📊 Alanine: Normal + Alkaline Phosphatase: Normal\n",
      "      879 patients (78.1%)\n",
      "   📊 Alanine: Normal + Alkaline Phosphatase: Above Normal\n",
      "      104 patients (9.2%)\n",
      "   📊 Alanine: Above Normal + Alkaline Phosphatase: Normal\n",
      "      74 patients (6.6%)\n",
      "   📊 Alanine: Normal + Alkaline Phosphatase: Below Normal\n",
      "      25 patients (2.2%)\n",
      "   📊 Alanine: Above Normal + Alkaline Phosphatase: Above Normal\n",
      "      25 patients (2.2%)\n",
      "   📊 Alanine: Below Normal + Alkaline Phosphatase: Normal\n",
      "      12 patients (1.1%)\n",
      "   📊 Alanine: Below Normal + Alkaline Phosphatase: Below Normal\n",
      "      3 patients (0.3%)\n",
      "   📊 Alanine: Above Normal + Alkaline Phosphatase: Below Normal\n",
      "      2 patients (0.2%)\n",
      "   📊 Alanine: Below Normal + Alkaline Phosphatase: Above Normal\n",
      "      1 patients (0.1%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 31 (2.8%)\n",
      "   Both Tests Normal: 879 (78.1%)\n",
      "   Mixed Results: 215 (19.1%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Aspartate Aminotransferase (AST) + Alkaline Phosphatase\n",
      "📊 Total Patients: 1,116\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Aspartate Aminotransferase (AST):\n",
      "   Total Records: 1,281\n",
      "   📉 Below Normal (bn): 9 (0.7%)\n",
      "   ✅ Normal (n): 1,104 (86.2%)\n",
      "   📈 Above Normal (an): 168 (13.1%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 724 (56.5%)\n",
      "      Male: 557 (43.5%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 938 (73.2%)\n",
      "      Biolab: 341 (26.6%)\n",
      "      Darugha: 2 (0.2%)\n",
      "\n",
      "📋 Alkaline Phosphatase:\n",
      "   Total Records: 1,252\n",
      "   📉 Below Normal (bn): 29 (2.3%)\n",
      "   ✅ Normal (n): 1,058 (84.5%)\n",
      "   📈 Above Normal (an): 165 (13.2%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 713 (56.9%)\n",
      "      Male: 539 (43.1%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 934 (74.6%)\n",
      "      Biolab: 316 (25.2%)\n",
      "      Darugha: 2 (0.2%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1116 patients):\n",
      "   📊 Aspartate: Normal + Alkaline Phosphatase: Normal\n",
      "      876 patients (78.5%)\n",
      "   📊 Aspartate: Normal + Alkaline Phosphatase: Above Normal\n",
      "      84 patients (7.5%)\n",
      "   📊 Aspartate: Above Normal + Alkaline Phosphatase: Normal\n",
      "      75 patients (6.7%)\n",
      "   📊 Aspartate: Above Normal + Alkaline Phosphatase: Above Normal\n",
      "      44 patients (3.9%)\n",
      "   📊 Aspartate: Normal + Alkaline Phosphatase: Below Normal\n",
      "      26 patients (2.3%)\n",
      "   📊 Aspartate: Below Normal + Alkaline Phosphatase: Normal\n",
      "      6 patients (0.5%)\n",
      "   📊 Aspartate: Above Normal + Alkaline Phosphatase: Below Normal\n",
      "      2 patients (0.2%)\n",
      "   📊 Aspartate: Below Normal + Alkaline Phosphatase: Above Normal\n",
      "      2 patients (0.2%)\n",
      "   📊 Aspartate: Below Normal + Alkaline Phosphatase: Below Normal\n",
      "      1 patients (0.1%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 49 (4.4%)\n",
      "   Both Tests Normal: 876 (78.5%)\n",
      "   Mixed Results: 191 (17.1%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: TSH + Total Cholesterol\n",
      "📊 Total Patients: 1,114\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 TSH:\n",
      "   Total Records: 1,286\n",
      "   📉 Below Normal (bn): 41 (3.2%)\n",
      "   ✅ Normal (n): 957 (74.4%)\n",
      "   📈 Above Normal (an): 288 (22.4%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 839 (65.2%)\n",
      "      Male: 447 (34.8%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,170 (91.0%)\n",
      "      Darugha: 112 (8.7%)\n",
      "      Biolab: 4 (0.3%)\n",
      "\n",
      "📋 Total Cholesterol:\n",
      "   Total Records: 1,189\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 919 (77.3%)\n",
      "   📈 Above Normal (an): 270 (22.7%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 743 (62.5%)\n",
      "      Male: 446 (37.5%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,077 (90.6%)\n",
      "      Darugha: 112 (9.4%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1114 patients):\n",
      "   📊 TSH: Normal + Total Cholesterol: Normal\n",
      "      690 patients (61.9%)\n",
      "   📊 TSH: Normal + Total Cholesterol: Above Normal\n",
      "      185 patients (16.6%)\n",
      "   📊 TSH: Above Normal + Total Cholesterol: Normal\n",
      "      157 patients (14.1%)\n",
      "   📊 TSH: Above Normal + Total Cholesterol: Above Normal\n",
      "      54 patients (4.8%)\n",
      "   📊 TSH: Below Normal + Total Cholesterol: Normal\n",
      "      24 patients (2.2%)\n",
      "   📊 TSH: Below Normal + Total Cholesterol: Above Normal\n",
      "      4 patients (0.4%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 58 (5.2%)\n",
      "   Both Tests Normal: 690 (61.9%)\n",
      "   Mixed Results: 366 (32.9%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Total Serum Bilirubin + Serum Ferritin\n",
      "📊 Total Patients: 1,088\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Total Serum Bilirubin:\n",
      "   Total Records: 1,225\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,225 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 947 (77.3%)\n",
      "      Male: 278 (22.7%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,137 (92.8%)\n",
      "      Biolab: 88 (7.2%)\n",
      "\n",
      "📋 Serum Ferritin:\n",
      "   Total Records: 1,247\n",
      "   📉 Below Normal (bn): 206 (16.5%)\n",
      "   ✅ Normal (n): 968 (77.6%)\n",
      "   📈 Above Normal (an): 73 (5.9%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 987 (79.1%)\n",
      "      Male: 260 (20.9%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,176 (94.3%)\n",
      "      Biolab: 71 (5.7%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1088 patients):\n",
      "   📊 Total: Normal + Serum Ferritin: Normal\n",
      "      861 patients (79.1%)\n",
      "   📊 Total: Normal + Serum Ferritin: Below Normal\n",
      "      162 patients (14.9%)\n",
      "   📊 Total: Normal + Serum Ferritin: Above Normal\n",
      "      65 patients (6.0%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 861 (79.1%)\n",
      "   Mixed Results: 227 (20.9%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Blood Glucose + Total Cholesterol\n",
      "📊 Total Patients: 1,077\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Blood Glucose:\n",
      "   Total Records: 1,311\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,311 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 777 (59.3%)\n",
      "      Male: 534 (40.7%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,308 (99.8%)\n",
      "      Biolab: 3 (0.2%)\n",
      "\n",
      "📋 Total Cholesterol:\n",
      "   Total Records: 1,167\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 910 (78.0%)\n",
      "   📈 Above Normal (an): 257 (22.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 686 (58.8%)\n",
      "      Male: 481 (41.2%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,167 (100.0%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1077 patients):\n",
      "   📊 Blood Glucose: Normal + Total Cholesterol: Normal\n",
      "      848 patients (78.7%)\n",
      "   📊 Blood Glucose: Normal + Total Cholesterol: Above Normal\n",
      "      229 patients (21.3%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 848 (78.7%)\n",
      "   Mixed Results: 229 (21.3%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Alanine Aminotransferase (ALT) + Total Serum Bilirubin\n",
      "📊 Total Patients: 1,076\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Alanine Aminotransferase (ALT):\n",
      "   Total Records: 1,258\n",
      "   📉 Below Normal (bn): 17 (1.4%)\n",
      "   ✅ Normal (n): 1,108 (88.1%)\n",
      "   📈 Above Normal (an): 133 (10.6%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 731 (58.1%)\n",
      "      Male: 527 (41.9%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 998 (79.3%)\n",
      "      Biolab: 254 (20.2%)\n",
      "      Darugha: 6 (0.5%)\n",
      "\n",
      "📋 Total Serum Bilirubin:\n",
      "   Total Records: 1,364\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,364 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 780 (57.2%)\n",
      "      Male: 584 (42.8%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,110 (81.4%)\n",
      "      Biolab: 248 (18.2%)\n",
      "      Darugha: 6 (0.4%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1076 patients):\n",
      "   📊 Alanine: Normal + Total: Normal\n",
      "      968 patients (90.0%)\n",
      "   📊 Alanine: Above Normal + Total: Normal\n",
      "      91 patients (8.5%)\n",
      "   📊 Alanine: Below Normal + Total: Normal\n",
      "      17 patients (1.6%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 968 (90.0%)\n",
      "   Mixed Results: 108 (10.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: TSH + Alanine Aminotransferase (ALT)\n",
      "📊 Total Patients: 1,068\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 TSH:\n",
      "   Total Records: 1,332\n",
      "   📉 Below Normal (bn): 46 (3.5%)\n",
      "   ✅ Normal (n): 993 (74.5%)\n",
      "   📈 Above Normal (an): 293 (22.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 747 (56.1%)\n",
      "      Male: 585 (43.9%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 643 (48.3%)\n",
      "      Biolab: 580 (43.5%)\n",
      "      Darugha: 109 (8.2%)\n",
      "\n",
      "📋 Alanine Aminotransferase (ALT):\n",
      "   Total Records: 1,237\n",
      "   📉 Below Normal (bn): 16 (1.3%)\n",
      "   ✅ Normal (n): 1,135 (91.8%)\n",
      "   📈 Above Normal (an): 86 (7.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 651 (52.6%)\n",
      "      Male: 586 (47.4%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 602 (48.7%)\n",
      "      Biolab: 526 (42.5%)\n",
      "      Darugha: 109 (8.8%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1068 patients):\n",
      "   📊 TSH: Normal + Alanine: Normal\n",
      "      797 patients (74.6%)\n",
      "   📊 TSH: Above Normal + Alanine: Normal\n",
      "      177 patients (16.6%)\n",
      "   📊 TSH: Normal + Alanine: Above Normal\n",
      "      39 patients (3.7%)\n",
      "   📊 TSH: Below Normal + Alanine: Normal\n",
      "      27 patients (2.5%)\n",
      "   📊 TSH: Normal + Alanine: Below Normal\n",
      "      12 patients (1.1%)\n",
      "   📊 TSH: Above Normal + Alanine: Above Normal\n",
      "      11 patients (1.0%)\n",
      "   📊 TSH: Above Normal + Alanine: Below Normal\n",
      "      4 patients (0.4%)\n",
      "   📊 TSH: Below Normal + Alanine: Above Normal\n",
      "      1 patients (0.1%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 16 (1.5%)\n",
      "   Both Tests Normal: 797 (74.6%)\n",
      "   Mixed Results: 255 (23.9%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Serum Creatinine + Complete Blood Count\n",
      "📊 Total Patients: 1,067\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Serum Creatinine:\n",
      "   Total Records: 1,597\n",
      "   📉 Below Normal (bn): 411 (25.7%)\n",
      "   ✅ Normal (n): 1,016 (63.6%)\n",
      "   📈 Above Normal (an): 170 (10.6%)\n",
      "   👥 Gender Distribution:\n",
      "      Male: 846 (53.0%)\n",
      "      Female: 751 (47.0%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 1,564 (97.9%)\n",
      "      Hawkari: 33 (2.1%)\n",
      "\n",
      "📋 Complete Blood Count:\n",
      "   Total Records: 1,527\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,527 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 785 (51.4%)\n",
      "      Male: 742 (48.6%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 1,525 (99.9%)\n",
      "      Hawkari: 2 (0.1%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1067 patients):\n",
      "   📊 Serum Creatinine: Normal + Complete: Normal\n",
      "      693 patients (64.9%)\n",
      "   📊 Serum Creatinine: Below Normal + Complete: Normal\n",
      "      319 patients (29.9%)\n",
      "   📊 Serum Creatinine: Above Normal + Complete: Normal\n",
      "      55 patients (5.2%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 693 (64.9%)\n",
      "   Mixed Results: 374 (35.1%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Aspartate Aminotransferase (AST) + Total Serum Bilirubin\n",
      "📊 Total Patients: 1,063\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Aspartate Aminotransferase (AST):\n",
      "   Total Records: 1,239\n",
      "   📉 Below Normal (bn): 9 (0.7%)\n",
      "   ✅ Normal (n): 1,062 (85.7%)\n",
      "   📈 Above Normal (an): 168 (13.6%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 714 (57.6%)\n",
      "      Male: 525 (42.4%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 982 (79.3%)\n",
      "      Biolab: 254 (20.5%)\n",
      "      Darugha: 3 (0.2%)\n",
      "\n",
      "📋 Total Serum Bilirubin:\n",
      "   Total Records: 1,349\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,349 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 770 (57.1%)\n",
      "      Male: 579 (42.9%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,100 (81.5%)\n",
      "      Biolab: 246 (18.2%)\n",
      "      Darugha: 3 (0.2%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1063 patients):\n",
      "   📊 Aspartate: Normal + Total: Normal\n",
      "      934 patients (87.9%)\n",
      "   📊 Aspartate: Above Normal + Total: Normal\n",
      "      120 patients (11.3%)\n",
      "   📊 Aspartate: Below Normal + Total: Normal\n",
      "      9 patients (0.8%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 934 (87.9%)\n",
      "   Mixed Results: 129 (12.1%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Serum Creatinine + Total Cholesterol\n",
      "📊 Total Patients: 1,047\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Serum Creatinine:\n",
      "   Total Records: 1,281\n",
      "   📉 Below Normal (bn): 330 (25.8%)\n",
      "   ✅ Normal (n): 911 (71.1%)\n",
      "   📈 Above Normal (an): 40 (3.1%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 774 (60.4%)\n",
      "      Male: 507 (39.6%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,278 (99.8%)\n",
      "      Biolab: 3 (0.2%)\n",
      "\n",
      "📋 Total Cholesterol:\n",
      "   Total Records: 1,131\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 869 (76.8%)\n",
      "   📈 Above Normal (an): 262 (23.2%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 684 (60.5%)\n",
      "      Male: 447 (39.5%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,131 (100.0%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1047 patients):\n",
      "   📊 Serum Creatinine: Normal + Total Cholesterol: Normal\n",
      "      587 patients (56.1%)\n",
      "   📊 Serum Creatinine: Below Normal + Total Cholesterol: Normal\n",
      "      216 patients (20.6%)\n",
      "   📊 Serum Creatinine: Normal + Total Cholesterol: Above Normal\n",
      "      162 patients (15.5%)\n",
      "   📊 Serum Creatinine: Below Normal + Total Cholesterol: Above Normal\n",
      "      68 patients (6.5%)\n",
      "   📊 Serum Creatinine: Above Normal + Total Cholesterol: Normal\n",
      "      10 patients (1.0%)\n",
      "   📊 Serum Creatinine: Above Normal + Total Cholesterol: Above Normal\n",
      "      4 patients (0.4%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 72 (6.9%)\n",
      "   Both Tests Normal: 587 (56.1%)\n",
      "   Mixed Results: 388 (37.1%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Alkaline Phosphatase + Total Serum Bilirubin\n",
      "📊 Total Patients: 1,042\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Alkaline Phosphatase:\n",
      "   Total Records: 1,171\n",
      "   📉 Below Normal (bn): 26 (2.2%)\n",
      "   ✅ Normal (n): 996 (85.1%)\n",
      "   📈 Above Normal (an): 149 (12.7%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 696 (59.4%)\n",
      "      Male: 475 (40.6%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 965 (82.4%)\n",
      "      Biolab: 201 (17.2%)\n",
      "      Darugha: 5 (0.4%)\n",
      "\n",
      "📋 Total Serum Bilirubin:\n",
      "   Total Records: 1,292\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,292 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 763 (59.1%)\n",
      "      Male: 529 (40.9%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,089 (84.3%)\n",
      "      Biolab: 198 (15.3%)\n",
      "      Darugha: 5 (0.4%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1042 patients):\n",
      "   📊 Alkaline Phosphatase: Normal + Total: Normal\n",
      "      902 patients (86.6%)\n",
      "   📊 Alkaline Phosphatase: Above Normal + Total: Normal\n",
      "      114 patients (10.9%)\n",
      "   📊 Alkaline Phosphatase: Below Normal + Total: Normal\n",
      "      26 patients (2.5%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 902 (86.6%)\n",
      "   Mixed Results: 140 (13.4%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Hepatitis B Surface Antigen + Blood Glucose\n",
      "📊 Total Patients: 1,039\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Hepatitis B Surface Antigen:\n",
      "   Total Records: 1,104\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,103 (99.9%)\n",
      "   📈 Above Normal (an): 1 (0.1%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 745 (67.5%)\n",
      "      Male: 359 (32.5%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 660 (59.8%)\n",
      "      Biolab: 444 (40.2%)\n",
      "\n",
      "📋 Blood Glucose:\n",
      "   Total Records: 1,321\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,321 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 927 (70.2%)\n",
      "      Male: 394 (29.8%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 840 (63.6%)\n",
      "      Biolab: 481 (36.4%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1039 patients):\n",
      "   📊 Hepatitis: Normal + Blood Glucose: Normal\n",
      "      1,038 patients (99.9%)\n",
      "   📊 Hepatitis: Above Normal + Blood Glucose: Normal\n",
      "      1 patients (0.1%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 1,038 (99.9%)\n",
      "   Mixed Results: 1 (0.1%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Hepatitis C Antibody + Blood Glucose\n",
      "📊 Total Patients: 1,036\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Hepatitis C Antibody:\n",
      "   Total Records: 1,099\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,099 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 742 (67.5%)\n",
      "      Male: 357 (32.5%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 659 (60.0%)\n",
      "      Biolab: 440 (40.0%)\n",
      "\n",
      "📋 Blood Glucose:\n",
      "   Total Records: 1,317\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,317 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 925 (70.2%)\n",
      "      Male: 392 (29.8%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 840 (63.8%)\n",
      "      Biolab: 477 (36.2%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1036 patients):\n",
      "   📊 Hepatitis: Normal + Blood Glucose: Normal\n",
      "      1,036 patients (100.0%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 1,036 (100.0%)\n",
      "   Mixed Results: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: HIV Antibody + Blood Glucose\n",
      "📊 Total Patients: 1,035\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 HIV Antibody:\n",
      "   Total Records: 1,098\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,098 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 741 (67.5%)\n",
      "      Male: 357 (32.5%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 659 (60.0%)\n",
      "      Biolab: 439 (40.0%)\n",
      "\n",
      "📋 Blood Glucose:\n",
      "   Total Records: 1,316\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,316 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 924 (70.2%)\n",
      "      Male: 392 (29.8%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 840 (63.8%)\n",
      "      Biolab: 476 (36.2%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1035 patients):\n",
      "   📊 HIV Antibody: Normal + Blood Glucose: Normal\n",
      "      1,035 patients (100.0%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 1,035 (100.0%)\n",
      "   Mixed Results: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Vitamin D3 + Erythrocyte Sedimentation Rate\n",
      "📊 Total Patients: 1,029\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Vitamin D3:\n",
      "   Total Records: 1,262\n",
      "   📉 Below Normal (bn): 923 (73.1%)\n",
      "   ✅ Normal (n): 306 (24.2%)\n",
      "   📈 Above Normal (an): 33 (2.6%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 875 (69.3%)\n",
      "      Male: 387 (30.7%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 849 (67.3%)\n",
      "      Hawkari: 383 (30.3%)\n",
      "      Darugha: 30 (2.4%)\n",
      "\n",
      "📋 Erythrocyte Sedimentation Rate:\n",
      "   Total Records: 1,207\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,207 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 872 (72.2%)\n",
      "      Male: 335 (27.8%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 772 (64.0%)\n",
      "      Hawkari: 405 (33.6%)\n",
      "      Darugha: 30 (2.5%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1029 patients):\n",
      "   📊 Vitamin D3: Below Normal + Erythrocyte: Normal\n",
      "      759 patients (73.8%)\n",
      "   📊 Vitamin D3: Normal + Erythrocyte: Normal\n",
      "      243 patients (23.6%)\n",
      "   📊 Vitamin D3: Above Normal + Erythrocyte: Normal\n",
      "      27 patients (2.6%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 243 (23.6%)\n",
      "   Mixed Results: 786 (76.4%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: TSH + Blood Urea Nitrogen\n",
      "📊 Total Patients: 1,027\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 TSH:\n",
      "   Total Records: 1,432\n",
      "   📉 Below Normal (bn): 57 (4.0%)\n",
      "   ✅ Normal (n): 1,001 (69.9%)\n",
      "   📈 Above Normal (an): 374 (26.1%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 844 (58.9%)\n",
      "      Male: 588 (41.1%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 926 (64.7%)\n",
      "      Hawkari: 475 (33.2%)\n",
      "      Darugha: 31 (2.2%)\n",
      "\n",
      "📋 Blood Urea Nitrogen:\n",
      "   Total Records: 1,369\n",
      "   📉 Below Normal (bn): 2 (0.1%)\n",
      "   ✅ Normal (n): 471 (34.4%)\n",
      "   📈 Above Normal (an): 896 (65.4%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 752 (54.9%)\n",
      "      Male: 617 (45.1%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 866 (63.3%)\n",
      "      Hawkari: 472 (34.5%)\n",
      "      Darugha: 31 (2.3%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1027 patients):\n",
      "   📊 TSH: Normal + Blood: Above Normal\n",
      "      478 patients (46.5%)\n",
      "   📊 TSH: Normal + Blood: Normal\n",
      "      304 patients (29.6%)\n",
      "   📊 TSH: Above Normal + Blood: Above Normal\n",
      "      138 patients (13.4%)\n",
      "   📊 TSH: Above Normal + Blood: Normal\n",
      "      78 patients (7.6%)\n",
      "   📊 TSH: Below Normal + Blood: Above Normal\n",
      "      19 patients (1.9%)\n",
      "   📊 TSH: Below Normal + Blood: Normal\n",
      "      8 patients (0.8%)\n",
      "   📊 TSH: Normal + Blood: Below Normal\n",
      "      2 patients (0.2%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 157 (15.3%)\n",
      "   Both Tests Normal: 304 (29.6%)\n",
      "   Mixed Results: 566 (55.1%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Vitamin D3 + Blood Glucose\n",
      "📊 Total Patients: 1,018\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Vitamin D3:\n",
      "   Total Records: 1,294\n",
      "   📉 Below Normal (bn): 888 (68.6%)\n",
      "   ✅ Normal (n): 373 (28.8%)\n",
      "   📈 Above Normal (an): 33 (2.6%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 885 (68.4%)\n",
      "      Male: 409 (31.6%)\n",
      "   🏥 Lab Distribution:\n",
      "      Biolab: 717 (55.4%)\n",
      "      Hawkari: 577 (44.6%)\n",
      "\n",
      "📋 Blood Glucose:\n",
      "   Total Records: 1,323\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,323 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 938 (70.9%)\n",
      "      Male: 385 (29.1%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 694 (52.5%)\n",
      "      Biolab: 629 (47.5%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1018 patients):\n",
      "   📊 Vitamin D3: Below Normal + Blood Glucose: Normal\n",
      "      711 patients (69.8%)\n",
      "   📊 Vitamin D3: Normal + Blood Glucose: Normal\n",
      "      287 patients (28.2%)\n",
      "   📊 Vitamin D3: Above Normal + Blood Glucose: Normal\n",
      "      20 patients (2.0%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 287 (28.2%)\n",
      "   Mixed Results: 731 (71.8%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Erythrocyte Sedimentation Rate + Blood Glucose\n",
      "📊 Total Patients: 1,018\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Erythrocyte Sedimentation Rate:\n",
      "   Total Records: 1,175\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,175 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 810 (68.9%)\n",
      "      Male: 365 (31.1%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 882 (75.1%)\n",
      "      Biolab: 293 (24.9%)\n",
      "\n",
      "📋 Blood Glucose:\n",
      "   Total Records: 1,300\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,300 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 889 (68.4%)\n",
      "      Male: 411 (31.6%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 1,008 (77.5%)\n",
      "      Biolab: 292 (22.5%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1018 patients):\n",
      "   📊 Erythrocyte: Normal + Blood Glucose: Normal\n",
      "      1,018 patients (100.0%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 1,018 (100.0%)\n",
      "   Mixed Results: 0 (0.0%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🧪 TEST COMBINATION: Blood Urea Nitrogen + Blood Glucose\n",
      "📊 Total Patients: 1,017\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "📋 Blood Urea Nitrogen:\n",
      "   Total Records: 1,452\n",
      "   📉 Below Normal (bn): 3 (0.2%)\n",
      "   ✅ Normal (n): 394 (27.1%)\n",
      "   📈 Above Normal (an): 1,055 (72.7%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 738 (50.8%)\n",
      "      Male: 714 (49.2%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 754 (51.9%)\n",
      "      Biolab: 698 (48.1%)\n",
      "\n",
      "📋 Blood Glucose:\n",
      "   Total Records: 1,369\n",
      "   📉 Below Normal (bn): 0 (0.0%)\n",
      "   ✅ Normal (n): 1,369 (100.0%)\n",
      "   📈 Above Normal (an): 0 (0.0%)\n",
      "   👥 Gender Distribution:\n",
      "      Female: 701 (51.2%)\n",
      "      Male: 668 (48.8%)\n",
      "   🏥 Lab Distribution:\n",
      "      Hawkari: 829 (60.6%)\n",
      "      Biolab: 540 (39.4%)\n",
      "\n",
      "🔍 COMBINED OUTCOME PATTERNS:\n",
      "   Outcome Pattern Analysis (1017 patients):\n",
      "   📊 Blood: Above Normal + Blood Glucose: Normal\n",
      "      687 patients (67.6%)\n",
      "   📊 Blood: Normal + Blood Glucose: Normal\n",
      "      327 patients (32.2%)\n",
      "   📊 Blood: Below Normal + Blood Glucose: Normal\n",
      "      3 patients (0.3%)\n",
      "\n",
      "   🚨 HIGH RISK ANALYSIS:\n",
      "   Both Tests Abnormal: 0 (0.0%)\n",
      "   Both Tests Normal: 327 (32.2%)\n",
      "   Mixed Results: 690 (67.8%)\n",
      "\n",
      "====================================================================================================\n",
      "\n",
      "🎯 SUMMARY TABLE - TEST COMBINATION OUTCOMES\n",
      "========================================================================================================================\n",
      "                          Test 1                           Test 2  Total Patients Test 1 Abnormal % Test 2 Abnormal %\n",
      "                Serum Creatinine                    Blood Glucose            4965             35.8%              0.0%\n",
      "     Hepatitis B Surface Antigen             Hepatitis C Antibody            4853              0.2%              0.0%\n",
      "     Hepatitis B Surface Antigen                     HIV Antibody            4846              0.2%              0.0%\n",
      "            Hepatitis C Antibody                     HIV Antibody            4846              0.0%              0.0%\n",
      "                             TSH                 Serum Creatinine            3779             29.5%             36.8%\n",
      "                             TSH                    Blood Glucose            3754             28.3%              0.0%\n",
      "                Serum Creatinine            Total Serum Bilirubin            3281             36.4%              0.0%\n",
      "           Total Serum Bilirubin                    Blood Glucose            3064              0.0%              0.0%\n",
      "             Blood Urea Nitrogen                 Serum Creatinine            2870             68.8%             36.1%\n",
      "                             TSH                       Vitamin D3            2610             28.1%             72.2%\n",
      "               Serum Cholesterol              Serum Triglycerides            2515              0.0%             56.7%\n",
      "                             TSH            Total Serum Bilirubin            2427             27.2%              0.0%\n",
      "                Serum Creatinine         C-Reactive Protein Titer            2227             36.9%              0.0%\n",
      "                   Blood Glucose         C-Reactive Protein Titer            2146              0.0%              0.0%\n",
      "               Serum Cholesterol            Serum LDL Cholesterol            1930              0.0%             68.9%\n",
      "             Serum Triglycerides            Serum LDL Cholesterol            1903             57.4%             68.6%\n",
      "                           HbA1c                    Blood Glucose            1855             82.2%              0.0%\n",
      "                             TSH                   Serum Ferritin            1843             31.5%             20.9%\n",
      "Aspartate Aminotransferase (AST)   Alanine Aminotransferase (ALT)            1820             11.8%             11.0%\n",
      "                             TSH             Complete Blood Count            1812             26.9%              0.0%\n",
      "                      Vitamin D3             Complete Blood Count            1682             76.7%              0.0%\n",
      "                          S.Iron                       Vitamin D3            1635              0.0%             76.6%\n",
      "                           HbA1c                 Serum Creatinine            1633             83.5%             35.5%\n",
      "           Serum HDL Cholesterol            Serum LDL Cholesterol            1602             37.9%             68.7%\n",
      "               Serum Cholesterol            Serum HDL Cholesterol            1586              0.0%             37.9%\n",
      "             Serum Triglycerides            Serum HDL Cholesterol            1580             57.1%             38.0%\n",
      "                           HbA1c                              TSH            1538             76.6%             32.6%\n",
      "                             TSH         C-Reactive Protein Titer            1518             30.3%              0.0%\n",
      "                     Blood Sugar             Complete Blood Count            1511             58.6%              0.0%\n",
      "               Total Cholesterol                  LDL Cholesterol            1467             22.9%              0.0%\n",
      "                Serum Creatinine   Alanine Aminotransferase (ALT)            1406             29.0%              9.2%\n",
      "                          S.Iron             Complete Blood Count            1399              0.0%              0.0%\n",
      "                             TSH   Erythrocyte Sedimentation Rate            1393             31.0%              0.0%\n",
      "                Serum Creatinine Aspartate Aminotransferase (AST)            1361             29.0%             10.9%\n",
      "                Serum Creatinine                   Serum Ferritin            1353             45.1%             22.9%\n",
      "                  Serum Ferritin                    Blood Glucose            1339             22.1%              0.0%\n",
      "                             TSH                        Prolactin            1288             25.2%             60.0%\n",
      "                  Serum Ferritin                       Vitamin D3            1273             17.1%             66.5%\n",
      "  Erythrocyte Sedimentation Rate         C-Reactive Protein Titer            1268              0.0%              0.0%\n",
      "           Total Serum Bilirubin         C-Reactive Protein Titer            1245              0.0%              0.0%\n",
      "                             TSH                  LDL Cholesterol            1241             25.1%              0.0%\n",
      "                   Blood Glucose                  LDL Cholesterol            1232              0.0%              0.0%\n",
      "                Serum Creatinine                  LDL Cholesterol            1230             28.7%              0.0%\n",
      "               Total Cholesterol                    Triglycerides            1215             23.1%             57.9%\n",
      "                Serum Creatinine   Erythrocyte Sedimentation Rate            1191             35.0%              0.0%\n",
      "                   Triglycerides                  LDL Cholesterol            1189             58.6%              0.0%\n",
      "  Alanine Aminotransferase (ALT)             Alkaline Phosphatase            1125             12.3%             15.5%\n",
      "Aspartate Aminotransferase (AST)             Alkaline Phosphatase            1116             13.8%             15.5%\n",
      "                             TSH                Total Cholesterol            1114             25.6%             22.7%\n",
      "           Total Serum Bilirubin                   Serum Ferritin            1088              0.0%             22.4%\n",
      "                   Blood Glucose                Total Cholesterol            1077              0.0%             22.0%\n",
      "  Alanine Aminotransferase (ALT)            Total Serum Bilirubin            1076             11.9%              0.0%\n",
      "                             TSH   Alanine Aminotransferase (ALT)            1068             25.5%              8.2%\n",
      "                Serum Creatinine             Complete Blood Count            1067             36.4%              0.0%\n",
      "Aspartate Aminotransferase (AST)            Total Serum Bilirubin            1063             14.3%              0.0%\n",
      "                Serum Creatinine                Total Cholesterol            1047             28.9%             23.2%\n",
      "            Alkaline Phosphatase            Total Serum Bilirubin            1042             14.9%              0.0%\n",
      "     Hepatitis B Surface Antigen                    Blood Glucose            1039              0.1%              0.0%\n",
      "            Hepatitis C Antibody                    Blood Glucose            1036              0.0%              0.0%\n",
      "                    HIV Antibody                    Blood Glucose            1035              0.0%              0.0%\n",
      "                      Vitamin D3   Erythrocyte Sedimentation Rate            1029             75.8%              0.0%\n",
      "                             TSH              Blood Urea Nitrogen            1027             30.1%             65.6%\n",
      "                      Vitamin D3                    Blood Glucose            1018             71.2%              0.0%\n",
      "  Erythrocyte Sedimentation Rate                    Blood Glucose            1018              0.0%              0.0%\n",
      "             Blood Urea Nitrogen                    Blood Glucose            1017             72.9%              0.0%\n",
      "\n",
      "✅ ANALYSIS COMPLETE!\n",
      "📈 Analyzed 65 test combinations covering 115,823 total patient-test-pair instances\n"
     ]
    }
   ],
   "source": [
    "# Show the Outcome status for each of the test combinations\n",
    "print(\"=== OUTCOME DISTRIBUTION ANALYSIS FOR TEST COMBINATIONS ===\")\n",
    "print(f\"Analyzing {len(results_df)} test combinations with >2000 patients each\")\n",
    "print(\"\\n\" + \"=\"*100)\n",
    "\n",
    "# For each combination, show detailed outcome breakdown\n",
    "for idx, row in results_df.iterrows():\n",
    "    test1, test2 = row['tests']\n",
    "    patient_count = row['count']\n",
    "    \n",
    "    print(f\"\\n🧪 TEST COMBINATION: {test1} + {test2}\")\n",
    "    print(f\"📊 Total Patients: {patient_count:,}\")\n",
    "    print(\"-\" * 80)\n",
    "    \n",
    "    # Get patients who have both tests\n",
    "    patients_with_both = df_pivot[(df_pivot[test1] > 0) & (df_pivot[test2] > 0)].index\n",
    "    \n",
    "    # Filter the main dataset for these patients and both tests\n",
    "    combo_data = df_combined[\n",
    "        (df_combined['Patient Name'].isin(patients_with_both)) & \n",
    "        (df_combined['Standard Test Name'].isin([test1, test2]))\n",
    "    ].copy()\n",
    "    \n",
    "    # Analyze outcomes for each test separately\n",
    "    for test_name in [test1, test2]:\n",
    "        test_data = combo_data[combo_data['Standard Test Name'] == test_name]\n",
    "        \n",
    "        print(f\"\\n📋 {test_name}:\")\n",
    "        print(f\"   Total Records: {len(test_data):,}\")\n",
    "        \n",
    "        # Outcome distribution\n",
    "        outcome_dist = test_data['Outcome'].value_counts()\n",
    "        total_records = len(test_data)\n",
    "        \n",
    "        for outcome in ['bn', 'n', 'an']:\n",
    "            count = outcome_dist.get(outcome, 0)\n",
    "            percentage = (count / total_records * 100) if total_records > 0 else 0\n",
    "            outcome_name = {'bn': 'Below Normal', 'n': 'Normal', 'an': 'Above Normal'}[outcome]\n",
    "            emoji = {'bn': '📉', 'n': '✅', 'an': '📈'}[outcome]\n",
    "            print(f\"   {emoji} {outcome_name} ({outcome}): {count:,} ({percentage:.1f}%)\")\n",
    "        \n",
    "        # Gender breakdown\n",
    "        gender_dist = test_data['Gender'].value_counts()\n",
    "        print(f\"   👥 Gender Distribution:\")\n",
    "        for gender, count in gender_dist.items():\n",
    "            percentage = (count / total_records * 100) if total_records > 0 else 0\n",
    "            print(f\"      {gender}: {count:,} ({percentage:.1f}%)\")\n",
    "        \n",
    "        # Lab distribution\n",
    "        lab_dist = test_data['Lab'].value_counts()\n",
    "        print(f\"   🏥 Lab Distribution:\")\n",
    "        for lab, count in lab_dist.items():\n",
    "            percentage = (count / total_records * 100) if total_records > 0 else 0\n",
    "            print(f\"      {lab}: {count:,} ({percentage:.1f}%)\")\n",
    "    \n",
    "    # Combined analysis - look at outcome patterns for patients with both tests\n",
    "    print(f\"\\n🔍 COMBINED OUTCOME PATTERNS:\")\n",
    "    \n",
    "    # Create a summary for each patient showing their outcomes for both tests\n",
    "    patient_outcomes = []\n",
    "    for patient in patients_with_both:\n",
    "        patient_data = combo_data[combo_data['Patient Name'] == patient]\n",
    "        \n",
    "        test1_outcomes = patient_data[patient_data['Standard Test Name'] == test1]['Outcome'].values\n",
    "        test2_outcomes = patient_data[patient_data['Standard Test Name'] == test2]['Outcome'].values\n",
    "        \n",
    "        if len(test1_outcomes) > 0 and len(test2_outcomes) > 0:\n",
    "            # Take the most recent outcome for each test\n",
    "            test1_outcome = test1_outcomes[-1]  # Most recent\n",
    "            test2_outcome = test2_outcomes[-1]  # Most recent\n",
    "            \n",
    "            patient_outcomes.append({\n",
    "                'patient': patient,\n",
    "                'test1_outcome': test1_outcome,\n",
    "                'test2_outcome': test2_outcome,\n",
    "                'combination': f\"{test1_outcome}-{test2_outcome}\"\n",
    "            })\n",
    "    \n",
    "    # Analyze outcome combinations\n",
    "    if patient_outcomes:\n",
    "        combo_df = pd.DataFrame(patient_outcomes)\n",
    "        combo_counts = combo_df['combination'].value_counts()\n",
    "        \n",
    "        print(f\"   Outcome Pattern Analysis ({len(patient_outcomes)} patients):\")\n",
    "        for combo, count in combo_counts.items():\n",
    "            percentage = (count / len(patient_outcomes) * 100)\n",
    "            test1_out, test2_out = combo.split('-')\n",
    "            \n",
    "            test1_name_short = test1.split()[0] if len(test1.split()) > 2 else test1\n",
    "            test2_name_short = test2.split()[0] if len(test2.split()) > 2 else test2\n",
    "            \n",
    "            outcome_names = {'bn': 'Below Normal', 'n': 'Normal', 'an': 'Above Normal'}\n",
    "            print(f\"   📊 {test1_name_short}: {outcome_names[test1_out]} + {test2_name_short}: {outcome_names[test2_out]}\")\n",
    "            print(f\"      {count:,} patients ({percentage:.1f}%)\")\n",
    "        \n",
    "        # Risk analysis - patients with abnormal results in both tests\n",
    "        both_abnormal = combo_df[\n",
    "            (combo_df['test1_outcome'] != 'n') & (combo_df['test2_outcome'] != 'n')\n",
    "        ]\n",
    "        both_normal = combo_df[\n",
    "            (combo_df['test1_outcome'] == 'n') & (combo_df['test2_outcome'] == 'n')\n",
    "        ]\n",
    "        \n",
    "        print(f\"\\n   🚨 HIGH RISK ANALYSIS:\")\n",
    "        print(f\"   Both Tests Abnormal: {len(both_abnormal):,} ({len(both_abnormal)/len(patient_outcomes)*100:.1f}%)\")\n",
    "        print(f\"   Both Tests Normal: {len(both_normal):,} ({len(both_normal)/len(patient_outcomes)*100:.1f}%)\")\n",
    "        print(f\"   Mixed Results: {len(patient_outcomes) - len(both_abnormal) - len(both_normal):,} ({(len(patient_outcomes) - len(both_abnormal) - len(both_normal))/len(patient_outcomes)*100:.1f}%)\")\n",
    "    \n",
    "    print(\"\\n\" + \"=\"*100)\n",
    "\n",
    "# Summary table of all combinations\n",
    "print(f\"\\n🎯 SUMMARY TABLE - TEST COMBINATION OUTCOMES\")\n",
    "print(\"=\"*120)\n",
    "\n",
    "summary_data = []\n",
    "for idx, row in results_df.iterrows():\n",
    "    test1, test2 = row['tests']\n",
    "    patient_count = row['count']\n",
    "    \n",
    "    # Get patients who have both tests\n",
    "    patients_with_both = df_pivot[(df_pivot[test1] > 0) & (df_pivot[test2] > 0)].index\n",
    "    combo_data = df_combined[\n",
    "        (df_combined['Patient Name'].isin(patients_with_both)) & \n",
    "        (df_combined['Standard Test Name'].isin([test1, test2]))\n",
    "    ].copy()\n",
    "    \n",
    "    # Calculate summary stats\n",
    "    test1_data = combo_data[combo_data['Standard Test Name'] == test1]\n",
    "    test2_data = combo_data[combo_data['Standard Test Name'] == test2]\n",
    "    \n",
    "    test1_abnormal = len(test1_data[test1_data['Outcome'] != 'n'])\n",
    "    test2_abnormal = len(test2_data[test2_data['Outcome'] != 'n'])\n",
    "    \n",
    "    test1_abnormal_pct = (test1_abnormal / len(test1_data) * 100) if len(test1_data) > 0 else 0\n",
    "    test2_abnormal_pct = (test2_abnormal / len(test2_data) * 100) if len(test2_data) > 0 else 0\n",
    "    \n",
    "    summary_data.append({\n",
    "        'Test 1': test1,\n",
    "        'Test 2': test2,\n",
    "        'Total Patients': patient_count,\n",
    "        'Test 1 Abnormal %': f\"{test1_abnormal_pct:.1f}%\",\n",
    "        'Test 2 Abnormal %': f\"{test2_abnormal_pct:.1f}%\"\n",
    "    })\n",
    "\n",
    "summary_df = pd.DataFrame(summary_data)\n",
    "print(summary_df.to_string(index=False))\n",
    "\n",
    "print(f\"\\n✅ ANALYSIS COMPLETE!\")\n",
    "print(f\"📈 Analyzed {len(results_df)} test combinations covering {results_df['count'].sum():,} total patient-test-pair instances\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "3acaf5c9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "🎯 ENHANCED SUMMARY TABLE - TEST COMBINATION OUTCOMES WITH RISK ANALYSIS\n",
      "============================================================================================================================================\n",
      "                          Test 1                           Test 2  Total Patients Test 1 Abnormal % Test 2 Abnormal % Both Tests Abnormal % Both Tests Normal % Mixed Results %\n",
      "                Serum Creatinine                    Blood Glucose            4965             35.8%              0.0%                  0.0%               64.6%           35.4%\n",
      "     Hepatitis B Surface Antigen             Hepatitis C Antibody            4853              0.2%              0.0%                  0.0%               99.8%            0.2%\n",
      "     Hepatitis B Surface Antigen                     HIV Antibody            4846              0.2%              0.0%                  0.0%               99.8%            0.2%\n",
      "            Hepatitis C Antibody                     HIV Antibody            4846              0.0%              0.0%                  0.0%              100.0%            0.0%\n",
      "                             TSH                 Serum Creatinine            3779             29.5%             36.8%                  9.1%               48.8%           42.1%\n",
      "                             TSH                    Blood Glucose            3754             28.3%              0.0%                  0.0%               77.6%           22.4%\n",
      "                Serum Creatinine            Total Serum Bilirubin            3281             36.4%              0.0%                  0.0%               64.6%           35.4%\n",
      "           Total Serum Bilirubin                    Blood Glucose            3064              0.0%              0.0%                  0.0%              100.0%            0.0%\n",
      "             Blood Urea Nitrogen                 Serum Creatinine            2870             68.8%             36.1%                 18.6%               18.6%           62.7%\n",
      "                             TSH                       Vitamin D3            2610             28.1%             72.2%                 15.4%               21.3%           63.3%\n",
      "               Serum Cholesterol              Serum Triglycerides            2515              0.0%             56.7%                  0.0%               47.9%           52.1%\n",
      "                             TSH            Total Serum Bilirubin            2427             27.2%              0.0%                  0.0%               77.8%           22.2%\n",
      "                Serum Creatinine         C-Reactive Protein Titer            2227             36.9%              0.0%                  0.0%               64.7%           35.3%\n",
      "                   Blood Glucose         C-Reactive Protein Titer            2146              0.0%              0.0%                  0.0%              100.0%            0.0%\n",
      "               Serum Cholesterol            Serum LDL Cholesterol            1930              0.0%             68.9%                  0.0%               31.6%           68.4%\n",
      "             Serum Triglycerides            Serum LDL Cholesterol            1903             57.4%             68.6%                 39.9%               19.7%           40.4%\n",
      "                           HbA1c                    Blood Glucose            1855             82.2%              0.0%                  0.0%               21.4%           78.6%\n",
      "                             TSH                   Serum Ferritin            1843             31.5%             20.9%                  4.8%               62.0%           33.2%\n",
      "Aspartate Aminotransferase (AST)   Alanine Aminotransferase (ALT)            1820             11.8%             11.0%                  5.4%               86.1%            8.5%\n",
      "                             TSH             Complete Blood Count            1812             26.9%              0.0%                  0.0%               80.7%           19.3%\n",
      "                      Vitamin D3             Complete Blood Count            1682             76.7%              0.0%                  0.0%               22.6%           77.4%\n",
      "                          S.Iron                       Vitamin D3            1635              0.0%             76.6%                  0.0%               22.6%           77.4%\n",
      "                           HbA1c                 Serum Creatinine            1633             83.5%             35.5%                 28.2%               13.0%           58.8%\n",
      "           Serum HDL Cholesterol            Serum LDL Cholesterol            1602             37.9%             68.7%                 23.6%               19.0%           57.4%\n",
      "               Serum Cholesterol            Serum HDL Cholesterol            1586              0.0%             37.9%                  0.1%               63.4%           36.5%\n",
      "             Serum Triglycerides            Serum HDL Cholesterol            1580             57.1%             38.0%                 26.0%               37.4%           36.6%\n",
      "                           HbA1c                              TSH            1538             76.6%             32.6%                 20.5%               20.9%           58.6%\n",
      "                             TSH         C-Reactive Protein Titer            1518             30.3%              0.0%                  0.0%               76.0%           24.0%\n",
      "                     Blood Sugar             Complete Blood Count            1511             58.6%              0.0%                  0.0%               42.0%           58.0%\n",
      "               Total Cholesterol                  LDL Cholesterol            1467             22.9%              0.0%                  0.0%               77.8%           22.2%\n",
      "                Serum Creatinine   Alanine Aminotransferase (ALT)            1406             29.0%              9.2%                  2.1%               65.3%           32.6%\n",
      "                          S.Iron             Complete Blood Count            1399              0.0%              0.0%                  0.0%              100.0%            0.0%\n",
      "                             TSH   Erythrocyte Sedimentation Rate            1393             31.0%              0.0%                  0.0%               75.4%           24.6%\n",
      "                Serum Creatinine Aspartate Aminotransferase (AST)            1361             29.0%             10.9%                  4.2%               65.5%           30.3%\n",
      "                Serum Creatinine                   Serum Ferritin            1353             45.1%             22.9%                  9.8%               45.0%           45.2%\n",
      "                  Serum Ferritin                    Blood Glucose            1339             22.1%              0.0%                  0.0%               79.5%           20.5%\n",
      "                             TSH                        Prolactin            1288             25.2%             60.0%                 12.4%               33.2%           54.4%\n",
      "                  Serum Ferritin                       Vitamin D3            1273             17.1%             66.5%                 11.2%               28.9%           59.9%\n",
      "  Erythrocyte Sedimentation Rate         C-Reactive Protein Titer            1268              0.0%              0.0%                  0.0%              100.0%            0.0%\n",
      "           Total Serum Bilirubin         C-Reactive Protein Titer            1245              0.0%              0.0%                  0.0%              100.0%            0.0%\n",
      "                             TSH                  LDL Cholesterol            1241             25.1%              0.0%                  0.0%               79.0%           21.0%\n",
      "                   Blood Glucose                  LDL Cholesterol            1232              0.0%              0.0%                  0.0%              100.0%            0.0%\n",
      "                Serum Creatinine                  LDL Cholesterol            1230             28.7%              0.0%                  0.0%               71.6%           28.4%\n",
      "               Total Cholesterol                    Triglycerides            1215             23.1%             57.9%                 15.7%               35.4%           48.9%\n",
      "                Serum Creatinine   Erythrocyte Sedimentation Rate            1191             35.0%              0.0%                  0.0%               66.2%           33.8%\n",
      "                   Triglycerides                  LDL Cholesterol            1189             58.6%              0.0%                  0.0%               41.1%           58.9%\n",
      "  Alanine Aminotransferase (ALT)             Alkaline Phosphatase            1125             12.3%             15.5%                  2.8%               78.1%           19.1%\n",
      "Aspartate Aminotransferase (AST)             Alkaline Phosphatase            1116             13.8%             15.5%                  4.4%               78.5%           17.1%\n",
      "                             TSH                Total Cholesterol            1114             25.6%             22.7%                  5.2%               61.9%           32.9%\n",
      "           Total Serum Bilirubin                   Serum Ferritin            1088              0.0%             22.4%                  0.0%               79.1%           20.9%\n",
      "                   Blood Glucose                Total Cholesterol            1077              0.0%             22.0%                  0.0%               78.7%           21.3%\n",
      "  Alanine Aminotransferase (ALT)            Total Serum Bilirubin            1076             11.9%              0.0%                  0.0%               90.0%           10.0%\n",
      "                             TSH   Alanine Aminotransferase (ALT)            1068             25.5%              8.2%                  1.5%               74.6%           23.9%\n",
      "                Serum Creatinine             Complete Blood Count            1067             36.4%              0.0%                  0.0%               64.9%           35.1%\n",
      "Aspartate Aminotransferase (AST)            Total Serum Bilirubin            1063             14.3%              0.0%                  0.0%               87.9%           12.1%\n",
      "                Serum Creatinine                Total Cholesterol            1047             28.9%             23.2%                  6.9%               56.1%           37.1%\n",
      "            Alkaline Phosphatase            Total Serum Bilirubin            1042             14.9%              0.0%                  0.0%               86.6%           13.4%\n",
      "     Hepatitis B Surface Antigen                    Blood Glucose            1039              0.1%              0.0%                  0.0%               99.9%            0.1%\n",
      "            Hepatitis C Antibody                    Blood Glucose            1036              0.0%              0.0%                  0.0%              100.0%            0.0%\n",
      "                    HIV Antibody                    Blood Glucose            1035              0.0%              0.0%                  0.0%              100.0%            0.0%\n",
      "                      Vitamin D3   Erythrocyte Sedimentation Rate            1029             75.8%              0.0%                  0.0%               23.6%           76.4%\n",
      "                             TSH              Blood Urea Nitrogen            1027             30.1%             65.6%                 15.3%               29.6%           55.1%\n",
      "                      Vitamin D3                    Blood Glucose            1018             71.2%              0.0%                  0.0%               28.2%           71.8%\n",
      "  Erythrocyte Sedimentation Rate                    Blood Glucose            1018              0.0%              0.0%                  0.0%              100.0%            0.0%\n",
      "             Blood Urea Nitrogen                    Blood Glucose            1017             72.9%              0.0%                  0.0%               32.2%           67.8%\n",
      "\n",
      "📊 KEY INSIGHTS FROM ENHANCED ANALYSIS:\n",
      "============================================================\n",
      "\n",
      "🚨 HIGHEST RISK COMBINATIONS (Both Tests Abnormal):\n",
      "1. Serum Triglycerides + Serum LDL Cholesterol: 39.9% (1903 patients)\n",
      "2. HbA1c + Serum Creatinine: 28.2% (1633 patients)\n",
      "3. Serum Triglycerides + Serum HDL Cholesterol: 26.0% (1580 patients)\n",
      "\n",
      "✅ LOWEST RISK COMBINATIONS (Both Tests Normal):\n",
      "1. Hepatitis C Antibody + HIV Antibody: 100.0% (4846 patients)\n",
      "2. Total Serum Bilirubin + Blood Glucose: 100.0% (3064 patients)\n",
      "3. Blood Glucose + C-Reactive Protein Titer: 100.0% (2146 patients)\n",
      "\n",
      "⚖️ MOST VARIABLE COMBINATIONS (Mixed Results):\n",
      "1. HbA1c + Blood Glucose: 78.6% (1855 patients)\n",
      "2. Vitamin D3 + Complete Blood Count: 77.4% (1682 patients)\n",
      "3. S.Iron + Vitamin D3: 77.4% (1635 patients)\n",
      "\n",
      "✅ ENHANCED ANALYSIS COMPLETE!\n",
      "📈 Enhanced summary includes individual and combined risk analysis for all 65 test combinations\n"
     ]
    }
   ],
   "source": [
    "# Enhanced Summary table including combined outcome analysis\n",
    "print(f\"\\n🎯 ENHANCED SUMMARY TABLE - TEST COMBINATION OUTCOMES WITH RISK ANALYSIS\")\n",
    "print(\"=\"*140)\n",
    "\n",
    "enhanced_summary_data = []\n",
    "for idx, row in results_df.iterrows():\n",
    "    test1, test2 = row['tests']\n",
    "    patient_count = row['count']\n",
    "    \n",
    "    # Get patients who have both tests\n",
    "    patients_with_both = df_pivot[(df_pivot[test1] > 0) & (df_pivot[test2] > 0)].index\n",
    "    combo_data = df_combined[\n",
    "        (df_combined['Patient Name'].isin(patients_with_both)) & \n",
    "        (df_combined['Standard Test Name'].isin([test1, test2]))\n",
    "    ].copy()\n",
    "    \n",
    "    # Calculate summary stats for individual tests\n",
    "    test1_data = combo_data[combo_data['Standard Test Name'] == test1]\n",
    "    test2_data = combo_data[combo_data['Standard Test Name'] == test2]\n",
    "    \n",
    "    test1_abnormal = len(test1_data[test1_data['Outcome'] != 'n'])\n",
    "    test2_abnormal = len(test2_data[test2_data['Outcome'] != 'n'])\n",
    "    \n",
    "    test1_abnormal_pct = (test1_abnormal / len(test1_data) * 100) if len(test1_data) > 0 else 0\n",
    "    test2_abnormal_pct = (test2_abnormal / len(test2_data) * 100) if len(test2_data) > 0 else 0\n",
    "    \n",
    "    # Calculate combined outcome patterns\n",
    "    patient_outcomes = []\n",
    "    for patient in patients_with_both:\n",
    "        patient_data = combo_data[combo_data['Patient Name'] == patient]\n",
    "        \n",
    "        test1_outcomes = patient_data[patient_data['Standard Test Name'] == test1]['Outcome'].values\n",
    "        test2_outcomes = patient_data[patient_data['Standard Test Name'] == test2]['Outcome'].values\n",
    "        \n",
    "        if len(test1_outcomes) > 0 and len(test2_outcomes) > 0:\n",
    "            # Take the most recent outcome for each test\n",
    "            test1_outcome = test1_outcomes[-1]  # Most recent\n",
    "            test2_outcome = test2_outcomes[-1]  # Most recent\n",
    "            \n",
    "            patient_outcomes.append({\n",
    "                'patient': patient,\n",
    "                'test1_outcome': test1_outcome,\n",
    "                'test2_outcome': test2_outcome\n",
    "            })\n",
    "    \n",
    "    # Analyze combined risk patterns\n",
    "    if patient_outcomes:\n",
    "        combo_df = pd.DataFrame(patient_outcomes)\n",
    "        \n",
    "        both_abnormal = combo_df[\n",
    "            (combo_df['test1_outcome'] != 'n') & (combo_df['test2_outcome'] != 'n')\n",
    "        ]\n",
    "        both_normal = combo_df[\n",
    "            (combo_df['test1_outcome'] == 'n') & (combo_df['test2_outcome'] == 'n')\n",
    "        ]\n",
    "        mixed_results = len(combo_df) - len(both_abnormal) - len(both_normal)\n",
    "        \n",
    "        both_abnormal_pct = len(both_abnormal) / len(combo_df) * 100\n",
    "        both_normal_pct = len(both_normal) / len(combo_df) * 100\n",
    "        mixed_results_pct = mixed_results / len(combo_df) * 100\n",
    "    else:\n",
    "        both_abnormal_pct = 0\n",
    "        both_normal_pct = 0\n",
    "        mixed_results_pct = 0\n",
    "    \n",
    "    enhanced_summary_data.append({\n",
    "        'Test 1': test1,\n",
    "        'Test 2': test2,\n",
    "        'Total Patients': patient_count,\n",
    "        'Test 1 Abnormal %': f\"{test1_abnormal_pct:.1f}%\",\n",
    "        'Test 2 Abnormal %': f\"{test2_abnormal_pct:.1f}%\",\n",
    "        'Both Tests Abnormal %': f\"{both_abnormal_pct:.1f}%\",\n",
    "        'Both Tests Normal %': f\"{both_normal_pct:.1f}%\",\n",
    "        'Mixed Results %': f\"{mixed_results_pct:.1f}%\"\n",
    "    })\n",
    "\n",
    "enhanced_summary_df = pd.DataFrame(enhanced_summary_data)\n",
    "\n",
    "# Display the enhanced summary table\n",
    "print(enhanced_summary_df.to_string(index=False))\n",
    "\n",
    "# Show some key insights\n",
    "print(f\"\\n📊 KEY INSIGHTS FROM ENHANCED ANALYSIS:\")\n",
    "print(\"=\"*60)\n",
    "\n",
    "# Find test combinations with highest risk (both abnormal)\n",
    "enhanced_summary_df['Both_Abnormal_Numeric'] = enhanced_summary_df['Both Tests Abnormal %'].str.rstrip('%').astype(float)\n",
    "highest_risk = enhanced_summary_df.nlargest(3, 'Both_Abnormal_Numeric')\n",
    "\n",
    "print(f\"\\n🚨 HIGHEST RISK COMBINATIONS (Both Tests Abnormal):\")\n",
    "for i, (_, row) in enumerate(highest_risk.iterrows(), 1):\n",
    "    print(f\"{i}. {row['Test 1']} + {row['Test 2']}: {row['Both Tests Abnormal %']} ({row['Total Patients']} patients)\")\n",
    "\n",
    "# Find test combinations with highest normal rates\n",
    "enhanced_summary_df['Both_Normal_Numeric'] = enhanced_summary_df['Both Tests Normal %'].str.rstrip('%').astype(float)\n",
    "lowest_risk = enhanced_summary_df.nlargest(3, 'Both_Normal_Numeric')\n",
    "\n",
    "print(f\"\\n✅ LOWEST RISK COMBINATIONS (Both Tests Normal):\")\n",
    "for i, (_, row) in enumerate(lowest_risk.iterrows(), 1):\n",
    "    print(f\"{i}. {row['Test 1']} + {row['Test 2']}: {row['Both Tests Normal %']} ({row['Total Patients']} patients)\")\n",
    "\n",
    "# Find test combinations with most mixed results\n",
    "enhanced_summary_df['Mixed_Numeric'] = enhanced_summary_df['Mixed Results %'].str.rstrip('%').astype(float)\n",
    "most_mixed = enhanced_summary_df.nlargest(3, 'Mixed_Numeric')\n",
    "\n",
    "print(f\"\\n⚖️ MOST VARIABLE COMBINATIONS (Mixed Results):\")\n",
    "for i, (_, row) in enumerate(most_mixed.iterrows(), 1):\n",
    "    print(f\"{i}. {row['Test 1']} + {row['Test 2']}: {row['Mixed Results %']} ({row['Total Patients']} patients)\")\n",
    "\n",
    "print(f\"\\n✅ ENHANCED ANALYSIS COMPLETE!\")\n",
    "print(f\"📈 Enhanced summary includes individual and combined risk analysis for all {len(enhanced_summary_df)} test combinations\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "c2147a9f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAABW0AAAMVCAYAAAAMNtYlAAAAOnRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjEwLjYsIGh0dHBzOi8vbWF0cGxvdGxpYi5vcmcvq6yFwwAAAAlwSFlzAAAPYQAAD2EBqD+naQAA1BdJREFUeJzs3Qd0VEXbwPEnvZAEQgfpTSmCYkH0FaSJoAhSFEWxIPaGDcUKqMgnimIHkSIgCKKIiki3gSg2sFBVEKUTQnrb7zxDdnN3sym7bMhN8v+dc082c8vO3L1l9tm5M0EOh8MhAAAAAAAAAABbCC7tDAAAAAAAAAAA8hC0BQAAAAAAAAAbIWgLAAAAAAAAADZC0BYAAAAAAAAAbISgLQAAAAAAAADYCEFbAAAAAAAAALARgrYAAAAAAAAAYCMEbQEAAAAAAADARgjaAgAAAAAAAICNELQFKrhGjRpJUFCQX9Nff/0ldjR9+vRi5T8yMrLY23zyySf93k+6blmXnp4uM2bMkMGDB0uzZs2kcuXKEhYWJlWrVpWzzjpL7rrrLlm1apU4HA4pCy644ILjOpY9z5uy6Hj3QUXneZ3x9zzX/W7djn4uJZnPwrZf1DXeOk/PgUDyvMZqviuK6667Lt+1xHmN8fy8PI8X66TX5Pj4eGnXrp3cdNNN8s0330hpWr16tVv+tJwn8h7vbQpUHsqiDz/8MN/+iIiIkEOHDpXa9QnHf6/2vFZYPzNf70vWa5HnFBoaKtWrV5f//e9/8vTTT8vBgwcDWk4AgHcEbQGgnAl0MG7x4sXmS4FW5ufNmyfbt2+XxMREycrKksOHD8v3338vL7/8snTt2tUsi9JVkoE1nPigLuzLbj/e6DU5ISFBfvnlF5kyZYqcd955Mnr06IC/T0UOsPvKMwimgezSMm3atHxpGRkZMmfOnFLJD8qW7OxsE6j9+uuv5dFHH5WWLVvKV199VdrZKjP4oRyAv0L9XhNAudC7d2/Zt2+fW9pvv/0mv//+u+v/hg0byplnnplv3UqVKklZMGDAAK/p4eHhxd5Gq1at8m0nJSVFlixZUuR76bpllQZjtRWtlVY2TzvtNKlXr57ZB5s2bZK9e/eaeTk5OVJRz5uypnPnzqbVTFk7n+0UsLOe72X5PC8ua3lr1qxZqnlB/s9Fn4j47rvvXNdjpUHbQYMGlavj0/Pcc3r//ffd/u/Vq5dER0e7pemTIRXR/v3789VXnDTofscdd5zwPMH+NDDrvHb8888/sn79etcTVXpMXXrppbJ161apVq1aKecUAMovgrZABffaa695bUVjbZ2jvw6X5ZY0CxYsOO5tXH755Way0l/JGzduHPD3sos1a9bIPffc45Z2/vnny9tvv226SLBau3ateVyuIp83ZU1JtMCrSPS6WNEeFS5P17fy+rkcPXpU2rRpIzt37jT/a4Bl5cqV5SpoW9C559naWa/TPG1wzKxZsyQzM9P1v3al4fx/w4YN5sdXPW4AK633Wp8S+eyzz8yP1s7ArT5tNXXqVHnwwQdLMZcAUL7RPQIAv2mryoULF5oWLw0aNJCoqCjTqqVJkyZy1VVXyfLly4v9aOWWLVvk6quvljp16pg+1jQo+Mgjj0hSUpKUB9qlwP333y+nn366VKlSxbTyrV27tlxyySXmC3dBfcEuXbrUVJp1n+q+da7Xtm1bueaaa+Sll14yX9Ktj15psNVKA8v+PJL1wAMPuLWcbd26tcmPZ8BWdezYUT7++GPTssnTrl27ZNSoUaaFk/a3qF8WtVWGPrqrgd4DBw4U6zH/tLQ0GTNmjLRo0cL0R6wtwPWLgrb2VXv27JFbbrlFTjrpJHMMNW/eXJ544gnz+Gdx6GOrF110kemnV/e1ti5/6623vH42hT0W7a0fR+1O4rHHHpNTTjnF5F1buA4cOFD++OOPfNvWxw/Hjh1rzivd5/p5a3k0T3qeacuW2bNn52vV7C0vf//9d4HdJRTnUT09/7S1dffu3aVWrVrm+NP+jPX40xbY1hb5Vt62rYGjiy++2Oxf3QdatokTJ3rdv7oP9DrRoUMHs7weM3FxceY86Natm4wcOVK++OILKS4NWDnzosee9T3XrVvnllf9UlrQZ63HVlHdHzjTr7/++nxB8uJ2l6CPueu5rdcL/dx1n+uxqXm1e9cbGhzSz01bbuu1TrtN+eSTT/zqG1OvHcOHDzet+vXY0+Nfj7sjR44UuM7PP/8st956qzm+9JjRc0fX19amy5YtK3C9uXPnSp8+faR+/frm+NT16tatK2eccYbceOON8sYbb5jHg63HhJ5fBe2f0uouITY2Vs4++2y3tNTUVK/L6nn2zDPPmD4q9Zrk7BNXr30PP/yw2f/e7t2eP/josV7c7hL0eq3XcW3BV9S1sKT8999/5t5wzjnnuK4vmg+9zmkAyhrctPr222/l2muvlZNPPtkc37pejRo1zPVF79PPPfecuQ9Zu0XQvuCtunTpUmB3Cb7c731l/UyCg4Pl8ccfL3B+UXT/aFlPPfVUU+/Ta6rer/Tc83S898NA1yO0PvB///d/Zp/qZ2g9T0uyzqHdCIwYMcJ8/k2bNjVl0D5i9dqu+1GvWd72n93ofUh/vLfS1reBqPN6u6f++eef5pjRfaz7y7NPau2PWY9Fvc846yj6fnp9ueGGG7zmTa+Hej3v2bOnyZOzXqPXPb22FdRXr+fxoXUwrSPqdSQmJsZMum88W7T7WjfXv3p+6P1IrzX6VIvmUbevx45eI7S+XRC9T02aNMkc487zU/e7Nq4obj/jJ+I+CsAHDgDw8MQTT2htyjVde+21+ZY5dOiQo0uXLm7LeZuuuOIKR3p6eqHbHzJkiCMqKsrr+qeddpp5L19MmzbNbRujRo0y73HNNdc4Ro4c6Vi8eLEjMzPzuPfTn3/+mS+/3rz66quO8PDwQvdTr169HMnJyW7rPffcc0XuX502btxolu/cuXOxltd8F2Xbtm351lu4cKHP+2j27NmOSpUqFZqf6tWrO5YvX55vXesytWrVcnTs2NHr+pr+66+/OmrWrOl1/oABA/Jt23Nf3X///Y6goCCv63s7/hs2bFjg575q1Sq3eeeff76jcePGXrddpUqVfJ/Hd999V6zPsWfPno6MjAyv+6ugSfNd0D7wzMdPP/3kaNSoUaHbCw0NdUyYMKHI/Tt06NACt3H33Xe7rbt///58+7e4n2tB7rzzTrd1f/75Z9e8Z5991m2eXiMKOse1HAVdZ/S65i29oMm5vOd7nH766Y5OnTp5XSciIsKxbt26YpfbW370sylIUdeKgo4lp9tuu63A8t50002F5sPzvnD99dc74uLivG7rrLPOcjv2nR555JECz2PrdrOystzWu/3224v1mR09etQsX5zjU6fi0muM5zrO9/DcT0XddxITE/PlT69JnvSaq9fewvIfHR1truEFfUYFTXrMebsW9ujRw9GqVatiXwt9VdTxq/Q+VtBx5ZzOPvtsx549e9zWmzdvniM4OLjIsmv9wvMzLWxyfja+3u99sWHDBrdtXHDBBY6EhARzPXGm1a5d22u9yPN403NP1/eWN93ekiVLAno/DGQ9ok6dOo5u3boVeP6UZJ2jONeYkJAQx9SpU/OtW9S92vNaYf3MnPeZ4vI8br2tP2jQILdlLrzwwoDUeT3vVZdeemm+c9VaH/v000+LvIZ55v+3335ztGjRotB19Fz45ptv8pXb8/jQcntbX+9B1vqyr3Xz+fPnF2v5G264IV8e9d6m+83b8nr9uvHGGwvcnyf6Pgqg+AjaAvAraOtZ8Y2MjDSBhnPOOccEcqzztJJQ2PZ10gre//73P0eHDh1MxdU6TwOuvihO0ES/NHz11VclHrR977338lXKzz33XMfFF1/sOOmkk/IFuJ00IBETE+O2f/TLjlbGdB/Xq1cv35e4xx9/3HxZ8KzEauVY053Tvn37iizbjBkz8uXbs4JdFP2y5vlZ6n7XYGPdunXd0vUL2R9//OG2vrfPrXnz5o7u3bvn+0KgwQX9265dO7OfPNfzrIB7q0THx8eboMIpp5ySb96UKVP8Dto6J91u165dzbliTR8+fLjXoK1+cdDz4aKLLjKfux43nj9uTJw40bWe8/P13C/Wz/7WW28t1hdBDZzqlxLr/GrVqhUYdJk1a1aR+1ePZy1/s2bN8n2R2Llzp2vdZ555xm2+Bo4vueQS13s794EvQduPPvrIbZsvvfSSa57uX+s83ecFXUtmzpxZ4Dznl0P9/DVvZ555ptv8li1bun0WGgQq6DriLLeW2fNLq6b5wjOfen2w5sM6HU/Qds6cOfnW189a86vnlue8ooK2zuuOfh46ec6zBhPV//3f/7nN1/NMg0v6+eqxW1Bgfvfu3W5fUPVapMdpnz59zGdoDcw4v2zqeaT7y3ndcU6e+7MkeDtenO+n54nneWu9rzj9/vvv+YJgek3Wa3OTJk3yfQarV6826+kxq++jx7J1Gd1P1nI7A5HHey30VVHH79dff+0ICwtzzdfPXfOu+61p06b5AnM5OTmuda2BHr1m6TGp1+XzzjvPnKvOY8gZtH3llVfMvvC8V2g9ybqvNm3a5Nf93heeP1q9+eabJr1fv35u6c68WxV0fdL9oed21apV3dL1XN+7d69r/eM9BkqiHqHL6f7V/Gug+ETUOTSgpceNltv52WrdzPNc0v3x77//+hS0DaSigrbZ2dlmnxT0HcHfOm9hdXc9/nVf6Y8pzkDlt99+6/ajg3Pf6TJ67W7dunW+/GsDEOu55LxHad4879d6z9B7g5W3vOkPAXoceda7dR85+Vo3dwZtGzRoYK5DvXv3Ntco/cHEev3S6YMPPnDLo2f9Sac2bdqYc83bDx+e3+9O5H0UQPERtAXgc9D2s88+y1dJ11YHBVWy9UauXxIL2r4GYTRQ5aQtNaw3f63o+lJJLW5LN61UWFvcBTpoq5VbrXRZ95P+yu+krVq0smhd//vvv3dVgAoKFjn99ddfjsmTJzv++++/gFfwPStuGkD0lX7ZtG5DAx26T1Rqamq+sg8ePNhtfW+VS+eXaG3J4TlfK8ZO2nrTOm/06NGF7iMNBlqD2Q899JDbfA1kHE/Q1vrFwXO+fgG10hZQW7Zs8bpPtfWXteJtDTAWtzVkcY4Tz/Lr+xw+fNg1f+zYsW7z9cuY87P1tm3Nhx6vzuPe80cf/ZHASb+0WwMDnq05tOX+ihUrHAsWLHAUl7Y+tP6Y1L9/f5Ou246NjTVpzmuWLuf8UuH5Bdb6ZbqgoG1x5xd2HdEvps5yaxDCGjDQ195amR7v9dDb5EvQ9tRTT3Wbf/PNN7vOVw3ieP4YUlTQVj8Pa8s5by1xreeMNeil56v1C3dSUpKjffv2bvvQ+VlqIM+63S+++CLfPtT7lwb6PZ8aKew6UFIKCqJ5mzSA4e1HOr3WWpfTAJJek5Wex56tovVabuX5WThb1no63muhr4o6fvWHYec8Pc+tn7Ueq3rMWte3XmOswZIxY8Z4vTbrfdpa1/F2DfHW6vl47vdF0WuFNVik5Th48KDXAJu3Hxq8HW8PPPCA2w98GhQq6H57vMdAoOsR+vTWP//845qflpZ2QuocW7duNdcpbzTAb1339ddft2XQVvfbLbfckm8/zJ0797jrvAXdqzQwaK1bOD8vz6dRNDBs/fFX6bmodQWnRx991G0dfcqmsB8e77jjDrf5nnnTQGZKSorr/Pdsef3333/79Tnq/XLXrl1e5+mPPAUFvvX+5BlYffrpp92OQc88Wr/fldZ9FEDRCNoC8Dlo6/kIrPXX1oIen9JH/wra/rBhw/Ktry0brMu89dZbxc7/+++/b7apfzXgoZUqrXjoFx7PFl/6C3ZJBW09H3PXwJZnSyx9FNpbBVkrNdbgnH751or8smXLzJc3awsgTyURtNXWW77QSqc18K6VO88vLBrot76Htii0Vs499621Qq6P7lvnaUXTWXn21rJSgxCF7aN33nnHbb5uyxnMc07aZYQ/QVv93D0fO7VuW/eNt4q5to7SL5jaEsiz9bpzqly5cr51AxG09WxN6/nIq5bHs5WT9YcXz217fgl9/vnn3eZr6xCnp556yi3A8OCDD5rggj7iezwtNPRLnXO7GsTQc2j9+vVeu3Bwltf6OWvLHauSCtpqyxbPLmE8A6KeLbFKO2irgSTrPD2mPcvg2Xq/qKCtZyssz0e8rY/kej5Oqq2cPK+1no/EOgONGojw3K7eb7R1qWdLK092D9rqpF/Sra0z9RrreW3zDDTqDzTWHwr0Wm4N/vobtPXnWuiLwo5fzb/1nqTXVc9jRFvNFlT3sT4hcPLJJztefPFFc53QQIjnD0u+Bm2P535fFK0HWd9fW+xZ73OeLXydAd2Cjjf9vDyfutEnLazLaHA8EMdASdQjvvzyywL3VUnWOTRP2lJdfzDUYJi21C3oEXTPLoNKM2hb1KT3Vef+Pp46r7d7lbcfbZ0/FFj3nb7esWNHkWVztr51Tn379nXLm2fLc8/6k2fZPa+b2qrUlye8CvscdV39HqM/iOgxXVDXLNrS22nt2rX5WgF7nmv6Y0JB17jSuo8CKFqoL/3fAoDyHLBIB1Hw1K5dO5k/f77rfx1MoCDaWb4nHcXYOpCZ54Avhenfv7+ZrLQzfh3QxjlghpO+hw6qoYNaBJpnmXfv3i3vv/9+sdbRQQd0IIKHHnrI/K+DKVgHVNCBATp16iQ33XST6fQ/0HRABysd5CM5OdkM3FEc+nlZB5rQAYR0oAcrHShCy+kctEMHJ9EBIHRgF0+6rg5sYB1sx0oHbtHPuKD56enphebX8xjUbemADz/99JNbmTTNVzoQhw6g4Vke54AynoOWvPfeezJkyBAzGFVRChuQqSTPcS2PDr7z77//uh27OpCHNzp4jJXnsWD9fPQ8nTx5suzcudOcmzpojJMOnKGD1/Tt21fuvfder8dKQXr06CHffPON63j+9ddf3QYB0oEPdYA3HSRD0/V9rNcdHaToRNCB/nSQmuLuL1917tzZrdxW/g6e5Xl91vPdswzervOF8eWY8bzWbt261UyFca6jA9zoYEI6QIr6/PPPzeSkgyTpIDd33HFHvgF47MJ5rdVjV8v16KOPyrx580zavn37ZNiwYWYQLaXXWOtgVnoN1sFurHQgH/0Mt23b5tq+XhN8Od8CcS0MJM2/9Z6UkJBQ7Pux0gGp9Lqs29i8ebPcc889bvcLHYxTB/XRAVV9PY9K8n4/bdo0t/+vvPJKt3z369fPDB7o3P9z5swxx3ph1ycdJM2zvmZVWH3Nl2Mg0PUIXe7cc88tMG8lVefQMmi988MPPyzWe5fUfT3QdPA4vVfrwHbHW+f1Rq+3ISEhXtfxPC50UK+ieL7XokWLCl1eB7/Ta6q3POigYFpHKIn79AsvvCD33Xefz8eK53mng4h5nmuF3Ycr+n0UsLNjV1kA8IHnqK+lNUq2PzwDL1rRL2jU4dKggVGnkSNHyooVK8wXRR212Lqf9YuJjh576aWXmlFiA01HZLbSiquObF1ax4gGEaycXxKcPANEdqI/FHjy9iXAeTzqiL3WgK1++dRRjvVLn06eX5hLQqA/P899UFD5lY6UrMFyHRFcv2BbfyjQfP3+++/y7LPPytlnn23OA3/PfR3J2Tmas44OrlP79u3N/xrU9AxsatDXbseLXXmen/4cQ74cM8d7rX399ddNcEF/7KtTp47bcnp/0B9SNNhd3KBLadF9pEG1GTNmmFG7nTQA6PxC723U9hOlrB3b1mNEg526H/VHpebNm7sd4zoa/cqVK2Xo0KHFDrZ4Kon7/d69e+Wzzz5zS9Mfu3QUeOe0ePFit/nTp08XuxwDgb4P6Y/R3q5NJV3n0GuL57VDfwjVz1Pv6RqQtyrNc9STBsWddY8rrrjC/HAwceJE+eOPP0zDjOOte1nPMU9169aV0pSTk2PO7RN5Lfvvv//MtcBKfzzo3bu363Mo7rESiPtwRbyPAnZE0BaAzzx/0d64cWO+ZX755ZdC1ylqfW0FZ6VfYopLW+f58qu+tmIpCZ5lvuiii0wFq7BpwYIFbuvoL9PaCkZbCWnlSFv4aMsZ/ZXf+qt8oCtl2qLUs6Xb448/XmAF1rNlQaNGjdzStdWkZ4BNK/3WVjXaUsVbRfhE8DwG09LSZMeOHX4fg/7S4/7QoUOu/0877TTT2kO/eOuxMXfuXLHDOa5B5d9++63QdY6HfhEcNWqUfP3116YFlgYfvvzyS7nssstcy+g5sXDhwmJv85xzznE7bzRA8tVXX5nXF1xwgdvfDRs2mCCJk7bE1y8bvihLP2YdL89zQ8/3pKQkt7Sff/65xN7f89jTFj9FXWsnTJjgto5+0dQvnNp6XPO+adMmeemll1xfxHWdF198sUx8xhqwjYyMzBcMcLZ4sp4Heg3esmWL27LaClU/Q2s5rdd0u5a7MJ6BUG0lV9Qx8v3337ttQ58k0JaFur/0Xrh9+3YTuLIGl1577TVz//BnX/lzvy+MbsvziQ29lmoLSOfk2apTr3167BdEy+xZDzie+lphAl2PKG7ANtD03mU1fvx4U0fWlp56X9frlV1dfvnlJo/O+sebb75pWpl7ts4PVJ23OJ+XHhfW80qPi8Ja7HrLn66v1/qi8mc9945Xca4F69atcztnL774YvOD2yeffGL21csvv1zgup7nnf7ArYHn4t6HS+s+CqBoBG0B+OySSy5x+1+/xGjF2VpBtQZTtKKiFY+C6CPJP/zwg+t/faTG2jWCVtz0y0xxaWXy1VdfNV88rbQSoa0YPR/VK+4j/77SVnv6yJC1XDNnzsy3nH7B+/TTT03l+J9//nGlP/PMM6Zlj/OXdH0UT1sDaosfbY3otGfPHrftWR/ZU/rFzB/PPfecW6VZv5hpi0/90uZJHzvXz3jJkiXmf82ftoS0BnM1COesQOr/zkdBnbQlQWl9qdKWm9YW10899ZTbl0OtzPrTNYKvPH9w0Mc5nV136L57+OGHJSUlpdBtWD9/fUzUn0f0PM/x0aNHu32512PD2jWCBi2crVSP16pVq+Sdd95xBa/1+qHH0//+9z/p1auX27Kex35h9DFBZ1BWaQszZ5mcAVnnX/3S9MEHH7iW7dChg89f3gJ1HpYFtWvXdutCQ69pTz75pOt/fUR/3LhxJfb+3bp1c2uBri1NrY9mOukPABpksx5Hej5pq25roErvCfpo6TXXXOMW/Cypa22gabDOMxjnDCzqNVavtVZ6LXZeJ5zXGWsgTK/l1sfN7Vruwug1RH+4cdI6i1739SkSKz339Rpk7VJCaQtXbX3vDKjotVkfkdcghfXeoPvRWvco7r7y935fGH9bzRa2nt4XtasI6z1G96NVoLqSKWv1iOLe163XKv08tb5RHhxvnbe49FpkfRpMzxntlkR/4LbSuqq2gHfSls3WdW6//XavT+toQF27K3E+6h8oxbkWeB4rev9xBnv1eC+sJf8ZZ5zh9oOF7g/9LuSk3d1Y/7fLfRRAMRSj31sAFUxRA5GpCy64wG2ZqKgoM5prx44d8w2aZB3l29v2dYqIiHCcf/75Zn3nKO7O6corr/Qp/871NB866IEODqCDJegAP57v++GHH5bYQGRq9uzZ+ZZp1KiRGXVWB0HTgaa07N4GJtBBpjRNR4PVAVJ0hG9dRwcXsG5Pt2E1YsQIt/k1atQwg4/oIAI6qJMvJk2alC//OiCCjiCr+enWrZujdu3arnkffPCBa10dtddz8AQdgEPLrgNUWNN1UA7rKMOqsAEhPPe956BGnoOfeB7DngNC6KSD1PXo0cPRsmXLfPPefPNNt/V9GYjM2/lT0Po6wIt1YBidmjZtakZc1lG19X/PwUs8eQ70oQNH6AAb+vnrYFAF7QPrsacDwOhxY52vg3fp4BKeg3noZN1uUdsuapCuiRMnmjS9Duhn0bNnT5N/HUXc89rg6/mrgwd55l0n50AZR44cyfce3kYCL6oM6ueff3abr9vV66ZzQA/nIDdFHcvF2Z+F8cynt+07+TsQmbeRt50DNukx4zkApLd8FDW4VVH7SUfJ9nyPU045xVwz9Zqjx6313mQddMuZptcy3a4OUKPHXdWqVd22p8eh1WWXXeY2v379+ua6qJ/vhAkTHCXB233HOpCO3g885+u54zl4k15zrcvowIJaZr1GW9P1Gr5y5Uq39RctWuS2jN7D9NrpzEdqaupxXwv9UdTxu2bNmnz1E72fat71HnnWWWe57RfroGE64I+m6aBAHTp0MPUKXcd5XbZeJ62DJ+lo6db5OuiWHpO6n6x1I3/v9wXxHBRKBxMtaMC0H374wW1ZPQ+cAxgVNPCd89z2HK1eB3jbs2ePa9vHewyUZD3CU0nVOTwHYdTyaH1XB9zV+73nPb2o+sqJHIisoAE0C3I8dd7iDt7pHKjLOliiTlrHd56ber7qfrVu48CBA271VZ10/+t3Fz3f9K+evwW9f1HHUlGDDhanbq77w/N418HInNcCz2PFMx86qKvn/td93rVrV7fBDgs61krjPgqgaARtAfgVtNURhrWC460yb520MpKWllbo9m+++WbzRcjb+jpquudoxkUpKk86aaXxlVdeOa79VJygrTPw6Vm5LGiyjlbs/BJX2KTBcv1SY6WjHHt+MXVOZ5xxhs/l1C/o+oWvOPnXZa1mzpxp8ljYOlqhW7p0ab73PZFB2xtvvLHA/F199dX58lZSQduCAuXO6Y477igyyPHqq68WuP59991X7C+CGzZscDRo0KDQz04Dkc8++2y+PAQiaFvUpF8irKOEF8emTZvybUdHhbfSc8Rzma+//jrftorzBVNHgS8o/xs3bixXQVt12223FVjeu+66y+1/DZQFMmirRo4cWeAo257Hrbcvm4VNGpzS48fqk08+KfTeVxIKCqIVNOk5vHnz5nzb0Wuu55dpz0mv3XoN96RB2cKuDUePHrVl0Fa99957BdY3PKcvv/wyX9C2qOPqnXfecXu/f//9t8D302PqeO/3Bbn99tvd1tX/C6MjxVuXX7x4sdfjTQNAZ555ptf8aT3n448/dttuII6BkqpHnKg6R0ZGhgkmFvSZjh07ttwEbY+nzutL0FbpMVrUNcxzG3rf9TzWC5r0cwlk0La4dfN77723wDzpj4GF5UN/mNEAtLd19b0979HDhw8v9fsogKLZ6/kRAGVG1apVzSOE2rG8jj6sA1o4+9HT/qZ0wAJnP5zWAVG80UcWdeAhHcRDH7N1Pnaoj2hqn5b6Xr7Qxx71UVx9XF8fa9fHfbQ/JR1YQvuke/DBB82j/vpo1Ilw5513mr6ldHAB7SdW++vU/Gi+9LFKfWRL+4XSPlStoxXrI+IPPPCAGWlV96n21abr6Qi12tep9iumfY16dh3Rrl07s+/1USct8/H2P6j50z61tG89fZxNPxtnXnT7+kiWjgirj6F5jmytj0U5y67Lad71MXXdB/q562P3Ov/CCy+U0vTII4+Yx/V0X2oe9TjWrjO0/zZ9ROxE0uNFzxvdP/o4nT6Wr4+I6v4vrD8zp9tuu830q6j5P55By/RRR33UTQcd6dKli+kLUz87zY8+8qbnj/aP5jloxvHSx421D7TBgweb99HBY7SLCL2O6Pmh57V+Jh999JHPj8Hq9jwHN7F2meDtf+3z2vqIri+0CwYduEjz7TmKc3mkj17q47C6v/TY1XNJr0P6iKX10dSSGmRGH9P+8ccfzfVIr4P62el1yjnS96BBg0werY/k6rXs3XffNeednnM6Erk+1qmfl957tCx6fdBzQY8fz0ex582bZwbMC2Tfh8dDzxMdBEYfUde+A7XvaX3M3pNec/VeOXbsWOnYsaO5JmuZdZ/pua/3Sb026zXck14f9Xqv56jes+08mJgnPQa0r1h9xF+7XNHHibXcWibtE1K7ANJ9ovdWne+k+/LRRx81+1XvgXps6/XHeT3U81z7wNXHtK30s9C6kt4b9Rpa0DXL3/u9N9q1hR7TVvpZFUbrbMXpIkHzo11g6b1bzyk93vTY0Xqg9sdZWFdY/ior9YiC6P1L+1DXc0o/W/1fH/EfOHCgfPfdd27HWXngb53Xn26c9FzW6752baTnl+5bPT60m7TrrrsuX1cwbdq0MfWWKVOmmHl6H9JjWNfTuoZ2u6BdEOjnpV1xBFJx6+a6b7Tuqctr3rQ8Wj6t8xQ10KHuZ+1TVq9X2mWRrq/3Md3na9euzdeNlbf78Im+jwIoWpBGbouxHAAEjPZ1qJVsJw1GaeUKAFB26Y873gYh0r74tP87DV5Z+10dMmTICc4hAADllw5k6DmIn9K+tjUobR1EVgdjtfYPDMCeyn+zDwAAAJS4a6+91gx20qlTJ9OCR1sv6oB1OvK1Dkbm1LZt23wt+wAAwPHRp4W05bA+QaEt/bV1vw5Kpk/+WAde05bGBGyBsoGgLQAAAAJCR8T2fDTbSh+T/PDDDytEdxEAAJxo+uOpTgXRgO3cuXNPaJ4A+I8aMwAAAI6b9ren/X1qP4179uwxj2Nqa1tt7aN9UWpfeNr3pa99EQMAgKJpf93ad+4PP/xgnnDR1rXan7D2M6t9DF911VXSo0eP0s4mAB/Qpy0AAAAAAAAA2AhNHQAAAAAAAADARgjaAgAAAAAAAICNELQFAAAAAAAAABshaAsAAAAAAAAANkLQFgAAAAAAAABshKAtAAAAAAAAANgIQVsAAAAAAAAAsBGCtgAAAAAAAABgIwRtAQAAAAAAAMBGCNoCAAAAAAAAgI0QtAUAAAAAAAAAGyFoCwAAAAAAAAA2QtAWAAAAAAAAAGyEoC0AAAAAAAAA2AhBWwAAAAAAAACwEYK2AAAAAAAAAGAjBG0BAAAAAAAAwEYI2gIAAAAAAACAjRC0BQAAAAAAAAAbIWgLAAAAAAAAADZC0BYAAAAAAAAAbCRUKpicnBz5999/JTY2VoKCgko7OwAAAAAAAAAqCIfDIUePHpW6detKcHDB7WkrXNBWA7b169cv7WwAAAAAAAAAqKB27dol9erVK3B+hQvaagtbtX3Hn67XAAAAAAAAAFDStJVt0yaNi4xLVrigrbNLBN0xcXFxpZ0dAAAAAAAAABVMUBHdtjIQGQAAAAAAAADYCEFbAAAAAAAAALARgrYAAAAAAAAAYCMEbQEAAAAAAADARgjaAgAAAAAAAICNELQFAAAAAAAAABshaAsAAAAAAAAANkLQFgAAAAAAAABshKAtAAAAAAAAANgIQVsAAAAAAAAAsBGCtgAAAAAAAABgIwRtAQAAAAAAAMBGCNoCAAAAAAAAgI0QtAUAAAAAAAAAGyFoCwAAAAAAAAA2QtAWAAAAAAAAAGyEoC0AAAAAAAAA2AhBWwAAAAAAAACwEYK2AAAAAAAAAGAjBG0BAAAAAAAAwEYI2gIAAAAAAACAjRC0BQAAAAAAAAAbIWgLAAAAAAAAADZC0BYAAAAAAAAAbISgLQAAAAAAAADYCEFbAAAAAAAAALARgrYAAAAAAAAAYCMEbQEAAAAAAADARgjaAgAAAAAAAICNELQFAAAAAAAAABshaAsAAAAAAAAANkLQFgAAAAAAAABshKAtAAAAAAAAANgIQVsAAAAAAAAAsBGCtgAAAAAAAABgIwRtAQAAAAAAAMBGCNoCAAAAAAAAgI0QtAVyLfn0U+ndq5c0btRQ4mJjJL5KZTn9tHby+OOPSVJSktuyGRkZMnbsGGndqpVZtkH9enLjjcNk9+7dxX6/uXPflfPO7ShVKsdJzRrV5eLeveXbb791WyYxMVFuueVmqV/vJDPdfPNNJs3q+QkTJKZStPz++2/HuQcAAAAAAABgB0EOh8MhFYgGvCpXriz79h+QuLi40s4ObOSJJx6X8c8+63XehRf2lI8WLzav9ZS5tE8fWbbs83zL1atfX77++hupVatWoe81fvyz8sTjj+dLDw8Pl8UffyKdO3c2/9966y0y7e235YUXJkpQUJCMGHGP3HDDMHnt9dfN/L1790qb1q3k6quvkYkvvuhXuQEAAAAAAHDiYpPaeO/IkSOFxiZpaQvkOuvMs+S99+bLn3/9LYcTjsiCBe9LRESEmff550vl0KFD5vXHixe7ArZXDRlifgDQQGtwcLD8s2uXjBk9utD32bdvnzz91FPmdZs2bWT7jj9l06ZfpX6DBqYF75133G4Cw+qTjz+WKlWqyG233y633Hqref3JJx+7tvXYY49KWFiYPOYlAAwAAAAAAICyiaAtkOuSPn3k0r59pU6dOhIVFWX+b9WqlWu+BkfVmjVrXGm33HKr+VWkR48ecuqpp5q0996bJzk5OQW+z7q1a01wVg2+8ko56aSTpFnz5tKvbz+TtmXLFtmwYYN5rctp61ulLW01D851f/jhB3ln5kx59NHHpGrVqiWwRwAAAAAAAFAaCNoCXqSmpspHixbJb78d6yf2yquuktjYWPM6LS2t0HWPHj0q27dtK3B+Wnrh66uffvrJ/D3//PNNy1wNFOu0f/9+k6buu+9eOfnkk+Wmm2/2qWwAAAAAAACwt9DSzgBgJ3v27JFGDRu4pQ0cOFAmT57i+r9t27au12+88bq0bNlS1q1bJxs3bnSlHzx0SJoX8B7OFrlq7rvvypVXXiVpqany4aIPXemHDh00f59/YaLJU88Le5j/zzzzTJnw/AtmELO133wjixd/LKGhx07jzMxMV2tgAAAAAAAAlF20tAWKsGDBAhk+/EbX/9qPbZMmTc3rObNnS43q1aTPJRe7dYlQWPC0ZctWMmjQIPN606ZN0rRJY2ndupXs2rkzb/3QY+s3aNBAvvzqa/l75y4zffX1N1K9enV55JFHpFev3tLjwgvl+QkT5KS6daRyXKx0OPss+f7770tkPwAAAAAAAODEIGgLWNSuXVvS0jPk0OEEWfr5MjmpXj1Xi1jtQ1bFxMTI8hUr5IrBgyU+Pt783/mCC0wQ1ale7noFmfr2NHlw5EipV7++GexMByQbNiwvMFyvvvv6tWrVMpN67rn/k31798r48eNl6WefySOPjJI2p54q02fMkG3btsngwVe4+r0FAAAAAABA2UPQFvAiOjpaOnfuLP0v6+9K27Ztq+t13bp1ZcaMmfLfnr1y4OAh+eyzpXLgwH4zT/uZdQZYC6KDi40ZM1a2bdsuRxKPyvcbfpDKlePMvJCQEDnvvP95Xe/vv/+WFydOlFtvvU1anHyyrFy50qTfcfsdcvnlV0jXrl3ln127ZMuWzQHZDwAAAAAAADjxCNoCuW655WZZvXq1GexLBxv75ptv5IMPP3DNb9y4iev11KlTZfMff5jl/vrrL7nj9tvlu+++M/PuvOtu13I6eFhkRLiZZs6c6Upf/NFHsn79eklKSpIDBw7IG6+/Li+//LKZN2DgQBMU9mbUww9JpUqVZNQjj5j/g4OPncLOfm2d3TJo4BcAAAAAAABlEwORAbmmT5tmJm8uueQSOeuss1z/jx//rNz+99/5lhswYIAMGzasyPda9NEimfXOO/nSTznlFHnhhYle1/nyyy/l/fffl5dffkWqVKli0nr17i0TJ74gM2fOkEoxMbJq1Spp1qyZNG/eosg8AAAAAAAAwJ5oaQvkuuOOO+X000+XqlWrmpaqGhg9p2NHE0R9d+48t2W124TmzZubbhR0at++vUya9LK8M2u2BAUFFfle2vWCvlflypVNVwlNmzaT+++/X9Z88aUZaMyTDnJ2/333mr5vb7AEhTt16iSvvPqa/PzzL3JZv76mb9v35s93tbwFAAAAAABA2RPkcDgcYkPPPvusPPzww3L33XfLiy++aNL0UfT77rtP5s6dK+np6dKzZ0957bXXiuw/1CoxMdEEyvbtPyBxccf6EAUAAAAAAACAkqaxyZo1qsuRI0cKjU3asqWt9g365ptvStu2bd3SR4wYIYsXL5b58+ebvkL//fdf6d8/b6AoAAAAAAAAACjrbBe01YGZhgwZIlOmTJH4+HhXukafdfCnF154Qbp27SpnnHGGTJs2zQwWtW7dulLNMwAAAAAAAAAEiu06vrz99tvl4osvlu7du8tTTz3lSt+wYYNkZmaadOugTQ0aNJC1a9fKOeec43V72o2CTtYmyM4+QnVS2gepTtpThLW3iKLSnev7mx4cHJxv276mF5ZHlZqaKmLdjmV5r+keefQ1PSg3j27b9jW9qDz6mk6ZKFMR6RGRka5zyZ9rQVm9RlAmykSZKBNlokyUiTJRJspEmSgTZaJMlCnnhJapTAZtta/aH374wXSP4GnPnj1mwCYdHMpK+7PVeQUZN26cjB49Ol/6wQMHJCM3mBsZFWX6kDh69KikaZAzV3SlShITEyNHEhIkIyPDlR4bFydRUVFy+PBhyc7KcqVr3sIjIuTgwQPiyMn7QKpWq2Y+qAP797vloXqNGuaDPnTwoCstKDhIatSoKZkZGZKQkOBKDwkNlWrVqpl+fY/mBp6V2Sfx8ZKcnCwpycmudC1TWFiYDLnqStOHr6vcBw+a6aSTTpJKlSq57V8NaDds2FAiIiJc6f/884+kpKRIs2bNTBmc/vrrLxNE18G4rLZu3Wret1GjRq40LeO2bdvMgF316tVzpWsw/e+//zb7vnbt2q50Lcvu3btNeXWytrbeu3ev+cwpE2UKZJnGPvW0RISHF3o+lcdrBGWiTJSJMlEmykSZKBNlokyUiTJRJspEmQ6f0DJp7KJMDUS2a9cuOfPMM2XZsmWuvmwvuOACOe2008xAZHPmzJHrr7/erdWsOvvss6VLly4yfvz4Yre0rV+/vuzZu8/V2W95/XVBD+ru3bpK0L59rnSzjMNh5muLxXzpluCYSXe2Ri7J9NwyWDJzLD8FpBeYd8pEmfwok9SqJcuWLTcX97L+a115/AWSMlEmykSZKBNlokyUiTJRJspEmSgTZXKUozJp17DFGYjMNi1ttfuDffv2Sfv27V1p2dnZ8sUXX8grr7wiS5cuNdFwjU5bW9tqiz5r6z9P2nLP2nrPuuOsrfesO99TQeme6/uT7ut7+ppuDoycHPnshhskqpiRfKAiSM3MlIveftucIxrQtZ6fgTr/ysI1gjJRpoLSKRNl8iedMlEmykSZCkunTJSJMlGmwtIpE2WqSGUqDtsEbbt16yYbN250S9OWtdpv7ciRI03rWG0+vGLFChkwYICZv3nzZtm5c6d07NixlHJddmjAlqAtAAAAAAAAYH+2CdrGxsZKmzZt3NK030vtu8KZPmzYMLn33nulatWqpvnwnXfeaQK2BQ1CBgAAAAAAAABljW2CtsUxceJE0wRZW9pqP7U9e/aU1157rbSzBQAAAAAAAAAVI2i7evVqt/8jIyPl1VdfNRMAAAAAAAAAlEfee9QFAAAAAAAAAJQKgrYAAAAAAAAAYCMEbQEAAAAAAADARgjaAgAAAAAAAICNELQFAAAAAAAAABshaAsAAAAAAAAANkLQFgAAAAAAAABshKAtAAAAAAAAANgIQVsAAAAAAAAAsBGCtgAAAAAAAABgIwRtAQAAAAAAAMBGCNoCAAAAAAAAgI0QtAUAAAAAAAAAGyFoCwAAAAAAAAA2QtAWAAAAAAAAAGyEoC0AAAAAAAAA2AhBWwAAAAAAAACwEYK2AAAAAAAAAGAjBG0BAAAAAAAAwEYI2gIAAAAAAACAjRC0BQAAAAAAAAAbIWgLAAAAAAAAADZC0BYAAAAAAAAAbISgLQAAAAAAAADYCEFbAAAAAAAAALARgrYAAAAAAAAAYCMEbQEAAAAAAADARgjaAgAAAAAAAICNELQFAAAAAAAAABshaAsAAAAAAAAANkLQFgAAAAAAAABshKAtAAAAAAAAANgIQVsAAAAAAAAAsBGCtgAAAAAAAABgIwRtAQAAAAAAAMBGCNoCAAAAAAAAgI0QtAUAAAAAAAAAGyFoCwAAAAAAAAA2QtAWAAAAAAAAAGyEoC0AAAAAAAAA2AhBWwAAAAAAAACwEYK2AAAAAAAAAGAjBG0BAAAAAAAAwEYI2gIAAAAAAACAjRC0BQAAAAAAAAAbIWgLAAAAAAAAADZC0BYAAAAAAAAAbISgLQAAAAAAAADYCEFbAAAAAAAAALARgrYAAAAAAAAAYCMEbQEAAAAAAADARgjaAgAAAAAAAICNELQFAAAAAAAAABshaAsAAAAAAAAANkLQFgAAAAAAAABshKAtAAAAAAAAANgIQVsAAAAAAAAAsBGCtgAAAAAAAABgIwRtAQAAAAAAAMBGCNoCAAAAAAAAgI0QtAUAAAAAAAAAG7FV0Pb111+Xtm3bSlxcnJk6duwoS5Yscc2/4IILJCgoyG265ZZbSjXPAAAAAAAAABBIoWIj9erVk2effVaaN28uDodDZsyYIX379pUff/xRWrdubZYZPny4jBkzxrVOdHR0KeYYAAAAAAAAAMpx0LZPnz5u/z/99NOm9e26detcQVsN0tauXbvY20xPTzeTU2Jiovmbk5NjJuVstauBYp2cikp3ru9venBwcL5t+5peWB5d84ODRd9Zp6DcSZe0bt2Z7p5D39ODvWzb1/Si8uhrOmWiTN7Sj20s9/zJvR74ey0oq9cIykSZKBNlokyUiTJRJspEmSgTZaJMlIky5ZzQMpXJoK1Vdna2zJ8/X5KTk003CU6zZ8+WWbNmmcCtBnkfe+yxQlvbjhs3TkaPHp0v/eCBA5KRG8yNjIoy3TEcPXpU0lJTXctEV6okMTExciQhQTIyMlzpsXFxEhUVJYcPH5bsrCxXepUqVSQ8IkIOHjwgjpy8D6RqtWrmgzqwf79bHqrXqGE+6EMHD7rSgoKDpEaNmpKZkSEJCQmu9JDQUKlWrZqkpaXJ0dzAswoPD5cq8fFmP6UkJ7vStUxhYWFSs2ZNqVy9uhyMjZXw0FCJycgwU0JkpKSH5n38cWlpEp2VJYeioyUrOK/XjPjUVInIzpb9lSqJIzcQbPKekiLBOTmyLybGrUw1k5IkR8tq+UyCHA6plZwsGSEhcjgqypUempNjtpMaGiqJkZGu9IisLIlPS5Pk8HBJCg93pUdlZkrl9HRJjIiQ1LAwVzplokz+lKnSkSMSV6WK1GreXA4eOiQR4eGFnk/l8RpBmSgTZaJMlIkyUSbKRJkoE2WiTJSJMlGmwye0TBqvK44gh7/h3hKyceNGE6TVD0R36Jw5c6R3795m3uTJk6Vhw4ZSt25d+eWXX2TkyJFy9tlny8KFC31qaVu/fn3Zs3ef+SDL868Lug+7d+sqQfv2ycrhwyUqLMx2rR3LYwtOylQ2ypSemSmdJ08WqVVLli1bbi7uZf3XuvL4CyRlokyUiTJRJspEmSgTZaJMlIkyUSbK5ChHZUpKSpKaNarLEW1MlhubLBNBW41479y502R8wYIF8tZbb8maNWukVatW+ZZduXKldOvWTbZt2yZNmzYt1vY1aFu5cmXZt/9AoTumPEhNTZVuXbtI0N69submm03QFsAxqRq0ffNNcdSqJStWrjK/rgEAAAAAAJQkjU0WJ2ib9yyyTWgT52bNmskZZ5xhujZo166dvPTSS16X7dChg/mrQVsAAAAAAAAAKA9sF7T1pE2Ord0bWP3000/mb506dU5wrgAAAAAAAACgZNhqILKHH35YevXqJQ0aNDCdBmt/tqtXr5alS5fK9u3bXf3baifE2qftiBEjpFOnTtK2bdvSzjoAAAAAAAAAlL+g7b59+2To0KHy33//mX5nNRirAdsePXrIrl27ZPny5fLiiy+a0eF0MLEBAwbIo48+WtrZBgAAAAAAAIDyGbSdOnVqgfM0SKsDkgEAAAAAAABAeWb7Pm0BAAAAAAAAoCIhaAsAAAAAAAAANkLQFgAAAAAAAABshKAtAAAAAAAAANgIQVsAAAAAAAAAsBGCtgAAAAAAAABgIwRtAQAAAAAAAMBGCNoCAAAAAAAAgI0QtAUAAAAAAAAAGyFoCwAAAAAAAAA2QtAWAAAAAAAAAGyEoC0AAAAAAAAA2AhBWwAAAAAAAACwEYK2AAAAAAAAAGAjBG0BAAAAAAAAwEYI2gIAAAAAAACAjRC0BQAAAAAAAAAbIWgLAAAAAAAAADZC0BYAAAAAAAAAbISgLQAAAAAAAADYCEFbAAAAAAAAALARgrYAAAAAAAAAYCMEbQEAAAAAAADARgjaAgAAAAAAAICNELQFAAAAAAAAABshaAsAAAAAAAAANkLQFgAAAAAAAABshKAtAAAAAAAAANgIQVsAAAAAAAAAsBGCtgAAAAAAAABgIwRtAQAAAAAAAMBGCNoCAAAAAAAAgI0QtAUAAAAAAAAAGyFoCwAAAAAAAAA2QtAWAAAAAAAAAGyEoC0AAAAAAAAA2AhBWwAAAAAAAACwEYK2AAAAAAAAAGAjBG0BAAAAAAAAwEYI2gIAAAAAAACAjRC0BQAAAAAAAAAbIWgLAAAAAAAAADZC0BYAAAAAAAAAbISgLQAAAAAAAADYCEFbAAAAAAAAALARgrYAAAAAAAAAYCMEbQEAAAAAAADARgjaAgAAAAAAAICNELQFAAAAAAAAABshaAsAAAAAAAAANkLQFgAAAAAAAABshKAtAAAAAAAAANgIQVsAAAAAAAAAsBGCtgAAAAAAAABgIwRtAQAAAAAAAMBGCNoCAAAAAAAAgI0QtAUAAAAAAAAAGyFoCwAAAAAAAAA2QtAWAAAAAAAAAGyEoC0AAAAAAAAA2AhBWwAAAAAAAACwEVsFbV9//XVp27atxMXFmaljx46yZMkS1/y0tDS5/fbbpVq1ahITEyMDBgyQvXv3lmqeAQAAAAAAAKDcBm3r1asnzz77rGzYsEG+//576dq1q/Tt21d+/fVXM3/EiBGyePFimT9/vqxZs0b+/fdf6d+/f2lnGwAAAAAAAAACJlRspE+fPm7/P/3006b17bp160xAd+rUqTJnzhwTzFXTpk2Tli1bmvnnnHOO122mp6ebySkxMdH8zcnJMZMKCgoyk8PhMJNTUenO9f1NDw4OzrdtX9MLy6NrfnCw6DvrFJQ76ZLWrTvT3XPoe3qwl237ml5UHn1Np0yUyVv6sY3lnj+51wN/rwVl9RpBmSgTZaJMlIkyUSbKRJkoE2WiTJSJMlGmnBNapjIZtLXKzs42LWqTk5NNNwna+jYzM1O6d+/uWuaUU06RBg0ayNq1awsM2o4bN05Gjx6dL/3ggQOSkRvMjYyKMt0xHD16VNJSU13LRFeqZLphOJKQIBkZGa702Lg4iYqKksOHD0t2VpYrvUqVKhIeESEHDx4QR07eB1K1WjXzQR3Yv98tD9Vr1DAf9KGDB11pQcFBUqNGTcnMyJCEhARXekhoqOkWQruIOJobeFbh4eFSJT7e7KeU5GRXupYpLCxMatasKZWrV5eDsbESHhoqMRkZZkqIjJT00LyPPy4tTaKzsuRQdLRkBec1wI5PTZWI7GzZX6mSOHIDwSbvKSkSnJMj+2Ji3MpUMylJcrSs0dF5ZXI4pFZysmSEhMjhqChXemhOjtlOamioJEZGutIjsrIkPi1NksPDJSk83JUelZkpldPTJTEiQlLDwlzplIky+VOmSkeOSFyVKlKreXM5eOiQRISHF3o+lcdrBGWiTJSJMlEmykSZKBNlokyUiTJRJspEmQ6f0DJpvK44ghz+hntLyMaNG02QVj8Q3aHasrZ3797m7/XXX+/WaladffbZ0qVLFxk/fnyxW9rWr19f9uzdZz7I8vzrgu7D7t26StC+fbJy+HCJCguzXWvH8tiCkzKVjTKlZ2ZK58mTRWrVkmXLlpuLe1n/ta48/gJJmSgTZaJMlIkyUSbKRJkoE2WiTJSJMjnKUZmSkpKkZo3qckQbk+XGJstES9uTTz5ZfvrpJ5PxBQsWyLXXXmv6r/VXRESEmTzpjtPJ2873VFC65/r+pPv6nr6mmwMjJ8cEroK9BL7y5dFrzn1LL2jbpZVOmShTQemSe/HULkSs52egzr+ycI2gTJSpoHTKRJn8SadMlIkyUabC0ikTZaJMlKmwdMpEmSpSmYrDdkFbbeLcrFkz8/qMM86Q7777Tl566SW54oorTBNmbVKszZSd9u7dK7Vr1y7FHAMAAAAAAABA4BTUiK1Av/32mxkgTLssaNSokenCQCd9rWk67/fffw9YBrXJsXZvoAFc7fNhxYoVrnmbN2+WnTt3mu4UAAAAAAAAAKA8KHZLWx0U7LnnnjMDgjlZ+2TQ4OmuXbtk6dKl8vjjj8tZZ50lDzzwgAwYMKDYmXn44YelV69eZnAx7TRY+7FdvXq12WblypVl2LBhcu+990rVqlVNnw933nmnCdgWNAgZAAAAAAAAAJTLoG27du1k06ZNbkFa7Se2YcOGEh8fb9J1pDUN3DoH/Vq/fr1cfvnl0rZtW/nxxx+LlZl9+/bJ0KFD5b///jNBWl1XA7Y9evQw8ydOnGj6jdBAsL5Pz5495bXXXvOv5AAAAAAAAABQVoO2GzduNH+1VWv//v1NELV169YSEhLitlxWVpbpPmHZsmWycOFCWbt2rfzyyy/FzszUqVMLnR8ZGSmvvvqqmQAAAAAAAACgwgZtb7zxRrnnnnukVatWhW8sNNS0jtXpvvvuk19//dUMIgYAAAAAAAAACOBAZJMnTy4yYOuNtsbVdQEAsINPPv5Yrr12qLRp3UpqVK8mtWvVlPPO7SgzZswwA186JSUlybPPjpMz2p8uNWtUN9OZZ7SXCROek9TU1IC9j3p+wgQ5uUULs1zvXr1ky+bNbvO1u6GoyAh56623ArgnAAAAAAB2FuSwdlTrp8zMTPOlcs+ePaaf2zPPPFPsKjEx0fSXu2//ATOYWXmmgYVuXbtI0N69submmyUqLKy0swTYRmpmpnR+801x1KolK1aukqioqNLOEk6APpdcIsuWfe513s033yIvTZpkXl/cu7esWLHc63J9+/aVee/ND8j7vPvuHLn+uutkyNVXy5VXXiWDr7hc6tWrJxt++NF0QaS36M6dzpe0tDRZ9+160687AAAAAKDs0tikNgw6cuRIobHJ4/729/PPP0vLli2lU6dOZuCxDh06yNlnny3//vvv8W4aAICAioyMkLvuult++PFHOZxwROa8+67p2kdNnvymGRBTf4B0BmxPqldPfv9js/yxeYt5rT766CM5ePDgcb+Ps0Wuuuuuu6R79+7SpUsX+eOPP2Tb1q0mffbsWeZH0ecmPE/AFgAAAAAqkGL1aVuYa665Rv78808zSFmjRo1k//79smbNGvMFdMGCBYHJJQAAAfD2tOkSGxvr+r9//wEy65135NNPPzWtWnfs2CFNmzZ1zT+3Y0dp3Lixed3xnHPMfU2X05avx/s+NWvWlIyMDDM/IjzC/A0PDzd/MzIzTBcNjz/2mPTr1086d+4c4D0BAAAAALCzYjfbOXr0aL60w4cPy6ZNm2Ts2LHy1VdfyaxZs2Tp0qUyb948Wb16daDzCgDAcbEGUp3S0tJdr+vWrSs1atQwgVL1zdq18tdff5lp7bp1Jk37eNfljvd91PnndzJ/31/4vmnhq/fSWrVqSYsWJ8v48c+aFr3PjHvW7/ICAAAAAMp50LZ58+Yybdo0t7TIyEjzuKY+yulsdaQDrPzyyy8SHR0d+NwCABBAX375paxevcq87tq1mzRo0MC8nvnOLLn8iitk9z//yCkntzCTvj6/UydZ8P5CCQoKCsj73HLrrXLlVVfJ2DFjpFHDBqYf2+kzZpouhia99JLceddd0qRJE7Oss1UuAAAAAKD8K3bQtlq1anLjjTea/mrX5bY20oF7Lr74YtPCNj4+XurXr28G+XryySdN/7YAANjV999/L5cPGmh+bDzppJNk8pQprnkP3H+/vDdvXr51/tn1j/z+228Be5+wsDCZNm267D9wUDZv2Srbd/xp+rV9aOSD5r46cuRD8vnSpdK6VSuJi42RJo0byaxZ7xxnyQEAAAAA5SZoq61nX3jhBdm2bZucd955MnToUPMo59tvvy2DBw82X0Z3795t+urT/myffvrpks05AAB+Wrt2rfTudZHp5ke7Kliy5DOplzvQ2M8//yRvvvmGed3x3HPlz7/+lp27/pHOF1wgf/65Q668crDpy/1438ezO4WGDRuaFryrVq2SRYsWyegxYyU1NVWGDLlKUlKSZe68eSaQe/NNN8mvv24K8B4BAAAAAJTJoK0+snn33XfL1q1bTYvbOXPmSIsWLWTKlCkyffp088Vy7969ZuCUiRMnSkTEsUFVAACwky+++EL6XHKxJCYmSsOGjWT5ipXS4uSTXfM3b97set2vbz+pU6eOGTSs/2X9Xd0UfPPN18f9Pt5kZ2fLA/ffJ+3btzc/jn63fr3pU37gwEHSr99lct1115tl1qxec1z7AAAAAABQToK21m4S3nzzTfO452mnnSajRo2S1q1by8cff2wGbwEAwK6WL18ufS/tY35g1L7aV6xc6eoz1qlOnbxBxj5c9KH8999/sm/fPln4wUJXepXKVcxfHaAsMiLcTGPHjvHpfbx5a8oUM8DncxOeN61utd94FRoa6upOwflDKgAAAACg/PI5aLt9+3b59ddfpU2bNqYVkba4TU9Pl8suu0x69uxpBiUDAMCOxo9/1jwZovTJkWZNm7iCrjrNnDnTdAF01llnmWXWfvONNG7UUBrUrydrVq82aRqE7da9+3G/jyftQmHMmNEyaNAgkwd1TseOUrVqVVm8+CPTn/zcue9KeHi4dOvWLeD7BgAAAABQBoO2//zzj/kSq10itG3bVpo1aybfffed6c9WHyV95JFHzOjY7dq1kxEjRsiRI0dKNucAAJQAbd26+ONPZMSIe829Trv70RaujRo1lptvvsV0cxAZGRnw9x07ZoykpKTI08+Mc6VpH7bzF7xvBvnUvnH13jpr1mxp1rx5wN8fAAAAAGAfQQ4dOawYtOXPwoULTQtb/QL7888/m0c9f//9d9cyf//9t9x3331mOe0qQfu4tRvtW1C//O7bf0Di4uKkPNNWXt26dpGgvXtlzc03S1TuY7UARFIzM6Xzm2+Ko1YtWbFylURFRZV2lgAAAAAAQDmXmJgoNWtUN41yCotNFrul7erVq2XWrFkmWLt+/XozbdmyxS0wqyNfL1iwQFasWCG1a9c+/lIAAAAAAAAAQAXjU5+2OihKcXTp0kV+/PFHf/MEAAAAAAAAABXWseGoi6FTp05y9dVXy/jx480gKNriVgdjqVWrltflnSNeAwBKjvZwk5aWVtrZAGxP+yEu7o/PAAAAAFBmgrYTJ06UHTt2mGCtqlu3rkyfPr0k8wYAKIIGbLXvagCFo+9qAAAAAOUyaNugQQP54YcfZOvWrZKeni6nnHKKGU0bAFD6/klPLe0sALZVL4JgLQAAAIByGrRV+lhhixYtSi43AAC/9Z/8moRGRpR2NgDbyEpLl4U33Vba2QAAAACAkgna9uzZU0aMGCEXXXSRTxtfunSpvPDCC+YvAKBkacA2NDKytLMBAAAAAABORNB22bJlsnz5ctOP7WWXXSYXXnihtG/f3vxvtXv3btOFgi77wQcfmP8BAAAAAAAAAAEO2vbq1UuWLFligrCvvvqqmVRERITEx8eb0csPHz4sGRkZrnU0TfXu3duH7AAAAAAAAABAxRZcnIU++eQTWbt2rfTv398MPqYBWZ101PL//vtP9uzZYwYnc6brMgMHDpR169bJxx9/XPKlAAAAAAAAAICKNhBZhw4dZMGCBXLo0CETxP3666/l999/lwMHDpj51atXl5YtW8p5550nl1xyiWmBCwAAAAAAAAAooaCtU9WqVeWaa64xEwAAAAAAAACgFLpHAAAAAAAAAACcGARtAQAAAAAAAMBGCNoCAAAAAAAAgI0QtAUAAAAAAAAAGyFoCwAAAAAAAAA2QtAWAAAAAAAAAGyEoC0AAAAAAAAA2EhocRa64YYbfN5wUFCQTJ061Z88AQAAAH755OOP5b3578mG77+XvXv3SkhIiDRt2lRuuvkWueaaayQ4OK/NQnZ2tkx96y2ZMWO6/PHHHyatXr16cskll8jTz4wr8r0SEhJkzOjRsmjRh7J//3456aR6MvjKwTJy5EMSGRnpWu75CRNk8uTJcujQQTnrrLPlxRdflBYnn+yav379eunc6Xx5+ZVX5cYbbwz4PgEAAEA5DdpOnz7dBGF9RdAWAAAAJ9Ibb7why5Z97pa2YcMGufmm4fLDhg3y0qRJJi0nJ0eGXHWlfPjhh27Lbt68WZKSkooM2qalpUnPC3vIzz//7Er7888dMu6ZZ+SHDT/Ih4sWmfrzu+/OkUceGSVDrr5arrzyKhl8xeVy+eWDZMMPP5qAssPhkPvvu1dOPfVUvxpKAAAAoIJ3j6AVSl8mAAAA4ESLjIyQu+66W3748Uc5nHBE5rz7roSGHmunMHnym7Jv3z7zesrkya6A7aDLL5dff/3NLK/rPfjgyCLf59VXXnEFbB97/HHZ/e9/MmzYsVayS5d+Ju+/v8DV8lfddddd0r17d+nSpYtp1btt61aTPnv2LNPS9rkJz7u1AgYAAEDFVqyWtqtWrSr5nAAAAADH6e1p0yU2Ntb1f//+A2TWO+/Ip59+ahoW7NixQ2rWrCmvvPKymd+kSVN5++1pEhYWZv5v1aq1mYqiLWhVTEyM6Q5BA8OPPvaYTJ36lkmf++67MnDgIMnIyDD/R4RHmL/h4eHmb0ZmhmnR+/hjj0m/fv2kc+fOAd8XAAAAKOdBWyqRAAAAKAusAVuntLR01+u6devKf//9J1tzW7rWPamuDBwwQNatW2taunbv0UPGj/8/s1xB0tPT5ffffzevmzRp4mrJW6dOHYmLi5PExET58aefTNr553eSjz76SN5f+L5pifvVV19JrVq1pEWLk+Wpp8bKwYMH5ZlxzwZ8PwAAAKACBG0Loy0EdBAG7RfMU4MGDY538wAAAIDfvvzyS1m9+thTY127djP10++++841/6svv3Rbfv57OojZBln/3XemFa03hw4dMoOYqdi4OLd5sblB2/253TDccuut8sOPP8jYMWPMpMHgqW9Pk3///VcmvfSS3HnXXSbwq7RVrrMlLgAAACo2vzvOmjVrlpxyyilSuXJladiwoTRu3NhtclY+AQAAgNLw/fffy+WDBprGBSeddJJMnjLFpGdlZbktN/Xtt2X/gYMy9Nprzf87dmyXObNn+/emuWM7OAfx1W4Xpk2bbra/ectW2b7jT9Ov7UMjH5T4+HjTtcLnS5dK61atJC42Rpo0biSzZr1zfAUHAABAxQzaLlq0SIYOHWoeK2MwMgAAANjN2rVrpXevi+Tw4cOmdeuSJZ9JvXr1zLxqVau6ltPA6ZAhV5tuFYYPv8mV/ssvvxS47apVq0pISIh5nXjkiNu8o0ePmr/Va9RwS9fta0MHDebqeBFanx49ZqykpqbKkCFXSUpKssydN8/k5+abbpJff90UoD0BAACAChO0nTRpkvlbvXp181crn6eeeqqpwKqTTz5ZOnXqFMh8AgAAAMXyxRdfSJ9LLjbdFDRs2EiWr1gpLU4+2TW/abNmBXZ94BQVFVXgvIiICGnZsqV5rQObOVvual+5+p7q9NNO87qudqvwwP33Sfv27U0jiO/WrzeBXh20rF+/y+S66643y6xZvcavsgMAAKACB21/+uknE6idMGGCK+3111+XnTt3So8ePUw/X6+88kog8wkAAAAUafny5dL30j5m3IXmzZvLipUr83Xbpa1kBw4aZF5rS9zZs2eZ5adMmexaxtoAITIi3Ew33jjMlXbllVeZv8nJyTJ+/LOm/vvU2LGu+YOvvNJr/t6aMkU2bdokz0143tSndfAz5RzMTLtTcOYRAAAAFZdfQVvnY1/OR7ycAydER0fLPffcI/v375e77747sDkFAAAAiqABVO1yQGlXXs2aNnEFXXWaOXOmmffEE0+afm7VsBtukOrVqsrMGTPM/926dZdL+vQp9H1uv+MOadeunXltBhirU1umTn3L/N+z50UyYMDAfOtogHjMmNEyaNAgOe+880zaOR07mqfVFi/+SNatWydz575rBiPr1q1bQPcLAAAAKkDQVgcfU/rolvP1559/7tb/17fffhu4XAIAAAABVKdOHVm95gu5asgQqVGjhmnh2qRJUxn1yCOy8IMPXA0TChIZGSlLP18mt912uwn+6vqNGjWWh0eNknnvved1fQ3upqSkyNPPjHOlaR+28xe8b+rU2gfvkSNHZNas2dKsefMSKTcAAADKhmPPYflIK6b6CJhWKrUv2y+//FLGjx8vb731lhw8eNBUUrXyCwAAAJxIy5YtL/ay9evXl7ffnlbkcmnpGV7Tq1SpIi9MnGim4ihoWW11+/U3a4u1DQAAAFQMfrW01YETHA6HeeRs2LC8vr00YKvpOg0fPjyQ+QQAAAAAAACACsGvlrZPPfWU3HzzzVK7dm3Tr60Ga3Xgsd27d5v/b7rpJhkxYkTgcwsAAAAAAAAA5ZxfQdu6deuayUkDtARpAQAAAk+fYEpLSyvtbAC2pn0MF9UPMQAAQLkP2gIAAODE0IBtt65dSjsbgK2tWLlKoqKiSjsbAAAApR+0Xblypbz55puybds2SUhIMK1ArPSX7u3btwcijwAAABXeruT00s4CYEv1K0WUdhYAAADsEbR9+eWX5Z577ilwvgZweTwJAAAgsC6Z+LaERkSWdjYAW8hKT5OPR9xQ2tkAAACwT9B2woQJ+VrWAgAAoGRpwJagLQAAAFD+Bfuz0v79+01L2ttuu828zsnJyTdlZ2cHPrcAAAAAAAAAUM75FbTt0KGD+XvhhRdKtWrVAp0nAAAAAAAAAKiw/AravvTSS1K5cmV5+OGHZc2aNZKUlBT4nAEAAAAAAABABeRX0LZt27ZyzTXXyO+//y5du3Y1AdyQkBC3KTTUr+5yAQAAAAAAAKBC8yuyOnr0aHnllVdMv7YMSAYAAAAAAAAApRy0feONN1zB2piYGImPj5fgYL8a7QIAAAAAAAAAjjdom5ycbFrZPvPMMzJy5Eh/NgEAAAAAAAAA8MKv5rGXXnqp+dukSRN/VgcAAAAAAAAABDJoe++995qA7V133SVvv/22bNy4UXbu3Jlv8tW4cePkrLPOktjYWKlZs6b069dPNm/e7LbMBRdcYFr5WqdbbrnFn2IAAAAAAAAAQPnoHkEDq0r7tR0+fLjXZTSYmpWV5dN216xZI7fffrvZvq47atQoufDCC+W3336TSpUquZbT9xwzZozr/+joaH+KAQAAAAAAAADlI2irwVoNyjpfB8pnn33m9v/06dNNi9sNGzZIp06d3IK0tWvXLtY209PTzeSUmJho/ubk5JhJOVvsalms5Skq3bm+v+k6eJvntn1NLyyPrvnBwaLvrFNQ7qRLWrfuTHfPoe/pwV627Wt6UXn0NZ0yUSZv6cc2lnv+5F4P/L0WlOY1QvOu67oGg9Trs2VZs6ZeDwKUHuSRF5/TvWzb13TKRJmKm66TnhvWOktJ3XNL8hrhXNeUJbdcBe33svg5+Zt3ykSZzPngPL8tdXs71svtWo+gTJSJMlEmykSZKFPQCS9TiQZtNYDqrCCVpCNHjpi/VatWdUufPXu2zJo1ywRu+/TpI4899liBrW21y4XRo0fnSz944IBk5AZzI6OiJC4uTo4ePSppqamuZaIrVZKYmBg5kpAgGRkZrvTYuDiJioqSw4cPS7alNXGVKlUkPCJCDh48II6cvA+karVq5oM6sH+/Wx6q16hhPuhDBw+60oKCg6RGjZqSmZEhCQkJrvSQ0FCpVq2apKWlydHcwLMKDw+XKvHxZnC4lORkV7qWKSwszAS9K1evLgdjYyU8NFRiMjLMlBAZKemheR9/XFqaRGdlyaHoaMlyBn9EJD41VSKys2V/pUrHKtzOvKekSHBOjuyLiXErU82kJMnRslo+D61Q10pOloyQEDkcFeVKD83JMdtJDQ2VxMhIV3pEVpbEp6VJcni4JIWHu9KjMjOlcnq6JEZESGpYmCudMlEmf8pU6cgRiatSRWo1by4HDx2SiPDwQs8nu14j0jMypHnz5hKVdOy6EJGVLTHpeXnJDAmRxKgIicrMkuiMTFd6WlioJEeES6WMTInMzMtjSniYpIaHSVxahoRlZ7vSkyLCJT0sVCqnpkuI5QaVGBkhmaEhEp+S5valPiE60gTWqybn7S91qFKUBDscUiUlzZWmn6+mh2XnSFxa3o9s2cHBZjuUiTL5W6bszExp06KFVA+LMAGd7OzsErvnluQ1Iio62tS72pzcQmpkp0pIxrF1DoTHSLAjR6pmprh9Tpoe5siWKpl5eckKCpbD4ZUkMidLYrPyPteM4FA5EhYl0dkZUik7L49pIWFyNDRSYrPTJTI77/NLDgmXlNAIqZyVJuE5eXnXZXWdKpkpEurI+5wSwqIkMyhUqmUmu31Oh8KiJUeCpXpGkiuNMlEmX8uUnZ0p8ZXjRDLTzPeGpKQk29bL7VqPoEyUiTJRJspEmShT1Akvk8briiPI4W+4t4RpYXXAMy3YV1995UqfPHmyNGzYUOrWrSu//PKLjBw5Us4++2xZuHBhsVva1q9fX/bs3Wc+yPL864Ie1N27dZWgfftk5fDhEhUWZrvWjuWxBSdlKhtlSs/MlM6TJ4vUqiXLli03F/ey+Gud3oh69OguuzPSZOD0KRIaEUHrLMpEmXLTs9LSZP71N8lJ4ZGyfMVKiYyMLJO/6Dvv57tTM6Xvy+9IaERkufqc/M07ZaJMWelp8uEdV0u96HBZvnyFuZfbtV5u13oEZaJMlIkyUSbKRJmCTniZ9IfmmjWqmx+dnbHJgLS0TUlJkUsuucRkctiwYXLVVVdJSdC+bTdt2uQWsFU33XST6/Wpp54qderUkW7dusn27duladOm+bYTERFhJk+641yPE3vsfE8FpXuu70+6r+/pa7o5MHK0jYT7qHPOwFe+PHrNuW/pBW27tNIpE2UqKF2/+Ok5ol2IWM/PQJ1/J+IaoXnXMrhuGnoj8rbxAKVbWz37nV7CeaRMlMmZrpOeG85KUknfc0vqGuFc15Qlt1zl6XM60XmkTOWnTOZ8cJ7fXur2dquX27EecaLTKRNlokyUqbB0ykSZKlKZiqOgeEiBtBuC7777TlavXm0evS8Jd9xxh3z88ceyatUqqVevXqHLdujQwfzdtm1bieQFAAAAAGAfn3z8sVx77VBp07qV1KheTWrXqinnndtRZsyY4db66YXnn5fz/3ee1DuprsRUijatmjp3Ol+mTp3q0/stW7ZMLrn4YqlTu5ZUjouVZs2ayjVXD5FDhw65lnl+wgQ5uUULk5/evXrJls2b3baxfv16iYqMkLfeeisAewAAUBH4HLRV55xzjvm7c+fOgGZGfynXgO0HH3wgK1eulMaNGxe5zk8//WT+aotbAAAAAED59sYbb8i8uXNNwx3tt1C71NPBq2++abiMuOce13KLP15sGhwdOHBAsrKyTFd53377rdx+260yYcJzxXqvlydNkj6XXCzLly8zfR5q13v/7Nol8+fPl8O5Qdt3350jjzwySv53/v/k3bnzZP36b+XyyweZvtSd33Pvv+9e86ToDTfcUEJ7BQBQ3vgVtJ04caIZHOyRRx4xwdVAdomgA4zNmTNHYmNjZc+ePWZKze08WLtAGDt2rLkh//XXX/LRRx/J0KFDzcBobdu2DVg+AAAAAAD2FBkZIXfddbf88OOPcjjhiMx5910JzR3odvLkN2Xfvn3m9RWXXyErVq6S//bslX37D8gjjz7q2oYGfYuyceMv8tBDI83rdu3ayZovvjTvt3nLVnnl1dckrnJlV8tfddddd0n37t2lS5cu8scff8i2rVtN+uzZs0xL2+cmPF/go7YAABx3n7ZKBwjTXw0PHjwoPXr0MAN7aFcJ1j4a9LUGWX3x+uuvm78XXHCBW/q0adPkuuuuM6PDLV++XF588UUzQpwOKDZgwAB51HLzBQAAAACUX29Pm24a+Tj17z9AZr3zjnz66aemVeuOHTvM99Nbbr3Vbb177hkhTz/1lHldnJG733j9DfO9V7/bznl3rmsMFR0Y+8Ybb3Qt5xyJPCL82Fgq+r3VpGdmmMFmHn/sMenXr5907tw5IOUHAFQMfgVttZWrtSNdbQlr7SrBDOzjRye7nqOpedIg7Zo1a/zIMQAAAACgPLAGbJ3S0tJdr+vWrZtvvnZt8PLLk1z/3zg8b4DrgnzxxbHvnhoA1v5xP/nkYzPS95lnnSVjxz7l6jbw/PM7madA31/4vgwbdqMZTLtWrVrSosXJ8tRTY01jp2fGPet3eQEAFZPfz2ZogNU5efsfAAAAAICS9uWXX8rq1avM665du0mDBg1c8957b55ERoSbQcSeefpp0z3B//3fc8XqW/aff/4xf/fu3StTp77l6rrvyy++kIt6Xig//3xsfBVt0XvlVVfJ2DFjpFHDBhISEiLTZ8yUf//9Vya99JLceddd0qRJE7dWuQAAlEjQVkfkLGpydroOAAAAAEBJ+P777+XyQQPNd9CTTjpJJk+ZUujyutzIkQ/K1KlTi9y2Dl7mNHz4TbL/wEF59bVjXfqlpaXJc//3f66uFqZNm27ma3+323f8afq1fWjkgxIfHy8jRz4kny9dKq1btZK42Bhp0riRzJr1znGXHQBQvtELOgAAAACgzFm7dq307nWR6fpAu0RYsuQzqVevntsyl19+haSlZ5jByN54c7IJsOrToaMefsgEcAtTrVo11+ubbr7JdMswbNgwiY6ONmm//PKL2/I6X/u71a4CV61aJYsWLZLRY8aa1rlDhlwlKSnJMnfePBPIvfmmm+TXXzcFdH8AAMqX4wrazp8/X/r37y9t2rQxk77WNAAAAAAASsoXX3whfS65WBITE6Vhw0ayfMVKaXHyyQUur4FSHdy6VatW5n/tm3bfvn2Fvke7dqcVOj8qKspruj51+sD990n79u1l6NCh8t369XL06FEZOHCQ9Ot3mVx33fVmmTWrGa8FAFACQdshQ4bI4MGDza+Hv//+u5n0taZdffXV/m4WAAAAAIACLV++XPpe2keSkpKkefPmsmLlSlefsU7a3+wTTzwuP/74owmYanB3zpzZ8ttvv5n5cXFxUr16dddA29rvrU5jx45xbeOKwVe4Xk9+c7J5v7fffltSUlJMWqdOnb3m760pU2TTpk3y3ITnTatb7UdXhYYeGwdcW/sq7fsWAICABm0nT54s7777rtvgY9ZJ500poi8hAAAAAAB8NX78s6bLAbV161Zp1rSJK+iq08yZMyUh4YiMf/ZZ6XhOB6lRvZrUrFFdbrj+esnMzDTrPfLIo64gakEGD77SDGympkyZLNWrVZXbbr3F/K/95953//351tGuGsaMGS2DBg2S8847z6Sd07GjVK1aVRYv/kjWrVsnc+e+K+Hh4dKt27FtAwAQsKCt/rqo9Mbz8ssvy7fffivr16+XSZMmmTQN3BanY3cAAAAAAAKtcePGcvU110iLFi1MX7MaoK1Vq5b06tVb3n9/odx9zz1FbkNbyL6/cKGMfOgh0wWDtpDVbVwzdKh88eVXUrt27XzrjB0zxrTEffqZcW5dM8xf8L5UrlzZ9MGrXTPMmjVbmjVvHvByAwDKj8J/WiyAPlKij3k899xzcv3117vSzzzzTNMp+4033uh67AQAAAAAgEBZtmx5sZZ7663iNSRq1KiRGaysoH5rR48eY6bieGHiRDN50la3X3+ztljbAADA75a2WVlZ5q+2qvXkTHMuAwAAAAAAAAAo4aCt/hKpnnjiCTMAmZO+Hj16tNsyAAAAAAAAAIAS7h7hsssuk3HjxsnGjRulTZs2pksE7S4hOTnZzNfX/fv3D3ReAQAAAKBc0fFA0tLSSjsbgO1FRkaaWAMAVBR+BW0feughWbhwoWzevNn87wzWOrVs2VJGjhwZmBwCAAAAQDmlAdtuXbuUdjYA21uxcpXpYxgAKgq/grY6+ubatWvl4Ycflvfee08OHz5s0qtUqSKDBw+Wp59+2iwDAAAAAChaUOL+0s4CYFuOuBqlnQUAKBtBW2eA9vXXX5fXXntN9u8/VsGoUaMGjysAAAAAgB8+G327RIWHlXY2ANtIzciUi554tbSzAQBlK2jrpEHamjVrBiY3AAAAAFBBacA2KiK8tLMBAADKctB25cqV8uabb8q2bdskISHBdKDvGczdvn17IPIIAAAAAAAAABWGX0Hbl19+We65554C52sAl24SAAAAAAAAAOAEBW0nTJiQr2UtAAAAAAAAAOD4Bfuz0r59+0xL2iuvvFL27NkjmZmZkpOT4zZlZ2cHIHsAAAAAAAAAULH4FbRt06aN+TtkyBAzCFlISEig8wUAAAAAAAAAFZJfQdunn37atLSdOnWqaWULAAAAAAAAACjFPm3nzp0r9evXlw8//FAaNGgg55xzjsTHx7st4wzqAgAAAAAAAABKOGg7ffp0E5RVe/fulY8++sjrcgRtAQAAAAAAAOAEBG2Vw+Hw+trJGdQFAAAAAAAAAJRw0HbVqlX+rAYAAAAAAAAAKImgbefOnf1ZDQAAAAAAAABQUt0jqE2bNsmiRYtkx44d5v8mTZpI3759pU2bNsezWQAAAAAAAACosPwK2mZnZ8udd94pb775Zr55jz/+uAwfPlxee+01CQ4ODkQeAQAAAAAAAKDC8CuqOnr0aHnjjTfMAGTepilTpsiTTz4Z+NwCAAAAAAAAQDnnV9B26tSp5m9ISIgMGTJEXnrpJZk0aZJ5rWkauHUuAwAAAAAAAAAo4e4REhISJCgoyLS4HTVqlCv9jjvukJYtW8qjjz5qlgEAAAAAAAAAnICWtmeffbb5e9ppp+Wb50w744wz/Nk0AAAAAAAAAFRofgVtX3zxRYmNjZVXXnlFjh496kpPSkoyadHR0TJhwoRA5hMAAAAAAAAAKoRidY/QtWvXfGnx8fGydOlSqVu3rpxyyikmbfPmzZKcnCwnnXSSPPzww7JixYrA5xgAAAAAAAAAKnrQdvXq1aYPW280SPvDDz+Y1zoAmS63e/duMwEAAAAAAAAASmggMg3IFmee83VBQV4AAAAAAAAAwHEGbf/888/iLAYAAAAAAAAAOBFB24YNG/q84bVr1/q1HgAAAAAAAABUZMXuHqE4fvrpJ3n33Xflvffek127dklWVlYgNw8AAAAAAAAA5d5xB203b95sArXz5s2TLVu2uA1IBgAAAAAAAADwTbD44e+//5bx48fL6aefLq1atZKxY8ea4K0Ga50DkTVo0MCfTQMAAAAAAKAC++Tjj+Xaa4dKm9atpEb1alK7Vk0579yOMmPGDMnJyXFb9ttvv5WLe/c2y1WNryIXXNBZPluypFjvM3PmTImMCPc6DRo4wLVcRkaGjHr4IWnSuJHJy+ArLpf//vvPbVsLFsw36y1btixAewEVXbFb2u7Zs8d0ezB37lxzQjg5g7RKW9defvnl8vDDD0vbtm0Dn1sAAAAAAACUa2+88YYsW/a5W9qGDRvk5puGyw8bNshLkyaZtC+//FIu7t3LBFWd1q1dK5dd1k+mz5ghV1wxOCD5eeGF5+WFF16Q+x94QNq3by9DrrpKjh5Nkk8+/dTMT01NlVGjRknv3r2lR48eAXlPoNgtbevVqycjRowwAVtri9pzzjlHnn/+eddy559/PgFbAAAAAAAA+CUyMkLuuutu+eHHH+VwwhGZ8+67Ehp6rN3h5Mlvyr59+8zrO++43QRsK1euLF9/s1Z+/e13qd+ggYlZ3TtihAmmFkeDhg0lLT3DbZq/4H23lr/q/vsfkP79B8ipp54qK1eucG1fg7r//fuvjB//fyWwN1BRFTtoa21+ft5558lLL70kO3fulG+++cYEcwEAAAAAAIDj9fa06fJ/zz0nrVq1lqioKBMovfDCC808Dcju2LFDfvzxR/njjz9M2qBBl8sZZ5whTZs2leHDh5u0gwcPyuefLw1IfpwteSMiIszf8PBwkw9N/+eff+T5CRPktttul+YtWgTk/QC/+7TdtWuX6ddW/wIAAAAAAACBEhsbmy8tLS3d9bpu3bomaOt08skne31tXaYw2kq2bp3aEhtTyfSjO3r0k5Kenvd+55/fydVv7ZbNm+WXX36Rdu3amRa+o0Y9LJUqVZJRjzziR0mBAPRpGxcXJ4mJiea1BmsnTpxoppNOOkn69+9f3M0AAAAAAAAAxaZ9165evcq87tq1mzRo0EAOHNjvmh8bF5f3Ojbv9f59ecsUJjMzUw4dOmReb9u2TcY984x8/933sji3W4RHH3tMtmzZIsNvvNH837x5c5ny1luydu1aeW/ePHn5lVdNAFdp61ttiQucsJa22l/IwoULZdCgQRIZGenq13b37t3y8ssvm0HI1KJFi2TJkiVunUADAAAAAAAAvvr+++/l8kEDTbed2nBw8pQphS7vHINJOWNVBWnWrJm88eZk2bxlq+k7d+nny6RWrVpmng6EtmbNGvO6SpUq8tHixfLfnr2yfcefsnHTr3LqqW3l/vvuNf3b3nDDDTJ79ixp2qSxxMXGSOtWreTzpYHpmgEVV7GDtvorQb9+/WTevHkmgDtr1iy5+OKLTUfQ1oHJli9fLpdccolUr169JPMNAAAAAACAckxbsvbudZEcPnzYdImwZMlnUq9ePTOvevUaruUSjxxxvU5KOup6Xb1G4bGpc889V6677jpp2LCh6Tu3c+fOcvsdd7jmb/j+e7fl4+PjTeBYzZgxQzZs2CDPTXhe/vjjd7lp+HAT3J07b56kpCTLkCFXuQZMA05Yn7baV8dVV10lixcvlj179sjkyZOla9eu5hcMZwA3OTnZrwwBAAAAAACgYvviiy+kzyUXm646GzZsJMtXrJQWlv5qTz/9dNdr7brAafPmzV6X8UZb73qyts4tqKXu0aNH5YnHH5O+ffvKBRdcIGtWr5Hs7Gy5/vobpF+/y2TAgIFmme/Wr/ehxEAAgraevzLceOONpoWtjpj34osvSocOHY53swAAAAAAAKiANMbU99I+kpSUZPqPXbFypTRp0sRtGQ3InnLKKeb1/PnvmVav27dtkym53SdUq1ZNLrywp3n9119/SWREuJnGjh3j2saA/v3l1VdekZ07d0paWprpDuGVl192ze947rle8zfumaclISFBxj073vwfHHwsvKZPo6uwsDDzNyQkJKD7BRXLcQdtrWrXri133XWXab6+Y8eOQG4aAAAAAAAAFcD48c9Kamqqeb1161Zp1rSJK+iq08yZM828SS+/YrrzPHLkiJx3bkdp3bqV7Nq507SQfWHiRNPlQWF27/5H7rvvXmnRvJlUqRwnPS/sIXv37jXzrhg8WM4555x862hg+JVXXpE777zTFUju3r27CdTOe2+erFu3zoz3VLVqVengZX2gVIK2VtofCAAAAAAAAFASOnXqJMuWr5Bu3bpLbGysREdHyzkdO8oHH3woV1wxuMj1H3/8CRl0+eXSpElTE+DV9du3by8vvviSTJs23es6Dz74gHnqfORDD7vSmjVvLrNnz5GEw4dNH7xVqlSW+QveN8sB/jrWbhsAAAAAAACwgWXLlhd7We2i85NPPy10mUaNGklaeka+9Ev69DGTL95f+IHX9Ev79jUTYPuWtgAAAAAAAAAA3xG0BQAAAAAAAAAboXsEAAAAAACAEuJwOCQtLa20swHYXmRkpBlEDiUQtNWR/dLT06VKlSqB3CwAAAAAAECZpAHbbl27lHY2ANtbsXKVGRAOxxG0/fLLL2XZsmVSqVIlGTlypCQmJsrgwYPl888/N78gXXTRRfLee++Z+QAAAAAAABVdQgatbYGCVAmPLO0slI+g7euvvy7z5s2TAQMGmP+ff/55+eyzz1zz9fVTTz0l48aNC1xOAQAAAAAAyrBHZ74p4ZERpZ0NwDYy0tLlqaE3l3Y2yk/QdsOGDeZvjx49zN/FixebPic6duwof/75p/z333+yaNEigrYAAAAAAAC5NGAbEUmLQgBFCxY/aFBWNWzYULKzs+XXX3+V4OBg08JWW92qv/76y+ftapD3rLPOktjYWKlZs6b069dPNm/enK8vmNtvv12qVasmMTExprXv3r17/SkGAAAAAAAAAJSPoK0ONqYyMzNl69at5m/jxo1NELVWrVp+Z2bNmjUmILtu3TrTZ65u98ILL5Tk5GTXMiNGjDAte+fPn2+W//fff6V///5+vycAAAAAAAAAlPnuEerUqSO7du2SJ554QqpXr27SWrdubf5qEFXVqFHD5+1a+8VV06dPNy1utTuGTp06yZEjR2Tq1KkyZ84c6dq1q1lm2rRp0rJlSxPoPeecc/wpDgAAAAAAAACU7aDtRRddJJMnT5Yff/zR/K/92V588cXm9c8//+wWxD0eGqRVVatWNX81eKutb7t37+5a5pRTTpEGDRrI2rVrvQZttVWws2WwSkxMNH9zcnLM5My/Tg6Hw0xORaU71/c3XbuU8Ny2r+mF5dE1PzhY9J11CsqddEnr1p3p7jn0PT3Yy7Z9TS8qj76mUybK5C392MZyz5/c64G/14LSvEZo3nVdTTMcDrN/nMyaej0IUHqQR158TveybV/TKRNlKm66TnpuOO+JJXnPLclrhHNdU5bcchW038vi5+Rv3ikTZTLng/P8ttTt7VgvLyrdWmfXRbRYOQ4vdSAf0oOP7a78dSMf0p3bDlQ6ZaJMPpdJ/2o9N7fO7jxf7FgvLyzdWWc/9o8W1nNn5u4ETyWZXhrvWdLpdspLoNLtlJdApXum5dbZj710FOv8CyqD391PWND2mWeeMd0irF692mT2yiuvlOuvv97MW7BggYSEhLhawvpLd8A999wj5513nrRp08ak7dmzR8LDw6VKlSpuy2qXDDqvoH5yR48enS/94IEDkpEbzI2MipK4uDg5evSopKWmupaJrlTJdPlwJCFBMjIyXOmxcXESFRUlhw8fluysLFe65is8IkIOHjwgDsudq2q1auaDOrB/v1seqteoYcp56OBBV1pQcJDUqFFTMjMyJCEhwZUeEhpq+vHVPn2P5gaeldkf8fGmC4kUSzcSWqawsDDTUrly9epyMDZWwkNDJSYjw0wJkZGSHpr38celpUl0VpYcio6WLGfwR0TiU1MlIjtb9leqdKzC7cx7SooE5+TIvpgYtzLVTEqSHC1rdHRemRwOqZWcLBkhIXI4KsqVHpqTY7aTGhoqiZaO2COysiQ+LU2Sw8MlKTzclR6VmSmV09MlMSJCUsPCXOmUiTL5U6ZKR45IXJUqUqt5czl46JBEhIcXej7Z9RqRnpEhzZs3l6ikY9eFiKxsiUnPy0tmSIgkRkVIVGaWRGdkutLTwkIlOSJcKmVkSmRmXh5TwsMkNTxM4tIyJCw725WeFBEu6WGhUjk1XUIsN6jEyAjJDA2R+JQ0ty/1CdGR5otn1eS8/aUOVYqSYIdDqqSkudL089X0sOwciUvL+5EtOzjYbIcyUSZ/y5SdmSltWrSQ6mER5suS9sNfUvfckrxGREVHm/pWm5NbSI3sVAnJOLbOgfAYCXbkSNXMFLfPSdPDHNlSJTMvL1lBwXI4vJJE5mRJbFbe55oRHCpHwqIkOjtDKmXn5TEtJEyOhkZKbHa6RGbnfX7JIeGSEhohlbPSJDwnL++6rK5TJTNFQh15n1NCWJRkBoVKtcxkt8/pUFi05EiwVM9IcqVRJsrka5myszMlvnKcSGaaaeyRlJRk23p5YdcI3YbeyyWlphwMipYgcUi0ZMshiZAsS+g6XjIkQnJkv0S6BbeqS7q5Zu8T94GNajrSJEeC5IDkjVKvW6slaZIhwXJY8upvoeIw20mVEEmUvPqbvp++b7KESpLlq2OUZEtlyTTL6jpOMZJlpgQJ11y50uMkkzJRJr/KlCJh0uyUViLRlU2dvXJ2tm3r5YVdI7TOXrduXTn853YJysyWIOv1MyxUJCpCJC1Dgix1I0d4mEhkuASlpOsFLy89MkIkPFSCktM0cJKXHh0pEhoiQUd1v+SVyVEpyrRkCTqa954mPTbaRNyD3OqBQeKIixbJzpEgSz1QNPAUEyWiebfUAyUkRByVIkXSMyXIUt+jTJTJlzKFZGRKi6bNZM/fO01DzaSjR21bL68aoGuExuuKI8jhb7hXv0glJUloaKhElsDIh7feeqssWbJEvvrqK6lXr55J024RNDhsbTmrzj77bOnSpYuMHz++WC1t69evL3v27jMfZFmKxPv664Ie1N27dZWgfftk5fDhEhUWZrvWjuWxBSdlKhtlSs/MlM6TJ+uvPrJs2XJzcS+Lv9bpjahHj+6yOyNNBk6fIqEREbTOokyUKTc9Ky1N5l9/k5wUHinLV6w09ZWy2NLWeT/fnZopfV9+R0IjIsvV5+Rv3ikTZcpKT5MP77ha6kWHy/LlK8y93K718sLSU1JSpEf3bhJ09ICsfPouiQ4Pt19rx/LYgpMylYkypaRnSJdHJokjtrqpszt/yLRjvbywdGed/XB6qoyZN00iPGModmjtWB7S7ZSXQKXbKS+BSvdIS09LkyevHCZxoeGuOrtd6+VBAbpGaDy1Zo3q5kdnZ2wyYC1tb7jhBpPJUaNGSdOmTd3mHThwQD799FPzeujQof5sXu644w75+OOP5YsvvnAFbFXt2rVNRFwj1NbWtnv37jXzvImIiDCTJ91xrseJPXa+p4LSPdf3J93X9/Q13RwYOdpGwn3UOWfgK18evebct/SCtl1a6ZSJMhWUrjcK84iVx/UgUOffibhGaN7dHiHRG5G3jQco3drq2e/0Es4jZaJMznSd9NxwVpJK+p5bUtcI57qmLLnlKk+f04nOI2UqP2Uy54Pz/PZSt7dbvbywdGud3bmIBrK85t2HdN2W17pRKaVTJsrkc7qe685uESxdHtmxXl5YurPOnjsj70R3X8FrXko0vTTes6TT7ZSXQKXbKS+BSveoz1q7Ly2Ne3RwKVwjiqOgeEihdIAwnTRY6mnz5s1y3XXXmcCur/QipgHbDz74QFauXCmNGzd2m3/GGWeYJsQrVqxwe7+dO3dKx44d/SkKAAAAAAAAANiKXy1tC6P9Rih/el24/fbbTRcIixYtktjYWFc/tZUrVzZ9TOjfYcOGyb333msGJ9MmxHfeeacJ2HobhAwAAAAAAAAAym3QVgOpOnkOSKYDXTlpc2btg1Zp0NVXr7/+uvl7wQUXuKVPmzbNtN5VEydONM2QBwwYYPqq7dmzp7z22ms+vxcAAAAAAAAAlOmg7U8//WS6RHD2w6AtaXWgMG90mXbt2vmcmeK0ztUOiV999VUzAQAAAAAAAIBU9O4RTAfglsCtNzoo2AsvvHD8uQMAAAAAAACACqbYQVvtnkC7LdBAbdeuXU3gdtKkSXLqqae6ltFuC+Lj46Vly5YSEhJSUnkGAAAAAAAAgHKr2EHbhg0bmkl16tTJBG27dOkirVu3Lsn8AQAAAAAAAECF4nP3CGr16tX50nQQsi1btpjBwdq2bevqQgEAAAAAAAAAUHzB4odFixbJ0KFD5e677zb/79mzR04//XTT6rZ9+/ZmELL9+/f7s2kAAAAAAAAAqND8CtrOnDlTZs+eLYmJieb/5557TjZu3Gj6u9Xp119/ldGjRwc6rwAAAAAAAABQ7vkVtP3xxx/N386dO5u/n332mekOYeDAgdKqVSsTuF2yZElgcwoAAAAAAAAAFYBfQdt9+/aZv/Xr15eMjAzTl21oaKjMmjVLxo4da+bt3r07sDkFAAAAAAAAgArAr6BtVlaW+Xv06FH5/fffJTs7W5o2bSrh4eESFxdn5oWFhQU2pwAAAAAAAABQAYT6s1KDBg1k+/btcu+990qVKlVM1wht27Z1a2Fbo0aNwOYUAAAAAAAAACoAv1ra9u3b1/Rb+/fff8tPP/1k0vr372/+rl+/3vw97bTTAplPAAAAAAAAAKgQ/Gppq/3WHjp0SD766CPTDcKwYcPk8ssvdw1Spl0l9OnTJ9B5BQAAAAAAAIByz6+gbWRkpEydOtXrvK+//vp48wQAAAAAAAAAFZZfQVsrbXH7xx9/SHJysvTo0SMwuQIAAAAAAACACsqvPm2V9md78cUXS82aNeX888+XXr16SVpamrRu3dp0j7Bhw4bA5hQAAAAAAAAAKgC/gra7d++Wc889Vz777DPJyckxg5LppN0mtG3bVv7880+ZO3du4HMLAAAAAAAAAOWcX0HbJ598Uv777z8TqG3UqJHbvP/973/m78qVKwOTQwAAAAAAAACoQPwK2i5ZskSCgoJk5MiR8s4777jNcwZx//nnn8DkEAAAAAAAAAAqEL+Ctvv37zd/u3fvnm9eSEiI+XvkyJHjzRsAAAAAAAAAVDh+BW2rVatm/n7//ff55i1btsz8rVWr1vHmDQAAAAAAAAAqHL+Ctp07dzb92T7++OMybtw4V/oNN9wgL774ouk6oUuXLoHMJwAAAAAAAABUCH4FbUeNGiURERGSlZXl6t9WzZgxwwRzdd6DDz4Y6LwCAAAAAAAAQLlX7KBt48aNpWnTpvLDDz/IqaeeKgsXLpTq1aubIK11qlGjhrz//vvSqlWrks05AAAAAAAAAJRDocVd8O+//zYtatPS0sz/vXr1kr/++ks+//xz2bJli0lr0aKF9OjRQ6Kjo0suxwAAAAAAAABQjhU7aOtNVFSU9O3bN3C5AQAAAAAAAIAKzuc+bZ391wIAAAAAAAAAbNDSduDAgWagseIEd7dv3+5vvgAAAAAAAACgQvI5aLtnz54il9EByWiRCwAAAAAAAAAnIGirAVkAAAAAAAAAgE2CtpMmTZJTTz21ZHIDAAAAAAAAABWcz0Hb9u3by7nnnlsyuQEAAAAAAACACi64tDMAAAAAAAAAAMhD0BYAAAAAAAAAymL3CKtWrTJ/6c8WAAAAAAAAAGwQtO3cuXMJZgMAAAAAAAAAoOgeAQAAAAAAAABshKAtAAAAAAAAANgIQVsAAAAAAAAAsBGCtgAAAAAAAABgIwRtAQAAAAAAAMBGQv1d8ciRIzJnzhzZtm2bJCQkiMPhcJsfFBQkU6dODUQeAQAAAAAAAKDC8Ctou2rVKrnsssvk6NGjhS5H0BYAAAAAAAAATkDQdsSIEZKYmFjoMtrSFgAAAAAAAABwAoK2f/zxhwnKtm3bVh5++GGpVq2ahIb63dMCAAAAAAAAACCXX5HW+vXry44dO+Spp56Siy++2J9NAAAAAAAAAAC8CBY/u0fQgce++eYbf1YHAAAAAAAAABxPS9uZM2e6/R8TEyMtW7aUZ599Vn7//Xfp3LmzxMfH51tv6NChxdk8AAAAAAAAAMCXoO11113ndWAxbW27aNEiM3nS5QnaAgAAAAAAAEAJ9WmrAVpf0gEAAAAAAAAAJRS0feKJJ/zYNAAAAAAAAADAVwRtAQAAAAAAAMBGgv1ZqWvXrtKtWzf59ddf883btWuXjBkzRsaOHRuI/AEAAAAAAABAhVLsPm2tVq9ebQYaO3LkSL55O3fulCeffNLMf+yxxwKRRwAAAAAAAACoMPxqaVuYAwcOBHqTAAAAAAAAAFBhFLul7YwZM8xkdeedd0rlypVd/+fk5MjGjRvN6/j4+EDmEwAAAAAAAAAqhGIHbf/66y9XtwjK4XDITz/95HVZXaZDhw6ByyUAAAAAAAAAVBA+92mrwVpr4NabM844QyZNmnT8uQMAAAAAAACACqbYQdt77rlHrrvuOhOobdKkiQncLliwwARonYKDg023CDExMSWVXwAAAAAAAAAo14odtNW+a5391w4dOtQEbdu1aycNGzYsyfwBAAAAAAAAQIXic/cIavr06a7Xv/zyi2zZssW8btGihbRt2zZwuQMAAAAAAACACsavoK3asGGD6S7ht99+c0tv3bq1Ceq2b98+EPkDAAAAAAAAgAol2J+Vtm3bJl27djUBW+3j1jpt2rTJzNu+fbvP2/3iiy+kT58+UrduXdP9wocffug2X4PEmm6dLrroIn+KAAAAAAAAAADlJ2j79NNPy9GjR02Qtnbt2tKrVy/p3bu31KlTx8zXebqMr5KTk00/ua+++mqBy2iQ9r///nNN7777rj9FAAAAAAAAAIDy0z3CihUrTCvXQYMGyaxZsyQ09NhmsrKy5Oqrr5b33ntPli1b5vN2NfirU2EiIiJMoBgAAAAAAAAAyiO/grZ79+51dVfgDNiajYWGmjQN2u7bt09KwurVq6VmzZoSHx9vumF46qmnpFq1agUun56ebianxMRE8zcnJ8dMytnVgrOLB6ei0p3r+5seHBycb9u+pheWR9f84GDRd9YpKHfSJa1bd6a759D39GAv2/Y1vag8+ppOmSiTt/RjG8s9f3KvB/5eC0rzGqF513U1zXA4zP5xMmvq9SBA6UEeefE53cu2fU2nTJSpuOk66bnhvCeW5D23JK8RznVNWXLLVdB+L4ufk795p0yUyZwPzvPbUre3Y728qHRrnV0X0WLlOLzUgXxIDz62u/LXjXxId247UOmUiTL5XCb9q/Xc3Dq783yxY728sHRnnf3YP1pYz52ZuxM8lWR6abxnSafbKS+BSrdTXgKV7pmWW2c/9tJRrPMvqAx+dz9hQdu4uDg5dOiQrFu3Ll+fsprmXCbQ9L369+8vjRs3Nn3mjho1yrTMXbt2rYSEhHhdZ9y4cTJ69Oh86QcPHJCM3GBuZFSUya9265CWmupaJrpSJYmJiZEjCQmSkZHhSo+Ni5OoqCg5fPiwZGdludKrVKki4RERcvDgAXFY7lxVq1UzH9SB/fvd8lC9Rg3zQR86eNCVFhQcJDVq1JTMjAxJSEhwpYeEhprgdFpamhzNDTyr8PBwqRIfb7qWSElOdqVrmcLCwkyAu3L16nIwNlbCQ0MlJiPDTAmRkZJuCbjHpaVJdFaWHIqOlixn8EdE4lNTJSI7W/ZXqnSswu3Me0qKBOfkyL6YGLcy1UxKkhwta3R0XpkcDqmVnCwZISFyOCrKlR6ak2O2kxoaKomRka70iKwsiU9Lk+TwcEkKD3elR2VmSuX0dEmMiJDUsDBXOmWiTP6UqdKRIxJXpYrUat5cDh46JBHh4YWeT3a9RqRnZEjz5s0lKunYdSEiK1ti0vPykhkSIolRERKVmSXRGZmu9LSwUEmOCJdKGZkSmZmXx5TwMEkND5O4tAwJy852pSdFhEt6WKhUTk2XEMsNKjEyQjJDQyQ+Jc3tS31CdKT54lk1OW9/qUOVoiTY4ZAqKWmuNP18NT0sO0fi0vJ+ZMsODjbboUyUyd8yZWdmSpsWLaR6WIT5spSdnV1i99ySvEZERUebymGbk1tIjexUCck4ts6B8BgJduRI1cwUt89J08Mc2VIlMy8vWUHBcji8kkTmZElsVt7nmhEcKkfCoiQ6O0MqZeflMS0kTI6GRkpsdrpEZud9fskh4ZISGiGVs9IkPCcv77qsrlMlM0VCHXmfU0JYlGQGhUq1zGS3z+lQWLTkSLBUz0hypVEmyuRrmbKzMyW+cpxIZpocOXJEkpKSbFsvL+waodvQe7mk1JSDQdESJA6Jlmw5JBGSZQldx0uGREiO7JdIt+BWdUk31+x9kldPUzUdaZIjQXJAIvLKJCK1JE0yJFgOS179LVQcZjupEiKJkld/0/fT902WUEmyfHWMkmypLJlmWV3HKUayzJQg4ZorV3qcZFImyuRXmVIkTJqd0kokurKps1fOzrZtvbywa4TW2XXsnsN/bpegzGwJsl4/w0JFoiJE0jIkyFI3coSHiUSGS1BKul7w8tIjI0TCQyUoOU1bo+WlR0eKhIZI0FHdL3llclSKMi1Zgo7mvadJj402Efcgt3pgkDjiokWycyTIUg8UDTzFRIlo3i31QAkJEUelSJH0TAmy1PcoE2XypUwhGZnSomkz2fP3TsnMzJSko0dtWy+vGqBrhMbriiPI4Ue495JLLpFPP/3UBEovu+wy6dChg0lfv369LFy40GRUg6kff/yxr5vOy1hQkHzwwQfSr1+/ApfZsWOHNG3aVJYvXy7dunUrdkvb+vXry569+1yB5bISiff11wU9qLt36ypB+/bJyuHDJSoszHatHctjC07KVDbKlJ6ZKZ0nTxapVUuWLVtuLu5l8dc6vRH16NFddmekycDpUyQ0IoLWWZSJMuWmZ6Wlyfzrb5KTwiNl+YqVEhkZWSZb2jrv57tTM6Xvy+9IaERkufqc/M07ZaJMWelp8uEdV0u96HBZvnyFuZfbtV5eWHpKSor06N5Ngo4ekJVP3yXR4eH2a+1YHltwUqYyUaaU9Azp8sgkccRWN3V25w+ZdqyXF5burLMfTk+VMfOmSYSlMYxtWjuWh3Q75SVQ6XbKS6DSPdLS09LkySuHSVxouKvObtd6eVCArhH6Q3PNGtXNj86FNXr1q6XtvffeK0uWLDGZfP/9983kpBnRTN13331S0po0aSLVq1eXbdu2FRi01T5wdfKkeXQ9Tuyx8z0VlO65vj/pvr6nr+nmwMjRNhLuo845A1/58ug1576lF7Tt0kqnTJSpoHS9UZhHrDyuB4E6/07ENULz7vYIid6IvG08QOnWVs9+p5dwHikTZXKm66TnhrOSVNL33JK6RjjXNWXJLVd5+pxOdB4pU/kpkzkfnOe3l7q93erlhaVb6+zORTSQ5TXvPqTrtrzWjUopnTJRJp/T9Vx3dotg6fLIjvXywtKddfbcGXknuvsKXvNSouml8Z4lnW6nvAQq3U55CVS6R33W2n1padyjg0vhGlEcBcVDCqV9yb788sumOa+rX8XcSdN0XpcuXaSk/fPPP3Lw4EGpU6dOib8XAAAAAAAAAJwIfrW0VbfddptceumlsmDBAtmyZYtJa9GihQwcOFDq1avn1za1ebC2mnX6888/5aeffpKqVauaSfumHTBggNSuXdv0afvggw9Ks2bNpGfPnv4WAwAAAAAAAADKR9BWaXD2nnvuCVhmvv/+e7cWutoNg7r22mvl9ddfl19++UVmzJhhOvDVTrwvvPBCGTt2rNfuDwAAAAAAAACgwgVtnfbt2ycfffSRHDp0yLS27dOnjxmkzFcXXHBBvs55rZYuXXqcOQUAAAAAAACAchS0feGFF+SVV16RPXv2yKmnniovvfSSJCYmSv/+/SU1NdW13BlnnCErV66UmJiYksgzAAAAAAAAAJRbxQ7azp49W+6//37X6KbalUG/fv0kKipKUlJS3JbdsGGDPPfcc6YPWgAAAAAAAABA8QUXd8Fp06aZv87uC/Svdovw999/m0DuRRddZAYECw4ONvM+/PBDH7IBAAAAAAAAAPApaLtx40YTnNWuEDZt2mQGAFOaNmbMGPn0009lyZIl5rXavn07exgAAAAAAAAASipoq4OMqdtvv11atWolDz74oGve//73P9fr8847z/y19nELAAAAAAAAAAhw0DY7O9v8jYiIMH/DwsJc86yvQ0N9GtsMAAAAAAAAAGDhc4T1mWeekZo1axaYpv3cAgAAAAAAAABOUNBW+6110v5sPdMAAAAAAAAAACcoaOtwOI7jrQAAAAAAAAAAAQvaPvHEE8VdFAAAAAAAAADgJ4K2AAAAAAAAAGAjwaWdAQAAAAAAAABAHoK2AAAAAAAAAGAjBG0BAAAAAAAAwEYI2gIAAAAAAACAjRC0BQAAAAAAAAAbIWgLAAAAAAAAADZC0BYAAAAAAAAAbISgLQAAAAAAAADYCEFbAAAAAAAAALARgrYAAAAAAAAAYCMEbQEAAAAAAADARgjaAgAAAAAAAICNELQFAAAAAAAAABshaAsAAAAAAAAANkLQFgAAAAAAAABshKAtAAAAAAAAANgIQVsAAAAAAAAAsBGCtgAAAAAAAABgIwRtAQAAAAAAAMBGCNoCAAAAAAAAgI0QtAUAAAAAAAAAGyFoCwAAAAAAAAA2QtAWAAAAAAAAAGyEoC0AAAAAAAAA2AhBWwAAAAAAAACwEYK2AAAAAAAAAGAjBG0BAAAAAAAAwEYI2gIAAAAAAACAjRC0BQAAAAAAAAAbIWgLAAAAAAAAADZC0BYAAAAAAAAAbISgLQAAAAAAAADYCEFbAAAAAAAAALARgrYAAAAAAAAAYCMEbQEAAAAAAADARgjaAgAAAAAAAICNELQFAAAAAAAAABshaAsAAAAAAAAANkLQFgAAAAAAAABshKAtAAAAAAAAANgIQVsAAAAAAAAAsBGCtgAAAAAAAABgIwRtAQAAAAAAAMBGCNoCAAAAAAAAgI0QtAUAAAAAAAAAGyFoCwAAAAAAAAA2QtAWAAAAAAAAAGyEoC0AAAAAAAAA2AhBWwAAAAAAAACwEYK2AAAAAAAAAGAjtgrafvHFF9KnTx+pW7euBAUFyYcffug23+FwyOOPPy516tSRqKgo6d69u2zdurXU8gsAAAAAAAAA5Tpom5ycLO3atZNXX33V6/z/+7//k0mTJskbb7wh3377rVSqVEl69uwpaWlpJzyvAAAAAAAAAFASQsVGevXqZSZvtJXtiy++KI8++qj07dvXpM2cOVNq1aplWuQOHjz4BOcWAAAAAAAAAMp50LYwf/75p+zZs8d0ieBUuXJl6dChg6xdu7bAoG16erqZnBITE83fnJwcMyntikEnDQzr5FRUunN9f9ODg4PzbdvX9MLy6JofHCz6zjoF5U66pHXrznT3HPqeHuxl276mF5VHX9MpE2Xyln5sY7nnT+71wN9rQWleIzTvuq6mGQ6H2T9OZk29HgQoPcgjLz6ne9m2r+mUiTIVN10nPTec98SSvOeW5DXCua4pS265CtrvZfFz8jfvlIkymfPBeX5b6vZ2rJcXlW6ts+siWqwch5c6kA/pwcd2V/66kQ/pzm0HKp0yUSafy6R/tZ6bW2d3ni92rJcXlu6ssx/7RwvruTNzd4Knkkwvjfcs6XQ75SVQ6XbKS6DSPdNy6+zHXjqKdf4FlcHv7uU6aKsBW6Uta630f+c8b8aNGyejR4/Ol37wwAHJyA3mRkZFSVxcnBw9elTSUlNdy0RXqiQxMTFyJCFBMjIyXOmxcXGmT93Dhw9LdlaWK71KlSoSHhEhBw8eEIflzlW1WjXzQR3Yv98tD9Vr1DAf9KGDB11pQcFBUqNGTcnMyJCEhARXekhoqFSrVs10BXE0N/CswsPDpUp8vOlaIiU52ZWuZQoLC5OaNWtK5erV5WBsrISHhkpMRoaZEiIjJT007+OPS0uT6KwsORQdLVnO4I+IxKemSkR2tuyvVOlYhduZ95QUCc7JkX0xMW5lqpmUJDla1ujovDI5HFIrOVkyQkLkcFSUKz00J8dsJzU0VBIjI13pEVlZEp+WJsnh4ZIUHu5Kj8rMlMrp6ZIYESGpYWGudMpEmfwpU6UjRySuShWp1by5HDx0SCLCwws9n+x6jUjPyJDmzZtLVNKx60JEVrbEpOflJTMkRBKjIiQqM0uiMzJd6WlhoZIcES6VMjIlMjMvjynhYZIaHiZxaRkSlp3tSk+KCJf0sFCpnJouIZYbVGJkhGSGhkh8Sprbl/qE6EjzxbNqct7+UocqRUmwwyFVUvK6tdHPV9PDsnMkLi3vR7bs4GCzHcpEmfwtU3ZmprRp0UKqh0WYL0vZ2dklds8tyWtEVHS0qRy2ObmF1MhOlZCMY+scCI+RYEeOVM1McfucND3MkS1VMvPykhUULIfD/7+9O4G3qWofOP6cOw/cayZlKEJkrMyF6FX0olGDQqK5pIGiaNKkSClElP5KFOotCpnK0Nug9FZKSSUz13Tne/f/8yz2vufce+7Yvc4+x+/7+RzuWWefvdfa56y913n22mvFS0x2ppTPzPlc08Mi5EBkrMRlpUt8Vk4eU8Mj5VBEjJTPSpOYrJzP70h4lCRHREtiZqpEZefkXZfV91TISJYIK+dzSoqMlQxPhFTOOOLzOe2LjJNsCZMq6YedNMpEmYpbpqysDKmYmCCSkSoHDhyQw4cPu7ZdXtAxQteh53JJriZ7PXHiEUviJEv2SbRkeoWuK0q6REu27JYYn+BWFUkzx+xdktNOU9WsVMkWj+yR6Jwy6e8nSZV0CZP9ktN+ixDLrCdFwuWg5LTfdHu63SMSIYe9fjrGSpYkSoZZVt9jKyeZ5pEkUZorJz1BMigTZSpRmZIlUuo3aiwSl2ja7IlZWa5tlxd0jNA2u87ds3/Lr+LJyBKP9/EzMkIkNlokNV08Xm0jKypSJCZKPMlpesDLSY+JFomKEM+RVO2NlpMeFyMSES6eQ7pfcspkxceaniyeQznbNOnl40zE3ePTDvSIlRAnkpUtHq92oGjgqVysiObdqx0o4eFixceIpGWIx6u9R5koU3HKFJ6eIQ3q1ZcdW/+QjIwMOXzokGvb5ZVK6Rih8bqi8FglDfeWMf1xMn/+fOnTp495vmbNGunQoYP8/fffZiIy25VXXmmWnTNnTpF72taqVUt27NxlPshgisQX9+qCfqm7dT1fPLt2yaeDB0tsZKTrejuGYg9OyhQcZUrLyJBOU6fqlR9ZsmSpObgH49U6PRFdcEE32ZaeKpfPfFUioqPpnUWZKNOx9MzUVJk7cIicHBUjS5d9KjExMUHZ09Y+n29LyZDeL86SiOiYkPqcSpp3ykSZMtNSZcHt/eSUuChZunSZOZe7tV1eUHpycrJc0K2reA7tkU+fuFPioqLc19sxFHtwUqagKFNyWrp0GTlRrPJVTJvdvpDpxnZ5Qel2m31/Woo8OmeGRHt1hnFNb8dQSHdTXkor3U15Ka30XGlpqaky5upBkhAR5bTZ3dou95TSMUIvNFerWsVcdLZjk0Hd07ZGjRrm/507d/oEbfV5ixYt8n1fdHS0eeSmO865nTjXzs8tv/Tc7y9JenG3Wdx088XI1j4SvrPO2YGvPHn0m/Pipee37kClUybKlF+6nijMLVa5jgelVf+OxzFC8+5zC4meiPytvJTSvXs9lzi9jPNImSiTna4PrRt2I6msz7lldYyw32vKcqxcXi8G/ed0vPNImUKnTKY+2PXbT9vebe3ygtK92+z2IhrI8pv3YqTruvy2jQKUTpkoU7HTta7bwyJ4DXnkxnZ5Qel2m/3YCzkV3fcNfvNSpumB2GZZp7spL6WV7qa8lFZ6rvas9/ClgThHhwXgGFEU+cVDXOfUU081gdtly5b59Jpdv369tGvXLqB5AwAAAAAAAIDS4qqetto9ePPmzT6Tj23YsEEqVaoktWvXlqFDh8rjjz9uxnzSIO5DDz1kxoWxh1AAAAAAAAAAgGDnqqDtl19+KV26dHGeDxs2zPzfv39/mTlzptx///1mkOEhQ4aYQXw7duwoixcvzjPeBQAAAAAAAAAEK1cFbTt37pxncF5vOgbEo48+ah4AAAAAAAAAEIqCZkxbAAAAAAAAADgRELQFAAAAAAAAABchaAsAAAAAAAAALkLQFgAAAAAAAABchKAtAAAAAAAAALgIQVsAAAAAAAAAcBGCtgAAAAAAAADgIgRtAQAAAAAAAMBFCNoCAAAAAAAAgIsQtAUAAAAAAAAAFyFoCwAAAAAAAAAuQtAWAAAAAAAAAFyEoC0AAAAAAAAAuAhBWwAAAAAAAABwEYK2AAAAAAAAAOAiBG0BAAAAAAAAwEUI2gIAAAAAAACAixC0BQAAAAAAAAAXIWgLAAAAAAAAAC5C0BYAAAAAAAAAXISgLQAAAAAAAAC4CEFbAAAAAAAAAHARgrYAAAAAAAAA4CIEbQEAAAAAAADARQjaAgAAAAAAAICLELQFAAAAAAAAABchaAsAAAAAAAAALkLQFgAAAAAAAABchKAtAAAAAAAAALgIQVsAAAAAAAAAcBGCtgAAAAAAAADgIgRtAQAAAAAAAMBFCNoCAAAAAAAAgIsQtAUAAAAAAAAAFyFoCwAAAAAAAAAuQtAWAAAAAAAAAFyEoC0AAAAAAAAAuAhBWwAAAAAAAABwEYK2AAAAAAAAAOAiBG0BAAAAAAAAwEUI2gIAAAAAAACAixC0BQAAAAAAAAAXIWgLAAAAAAAAAC5C0BYAAAAAAAAAXISgLQAAAAAAAAC4CEFbAAAAAAAAAHARgrYAAAAAAAAA4CIEbQEAAAAAAADARQjaAgAAAAAAAICLELQFAAAAAAAAABchaAsAAAAAAAAALkLQFgAAAAAAAABchKAtAAAAAAAAALgIQVsAAAAAAAAAcBGCtgAAAAAAAADgIgRtAQAAAAAAAMBFCNoCAAAAAAAAgIsQtAUAAAAAAAAAFyFoCwAAAAAAAAAuQtAWAAAAAAAAAFyEoC0AAAAAAAAAuEhQBW3HjBkjHo/H59GoUaNAZwsAAAAAAAAASk2EBJkmTZrI0qVLnecREUFXBAAAAAAAAADIV9BFPDVIW6NGjSIvn5aWZh62gwcPmv+zs7PNQ9m9di3LMg9bYen2+0uaHhYWlmfdxU0vKI/O62FholvWh+fYQ5f0Xrud7pvD4qeH+Vl3cdMLy2Nx0ykTZfKXfnRlx+rPseNBSY8FgTxGaN71vZpmWJbZPzbzTj0elFK6J1deip3uZ93FTadMlKmo6frQumGfE8vynFuWxwj7vaYsx8qV334Pxs+ppHmnTJTJ1Ae7fnu17d3YLi8s3bvNrotosbItP22gYqSHHd1dedtGxUi3111a6ZSJMhW7TPq/tnOPtdnt+uLGdnlB6Xab/egTLWzunXlsJ+RWlumB2GZZp7spL6WV7qa8lFZ67rRjbfajf1pFqn+eIPztfkIEbX/55RepWbOmxMTESLt27eTJJ5+U2rVr57u8vv7II4/kSd+7Z4+kHwvmxsTGSkJCghw6dEhSU1KcZeLi46VcuXJyIClJ0tPTnfTyCQkSGxsr+/fvl6zMTCe9QoUKEhUdLXv37hHL68xVqXJl80Ht2b3bJw9VqlY1H/S+vXudNE+YR6pWrSYZ6emSlJTkpIdHREjlypUlNTVVDh0LPKuoqCipULGiHDlyRJKPHHHStUyRkZFSrVo1SaxSRfaWLy9RERFSLj3dPJJiYiTNq5dyQmqqxGVmyr64OMm0gz8iUjElRaKzsmR3fPzRBred9+RkCcvOll3lyvmUqdrhw5KtZY2LyymTZUn1I0ckPTxc9sfGOukR2dlmPSkREXIwJsZJj87MlIqpqXIkKkoOR0U56bEZGZKYliYHo6MlJTLSSadMlKkkZYo/cEASKlSQ6qefLnv37ZPoqKgC65NbjxFp6ely+umnS+zho8eF6MwsKZeWk5eM8HA5GBstsRmZEpee4aSnRkbIkegoiU/PkJiMnDwmR0VKSlSkJKSmS2RWlpN+ODpK0iIjJDElTcK9TlAHY6IlIyJcKian+vyoT4qLMT88Kx3J2V9qX3yshFmWVEhOddL089X0yKxsSUjNuciWFRZm1kOZKFNJy5SVkSFnNmggVSKjzY+lrKysMjvnluUxIjYuzjQOz2zYQKpmpUh4+tH37IkqJ2FWtlTKSPb5nDQ90sqSChk5ecn0hMn+qHiJyc6U8pk5n2t6WIQciIyVuKx0ic/KyWNqeKQcioiR8llpEpOV8/kdCY+S5IhoScxMlajsnLzrsvqeChnJEmHlfE5JkbGS4YmQyhlHfD6nfZFxki1hUiX9sJNGmShTccuUlZUhFRMTRDJS5cCBA3L48GHXtssLOkboOvRcLsnVZK8nTjxiSZxkyT6Jlkyv0HVFSZdoyZbdEuMT3KoiaeaYvUty2mmqmpUq2eKRPRKdUyYRqS6pki5hsl9y2m8RYpn1pEi4HJSc9ptuT7d7RCLksNdPx1jJkkTJMMvqe2zlJNM8kiRKc+WkJ0gGZaJMJSpTskRK/UaNReISTZs9MSvLte3ygo4R2mbXOMb+Lb+KJyNLPN7Hz8gIkdhokdR08Xi1jayoSJGYKPEkp+kBLyc9JlokKkI8R1K1N1pOelyMSES4eA7pfskpkxUfa3qyeA7lbNOkl48zEXePTzvQI1ZCnEhWtni82oGigadysSKad692oISHixUfI5KWIR6v9h5lokzFKVN4eoY0qFdfdmz9QzIyMuTwoUOubZdXKqVjhMbrisJjlTTcGwCLFi0yjbGGDRvK9u3bTTB227Zt8v3330v58uWL3NO2Vq1asmPnLvNBBlMkvrhXF/RL3a3r+eLZtUs+HTxYYiMjXdfbMRR7cFKm4ChTWkaGdJo6VaR6dVmyZKk5uAfj1To9EV1wQTfZlp4ql898VSKio+mdRZko07H0zNRUmTtwiJwcFSNLl31qLvgGY09b+3y+LSVDer84SyKiY0Lqcypp3ikTZcpMS5UFt/eTU+KiZOnSZeZc7tZ2eUHpycnJckG3ruI5tEc+feJOiYuKcl9vx1DswUmZgqJMyWnp0mXkRLHKVzFtdvtCphvb5QWl2232/Wkp8uicGRLt1RnGNb0dQyHdTXkprXQ35aW00nOlpaWmypirB0lCRJTTZndru9xTSscIjW1Wq1rFXHS2Y5NB39P2oosucv5u1qyZtGnTRurUqSPvvPOODBo0yO97oqOjzSM33XHO7cS5dn5u+aXnfn9J0ou7zeKmmy9GtvaR8J11zg585cmj35wXLz2/dQcqnTJRpvzS9URhbrHKdTworfp3PI4RmnefW0j0RORv5aWU7t3rucTpZZxHykSZ7HR9aN2wG0llfc4tq2OE/V5TlmPlCqXP6XjnkTKFTplMfbDrt5+2vdva5QWle7fZ7UU0kOU378VI13X5bRsFKJ0yUaZip2tdt4dF8BryyI3t8oLS7Tb7sRdyKrrvG/zmpUzTA7HNsk53U15KK91NeSmt9FztWe/hSwNxjg4LwDGiKPKLhwQF7a7coEED2bx5c6CzAgAAAAAAAAClIqiDttqd+Ndff5WTTjop0FkBAAAAAAAAgBMvaHvvvffKypUr5ffff5c1a9bIJZdcIuHh4XL11VcHOmsAAAAAAAAAUCqCakzbv/76ywRo9+7dK1WrVpWOHTvKunXrzN8AAAAAAAAAEAqCKmj79ttvBzoLAAAAAAAAAFCmgmp4BAAAAAAAAAAIdQRtAQAAAAAAAMBFCNoCAAAAAAAAgIsQtAUAAAAAAAAAFyFoCwAAAAAAAAAuQtAWAAAAAAAAAFyEoC0AAAAAAAAAuAhBWwAAAAAAAABwEYK2AAAAAAAAAOAiBG0BAAAAAAAAwEUI2gIAAAAAAACAixC0BQAAAAAAAAAXIWgLAAAAAAAAAC5C0BYAAAAAAAAAXISgLQAAAAAAAAC4CEFbAAAAAAAAAHARgrYAAAAAAAAA4CIEbQEAAAAAAADARQjaAgAAAAAAAICLELQFAAAAAAAAABchaAsAAAAAAAAALkLQFgAAAAAAAABchKAtAAAAAAAAALgIQVsAAAAAAAAAcBGCtgAAAAAAAADgIgRtAQAAAAAAAMBFCNoCAAAAAAAAgIsQtAUAAAAAAAAAFyFoCwAAAAAAAAAuQtAWAAAAAAAAAFyEoC0AAAAAAAAAuAhBWwAAAAAAAABwEYK2AAAAAAAAAOAiBG0BAAAAAAAAwEUI2gIAAAAAAACAixC0BQAAAAAAAAAXIWgLAAAAAAAAAC5C0BYAAAAAAAAAXISgLQAAAAAAAAC4CEFbAAAAAAAAAHARgrYAAAAAAAAA4CIEbQEAAAAAAADARQjaAgAAAAAAAICLELQFAAAAAAAAABchaAsAAAAAAAAALkLQFgAAAAAAAABchKAtAAAAAAAAALgIQVsAAAAAAAAAcBGCtgAAAAAAAADgIgRtAQAAAAAAAMBFCNoCAAAAAAAAgIsQtAUAAAAAAAAAFyFoCwAAAAAAAAAuQtAWAAAAAAAAAFyEoC0AAAAAAAAAuAhBWwAAAAAAAABwEYK2AAAAAAAAAOAiBG0BAAAAAAAAwEUI2gIAAAAAAACAixC0BQAAAAAAAAAXIWgLAAAAAAAAAC4SlEHbSZMmSd26dSUmJkbatGkjX3zxRaCzBAAAAAAAAAClIkKCzJw5c2TYsGEyefJkE7CdMGGCdO/eXTZt2iTVqlULdPZcKyUjI9BZAFwlFOtEZmpaoLMAuEoo1onMtNRAZwFwjVCsDynpodc+Af6JUKwT6SHYPgH+CepECAVtn3/+eRk8eLAMHDjQPNfg7YcffiivvfaajBgxIs/yaWlp5mE7cOCA8392drb52+PxmIdlWeZhKyzdfn9J08PCwvKsu7jpBeUxNTXVbNMjIv967TWTbpaxLPO66OMYJz3Mt/O1Ze+jskw/VgavzBzNTz7p+eadMlGmEpRJsrPlQFKSOU6U9FgQyGNEakrK0fdZlswbdJOzLu/9a38epZGu2/Zm57ks0ykTZfqnZdK0gwcPSnp6epmdc8vyGKHn86ysLFPP/zN0YIn2QTB8TpSJMpU0XeuHfS53a7u8oPTk5OSj+8gS+dfDk44to2XN1Xax7N8uZZnup10nVr7pHvHTrisonTJRphKWSdvuWs/1XO7WdnlB6XabPTsrSx7rN5hjOWWiTH7Szfn8wAGf87nb2uWldYw4cuSI+T93em4eq7AlXEQP0HFxcTJv3jzp06ePk96/f39JSkqShQsX5nnPmDFj5JFHHjnOOQUAAAAAAAAA//7880855ZRTQqOn7Z49e0zkvXr16j7p+vynn37y+54HHnjADKdg02j4vn37pHLlyr5X8oDjQHt61apVy1TMhISEQGcHQBmgngOhjToOhD7qORD6qOcIJO0/e+jQIalZs2aBywVV0LYkoqOjzcNbhQoVApYfQOlJgRMDENqo50Boo44DoY96DoQ+6jkCJTExsdBlfAeQcLkqVapIeHi47Ny50yddn9eoUSNg+QIAAAAAAACA0hJUQduoqCg566yzZNmyZT7DHejzdu3aBTRvAAAAAAAAAFAagm54BB2fViceO/vss6V169YyYcIEM+vawIE5sykDbqVDdYwePTrPkB0AQgf1HAht1HEg9FHPgdBHPUcw8Fg6+m2Qeemll+TZZ5+VHTt2SIsWLWTixInSpk2bQGcLAAAAAAAAAE7MoC0AAAAAAAAAhKqgGtMWAAAAAAAAAEIdQVsAAAAAAAAAcBGCtgAAAAAAAADgIgRtgTJSt25dmTBhQpGX//3338Xj8ciGDRvKNF+lkY8VK1aYZZKSko5r3oBAmDlzplSoUCHQ2QAQIJzPAQAIDrTbEWoI2qLM7d69W2655RapXbu2REdHS40aNaR79+7y+eefS7Ac+PUHTUEP/WGU23//+18ZMmSIBJtatWrJ9u3b5cwzzwx0VoAyN2DAAOnTp0+pBTJSUlKkUqVKUqVKFUlLS8vz+tSpU6Vz586SkJBAoARBh/N5cOF8jhNNsB+jABSMdjtORBGBzgBC32WXXSbp6eny+uuvy2mnnSY7d+6UZcuWyd69e0u8Tl1fVFSUHA99+/aVCy+80Hl+6aWXmh9Ajz76qJNWtWrVPHnzTgsWdt61kQug+N59911p0qSJWJYlCxYsMMcPb8nJyeZ4oo8HHnggYPkESoLzefDgfI4TUWkfo47n8QnA8Ue7HcGAnrYoU3o1avXq1fL0009Lly5dpE6dOtK6dWtz0OvVq5fPcjfeeKP5YaRXss4//3z59ttvndfHjBkjLVq0kGnTpsmpp54qMTEx+d6yqMvp8ja9KjZlyhS5+OKLJS4uTs444wxZu3atbN682Vw5i4+Pl/bt28uvv/7qtwyxsbHmR4/90Mabrsd+PmLECNNIfOKJJ6RmzZrSsGFDv3n76aefpGPHjibvjRs3lqVLl5q86QkiNz1x1K9fX8aNG+eTrrc46ns07/Z+u+mmm6R69epmvfrj8z//+Y+z/GeffSbnnnuuKYP2uLnzzjvlyJEjzuuax8cee0yuv/56s9+1J5G/2yk/+ugjadCggVmPfo7+eiIVtq2XX35ZTj/9dJNPze/ll1/ud38DbqV11f4Oa8+dP//8M88y06dPl379+pmH/p3b0KFDzTGjbdu2+W7nr7/+kquvvtpc+dfj09lnny3r168v9fIAxcH5nPO5jfM5gvUY5ebjE4DSRbsdoYKgLcpUuXLlzEMPmv5uObBdccUVsmvXLlm0aJF89dVX0qpVK+natavs27fPWUYbPXo17L333iv2OHH2Dxl9X6NGjeSaa64xP460Iffll1+aH1W33357icupV/E3bdokS5Ys8fmRZcvKyjK3cmgjTg/ieqvFyJEj812fNvxuuOEGmTFjhk+6Pj/vvPPMD8Ds7Gy56KKLzC1fb775pvzwww/y1FNPSXh4uFlWG4V6VVB/gH733XcyZ84c80Msdzn1h2Tz5s3lm2++kYceeihPXvQEp72R/v3vf5v9p41dPXl5K2xbuo/1R5/2ZtL9tHjxYlMOIFjolXYN5LzxxhumzukPv6uuuipPPdAfaFdeeaV56I/HrVu3Fms7hw8flk6dOsm2bdvk/fffNz8m77//flPfgUDifH4U53PO5wjeY1SwH58AFA3tdoQUCyhj8+bNsypWrGjFxMRY7du3tx544AHr22+/dV5fvXq1lZCQYKWmpvq8r169etaUKVPM36NHj7YiIyOtXbt2+SxTp04da/z48T5pzZs3N8vb9Gs+atQo5/natWtN2vTp0520t956y+SvKDp16mTdddddzvP+/ftb1atXt9LS0vLN26JFi6yIiAhr+/btzutLliwx+Zg/f755vmXLFvP8m2++Mc+3bdtmhYeHW+vXrzfP09PTrSpVqlgzZ840zz/++GMrLCzM2rRpk998Dho0yBoyZIhPmu5rfU9KSoqTxz59+vgskzsf+nk1btzYZ5nhw4ebZfbv31+kbb377rvmMz548GAR9jBw/Gj91XoWHx/v89Djgf0dnzFjhvl73bp1zvt+/PFHk2bXT/Xggw/61KfevXv7HIu8LV++3KcO2fSYV758eWvv3r1lUl7gn+B8zvmc8zmC9RgVbMcnAHnRbseJiJ62KHPaW+Pvv/82V5+094YOFK5XtnVCEKVXpPQqVeXKlZ2r5PrYsmWLzy1EeptTSceVa9asmfO33sqnmjZt6pOWmpoqBw8eLNH6dV0FjXmlvVH0FkPvseX0lq2C6K2ZPXv2lNdee808/+CDD0zPAe0loPQq/imnnGJuc/RH96vuY+99qreG6JU/3bc2vYWjID/++KO0adPGJ61du3bF2tYFF1xgPj8dX+y6666T//u//zNXQAE30NsotT55P/TWSG8RERFyzjnnOM+1B43OTKv1w+59p2Po6e1VNv1b60Vxrrbrtlu2bGlusQLchvM553PO5wjWY1QoHJ8A0G7HiYeJyHBc6Fgy2tDXh96yp7fkjR492swAqQ2ok046yTSsctODq03HiMktLCzM3GrkLSMjI89ykZGRPrcq5pdW0lsZ/OWtNOh+0h9F48ePN7dS6uDoekum0rHmCqL7VW/J0tsYc9NZdUsz74VtS38Af/311+Yz/uSTT+Thhx8244DpjNzenzEQCFoH9Bbl3ONTFcfHH39sbo3KPYGBNgr1dms99hVFYfUaCDTO5yXD+RwI7DHq1ltvDfrjEwDa7TjxELRFQOjEHfaEHXoFfMeOHeaKmA70Xxx6JXz79u3Oc71y7d3rxC10MhMdS05nsbWvvOsPnML06NHDnJheeeUVM27cqlWrfK7m6wnq559/9ts7R/erjouX+6RWXDqRgvZY8LZu3bpib0s/327dupmHNp61gfzpp5+a8fUAt8vMzDTj0dk96rS3nY6PpfVD6eQFOlZW7rEtdTwtfa2ojT+t19pbQMfX46o9ggHnc87nnM8RDMeoE+H4BOAo2u0IJQyPgDK1d+9eMzOrTqyhE1poA2fu3LnyzDPPSO/evc0y2ujX2/N0Yg/ttaEzGa9Zs8YcRPVgWxBd96xZs8zA4Rs3bpT+/fs7E3e4iR7469WrZ/Kn+0EHRB81apTPVXd/tCzae0knMNDZL71vY9RBz3XyD70VTCdM0X2rEyvoj0E1fPhwsx91wgO9deOXX36RhQsXFnsChJtvvtm897777jMnvNmzZzu3wtoK25ZO5jJx4kTzmg7wroPCay8De2ZuwO20p8wdd9xhJh7SyUu0XupMstoY3L17t7ndWeu3zvju/dAJSfTHoj3Jif5g1Hpgzxivxy19br+us8/qbdd6PNTjxG+//WYmRNGJEoBA4nx+FOdzzucIzmPUiXB8AnAU7XaEEoK2KFM6VpSOn6a3A+oPEj0Y6q1KgwcPlpdeesn5kfPRRx+Z1wcOHGh6meiVL/0xYPdiyY/++NEfOxdffLEZL04PmPpjym20YacnAL3tUMfX0Vu17Ct7ehtXQQYNGiTp6elm3+SmJwVdn54wtCeBzlapt3XYV/5Wrlxpeu6ce+65ZrwdvY1Rx9YrDr0dUrej+ddZqSdPnixjx471WaawbWkvHJ2FVxu9eoVT1/HWW29JkyZNipUXIFD0NmYNZuhM0B06dDDHNp1VXWnQQnvQ6QzUuWma3jqlPyKVfve1fugxUOlxT5/bvd/01mP9MVmtWjXTM0/HwvOeRR4IFM7nR3E+53yO4DxGnQjHJwBH0W5HKPHobGSBzgRwItKrcR07djRX7gpq+OlVfT2B6O2YhTUqAQDA8cX5HAAAAGWBoC1wnMyfP99c5dPbIvWH3V133SUVK1aUzz77zO/yOrO03r6ht27obRc6QzMAAAgszucAAAA4HhgeAThODh06JLfddps0atTIjKujt0HqOHH50dsN69SpYwZN1/G4AABA4HE+BwAAwPFAT1sAAAAAAAAAcBF62gIAAAAAAACAixC0BQAAAAAAAAAXIWgLAAAAAAAAAC5C0BY4jjp37iwzZ84MdDYAlCHqORD6qOdA6KOeA6GPeg63I2gLAAAAAAAAAC5C0BYAAAAAAAAAXISgLQAAAAAAAAC4iMeyLCvQmQBC1dixY83DlpKSIpGRkRIREeGk/fDDD1K7du0A5RDAP0U9B0If9RwIfdRzIPRRzxFsCNoCZWjfvn3mYbv22mvlsssuk0svvdRJq1u3rs9JAkBwoZ4DoY96DoQ+6jkQ+qjnCDZ8E4EyVKlSJfOwxcbGSrVq1aR+/foBzReA0kM9B0If9RwIfdRzIPRRzxFsGNMWAAAAAAAAAFyEoC0AAAAAAAAAuAhj2gIAAAAAAACAi9DTFgAAAAAAAABchKAtAAAAAAAAALgIQVsAAAAAAAAAcBGCtgAAAAAAAADgIgRtAQAIYitWrBCPxyNJSUlFfs+AAQOkT58+ZZovAAAAAEDJEbQFCrB792655ZZbpHbt2hIdHS01atSQ7t27y+effx7orAFBJZTq0vLly6VHjx5SuXJliYuLk8aNG8s999wj27ZtK/Ntd+7cWYYOHeqT1r59e9m+fbskJiYWeT0vvPCCzJw5swxyCLhTKB2DAPhHPQdOXNqBoaDHmDFjzHLz58+Xtm3bmnZz+fLlpUmTJj5ta20fV6hQId9tLFiw4LiVCVAR7AYgf5dddpmkp6fL66+/Lqeddprs3LlTli1bJnv37i3R+nRdUVFRpZ5P4ESrS4GqT1OmTJFbb71V+vfvL++++67UrVtX/vjjD3njjTfkueeek+effz7Pe7KyskwjLyysbK6T6j7QH6bFUZwALxAKOJ8DoY96Dpy4tAODbc6cOfLwww/Lpk2bnLRy5cqZ40Hfvn3liSeekF69epn2+Q8//CBLliwJUK6BIrAA+LV//35Lq8iKFSsKXGbQoEFWlSpVrPLly1tdunSxNmzY4Lw+evRoq3nz5tarr75q1a1b1/J4PCa9Tp061vjx433Wpcvp8jbd9uTJk62ePXtasbGxVqNGjaw1a9ZYv/zyi9WpUycrLi7OateunbV58+YyKT9wPOtSMNSnP//804qKirKGDh2ab/7VjBkzrMTERGvhwoXWGWecYYWHh1tbtmyxUlNTrXvuuceqWbOm2V7r1q2t5cuXO+/fs2ePddVVV5nXNY9nnnmmNXv2bOf1/v37m3J4P3S9ug79O/f2Fy9ebMoZHx9vde/e3fr777991tW7d2/nue6DO+64w7rvvvusihUrWtWrV/fZf0X5fAC34nwOhD7qOQCb3RbO7a677rI6d+5covfa9Xz+/Pmllk+gKBgeAciHXo3Th94CkZaW5neZK664Qnbt2iWLFi2Sr776Slq1aiVdu3aVffv2Octs3rzZ9Mh77733ZMOGDcXKw2OPPSbXX3+9eV+jRo3kmmuukZtuukkeeOAB+fLLL/Wii9x+++3/uKxAoOtSMNSnuXPnml43999/v9/XvW+lSk5OlqefflqmTZsm//vf/6RatWpm3WvXrpW3335bvvvuO1PeCy+8UH755RfzntTUVDnrrLPkww8/lO+//16GDBki1113nXzxxRfOkAbt2rWTwYMHm94E+qhVq5bfvOj2x40bJ7NmzZJVq1aZ3sD33ntvgftHeybFx8fL+vXr5ZlnnpFHH33Up+dBUT4fwI04nwOhj3oOoDB6Z5q2y7WdDQSNIoV2gRPUvHnzTK+zmJgYq3379tYDDzxgffvtt+a11atXWwkJCab3nLd69epZU6ZMMX/rFfjIyEhr165dPssU9Yr9qFGjnOdr1641adOnT3fS3nrrLZM3IJjrUrDUp1tuucXksTB6hV7X7d17Z+vWrabH7bZt23yW7dq1q9kX+dEeO9o716a9dbSXgDd/PW31uXdvnkmTJpneswX1tO3YsaPPes855xxr+PDhRf58ADfjfA6EPuo5gIJ6yx4+fNjq0aOHqZtar/v27WvqqPdxwW5H651quR/0tEUgMKYtUMjYWD179pTVq1fLunXrzJV57YGmveeOHDkihw8fNpMReUtJSZFff/3VeV6nTh2pWrVqibbfrFkz5+/q1aub/5s2beqTpr3zDh48KAkJCSXaBhDoujRgwAD59ttvXV+f9DeZjn1VFDoGnvf2Nm7caMa2bdCggc9y2hvILrO+PnbsWHnnnXfMpGbaq1df18nOikvfU69ePef5SSedZHoXFcQ7v7nfU9TPB3ArzudA6KOeAyiI3lGmd7RpndeJhfU4oZMJ691sejec3ebWCcq+/vrrPO8//fTTA5BrnOgI2gKFiImJkQsuuMA8HnroIbnxxhtl9OjRZjIiDWqsWLGiwNuk9eSQm05IdPSifI6MjIw8y0VGRjp/28Eif2nZ2dklLh8Q6LqkQVv9IeX2+qQB1wMHDphhCTSvBYmNjfUJ8Gr5wsPDze2Y+r83vZ1TPfvss6bROGHCBPMjT8uqs9lq8La4vMtlly33PirKe+x9UdTPB3AzzudA6KOeAyiMdmzQhx4fRo4cadr4OnnZwIEDnTpfv379QGcTMAjaAsXUuHFjM16WjoO1Y8cOiYiIMDPIF4dewfee4VKvuG/ZsqUMcgu4vy6pYKhPl19+uYwYMcL02hk/fnye15OSkvINYLZs2dL0pNWeq+eee67fZT7//HPp3bu39OvXz/lR9/PPP5v95N2DV9dzvP2TzwdwK87nQOijngMoiB4PtIet9sYH3IiJyIB87N27V84//3x58803zaRB2jjTiYg0YKOBlW7duplJgfr06SOffPKJ/P7777JmzRpztU4nGyiIrlcnCNLbt/S26f79++fpfQecKHVJBUN90km/NFirvWEHDRokK1eulK1bt5pgq040ohOQ5Eev4F977bVmghKd3ET3gU4w9uSTT5rbtOxbrnTiLy33jz/+aNa5c+fOPA1LnShM98+ePXuOW2+df/L5AIHG+RwIfdRzAIUZM2aMmVBYe9zrMeKbb76RG264wfSc1975gBvR0xbIh96y3KZNGxOk0XFv9GCuQRuduf3BBx80tzh99NFHprGnt1Ls3r3bzEh53nnnOeNY5UdnkdUTxcUXXyyJiYkm2MMVe5yodUkFS33S2ys1ADtu3Di55JJLzFh4GkjVbQ8bNqzA986YMUMef/xxM3aWjllbpUoVadu2rXmvGjVqlPz222/SvXt3c8V/yJAh5selDslgu/fee82PRe05pNs+XseNf/L5AIHG+RwIfdRzAIXp1KmTTJo0yXSi0I4RFStWNHfD6YWchg0bBjp7gF8enY3M/0sAAAAAAAAAgOON4REAAAAAAAAAwEUI2gIAAAAAAACAixC0BQAAAAAAAAAXIWgLAAAAAAAAAC5C0Baut3fvXqlWrZr8/vvvcqIbMGCAmU0+0HTG+3fffTfQ2UAIoZ7noJ4jVFHPc1DPEaqo5zmo5whF1PEc1HEcDwRt4XpPPPGE9O7dW+rWreuk3XnnnXLWWWdJdHS0tGjRwu/73nnnHfNaXFyc1KlTR5599tk8y6xYsUJatWpl1lO/fn2ZOXOmz+uvvPKKNGvWTBISEsyjXbt2smjRIilrehL0eDyyYcMGn/QXXnghTx7/qTFjxuS7D/MzatQoGTFihGRnZ5dqXnDiKmk9tyxLxo0bJw0aNDDLnXzyyWZdts8++0w6dOgglStXltjYWGnUqJGMHz/eZx3Uc/+o53BDPbfrSe7HunXrfJabMGGCNGzY0NTzWrVqyd133y2pqak+y0yaNMlsOyYmRtq0aSNffPFFGZbWN//Uc5woyup8XpR2+5NPPinnnHOOlC9f3gSVNJiyadMmKWvUc5xIyupc/t5778nZZ58tFSpUkPj4eLOeWbNm+azn8OHDcvvtt8spp5xizveNGzeWyZMnl3GJqeMILIK2cLXk5GSZPn26DBo0KM9rN9xwg/Tt29fv+zTgcu2118rNN98s33//vbz88ssmUPPSSy85y2zZskV69uwpXbp0MQfgoUOHyo033igff/yxs4yeEJ566in56quv5Msvv5Tzzz/fnKT+97//SSAkJiaaE1mgXXTRRXLo0KHjEthC6CtpPVd33XWXTJs2zfzQ++mnn+T999+X1q1bO69ro08bd6tWrZIff/zRNGr0MXXqVGcZ6rl/1HO4pZ6rpUuXyvbt252H/ji0zZ492/xYGT16tKnnup05c+bIgw8+6Cyjz4cNG2aW+frrr6V58+bSvXt32bVrlwQC9RyhqCzP50Vpt69cuVJuu+02EwhasmSJZGRkyL/+9S85cuSIBAL1HKGmLM/llSpVkpEjR8ratWvlu+++k4EDB5qHdx3X8/jixYvlzTffNOd7PQ5oO1+PF4FAHcdxYQEuNnfuXKtq1ar5vj569GirefPmedKvvvpq6/LLL/dJmzhxonXKKadY2dnZ5vn9999vNWnSxGeZvn37Wt27dy8wTxUrVrSmTZuW7+v9+/e3evfubY0ZM8aqUqWKVb58eeumm26y0tLSnGUWLVpkdejQwUpMTLQqVapk9ezZ09q8ebPzulZN70enTp181m3Lysqyxo4da9WtW9eKiYmxmjVrZvaZbfny5eb9S5cutc466ywrNjbWateunfXTTz+Z12fMmJFnW5qm+0j3ba1atayoqCjrpJNOsu644w6fcg4cONDq169fgfsKKMt6/sMPP1gRERHO97moLrnkkkK/u9Tzo6jnCHQ937Jli/nOfvPNN/m+97bbbrPOP/98n7Rhw4aZ+mdr3bq1Wc67XtWsWdN68skn810v9Rxwz/m8JO32Xbt2mbqwcuXKfJehngPuOJf707JlS2vUqFHOcz0GPProoz7LtGrVyho5cmS+66COI9jR0xautnr1ap8rcEWVlpZmbn/0prdQ/PXXX7J161bzXK/idevWzWcZ7XWj6f5kZWXJ22+/ba7W6+3TBVm2bJm5+qe3cb311lvmdo9HHnnEeV3XoVcKtVefLhsWFiaXXHKJc0uDfcumfTVS3++P3gb2xhtvmNtCtFeg3g7ar18/09PAm161fO6558z2IiIizJVQpVdD77nnHmnSpIlzxVPTdEwc7Zk8ZcoU+eWXX2TBggXStGlTn3Vq7wf9fIBA1fMPPvhATjvtNPnPf/4jp556qrlNS3vd7Nu3L9/3fPPNN7JmzRrp1KmT39ep59RzuKue23r16mVud+7YsWOeHjXt27c3PeXtOvXbb7/JRx99JD169DDP09PTzeve53ytj/o8v3O+jXoOuON8Xtx2uzpw4IDTg68g1HMg8Odybxon1bqmw5ucd955Pud7fd+2bdvMMsuXL5eff/7Z9KgvCHUcQS3QUWOgIHrl6oYbbij21bwpU6ZYcXFx5iqWXvHatGmT1ahRI3O1as2aNWaZ008/3VwJ8/bhhx+aZZKTk5207777zoqPj7fCw8PN1TddpiB6xU2v0B05csRJe+WVV6xy5cqZvPize/dus92NGzcWeDXS+2peamqqKaNdHtugQYNMT+PcV/NylzElJSXfffjcc89ZDRo0sNLT0/Mt58KFC62wsLB8ywSUdT3Xq+TR0dFWmzZtrFWrVpnve4sWLawuXbrkWfbkk082V6b1O5v7Cr2invtHPUeg67nWG/2urlu3zvriiy+s4cOHWx6Px3w3vb3wwgtWZGSk6a2n3/2bb77ZeW3btm0+53/bfffdZ3rg5od6DrjnfF7UdrtNv8/aW867x70/1HPAPefypKQk0x7Xc7keE6ZPn+7zutaj66+/3tQJXUbb9q+//nqBeaaOI9jR0xaulpKSkqfHbFEMHjzYjG9z8cUXS1RUlJlR8aqrrjKv6ZWz4tCJTXTsrPXr18stt9wi/fv3lx9++KHA9+hYeToBmk177OnA6X/++ad5rlfIrr76atOrQCc+sgdy/+OPP4qcr82bN5txhS644AIpV66c89Cre7/++qvPsjrJku2kk04y/xc0jt8VV1xh9r3mT/fl/PnzJTMzM0/PZb36qL2agUDUc/v7p9/5c889Vzp37mzG2dKr7rknHtErz3o1W69864RFepXdG/Wceg531vMqVaqY3i86cZhOMKTjT2uvFe/JRbXnzNixY8349TperfaA+fDDD+Wxxx77x/mmngPuOp8XlY5tq/Na6N0zhaGeA0VTludypZMIanv8v//9r5nwTN+j53jbiy++aMas1t62egeN9lbVuq49YAtCHUcwiwh0BoDCDvD79+8v9vt0dsenn37a/IjbsWOHVK1a1dzqoPRgp2rUqCE7d+70eZ8+1wO1HvRsGvTVGWqV3g6iJxGdKVJvTyipf//731KnTh159dVXpWbNmuYAe+aZZ5pbOItKTzRKf5jqDLvedOZOb5GRkT77RhU0u6TOvK2NZD0B6kQOt956qzmp6q0d9rr0ljWd5Ml7XwHHs55rI0dvKdKZpm1nnHGG08jSQKxNb7dUeiuR1nOdmVUbZzbqOfUc7qzn/uiPPv3O2h566CG57rrrzO3Udj3XWx2HDBlibkHUbYeHh/s952tb4J+gngPH53xe1Ha70o4bOtSCTkKqk43+U9RzoOzP5XbnKrs93qJFCzOkgQ45oBdyNGipE4xqwFInJbSDnxrk1QkMcw+fUhzUcbgZPW3hai1btiy0t1tB9EeaHjQ1IKM96/SqmgZwlf5tB3JtehAsbBzLolzB+vbbb82JxaZXBPVKmx5w9+7daw66OoN9165dTaM098lP82uPr5mfxo0bmxOANmb15Ob90O0UlW7L33b0gK8nsIkTJ5ornDpm2MaNG53XtfeCfj5AoOp5hw4dzFVm76vXOq6V0obXP6nD1POjqOdwy/ncm/5As3umKO3ZkvsuGj3/Kx3zTr//ejHG+5yvdVyfF3bOp54D7jifF6XdrvVdA7Ya1Pn000+dC7aFoZ4DgT+XF9Yez8jIMA9/5/uCAp6KOo5gRk9buJpOMPDAAw+YA2fFihV9bj/Qq1nai1YPwHrQtw+WeqDbs2ePzJs3z1yVS01NlRkzZsjcuXN9BgG/+eab5aWXXpL777/fDP6tjbt33nnHXB2z6bYvuugiqV27thw6dEhmz55tDpIff/xxgfnWq3KDBg0yB//ff/9dRo8ebRqRepLRclSuXFmmTp1qTlR6YB8xYoTP+3WAdj0wL1682PQQ0NtQEhMT89w+cu+995oBzvVEpQO664QLn3/+uel1oLd3F4Xe/rFlyxazD3Vbul4NcOvJQq+A6q0kb775psmPdyBMbzcvbNB3oCzruV5Rb9Wqlam/OuSB1gO9RUpvS7J760yaNMnU30aNGpnn2utGr8bfeeedznao59RzuLeev/766+Z/+4eIDn3w2muvybRp05x16I+Y559/3iyj32ddp/a+1XQ7eKu3WGp9Ofvss81kHXrM0N64AwcOLDDf1HPAHefzorTb9T16Dl+4cKH5/uv2lNa5gnqfUc+BwJ/LtUetnqPr1atnArU6oeisWbPklVdeMa9rPdGJhO+77z7n+62/7XX4AW0DFIQ6jqAW6EF1gcLoJCGTJ0/2SevUqZMZsDv3QwcJtwcPb9u2rRnIXAcE79q1qxn4PDd7ogMdxPy0006zZsyY4fO6DrRep04d83rVqlXNej755JMC82sPSP7www9blStXNoOcDx482AxObluyZIl1xhlnmAHWmzVrZq1YscLkf/78+c4yr776qlWrVi0zoLiW13vdtuzsbGvChAlWw4YNzQQsmsfu3btbK1eudMqn692/f7/zHh1A3Xtfab4uu+wyq0KFCiZd94HmQyeDSEhIMPtQ96X3gOl//fWX2d6ff/5Z6OcHlFU9tycYuvTSS009q169ujVgwABr7969zusTJ060mjRpYo4D+n1u2bKl9fLLL/sM0k89p57DvfV85syZph7ZdVjXMXfuXJ91ZGRkWGPGjLHq1atnxcTEmDp16623+tQJ9eKLL1q1a9c2dV3X469d4I16DrjnfF6Udru/bdh1IT/Uc8Ad5/KRI0da9evXN+fxihUrWu3atbPefvttn2W2b99ujg01a9Y0y2ld0km6tG7lhzqOYOfRfwIdOAYKolfQ9Yqadvkv7iRigTBgwABJSkqSBQsWSKgaPny4ucKqVySB0kA9dx/qOUob9dx9qOcobdRz96GeozRRx92HOh7aGB4BrqcDjeuMjtu2bSvWeDAoO3qLiN5qCpQW6rn7UM9R2qjn7kM9R2mjnrsP9RyliTruPtTx0EZPW6CUnQhX84ATHfUcCH3UcyD0Uc+B0EYdR7AjaAsAAAAAAAAALuL+QUgAAAAAAAAA4ARC0BYAAAAAAAAAXISgLQAAAAAAAAC4CEFbAAAAAAAAAHARgrYAAAAAAAAA4CIEbQEAAIBimDlzpng8HvMYM2ZMocvrMvby+l43sPNTt27dQGcFAAAAfkT4SwQAAEDw04Dc1q1bi7Ts8uXLpXPnzqW6/QkTJkhSUpL5uyjBTW8ZGRkya9Ysefvtt2XDhg1y4MABqV69ujRo0ECuuOIKueaaa6R8+fKlmt9QsmDBArPf1IABAwjOAgAABBmCtgAAACgTGrS1g8bFCdpu27ZNevfuLV999ZVP+p9//mkey5YtMwHcPn36SDC44YYbpFu3buZvDTofr6Dt66+/bv7WYHzuoO3q1avN/zExMcclPwAAACgegrYAAAAhat68eZKamuo81x6qO3bsMH9PnDhRWrZs6bzWtGlTcYP09HTp1auXfP311+Z5hQoV5J577pG2bdtKWlqarF27VqZPny7BpHbt2ubhJh07dgx0FgAAAFAAxrQFAAAIUWeffbYJztmP6OhonyCt92vh4eGmN+yZZ54psbGxkpCQYHpoLlq0KM963333XfOexMREiYqKkho1apjnw4cPF8uynDFfvYdmsMdQ1UdB9L12wFbzpMM2jBo1yvRU7dmzpzz++OPy888/m7LZdJtTp041gV0dMkF7jzZq1EgefPBBM6yCNy2TnQ/tyduvXz/zHi2Dll/X9d1330mXLl3MftBgqwa4C/LOO++Y/anbbdy4scyePdvn9fzGtNXer3a6BtOvu+46qVixoslP3759Zd++fT7r0eB1+/bt5aSTTjKfZbly5aRVq1Yybtw4yczMNMv8/vvvZn12L1ulZbG3s2LFCp/PI3cPXA2aP/3009KiRQuJj4+XuLg4ad68uTz11FPmNW/FzX9h3xsAAAB4sQAAAHBCqFOnjkbGzGP58uVOelJSktW0aVPntdyPSZMmOcuuWLHCCgsLy3fZjIwMa8aMGfm+Xljz8/zzz3eWGzBgQKFlys7Otq666qp8t9WoUSNr3759zvKdOnVyXqtXr16e5e+44w6rQoUKedKXLFnirMO7fPntt9mzZzvLjx492knX9/r7PE477bQ867j22mt9yhodHZ1vOQcOHGiW2bJlS4H73v7c7eeaB1tqaqp13nnn5ftefS0tLa1E+S/K9wYAAAA56GkLAABwghs5cqRs3LjR/N2jRw/58MMP5Y033jA9IdXdd99txpJVH3zwgWRnZ5u/x44da8aX1cnCtDes9jLVXpe6Dh0z1X6/0uf2oyDffvut8/e5555baN61l6tuX2kvT+1xO3/+fGnWrJlJ++mnn0yPW38OHTokb731limH7cUXXzT51nXccsstTvqUKVP8rkP321133WX2mfbatQ0bNsxMplZUKSkp8uabb8rLL79seqEqLZd3T2H9nDS/ixcvNj1m33vvPWnTpo15TXvw/vXXX6YXru7jiy66yHmf9hS29733kBj+xiBetWqV+btWrVqmx7Buzx7aQV8bP358ifJflO8NAAAAvHgFcAEAAHCC9bTNysqyKlasaNKioqKspUuXWqtXrzaPW2+91Vl+3LhxZvkRI0Y4aXPnzrX27NlTpO0VVUREhPOeRYsWFbp8r169nOVffPFFJ33jxo1OupZPe+Tm7mk7depUZ/ly5co56cuWLTNpu3fvdtJatGjht6dthw4dnPTMzEyrdu3azmurVq0qck/b+fPnO+kXXnihk75hwwYn/bPPPrN69+5t1ahRw2c/2Y+FCxc6y/bv399vr2qbv562zZo1c9I/+OADJ13/ttObN29eovwX53sDAAAAetoCAACc0Pbs2SP79+83f+uYpTp2rPZw1Yf2mrT9+OOP5v9rr73WGRtXJzarUqWKVK9eXS699FJZunTpP86Pjndq+/vvvwtdXse3tdm9TpWOzavjsSot3+7du/O8t3Xr1s7f2kvXZo+Xq2WzJSUl+d2+9zZ1DN6zzjrLef7bb79JUXXq1Mn5u3Llynm2+8UXX5ixaRcuXGjGj7XHsPWWXx6LKr996b2fvJcpTv7L+nsDAAAQagjaAgAAoFBHjhxxgqE6gdedd95pAnsaZN21a5cZTqB79+6yZs2af7QdnfTK9vnnn0tZ8g4Qh4XlNIt1ErbcijpRVklv8/cOGkdEROTZ7uTJk53hFi6++GL56KOPzHAH119/vbOsPfxAaStKmQrLf1l/bwAAAEINQVsAAIATmPZ4tANu5cqVM+O8aqDN+5GVlSUzZswwy+jzJk2ayAsvvCDr1q0zPSnnzZvnBA0XLFjgNxBa1IBi3759nb91XN3vvvsuzzKaRx2/VTVo0MBJ196otu+//16Sk5PN31q+qlWrSlnw3qbupy+//NJ5ftppp5XadrZt2+b8/eSTT5oxazt27Cg7d+70u3xJ9n1++3L9+vV+lymO4nxvAAAAIJJzGRwAAAAnHA3uXX311WYohMOHD8u//vUv0xtSg7kaGNXgp0549dprr0nnzp3lmWeeMZNg9ezZ00xQFR8fLx9//LGzvrS0NOdvDZZu2bLFmeBLhw7QHpZNmzbNNz8DBgwwvUq/+eYbMwSAbvPee+81t+jruteuXSvTp0+XV155RU455RS55ppr5P333zfvffjhh80t+Jr3Rx55xCcQXFYTXX322Wdm0rELLrjATKz1xx9/mHS99b9t27altp06der4BG379+8vixYt8tn3+fV81QnCdOgGfWigNz+6L+0g+W233WaC47rfRowY4Syj35WSKM73BgAAAARtAQAATnhPPPGEudV+48aNJiiqj/zoLfqLFy82D38B4CuvvNJ5rmOwfv311+bvoUOHOmOfavAuP1FRUfLBBx9Ir169zHt1PNqRI0fmu7xuT2+xnzNnjuzbt08GDx7s83qjRo1k7NixUlbq168v48ePNw9v48aNk8jIyFLbzo033ijTpk0zPVZnz55tHhpQbdeund/PS/f9888/b/7WXtLePaXzo5/Rhx9+aL4LW7duzROgPe+88+Tuu+8uUf6L870BAAAAwyMAAACc8CpUqGACf4899pgZUzY2NtZM4nX66afL5ZdfLm+99ZbTa7RHjx5y0003mTFKtTen9t6sVKmS6aGrPSc7dOjgrHf06NEyZMgQqVmzZrF6up588snmFnoNUurEaNpzVgOguh4N+k6aNEm6du1qltX1agBTe+dqb1ztwam9bfU2fu0hquvx7nVa2nSCLQ2IanBYA84NGzaUWbNmSb9+/Up1O1o2DU5rL+WYmBgz1MDcuXPNfvdHx73VwHG9evV8xpgtiO63JUuWyFNPPSXNmjUz3wPdlm5Te/d+8sknpowlUZzvDQAAAEQ8VlFnVQAAAAAAAAAAlDl62gIAAAAAAACAixC0BQAAAAAAAAAXIWgLAAAAAAAAAC5C0BYAAAAAAAAAXISgLQAAAAAAAAC4CEFbAAAAAAAAAHARgrYAAAAAAAAA4CIEbQEAAAAAAADARQjaAgAAAAAAAICLELQFAAAAAAAAABchaAsAAAAAAAAALkLQFgAAAAAAAADEPf4f/I+uHfLFrB4AAAAASUVORK5CYII=",
      "text/plain": [
       "<Figure size 1400x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "🏆 TOP 5 HIGHEST RISK TEST COMBINATIONS\n",
      "============================================================\n",
      "1. Serum Triglycerides + Serum LDL Cholesterol\n",
      "   📊 Both Tests Abnormal: 39.9%\n",
      "   👥 Total Patients: 1,903\n",
      "   📈 Individual Abnormal Rates: 57.4% | 68.6%\n",
      "\n",
      "2. HbA1c + Serum Creatinine\n",
      "   📊 Both Tests Abnormal: 28.2%\n",
      "   👥 Total Patients: 1,633\n",
      "   📈 Individual Abnormal Rates: 83.5% | 35.5%\n",
      "\n",
      "3. Serum Triglycerides + Serum HDL Cholesterol\n",
      "   📊 Both Tests Abnormal: 26.0%\n",
      "   👥 Total Patients: 1,580\n",
      "   📈 Individual Abnormal Rates: 57.1% | 38.0%\n",
      "\n",
      "4. Serum HDL Cholesterol + Serum LDL Cholesterol\n",
      "   📊 Both Tests Abnormal: 23.6%\n",
      "   👥 Total Patients: 1,602\n",
      "   📈 Individual Abnormal Rates: 37.9% | 68.7%\n",
      "\n",
      "5. HbA1c + TSH\n",
      "   📊 Both Tests Abnormal: 20.5%\n",
      "   👥 Total Patients: 1,538\n",
      "   📈 Individual Abnormal Rates: 76.6% | 32.6%\n",
      "\n",
      "💡 INSIGHTS:\n",
      "- Higher percentages indicate test combinations where patients frequently show abnormal results in both tests\n",
      "- These combinations may indicate related health conditions or risk factors\n",
      "- The patient count shows the statistical significance of each combination\n"
     ]
    }
   ],
   "source": [
    "# Create a bar chart for the top 5 test combinations with highest \"Both Tests Abnormal\" percentages\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Get the top 5 combinations with highest both abnormal percentages\n",
    "top_5_highest_risk = enhanced_summary_df.nlargest(5, 'Both_Abnormal_Numeric')\n",
    "\n",
    "# Create the figure and axis\n",
    "plt.figure(figsize=(14, 8))\n",
    "\n",
    "# Prepare data for plotting\n",
    "test_combinations = []\n",
    "both_abnormal_values = []\n",
    "\n",
    "for _, row in top_5_highest_risk.iterrows():\n",
    "    # Create shorter labels for better readability\n",
    "    test1_short = row['Test 1'].split()[0] if len(row['Test 1'].split()) > 2 else row['Test 1']\n",
    "    test2_short = row['Test 2'].split()[0] if len(row['Test 2'].split()) > 2 else row['Test 2']\n",
    "    \n",
    "    combination_label = f\"{test1_short}\\n+\\n{test2_short}\\n({row['Total Patients']} patients)\"\n",
    "    test_combinations.append(combination_label)\n",
    "    both_abnormal_values.append(row['Both_Abnormal_Numeric'])\n",
    "\n",
    "# Create the bar chart\n",
    "bars = plt.bar(range(len(test_combinations)), both_abnormal_values, \n",
    "               color=['#FF6B6B', '#4ECDC4', '#45B7D1', '#FFA07A', '#98D8C8'],\n",
    "               edgecolor='black', linewidth=1.5, alpha=0.8)\n",
    "\n",
    "# Customize the chart\n",
    "plt.title('Top 5 Test Combinations with Highest \"Both Tests Abnormal\" Percentages', \n",
    "          fontsize=16, fontweight='bold', pad=20)\n",
    "plt.xlabel('Test Combinations', fontsize=12, fontweight='bold')\n",
    "plt.ylabel('Both Tests Abnormal (%)', fontsize=12, fontweight='bold')\n",
    "\n",
    "# Set x-axis labels\n",
    "plt.xticks(range(len(test_combinations)), test_combinations, fontsize=10)\n",
    "\n",
    "# Add value labels on top of bars\n",
    "for i, (bar, value) in enumerate(zip(bars, both_abnormal_values)):\n",
    "    plt.text(bar.get_x() + bar.get_width()/2, bar.get_height() + 0.2, \n",
    "             f'{value:.1f}%', ha='center', va='bottom', fontweight='bold', fontsize=11)\n",
    "\n",
    "# Customize grid and layout\n",
    "plt.grid(axis='y', alpha=0.3, linestyle='--')\n",
    "plt.ylim(0, max(both_abnormal_values) * 1.1)\n",
    "\n",
    "# Add a subtle background color\n",
    "plt.gca().set_facecolor('#F8F9FA')\n",
    "\n",
    "# Adjust layout to prevent label cutoff\n",
    "plt.tight_layout()\n",
    "\n",
    "# Show the plot\n",
    "plt.show()\n",
    "\n",
    "# Print summary information\n",
    "print(\"🏆 TOP 5 HIGHEST RISK TEST COMBINATIONS\")\n",
    "print(\"=\"*60)\n",
    "for i, (_, row) in enumerate(top_5_highest_risk.iterrows(), 1):\n",
    "    print(f\"{i}. {row['Test 1']} + {row['Test 2']}\")\n",
    "    print(f\"   📊 Both Tests Abnormal: {row['Both Tests Abnormal %']}\")\n",
    "    print(f\"   👥 Total Patients: {row['Total Patients']:,}\")\n",
    "    print(f\"   📈 Individual Abnormal Rates: {row['Test 1 Abnormal %']} | {row['Test 2 Abnormal %']}\")\n",
    "    print()\n",
    "\n",
    "print(\"💡 INSIGHTS:\")\n",
    "print(\"- Higher percentages indicate test combinations where patients frequently show abnormal results in both tests\")\n",
    "print(\"- These combinations may indicate related health conditions or risk factors\")\n",
    "print(\"- The patient count shows the statistical significance of each combination\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "72b1aa70",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1600x1200 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "🎯 DETAILED BREAKDOWN OF TOP 5 HIGHEST RISK COMBINATIONS\n",
      "================================================================================\n",
      "\n",
      "1. Serum Triglycerides + Serum LDL Cholesterol\n",
      "   👥 Total Patients: 1,903\n",
      "   ⚠️ Both Tests Abnormal: 39.9%\n",
      "   📊 Serum Triglycerides:\n",
      "      ✅ Normal: 42.6% (1191 patients)\n",
      "      📉 Below Normal: 0.0% (0 patients)\n",
      "      📈 Above Normal: 57.4% (1606 patients)\n",
      "   📊 Serum LDL Cholesterol:\n",
      "      ✅ Normal: 31.4% (791 patients)\n",
      "      📉 Below Normal: 0.0% (0 patients)\n",
      "      📈 Above Normal: 68.6% (1729 patients)\n",
      "------------------------------------------------------------\n",
      "\n",
      "2. HbA1c + Serum Creatinine\n",
      "   👥 Total Patients: 1,633\n",
      "   ⚠️ Both Tests Abnormal: 28.2%\n",
      "   📊 HbA1c:\n",
      "      ✅ Normal: 16.5% (381 patients)\n",
      "      📉 Below Normal: 0.1% (2 patients)\n",
      "      📈 Above Normal: 83.4% (1926 patients)\n",
      "   📊 Serum Creatinine:\n",
      "      ✅ Normal: 64.5% (1482 patients)\n",
      "      📉 Below Normal: 27.4% (629 patients)\n",
      "      📈 Above Normal: 8.2% (188 patients)\n",
      "------------------------------------------------------------\n",
      "\n",
      "3. Serum Triglycerides + Serum HDL Cholesterol\n",
      "   👥 Total Patients: 1,580\n",
      "   ⚠️ Both Tests Abnormal: 26.0%\n",
      "   📊 Serum Triglycerides:\n",
      "      ✅ Normal: 42.9% (1010 patients)\n",
      "      📉 Below Normal: 0.0% (0 patients)\n",
      "      📈 Above Normal: 57.1% (1345 patients)\n",
      "   📊 Serum HDL Cholesterol:\n",
      "      ✅ Normal: 62.0% (1238 patients)\n",
      "      📉 Below Normal: 37.9% (758 patients)\n",
      "      📈 Above Normal: 0.1% (2 patients)\n",
      "------------------------------------------------------------\n",
      "\n",
      "4. Serum HDL Cholesterol + Serum LDL Cholesterol\n",
      "   👥 Total Patients: 1,602\n",
      "   ⚠️ Both Tests Abnormal: 23.6%\n",
      "   📊 Serum HDL Cholesterol:\n",
      "      ✅ Normal: 62.1% (1255 patients)\n",
      "      📉 Below Normal: 37.8% (764 patients)\n",
      "      📈 Above Normal: 0.0% (1 patients)\n",
      "   📊 Serum LDL Cholesterol:\n",
      "      ✅ Normal: 31.3% (677 patients)\n",
      "      📉 Below Normal: 0.0% (0 patients)\n",
      "      📈 Above Normal: 68.7% (1488 patients)\n",
      "------------------------------------------------------------\n",
      "\n",
      "5. HbA1c + TSH\n",
      "   👥 Total Patients: 1,538\n",
      "   ⚠️ Both Tests Abnormal: 20.5%\n",
      "   📊 HbA1c:\n",
      "      ✅ Normal: 23.4% (477 patients)\n",
      "      📉 Below Normal: 0.1% (2 patients)\n",
      "      📈 Above Normal: 76.5% (1561 patients)\n",
      "   📊 TSH:\n",
      "      ✅ Normal: 67.4% (1398 patients)\n",
      "      📉 Below Normal: 4.4% (92 patients)\n",
      "      📈 Above Normal: 28.2% (584 patients)\n",
      "------------------------------------------------------------\n",
      "\n",
      "💡 KEY INSIGHTS:\n",
      "- The first chart shows which test combinations have the highest percentage of patients with both tests abnormal\n",
      "- The second chart breaks down each individual test's normal vs abnormal rates\n",
      "- Green bars = Normal results, Pink bars = Abnormal results (below + above normal combined)\n",
      "- Higher abnormal percentages in individual tests contribute to higher combined risk\n"
     ]
    }
   ],
   "source": [
    "import numpy as np\n",
    "\n",
    "# Create a comprehensive visualization showing the top 5 test combinations with detailed outcome breakdown\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Get the top 5 combinations with highest both abnormal percentages\n",
    "top_5_highest_risk = enhanced_summary_df.nlargest(5, 'Both_Abnormal_Numeric')\n",
    "\n",
    "# Prepare data for detailed visualization\n",
    "fig, (ax1, ax2) = plt.subplots(2, 1, figsize=(16, 12))\n",
    "\n",
    "# Chart 1: Both Tests Abnormal Percentages (as before)\n",
    "test_combinations = []\n",
    "both_abnormal_values = []\n",
    "\n",
    "for _, row in top_5_highest_risk.iterrows():\n",
    "    test1_short = row['Test 1'].split()[0] if len(row['Test 1'].split()) > 2 else row['Test 1']\n",
    "    test2_short = row['Test 2'].split()[0] if len(row['Test 2'].split()) > 2 else row['Test 2']\n",
    "    \n",
    "    combination_label = f\"{test1_short}\\n+\\n{test2_short}\\n({row['Total Patients']} patients)\"\n",
    "    test_combinations.append(combination_label)\n",
    "    both_abnormal_values.append(row['Both_Abnormal_Numeric'])\n",
    "\n",
    "bars1 = ax1.bar(range(len(test_combinations)), both_abnormal_values, \n",
    "               color=['#FF6B6B', '#4ECDC4', '#45B7D1', '#FFA07A', '#98D8C8'],\n",
    "               edgecolor='black', linewidth=1.5, alpha=0.8)\n",
    "\n",
    "ax1.set_title('Top 5 Test Combinations with Highest \"Both Tests Abnormal\" Percentages', \n",
    "             fontsize=14, fontweight='bold', pad=20)\n",
    "ax1.set_xlabel('Test Combinations', fontsize=12, fontweight='bold')\n",
    "ax1.set_ylabel('Both Tests Abnormal (%)', fontsize=12, fontweight='bold')\n",
    "ax1.set_xticks(range(len(test_combinations)))\n",
    "ax1.set_xticklabels(test_combinations, fontsize=9)\n",
    "ax1.grid(axis='y', alpha=0.3, linestyle='--')\n",
    "ax1.set_ylim(0, max(both_abnormal_values) * 1.1)\n",
    "\n",
    "# Add value labels on top of bars\n",
    "for i, (bar, value) in enumerate(zip(bars1, both_abnormal_values)):\n",
    "    ax1.text(bar.get_x() + bar.get_width()/2, bar.get_height() + 0.2, \n",
    "             f'{value:.1f}%', ha='center', va='bottom', fontweight='bold', fontsize=10)\n",
    "\n",
    "# Chart 2: Detailed outcome breakdown for each test in the combinations\n",
    "# Prepare data for the detailed breakdown\n",
    "detailed_data = []\n",
    "x_labels = []\n",
    "colors_normal = []\n",
    "colors_abnormal = []\n",
    "\n",
    "position = 0\n",
    "x_positions = []\n",
    "\n",
    "for _, row in top_5_highest_risk.iterrows():\n",
    "    test1, test2 = row['Test 1'], row['Test 2']\n",
    "    patient_count = row['Total Patients']\n",
    "    \n",
    "    # Get patients who have both tests\n",
    "    patients_with_both = df_pivot[(df_pivot[test1] > 0) & (df_pivot[test2] > 0)].index\n",
    "    combo_data = df_combined[\n",
    "        (df_combined['Patient Name'].isin(patients_with_both)) & \n",
    "        (df_combined['Standard Test Name'].isin([test1, test2]))\n",
    "    ].copy()\n",
    "    \n",
    "    # Analyze each test separately\n",
    "    for i, test_name in enumerate([test1, test2]):\n",
    "        test_data = combo_data[combo_data['Standard Test Name'] == test_name]\n",
    "        \n",
    "        if len(test_data) > 0:\n",
    "            # Count outcomes\n",
    "            outcome_counts = test_data['Outcome'].value_counts()\n",
    "            total = len(test_data)\n",
    "            \n",
    "            normal_count = outcome_counts.get('n', 0)\n",
    "            below_count = outcome_counts.get('bn', 0)\n",
    "            above_count = outcome_counts.get('an', 0)\n",
    "            \n",
    "            normal_pct = (normal_count / total * 100) if total > 0 else 0\n",
    "            abnormal_pct = ((below_count + above_count) / total * 100) if total > 0 else 0\n",
    "            \n",
    "            # Create short label\n",
    "            test_short = test_name.split()[0] if len(test_name.split()) > 2 else test_name[:12]\n",
    "            if len(test_short) > 12:\n",
    "                test_short = test_short[:12] + \"...\"\n",
    "            \n",
    "            detailed_data.append([normal_pct, abnormal_pct])\n",
    "            x_labels.append(f\"{test_short}\\n({total} records)\")\n",
    "            x_positions.append(position)\n",
    "            \n",
    "            # Color coding\n",
    "            colors_normal.append('#90EE90')  # Light green for normal\n",
    "            colors_abnormal.append('#FFB6C1')  # Light pink for abnormal\n",
    "            \n",
    "            position += 1\n",
    "    \n",
    "    # Add separator\n",
    "    if position < len(top_5_highest_risk) * 2:\n",
    "        position += 0.5\n",
    "\n",
    "# Create the detailed breakdown chart\n",
    "x_pos = np.arange(len(detailed_data))\n",
    "width = 0.35\n",
    "\n",
    "normal_values = [data[0] for data in detailed_data]\n",
    "abnormal_values = [data[1] for data in detailed_data]\n",
    "\n",
    "bars_normal = ax2.bar(x_pos - width/2, normal_values, width, \n",
    "                     label='Normal Results', color='#90EE90', \n",
    "                     edgecolor='black', linewidth=1, alpha=0.8)\n",
    "\n",
    "bars_abnormal = ax2.bar(x_pos + width/2, abnormal_values, width,\n",
    "                       label='Abnormal Results (Below + Above Normal)', color='#FFB6C1',\n",
    "                       edgecolor='black', linewidth=1, alpha=0.8)\n",
    "\n",
    "ax2.set_title('Individual Test Outcome Breakdown for Top 5 Risk Combinations', \n",
    "             fontsize=14, fontweight='bold', pad=20)\n",
    "ax2.set_xlabel('Individual Tests in Combinations', fontsize=12, fontweight='bold')\n",
    "ax2.set_ylabel('Percentage of Results (%)', fontsize=12, fontweight='bold')\n",
    "ax2.set_xticks(x_pos)\n",
    "ax2.set_xticklabels(x_labels, fontsize=9, rotation=45, ha='right')\n",
    "ax2.legend(loc='upper right')\n",
    "ax2.grid(axis='y', alpha=0.3, linestyle='--')\n",
    "ax2.set_ylim(0, 100)\n",
    "\n",
    "# Add value labels on bars\n",
    "for bar, value in zip(bars_normal, normal_values):\n",
    "    if value > 0:\n",
    "        ax2.text(bar.get_x() + bar.get_width()/2, bar.get_height() + 1, \n",
    "                f'{value:.1f}%', ha='center', va='bottom', fontsize=8, fontweight='bold')\n",
    "\n",
    "for bar, value in zip(bars_abnormal, abnormal_values):\n",
    "    if value > 0:\n",
    "        ax2.text(bar.get_x() + bar.get_width()/2, bar.get_height() + 1, \n",
    "                f'{value:.1f}%', ha='center', va='bottom', fontsize=8, fontweight='bold')\n",
    "\n",
    "# Add separator lines between test combinations\n",
    "separator_positions = []\n",
    "pos = 1.5\n",
    "for i in range(len(top_5_highest_risk) - 1):\n",
    "    ax2.axvline(x=pos, color='gray', linestyle=':', alpha=0.7)\n",
    "    separator_positions.append(pos)\n",
    "    pos += 2\n",
    "\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# Print detailed summary\n",
    "print(\"🎯 DETAILED BREAKDOWN OF TOP 5 HIGHEST RISK COMBINATIONS\")\n",
    "print(\"=\"*80)\n",
    "\n",
    "for i, (_, row) in enumerate(top_5_highest_risk.iterrows(), 1):\n",
    "    test1, test2 = row['Test 1'], row['Test 2']\n",
    "    patient_count = row['Total Patients']\n",
    "    \n",
    "    print(f\"\\n{i}. {test1} + {test2}\")\n",
    "    print(f\"   👥 Total Patients: {patient_count:,}\")\n",
    "    print(f\"   ⚠️ Both Tests Abnormal: {row['Both Tests Abnormal %']}\")\n",
    "    \n",
    "    # Get individual test breakdown\n",
    "    patients_with_both = df_pivot[(df_pivot[test1] > 0) & (df_pivot[test2] > 0)].index\n",
    "    combo_data = df_combined[\n",
    "        (df_combined['Patient Name'].isin(patients_with_both)) & \n",
    "        (df_combined['Standard Test Name'].isin([test1, test2]))\n",
    "    ].copy()\n",
    "    \n",
    "    for test_name in [test1, test2]:\n",
    "        test_data = combo_data[combo_data['Standard Test Name'] == test_name]\n",
    "        \n",
    "        if len(test_data) > 0:\n",
    "            outcome_counts = test_data['Outcome'].value_counts()\n",
    "            total = len(test_data)\n",
    "            \n",
    "            normal_pct = (outcome_counts.get('n', 0) / total * 100) if total > 0 else 0\n",
    "            below_pct = (outcome_counts.get('bn', 0) / total * 100) if total > 0 else 0\n",
    "            above_pct = (outcome_counts.get('an', 0) / total * 100) if total > 0 else 0\n",
    "            \n",
    "            print(f\"   📊 {test_name}:\")\n",
    "            print(f\"      ✅ Normal: {normal_pct:.1f}% ({outcome_counts.get('n', 0)} patients)\")\n",
    "            print(f\"      📉 Below Normal: {below_pct:.1f}% ({outcome_counts.get('bn', 0)} patients)\")\n",
    "            print(f\"      📈 Above Normal: {above_pct:.1f}% ({outcome_counts.get('an', 0)} patients)\")\n",
    "    \n",
    "    print(\"-\" * 60)\n",
    "\n",
    "print(f\"\\n💡 KEY INSIGHTS:\")\n",
    "print(\"- The first chart shows which test combinations have the highest percentage of patients with both tests abnormal\")\n",
    "print(\"- The second chart breaks down each individual test's normal vs abnormal rates\")\n",
    "print(\"- Green bars = Normal results, Pink bars = Abnormal results (below + above normal combined)\")\n",
    "print(\"- Higher abnormal percentages in individual tests contribute to higher combined risk\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "5f529067",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(65, 3)"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "results_df.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "6c8b8a14",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>subset</th>\n",
       "      <th>count</th>\n",
       "      <th>tests</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>('Serum Creatinine', 'Blood Glucose')</td>\n",
       "      <td>4965</td>\n",
       "      <td>[Serum Creatinine, Blood Glucose]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>('Hepatitis B Surface Antigen', 'Hepatitis C A...</td>\n",
       "      <td>4853</td>\n",
       "      <td>[Hepatitis B Surface Antigen, Hepatitis C Anti...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>('Hepatitis B Surface Antigen', 'HIV Antibody')</td>\n",
       "      <td>4846</td>\n",
       "      <td>[Hepatitis B Surface Antigen, HIV Antibody]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>('Hepatitis C Antibody', 'HIV Antibody')</td>\n",
       "      <td>4846</td>\n",
       "      <td>[Hepatitis C Antibody, HIV Antibody]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>('TSH', 'Serum Creatinine')</td>\n",
       "      <td>3779</td>\n",
       "      <td>[TSH, Serum Creatinine]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>('Vitamin D3', 'Erythrocyte Sedimentation Rate')</td>\n",
       "      <td>1029</td>\n",
       "      <td>[Vitamin D3, Erythrocyte Sedimentation Rate]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>('TSH', 'Blood Urea Nitrogen')</td>\n",
       "      <td>1027</td>\n",
       "      <td>[TSH, Blood Urea Nitrogen]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>('Vitamin D3', 'Blood Glucose')</td>\n",
       "      <td>1018</td>\n",
       "      <td>[Vitamin D3, Blood Glucose]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>('Erythrocyte Sedimentation Rate', 'Blood Gluc...</td>\n",
       "      <td>1018</td>\n",
       "      <td>[Erythrocyte Sedimentation Rate, Blood Glucose]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>('Blood Urea Nitrogen', 'Blood Glucose')</td>\n",
       "      <td>1017</td>\n",
       "      <td>[Blood Urea Nitrogen, Blood Glucose]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>65 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                               subset  count  \\\n",
       "30              ('Serum Creatinine', 'Blood Glucose')   4965   \n",
       "51  ('Hepatitis B Surface Antigen', 'Hepatitis C A...   4853   \n",
       "52    ('Hepatitis B Surface Antigen', 'HIV Antibody')   4846   \n",
       "54           ('Hepatitis C Antibody', 'HIV Antibody')   4846   \n",
       "5                         ('TSH', 'Serum Creatinine')   3779   \n",
       "..                                                ...    ...   \n",
       "48   ('Vitamin D3', 'Erythrocyte Sedimentation Rate')   1029   \n",
       "4                      ('TSH', 'Blood Urea Nitrogen')   1027   \n",
       "49                    ('Vitamin D3', 'Blood Glucose')   1018   \n",
       "57  ('Erythrocyte Sedimentation Rate', 'Blood Gluc...   1018   \n",
       "24           ('Blood Urea Nitrogen', 'Blood Glucose')   1017   \n",
       "\n",
       "                                                tests  \n",
       "30                  [Serum Creatinine, Blood Glucose]  \n",
       "51  [Hepatitis B Surface Antigen, Hepatitis C Anti...  \n",
       "52        [Hepatitis B Surface Antigen, HIV Antibody]  \n",
       "54               [Hepatitis C Antibody, HIV Antibody]  \n",
       "5                             [TSH, Serum Creatinine]  \n",
       "..                                                ...  \n",
       "48       [Vitamin D3, Erythrocyte Sedimentation Rate]  \n",
       "4                          [TSH, Blood Urea Nitrogen]  \n",
       "49                        [Vitamin D3, Blood Glucose]  \n",
       "57    [Erythrocyte Sedimentation Rate, Blood Glucose]  \n",
       "24               [Blood Urea Nitrogen, Blood Glucose]  \n",
       "\n",
       "[65 rows x 3 columns]"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "results_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "046a0d8c",
   "metadata": {},
   "outputs": [],
   "source": [
    "enhanced_summary_df.to_csv(\"model_data_insight/enhanced_test_combination_summary.csv\", index=False)\n",
    "df_combined.to_csv(\"model_data_insight/cleaned_combined_dataset.csv\", index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "086d028a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Test 1</th>\n",
       "      <th>Test 2</th>\n",
       "      <th>Total Patients</th>\n",
       "      <th>Test 1 Abnormal %</th>\n",
       "      <th>Test 2 Abnormal %</th>\n",
       "      <th>Both Tests Abnormal %</th>\n",
       "      <th>Both Tests Normal %</th>\n",
       "      <th>Mixed Results %</th>\n",
       "      <th>Both_Abnormal_Numeric</th>\n",
       "      <th>Both_Normal_Numeric</th>\n",
       "      <th>Mixed_Numeric</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Serum Creatinine</td>\n",
       "      <td>Blood Glucose</td>\n",
       "      <td>4965</td>\n",
       "      <td>35.8%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>64.6%</td>\n",
       "      <td>35.4%</td>\n",
       "      <td>0.0</td>\n",
       "      <td>64.6</td>\n",
       "      <td>35.4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Hepatitis B Surface Antigen</td>\n",
       "      <td>Hepatitis C Antibody</td>\n",
       "      <td>4853</td>\n",
       "      <td>0.2%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>99.8%</td>\n",
       "      <td>0.2%</td>\n",
       "      <td>0.0</td>\n",
       "      <td>99.8</td>\n",
       "      <td>0.2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Hepatitis B Surface Antigen</td>\n",
       "      <td>HIV Antibody</td>\n",
       "      <td>4846</td>\n",
       "      <td>0.2%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>99.8%</td>\n",
       "      <td>0.2%</td>\n",
       "      <td>0.0</td>\n",
       "      <td>99.8</td>\n",
       "      <td>0.2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Hepatitis C Antibody</td>\n",
       "      <td>HIV Antibody</td>\n",
       "      <td>4846</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>100.0%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>0.0</td>\n",
       "      <td>100.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>TSH</td>\n",
       "      <td>Serum Creatinine</td>\n",
       "      <td>3779</td>\n",
       "      <td>29.5%</td>\n",
       "      <td>36.8%</td>\n",
       "      <td>9.1%</td>\n",
       "      <td>48.8%</td>\n",
       "      <td>42.1%</td>\n",
       "      <td>9.1</td>\n",
       "      <td>48.8</td>\n",
       "      <td>42.1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>Vitamin D3</td>\n",
       "      <td>Erythrocyte Sedimentation Rate</td>\n",
       "      <td>1029</td>\n",
       "      <td>75.8%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>23.6%</td>\n",
       "      <td>76.4%</td>\n",
       "      <td>0.0</td>\n",
       "      <td>23.6</td>\n",
       "      <td>76.4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>TSH</td>\n",
       "      <td>Blood Urea Nitrogen</td>\n",
       "      <td>1027</td>\n",
       "      <td>30.1%</td>\n",
       "      <td>65.6%</td>\n",
       "      <td>15.3%</td>\n",
       "      <td>29.6%</td>\n",
       "      <td>55.1%</td>\n",
       "      <td>15.3</td>\n",
       "      <td>29.6</td>\n",
       "      <td>55.1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>Vitamin D3</td>\n",
       "      <td>Blood Glucose</td>\n",
       "      <td>1018</td>\n",
       "      <td>71.2%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>28.2%</td>\n",
       "      <td>71.8%</td>\n",
       "      <td>0.0</td>\n",
       "      <td>28.2</td>\n",
       "      <td>71.8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63</th>\n",
       "      <td>Erythrocyte Sedimentation Rate</td>\n",
       "      <td>Blood Glucose</td>\n",
       "      <td>1018</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>100.0%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>0.0</td>\n",
       "      <td>100.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>Blood Urea Nitrogen</td>\n",
       "      <td>Blood Glucose</td>\n",
       "      <td>1017</td>\n",
       "      <td>72.9%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>0.0%</td>\n",
       "      <td>32.2%</td>\n",
       "      <td>67.8%</td>\n",
       "      <td>0.0</td>\n",
       "      <td>32.2</td>\n",
       "      <td>67.8</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>65 rows × 11 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                            Test 1                          Test 2  \\\n",
       "0                 Serum Creatinine                   Blood Glucose   \n",
       "1      Hepatitis B Surface Antigen            Hepatitis C Antibody   \n",
       "2      Hepatitis B Surface Antigen                    HIV Antibody   \n",
       "3             Hepatitis C Antibody                    HIV Antibody   \n",
       "4                              TSH                Serum Creatinine   \n",
       "..                             ...                             ...   \n",
       "60                      Vitamin D3  Erythrocyte Sedimentation Rate   \n",
       "61                             TSH             Blood Urea Nitrogen   \n",
       "62                      Vitamin D3                   Blood Glucose   \n",
       "63  Erythrocyte Sedimentation Rate                   Blood Glucose   \n",
       "64             Blood Urea Nitrogen                   Blood Glucose   \n",
       "\n",
       "    Total Patients Test 1 Abnormal % Test 2 Abnormal % Both Tests Abnormal %  \\\n",
       "0             4965             35.8%              0.0%                  0.0%   \n",
       "1             4853              0.2%              0.0%                  0.0%   \n",
       "2             4846              0.2%              0.0%                  0.0%   \n",
       "3             4846              0.0%              0.0%                  0.0%   \n",
       "4             3779             29.5%             36.8%                  9.1%   \n",
       "..             ...               ...               ...                   ...   \n",
       "60            1029             75.8%              0.0%                  0.0%   \n",
       "61            1027             30.1%             65.6%                 15.3%   \n",
       "62            1018             71.2%              0.0%                  0.0%   \n",
       "63            1018              0.0%              0.0%                  0.0%   \n",
       "64            1017             72.9%              0.0%                  0.0%   \n",
       "\n",
       "   Both Tests Normal % Mixed Results %  Both_Abnormal_Numeric  \\\n",
       "0                64.6%           35.4%                    0.0   \n",
       "1                99.8%            0.2%                    0.0   \n",
       "2                99.8%            0.2%                    0.0   \n",
       "3               100.0%            0.0%                    0.0   \n",
       "4                48.8%           42.1%                    9.1   \n",
       "..                 ...             ...                    ...   \n",
       "60               23.6%           76.4%                    0.0   \n",
       "61               29.6%           55.1%                   15.3   \n",
       "62               28.2%           71.8%                    0.0   \n",
       "63              100.0%            0.0%                    0.0   \n",
       "64               32.2%           67.8%                    0.0   \n",
       "\n",
       "    Both_Normal_Numeric  Mixed_Numeric  \n",
       "0                  64.6           35.4  \n",
       "1                  99.8            0.2  \n",
       "2                  99.8            0.2  \n",
       "3                 100.0            0.0  \n",
       "4                  48.8           42.1  \n",
       "..                  ...            ...  \n",
       "60                 23.6           76.4  \n",
       "61                 29.6           55.1  \n",
       "62                 28.2           71.8  \n",
       "63                100.0            0.0  \n",
       "64                 32.2           67.8  \n",
       "\n",
       "[65 rows x 11 columns]"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "enhanced_summary_df"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ae50ff9b",
   "metadata": {},
   "source": [
    "# 🔬 **Choosing the Right Test Combinations for Health Data Analysis**\n",
    "\n",
    "When analyzing lab test combinations from our dataset, different analysis goals require different selection criteria. Here's how to choose the best test combinations based on your specific needs:\n",
    "\n",
    "---\n",
    "\n",
    "## 🎯 **1. For Classification Models (Predicting Normal vs Abnormal)**\n",
    "\n",
    "**Goal:** Build models that can predict whether test results will be normal or abnormal.\n",
    "\n",
    "**What to Look For:**\n",
    "- ✅ **Balanced datasets** where abnormal rates are **30-70%** for both tests\n",
    "- ❌ **Avoid** combinations where one test is almost always normal (0-10% abnormal)\n",
    "- ❌ **Avoid** combinations where one test is almost always abnormal (90-100% abnormal)\n",
    "\n",
    "**Why:** If everyone has normal results, the model will just predict \"normal\" every time and won't learn meaningful patterns.\n",
    "\n",
    "**Best Choices from Our Data:**\n",
    "- TSH + Serum Creatinine (29.5% + 36.8% abnormal rates)\n",
    "- Serum Triglycerides + Serum HDL Cholesterol (57.1% + 38.0% abnormal rates)\n",
    "\n",
    "---\n",
    "\n",
    "## 🔍 **2. For Association Rule Mining (Finding \"If-Then\" Patterns)**\n",
    "\n",
    "**Goal:** Discover rules like \"If Test A is abnormal → Then Test B is likely abnormal.\"\n",
    "\n",
    "**What to Look For:**\n",
    "- ✅ **Higher \"Both Tests Abnormal\" percentages** (15-40%)\n",
    "- ✅ **Decent \"Mixed Results\" percentages** (30-60%)\n",
    "- ❌ **Avoid** combinations where \"Both Normal\" dominates (>90%)\n",
    "\n",
    "**Why:** You need variety in outcomes to find interesting patterns. If everyone is normal, there are no rules to discover.\n",
    "\n",
    "**Best Choices from Our Data:**\n",
    "- Serum Triglycerides + Serum LDL Cholesterol (39.9% both abnormal)\n",
    "- HbA1c + Serum Creatinine (28.2% both abnormal)\n",
    "\n",
    "---\n",
    "\n",
    "## 🎭 **3. For Clustering (Grouping Similar Patients)**\n",
    "\n",
    "**Goal:** Find natural groups of patients with similar health patterns.\n",
    "\n",
    "**What to Look For:**\n",
    "- ✅ **High \"Mixed Results\" percentages** (40-70%)\n",
    "- ✅ **Diverse outcome patterns** across the population\n",
    "- ❌ **Avoid** combinations where most patients fall into the same category\n",
    "\n",
    "**Why:** Clustering works best when patients have diverse health profiles to create meaningful groups.\n",
    "\n",
    "**Best Choices from Our Data:**\n",
    "- HbA1c + Serum Creatinine (58.8% mixed results)\n",
    "- HbA1c + TSH (58.6% mixed results)\n",
    "\n",
    "---\n",
    "\n",
    "## 📊 **4. General Selection Strategy**\n",
    "\n",
    "### **Step 1: Filter by Sample Size**\n",
    "- Choose combinations with **≥1,500 patients** for statistical reliability\n",
    "- Larger samples = more robust results\n",
    "\n",
    "### **Step 2: Check Balance**\n",
    "- Look for abnormal rates between **20-80%** for individual tests\n",
    "- Avoid extreme values (too rare or too common)\n",
    "\n",
    "### **Step 3: Consider Your Analysis Goal**\n",
    "- **Classification:** Prioritize balanced individual test abnormal rates\n",
    "- **Association Rules:** Prioritize higher \"Both Abnormal\" percentages\n",
    "- **Clustering:** Prioritize higher \"Mixed Results\" percentages\n",
    "\n",
    "### **Step 4: Validate Medical Relevance**\n",
    "- Choose test combinations that make clinical sense\n",
    "- Examples: Lipid panel tests, kidney function tests, diabetes markers\n",
    "\n",
    "---\n",
    "\n",
    "## ⚠️ **What to Avoid**\n",
    "\n",
    "- **Infectious disease markers** (Hepatitis, HIV) - usually 99%+ normal\n",
    "- **Single-outcome tests** where one result dominates completely\n",
    "- **Very small sample sizes** (<1,000 patients)\n",
    "- **Medically unrelated test combinations**\n",
    "\n",
    "---\n",
    "\n",
    "This guidance ensures your analysis will have meaningful, statistically significant results that can provide actionable health insights! 🎯\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6a5b2ede",
   "metadata": {},
   "source": [
    "## Dataset Selection Process\n",
    "\n",
    "In order to choose the best dataset for applying **classification, association, and clustering techniques**, I am following these steps:\n",
    "\n",
    "1. **Filter by Sample Size (Total Patients)**\n",
    "\n",
    "   * I will prioritize datasets with a larger number of patients, since bigger sample sizes provide stronger and more reliable results.\n",
    "\n",
    "2. **Check Balance for Classification**\n",
    "\n",
    "   * For classification tasks, I will select datasets where the outcome distribution (Normal vs. Abnormal) is reasonably balanced.\n",
    "   * Specifically, I want Test 1 Abnormal % and Test 2 Abnormal % to be neither too close to 0% nor too close to 100% ***(ideally between 30–70%)***.\n",
    "   * This ensures the model has enough variation to learn effectively.\n",
    "\n",
    "3. **Evaluate for Association Rule Mining**\n",
    "\n",
    "   * For association analysis, I will look for datasets with meaningful variation between test results.\n",
    "   * I will focus on datasets where **Both Tests Abnormal %** and **Mixed Results %** are not negligible.\n",
    "   * If “Both Normal” dominates heavily, there will be fewer interesting patterns to discover.\n",
    "\n",
    "4. **Evaluate for Clustering**\n",
    "\n",
    "   * For clustering tasks, I will select datasets that contain diversity in patient outcomes.\n",
    "   * A higher **Mixed Results %** is desirable, as it introduces variability and allows clusters to naturally form.\n",
    "   * If all patients are similar (e.g., mostly Normal), clustering will not produce meaningful groups.\n",
    "\n",
    "5. **Final Selection**\n",
    "\n",
    "   * I will combine these criteria:\n",
    "\n",
    "     * Large patient sample size.\n",
    "     * Balanced distribution of Normal and Abnormal outcomes.\n",
    "     * Sufficient variety in joint test results (especially Mixed Results).\n",
    "   * The dataset that best satisfies these conditions will be used for the subsequent classification, association, and clustering experiments.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "f2b54f0b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "🎯 BEST DATASETS FOR CLASSIFICATION ANALYSIS\n",
      "================================================================================\n",
      "Found 8 datasets meeting classification criteria:\n",
      "- Minimum 1,500 patients\n",
      "- Both tests have 20-80% abnormal rates\n",
      "\n",
      "================================================================================\n",
      "TOP CLASSIFICATION DATASETS (sorted by balance score):\n",
      "------------------------------------------------------------\n",
      "\n",
      "1. Serum Triglycerides + Serum HDL Cholesterol\n",
      "   👥 Total Patients: 1,580\n",
      "   📊 Test 1 Abnormal Rate: 57.1% (Balance Score: 92.9)\n",
      "   📊 Test 2 Abnormal Rate: 38.0% (Balance Score: 88.0)\n",
      "   🎯 Combined Balance Score: 90.5\n",
      "   ⚖️ Both Abnormal: 26.0% | Both Normal: 37.4% | Mixed: 36.6%\n",
      "\n",
      "2. Serum Triglycerides + Serum LDL Cholesterol\n",
      "   👥 Total Patients: 1,903\n",
      "   📊 Test 1 Abnormal Rate: 57.4% (Balance Score: 92.6)\n",
      "   📊 Test 2 Abnormal Rate: 68.6% (Balance Score: 81.4)\n",
      "   🎯 Combined Balance Score: 87.0\n",
      "   ⚖️ Both Abnormal: 39.9% | Both Normal: 19.7% | Mixed: 40.4%\n",
      "\n",
      "3. Serum HDL Cholesterol + Serum LDL Cholesterol\n",
      "   👥 Total Patients: 1,602\n",
      "   📊 Test 1 Abnormal Rate: 37.9% (Balance Score: 87.9)\n",
      "   📊 Test 2 Abnormal Rate: 68.7% (Balance Score: 81.3)\n",
      "   🎯 Combined Balance Score: 84.6\n",
      "   ⚖️ Both Abnormal: 23.6% | Both Normal: 19.0% | Mixed: 57.4%\n",
      "\n",
      "4. Blood Urea Nitrogen + Serum Creatinine\n",
      "   👥 Total Patients: 2,870\n",
      "   📊 Test 1 Abnormal Rate: 68.8% (Balance Score: 81.2)\n",
      "   📊 Test 2 Abnormal Rate: 36.1% (Balance Score: 86.1)\n",
      "   🎯 Combined Balance Score: 83.7\n",
      "   ⚖️ Both Abnormal: 18.6% | Both Normal: 18.6% | Mixed: 62.7%\n",
      "\n",
      "5. TSH + Serum Creatinine\n",
      "   👥 Total Patients: 3,779\n",
      "   📊 Test 1 Abnormal Rate: 29.5% (Balance Score: 79.5)\n",
      "   📊 Test 2 Abnormal Rate: 36.8% (Balance Score: 86.8)\n",
      "   🎯 Combined Balance Score: 83.2\n",
      "   ⚖️ Both Abnormal: 9.1% | Both Normal: 48.8% | Mixed: 42.1%\n",
      "\n",
      "6. HbA1c + TSH\n",
      "   👥 Total Patients: 1,538\n",
      "   📊 Test 1 Abnormal Rate: 76.6% (Balance Score: 73.4)\n",
      "   📊 Test 2 Abnormal Rate: 32.6% (Balance Score: 82.6)\n",
      "   🎯 Combined Balance Score: 78.0\n",
      "   ⚖️ Both Abnormal: 20.5% | Both Normal: 20.9% | Mixed: 58.6%\n",
      "\n",
      "7. TSH + Vitamin D3\n",
      "   👥 Total Patients: 2,610\n",
      "   📊 Test 1 Abnormal Rate: 28.1% (Balance Score: 78.1)\n",
      "   📊 Test 2 Abnormal Rate: 72.2% (Balance Score: 77.8)\n",
      "   🎯 Combined Balance Score: 77.9\n",
      "   ⚖️ Both Abnormal: 15.4% | Both Normal: 21.3% | Mixed: 63.3%\n",
      "\n",
      "8. TSH + Serum Ferritin\n",
      "   👥 Total Patients: 1,843\n",
      "   📊 Test 1 Abnormal Rate: 31.5% (Balance Score: 81.5)\n",
      "   📊 Test 2 Abnormal Rate: 20.9% (Balance Score: 70.9)\n",
      "   🎯 Combined Balance Score: 76.2\n",
      "   ⚖️ Both Abnormal: 4.8% | Both Normal: 62.0% | Mixed: 33.2%\n",
      "\n",
      "====================================================================================================\n",
      "DETAILED CLASSIFICATION CANDIDATES TABLE:\n",
      "               Test 1                Test 2  Total Patients Test 1 Abnormal % Test 2 Abnormal %  Combined_Balance_Score Both Tests Abnormal % Both Tests Normal % Mixed Results %\n",
      "  Serum Triglycerides Serum HDL Cholesterol            1580             57.1%             38.0%                   90.45                 26.0%               37.4%           36.6%\n",
      "  Serum Triglycerides Serum LDL Cholesterol            1903             57.4%             68.6%                   87.00                 39.9%               19.7%           40.4%\n",
      "Serum HDL Cholesterol Serum LDL Cholesterol            1602             37.9%             68.7%                   84.60                 23.6%               19.0%           57.4%\n",
      "  Blood Urea Nitrogen      Serum Creatinine            2870             68.8%             36.1%                   83.65                 18.6%               18.6%           62.7%\n",
      "                  TSH      Serum Creatinine            3779             29.5%             36.8%                   83.15                  9.1%               48.8%           42.1%\n",
      "                HbA1c                   TSH            1538             76.6%             32.6%                   78.00                 20.5%               20.9%           58.6%\n",
      "                  TSH            Vitamin D3            2610             28.1%             72.2%                   77.95                 15.4%               21.3%           63.3%\n",
      "                  TSH        Serum Ferritin            1843             31.5%             20.9%                   76.20                  4.8%               62.0%           33.2%\n",
      "\n",
      "🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆\n",
      "RECOMMENDED DATASET FOR CLASSIFICATION:\n",
      "🏆 Serum Triglycerides + Serum HDL Cholesterol\n",
      "   👥 Sample Size: 1,580 patients\n",
      "   📈 Test 1 (Serum Triglycerides): 57.1% abnormal\n",
      "   📈 Test 2 (Serum HDL Cholesterol): 38.0% abnormal\n",
      "   🎯 Balance Score: 90.5/100\n",
      "   📊 Outcome Distribution:\n",
      "      - Both Abnormal: 26.0%\n",
      "      - Both Normal: 37.4%\n",
      "      - Mixed Results: 36.6%\n",
      "🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆\n",
      "\n",
      "⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️⚠️\n",
      "WHY SOME HIGH-VOLUME DATASETS ARE NOT SUITABLE FOR CLASSIFICATION:\n",
      "----------------------------------------------------------------------\n",
      "1. Serum Creatinine + Blood Glucose (4,965 patients)\n",
      "   ❌ Issues: Test 2 too normal (0.0%)\n",
      "2. Hepatitis B Surface Antigen + Hepatitis C Antibody (4,853 patients)\n",
      "   ❌ Issues: Test 1 too normal (0.2%); Test 2 too normal (0.0%)\n",
      "3. Hepatitis B Surface Antigen + HIV Antibody (4,846 patients)\n",
      "   ❌ Issues: Test 1 too normal (0.2%); Test 2 too normal (0.0%)\n",
      "4. Hepatitis C Antibody + HIV Antibody (4,846 patients)\n",
      "   ❌ Issues: Test 1 too normal (0.0%); Test 2 too normal (0.0%)\n",
      "5. TSH + Blood Glucose (3,754 patients)\n",
      "   ❌ Issues: Test 2 too normal (0.0%)\n",
      "\n",
      "✅ ANALYSIS COMPLETE! Use the recommended dataset for classification tasks.\n"
     ]
    }
   ],
   "source": [
    "# Sort and filter the enhanced_summary_df to find the best datasets for classification\n",
    "\n",
    "# First, convert percentage strings to numeric values for better sorting\n",
    "enhanced_summary_df_sorted = enhanced_summary_df.copy()\n",
    "\n",
    "# Convert percentage columns to numeric\n",
    "enhanced_summary_df_sorted['Test1_Abnormal_Numeric'] = enhanced_summary_df_sorted['Test 1 Abnormal %'].str.rstrip('%').astype(float)\n",
    "enhanced_summary_df_sorted['Test2_Abnormal_Numeric'] = enhanced_summary_df_sorted['Test 2 Abnormal %'].str.rstrip('%').astype(float)\n",
    "\n",
    "# Define criteria for good classification datasets\n",
    "min_patients = 1500  # Minimum sample size\n",
    "min_abnormal_rate = 20  # Minimum abnormal rate (%)\n",
    "max_abnormal_rate = 80  # Maximum abnormal rate (%)\n",
    "\n",
    "# Filter datasets that meet classification criteria\n",
    "classification_candidates = enhanced_summary_df_sorted[\n",
    "    (enhanced_summary_df_sorted['Total Patients'] >= min_patients) &\n",
    "    (enhanced_summary_df_sorted['Test1_Abnormal_Numeric'] >= min_abnormal_rate) &\n",
    "    (enhanced_summary_df_sorted['Test1_Abnormal_Numeric'] <= max_abnormal_rate) &\n",
    "    (enhanced_summary_df_sorted['Test2_Abnormal_Numeric'] >= min_abnormal_rate) &\n",
    "    (enhanced_summary_df_sorted['Test2_Abnormal_Numeric'] <= max_abnormal_rate)\n",
    "].copy()\n",
    "\n",
    "# Calculate a \"balance score\" - closer to 50% abnormal rate is better for both tests\n",
    "classification_candidates['Test1_Balance_Score'] = 100 - abs(classification_candidates['Test1_Abnormal_Numeric'] - 50)\n",
    "classification_candidates['Test2_Balance_Score'] = 100 - abs(classification_candidates['Test2_Abnormal_Numeric'] - 50)\n",
    "classification_candidates['Combined_Balance_Score'] = (classification_candidates['Test1_Balance_Score'] + classification_candidates['Test2_Balance_Score']) / 2\n",
    "\n",
    "# Sort by combined balance score (higher is better) and then by total patients (higher is better)\n",
    "classification_candidates = classification_candidates.sort_values(\n",
    "    ['Combined_Balance_Score', 'Total Patients'], \n",
    "    ascending=[False, False]\n",
    ")\n",
    "\n",
    "print(\"🎯 BEST DATASETS FOR CLASSIFICATION ANALYSIS\")\n",
    "print(\"=\"*80)\n",
    "print(f\"Found {len(classification_candidates)} datasets meeting classification criteria:\")\n",
    "print(f\"- Minimum {min_patients:,} patients\")\n",
    "print(f\"- Both tests have {min_abnormal_rate}-{max_abnormal_rate}% abnormal rates\")\n",
    "print(\"\\n\" + \"=\"*80)\n",
    "\n",
    "if len(classification_candidates) > 0:\n",
    "    # Display the top classification candidates\n",
    "    print(\"TOP CLASSIFICATION DATASETS (sorted by balance score):\")\n",
    "    print(\"-\" * 60)\n",
    "    \n",
    "    for i, (_, row) in enumerate(classification_candidates.head(10).iterrows(), 1):\n",
    "        print(f\"\\n{i}. {row['Test 1']} + {row['Test 2']}\")\n",
    "        print(f\"   👥 Total Patients: {row['Total Patients']:,}\")\n",
    "        print(f\"   📊 Test 1 Abnormal Rate: {row['Test 1 Abnormal %']} (Balance Score: {row['Test1_Balance_Score']:.1f})\")\n",
    "        print(f\"   📊 Test 2 Abnormal Rate: {row['Test 2 Abnormal %']} (Balance Score: {row['Test2_Balance_Score']:.1f})\")\n",
    "        print(f\"   🎯 Combined Balance Score: {row['Combined_Balance_Score']:.1f}\")\n",
    "        print(f\"   ⚖️ Both Abnormal: {row['Both Tests Abnormal %']} | Both Normal: {row['Both Tests Normal %']} | Mixed: {row['Mixed Results %']}\")\n",
    "    \n",
    "    # Show the detailed table\n",
    "    print(f\"\\n\" + \"=\"*100)\n",
    "    print(\"DETAILED CLASSIFICATION CANDIDATES TABLE:\")\n",
    "    classification_display = classification_candidates[['Test 1', 'Test 2', 'Total Patients', \n",
    "                                                       'Test 1 Abnormal %', 'Test 2 Abnormal %',\n",
    "                                                       'Combined_Balance_Score', 'Both Tests Abnormal %',\n",
    "                                                       'Both Tests Normal %', 'Mixed Results %']].head(10)\n",
    "    print(classification_display.to_string(index=False))\n",
    "    \n",
    "    # Recommend the best dataset\n",
    "    best_dataset = classification_candidates.iloc[0]\n",
    "    print(f\"\\n\" + \"🏆\" * 60)\n",
    "    print(f\"RECOMMENDED DATASET FOR CLASSIFICATION:\")\n",
    "    print(f\"🏆 {best_dataset['Test 1']} + {best_dataset['Test 2']}\")\n",
    "    print(f\"   👥 Sample Size: {best_dataset['Total Patients']:,} patients\")\n",
    "    print(f\"   📈 Test 1 ({best_dataset['Test 1']}): {best_dataset['Test 1 Abnormal %']} abnormal\")\n",
    "    print(f\"   📈 Test 2 ({best_dataset['Test 2']}): {best_dataset['Test 2 Abnormal %']} abnormal\")\n",
    "    print(f\"   🎯 Balance Score: {best_dataset['Combined_Balance_Score']:.1f}/100\")\n",
    "    print(f\"   📊 Outcome Distribution:\")\n",
    "    print(f\"      - Both Abnormal: {best_dataset['Both Tests Abnormal %']}\")\n",
    "    print(f\"      - Both Normal: {best_dataset['Both Tests Normal %']}\")\n",
    "    print(f\"      - Mixed Results: {best_dataset['Mixed Results %']}\")\n",
    "    print(f\"🏆\" * 60)\n",
    "\n",
    "else:\n",
    "    print(\"❌ No datasets found meeting the classification criteria.\")\n",
    "    print(\"\\nLet's relax the criteria and show the best available options:\")\n",
    "    \n",
    "    # Show all datasets sorted by sample size\n",
    "    all_sorted = enhanced_summary_df_sorted.sort_values('Total Patients', ascending=False)\n",
    "    \n",
    "    print(f\"\\nTOP 10 DATASETS BY SAMPLE SIZE:\")\n",
    "    for i, (_, row) in enumerate(all_sorted.head(10).iterrows(), 1):\n",
    "        print(f\"{i:2d}. {row['Test 1']} + {row['Test 2']}\")\n",
    "        print(f\"    👥 {row['Total Patients']:,} patients | Abnormal rates: {row['Test 1 Abnormal %']} & {row['Test 2 Abnormal %']}\")\n",
    "\n",
    "# Additional analysis: Show why some high-volume datasets are not suitable for classification\n",
    "print(f\"\\n\" + \"⚠️\" * 50)\n",
    "print(f\"WHY SOME HIGH-VOLUME DATASETS ARE NOT SUITABLE FOR CLASSIFICATION:\")\n",
    "print(\"-\" * 70)\n",
    "\n",
    "high_volume_poor_balance = enhanced_summary_df_sorted[\n",
    "    (enhanced_summary_df_sorted['Total Patients'] >= 2000) &\n",
    "    ((enhanced_summary_df_sorted['Test1_Abnormal_Numeric'] < 20) | \n",
    "     (enhanced_summary_df_sorted['Test1_Abnormal_Numeric'] > 80) |\n",
    "     (enhanced_summary_df_sorted['Test2_Abnormal_Numeric'] < 20) | \n",
    "     (enhanced_summary_df_sorted['Test2_Abnormal_Numeric'] > 80))\n",
    "].head(5)\n",
    "\n",
    "for i, (_, row) in enumerate(high_volume_poor_balance.iterrows(), 1):\n",
    "    reasons = []\n",
    "    if row['Test1_Abnormal_Numeric'] < 20:\n",
    "        reasons.append(f\"Test 1 too normal ({row['Test 1 Abnormal %']})\")\n",
    "    if row['Test1_Abnormal_Numeric'] > 80:\n",
    "        reasons.append(f\"Test 1 too abnormal ({row['Test 1 Abnormal %']})\")\n",
    "    if row['Test2_Abnormal_Numeric'] < 20:\n",
    "        reasons.append(f\"Test 2 too normal ({row['Test 2 Abnormal %']})\")\n",
    "    if row['Test2_Abnormal_Numeric'] > 80:\n",
    "        reasons.append(f\"Test 2 too abnormal ({row['Test 2 Abnormal %']})\")\n",
    "    \n",
    "    print(f\"{i}. {row['Test 1']} + {row['Test 2']} ({row['Total Patients']:,} patients)\")\n",
    "    print(f\"   ❌ Issues: {'; '.join(reasons)}\")\n",
    "\n",
    "print(f\"\\n✅ ANALYSIS COMPLETE! Use the recommended dataset for classification tasks.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "66d3d713",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "🎯 BEST DATASETS FOR CLUSTERING ANALYSIS\n",
      "================================================================================\n",
      "Found 19 datasets meeting clustering criteria:\n",
      "- Minimum 1,500 patients\n",
      "- At least 30% mixed results (for diversity)\n",
      "- At most 70% both normal (to avoid homogeneity)\n",
      "\n",
      "================================================================================\n",
      "TOP CLUSTERING DATASETS (sorted by diversity score):\n",
      "------------------------------------------------------------\n",
      "\n",
      "1. S.Iron + Vitamin D3\n",
      "   👥 Total Patients: 1,635\n",
      "   🎭 Mixed Results: 77.4% (higher = more diverse)\n",
      "   ✅ Both Normal: 22.6% (lower = more variety)\n",
      "   ⚠️ Both Abnormal: 0.0%\n",
      "   📊 Individual Abnormal Rates: 0.0% & 76.6%\n",
      "   🎯 Diversity Score: 71.1/100\n",
      "\n",
      "2. Vitamin D3 + Complete Blood Count\n",
      "   👥 Total Patients: 1,682\n",
      "   🎭 Mixed Results: 77.4% (higher = more diverse)\n",
      "   ✅ Both Normal: 22.6% (lower = more variety)\n",
      "   ⚠️ Both Abnormal: 0.0%\n",
      "   📊 Individual Abnormal Rates: 76.7% & 0.0%\n",
      "   🎯 Diversity Score: 71.1/100\n",
      "\n",
      "3. Blood Urea Nitrogen + Serum Creatinine\n",
      "   👥 Total Patients: 2,870\n",
      "   🎭 Mixed Results: 62.7% (higher = more diverse)\n",
      "   ✅ Both Normal: 18.6% (lower = more variety)\n",
      "   ⚠️ Both Abnormal: 18.6%\n",
      "   📊 Individual Abnormal Rates: 68.8% & 36.1%\n",
      "   🎯 Diversity Score: 71.1/100\n",
      "\n",
      "4. HbA1c + Blood Glucose\n",
      "   👥 Total Patients: 1,855\n",
      "   🎭 Mixed Results: 78.6% (higher = more diverse)\n",
      "   ✅ Both Normal: 21.4% (lower = more variety)\n",
      "   ⚠️ Both Abnormal: 0.0%\n",
      "   📊 Individual Abnormal Rates: 82.2% & 0.0%\n",
      "   🎯 Diversity Score: 70.7/100\n",
      "\n",
      "5. TSH + Vitamin D3\n",
      "   👥 Total Patients: 2,610\n",
      "   🎭 Mixed Results: 63.3% (higher = more diverse)\n",
      "   ✅ Both Normal: 21.3% (lower = more variety)\n",
      "   ⚠️ Both Abnormal: 15.4%\n",
      "   📊 Individual Abnormal Rates: 28.1% & 72.2%\n",
      "   🎯 Diversity Score: 69.2/100\n",
      "\n",
      "6. Serum HDL Cholesterol + Serum LDL Cholesterol\n",
      "   👥 Total Patients: 1,602\n",
      "   🎭 Mixed Results: 57.4% (higher = more diverse)\n",
      "   ✅ Both Normal: 19.0% (lower = more variety)\n",
      "   ⚠️ Both Abnormal: 23.6%\n",
      "   📊 Individual Abnormal Rates: 37.9% & 68.7%\n",
      "   🎯 Diversity Score: 68.3/100\n",
      "\n",
      "7. Serum Cholesterol + Serum LDL Cholesterol\n",
      "   👥 Total Patients: 1,930\n",
      "   🎭 Mixed Results: 68.4% (higher = more diverse)\n",
      "   ✅ Both Normal: 31.6% (lower = more variety)\n",
      "   ⚠️ Both Abnormal: 0.0%\n",
      "   📊 Individual Abnormal Rates: 0.0% & 68.9%\n",
      "   🎯 Diversity Score: 67.3/100\n",
      "\n",
      "8. HbA1c + TSH\n",
      "   👥 Total Patients: 1,538\n",
      "   🎭 Mixed Results: 58.6% (higher = more diverse)\n",
      "   ✅ Both Normal: 20.9% (lower = more variety)\n",
      "   ⚠️ Both Abnormal: 20.5%\n",
      "   📊 Individual Abnormal Rates: 76.6% & 32.6%\n",
      "   🎯 Diversity Score: 66.4/100\n",
      "\n",
      "9. HbA1c + Serum Creatinine\n",
      "   👥 Total Patients: 1,633\n",
      "   🎭 Mixed Results: 58.8% (higher = more diverse)\n",
      "   ✅ Both Normal: 13.0% (lower = more variety)\n",
      "   ⚠️ Both Abnormal: 28.2%\n",
      "   📊 Individual Abnormal Rates: 83.5% & 35.5%\n",
      "   🎯 Diversity Score: 65.7/100\n",
      "\n",
      "10. Blood Sugar + Complete Blood Count\n",
      "   👥 Total Patients: 1,511\n",
      "   🎭 Mixed Results: 58.0% (higher = more diverse)\n",
      "   ✅ Both Normal: 42.0% (lower = more variety)\n",
      "   ⚠️ Both Abnormal: 0.0%\n",
      "   📊 Individual Abnormal Rates: 58.6% & 0.0%\n",
      "   🎯 Diversity Score: 63.1/100\n",
      "\n",
      "========================================================================================================================\n",
      "DETAILED CLUSTERING CANDIDATES TABLE:\n",
      "               Test 1                Test 2  Total Patients Mixed Results % Both Tests Normal % Both Tests Abnormal % Test 1 Abnormal % Test 2 Abnormal %  Diversity_Score\n",
      "               S.Iron            Vitamin D3            1635           77.4%               22.6%                  0.0%              0.0%             76.6%            71.12\n",
      "           Vitamin D3  Complete Blood Count            1682           77.4%               22.6%                  0.0%             76.7%              0.0%            71.10\n",
      "  Blood Urea Nitrogen      Serum Creatinine            2870           62.7%               18.6%                 18.6%             68.8%             36.1%            71.08\n",
      "                HbA1c         Blood Glucose            1855           78.6%               21.4%                  0.0%             82.2%              0.0%            70.72\n",
      "                  TSH            Vitamin D3            2610           63.3%               21.3%                 15.4%             28.1%             72.2%            69.16\n",
      "Serum HDL Cholesterol Serum LDL Cholesterol            1602           57.4%               19.0%                 23.6%             37.9%             68.7%            68.28\n",
      "    Serum Cholesterol Serum LDL Cholesterol            1930           68.4%               31.6%                  0.0%              0.0%             68.9%            67.26\n",
      "                HbA1c                   TSH            1538           58.6%               20.9%                 20.5%             76.6%             32.6%            66.36\n",
      "                HbA1c      Serum Creatinine            1633           58.8%               13.0%                 28.2%             83.5%             35.5%            65.68\n",
      "          Blood Sugar  Complete Blood Count            1511           58.0%               42.0%                  0.0%             58.6%              0.0%            63.08\n",
      "\n",
      "🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆\n",
      "RECOMMENDED DATASET FOR CLUSTERING:\n",
      "🏆 S.Iron + Vitamin D3\n",
      "   👥 Sample Size: 1,635 patients\n",
      "   🎭 Mixed Results: 77.4% (excellent diversity)\n",
      "   ✅ Both Normal: 22.6% (good variety)\n",
      "   ⚠️ Both Abnormal: 0.0% (interesting patterns)\n",
      "   📈 Individual Abnormal Rates:\n",
      "      - S.Iron: 0.0%\n",
      "      - Vitamin D3: 76.6%\n",
      "   🎯 Diversity Score: 71.1/100\n",
      "🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆\n",
      "\n",
      "💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡\n",
      "WHY CLUSTERING NEEDS DIVERSE DATASETS:\n",
      "----------------------------------------------------------------------\n",
      "✅ GOOD for clustering:\n",
      "   - High Mixed Results % (40-70%): Creates natural patient groups\n",
      "   - Balanced abnormal rates (20-80%): Allows meaningful clusters\n",
      "   - Moderate Both Normal % (20-60%): Ensures variety in patient profiles\n",
      "\n",
      "❌ BAD for clustering:\n",
      "   - Very high Both Normal % (>80%): All patients look similar\n",
      "   - Very low Mixed Results % (<20%): Not enough pattern diversity\n",
      "   - Extreme abnormal rates (0-10% or 90-100%): One-sided distributions\n",
      "\n",
      "📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊📊\n",
      "CLUSTERING POTENTIAL ANALYSIS:\n",
      "----------------------------------------------------------------------\n",
      "Top 3 datasets show excellent clustering potential:\n",
      "\n",
      "1. S.Iron + Vitamin D3\n",
      "   🎭 Diversity Analysis:\n",
      "      - 77.4% patients have mixed results → Creates boundary clusters\n",
      "      - 22.6% patients are both normal → Forms healthy cluster\n",
      "      - 0.0% patients are both abnormal → Forms high-risk cluster\n",
      "   🎯 Expected Cluster Types:\n",
      "      ✅ Healthy Cluster: ~23% of patients\n",
      "      ⚖️ Mixed-Risk Clusters: ~77% of patients (2-3 sub-clusters)\n",
      "\n",
      "2. Vitamin D3 + Complete Blood Count\n",
      "   🎭 Diversity Analysis:\n",
      "      - 77.4% patients have mixed results → Creates boundary clusters\n",
      "      - 22.6% patients are both normal → Forms healthy cluster\n",
      "      - 0.0% patients are both abnormal → Forms high-risk cluster\n",
      "   🎯 Expected Cluster Types:\n",
      "      ✅ Healthy Cluster: ~23% of patients\n",
      "      ⚖️ Mixed-Risk Clusters: ~77% of patients (2-3 sub-clusters)\n",
      "\n",
      "3. Blood Urea Nitrogen + Serum Creatinine\n",
      "   🎭 Diversity Analysis:\n",
      "      - 62.7% patients have mixed results → Creates boundary clusters\n",
      "      - 18.6% patients are both normal → Forms healthy cluster\n",
      "      - 18.6% patients are both abnormal → Forms high-risk cluster\n",
      "   🎯 Expected Cluster Types:\n",
      "      ✅ Healthy Cluster: ~19% of patients\n",
      "      🚨 High-Risk Cluster: ~19% of patients\n",
      "      ⚖️ Mixed-Risk Clusters: ~63% of patients (2-3 sub-clusters)\n",
      "\n",
      "✅ CLUSTERING ANALYSIS COMPLETE!\n",
      "📈 Use the recommended dataset for clustering to discover natural patient health groups.\n"
     ]
    }
   ],
   "source": [
    "# Sort and filter enhanced_summary_df to find the best datasets for clustering\n",
    "\n",
    "print(\"🎯 BEST DATASETS FOR CLUSTERING ANALYSIS\")\n",
    "print(\"=\"*80)\n",
    "\n",
    "# Convert percentage columns to numeric for clustering analysis\n",
    "clustering_df = enhanced_summary_df_sorted.copy()\n",
    "\n",
    "# Define criteria for good clustering datasets\n",
    "min_patients_clustering = 1500  # Minimum sample size for clustering\n",
    "min_mixed_results = 30  # Minimum mixed results percentage for diversity\n",
    "max_both_normal = 70   # Maximum \"both normal\" percentage to ensure variety\n",
    "\n",
    "# Filter datasets that meet clustering criteria\n",
    "clustering_candidates = clustering_df[\n",
    "    (clustering_df['Total Patients'] >= min_patients_clustering) &\n",
    "    (clustering_df['Mixed_Numeric'] >= min_mixed_results) &\n",
    "    (clustering_df['Both_Normal_Numeric'] <= max_both_normal)\n",
    "].copy()\n",
    "\n",
    "# Calculate a \"diversity score\" - higher mixed results and balanced abnormal distributions are better\n",
    "clustering_candidates['Diversity_Score'] = (\n",
    "    clustering_candidates['Mixed_Numeric'] * 0.6 +  # 60% weight for mixed results\n",
    "    (100 - abs(clustering_candidates['Test1_Abnormal_Numeric'] - 50)) * 0.2 +  # 20% weight for Test 1 balance\n",
    "    (100 - abs(clustering_candidates['Test2_Abnormal_Numeric'] - 50)) * 0.2     # 20% weight for Test 2 balance\n",
    ")\n",
    "\n",
    "# Sort by diversity score (higher is better) and then by total patients (higher is better)\n",
    "clustering_candidates = clustering_candidates.sort_values(\n",
    "    ['Diversity_Score', 'Total Patients'], \n",
    "    ascending=[False, False]\n",
    ")\n",
    "\n",
    "print(f\"Found {len(clustering_candidates)} datasets meeting clustering criteria:\")\n",
    "print(f\"- Minimum {min_patients_clustering:,} patients\")\n",
    "print(f\"- At least {min_mixed_results}% mixed results (for diversity)\")\n",
    "print(f\"- At most {max_both_normal}% both normal (to avoid homogeneity)\")\n",
    "print(\"\\n\" + \"=\"*80)\n",
    "\n",
    "if len(clustering_candidates) > 0:\n",
    "    # Display the top clustering candidates\n",
    "    print(\"TOP CLUSTERING DATASETS (sorted by diversity score):\")\n",
    "    print(\"-\" * 60)\n",
    "    \n",
    "    for i, (_, row) in enumerate(clustering_candidates.head(10).iterrows(), 1):\n",
    "        print(f\"\\n{i}. {row['Test 1']} + {row['Test 2']}\")\n",
    "        print(f\"   👥 Total Patients: {row['Total Patients']:,}\")\n",
    "        print(f\"   🎭 Mixed Results: {row['Mixed Results %']} (higher = more diverse)\")\n",
    "        print(f\"   ✅ Both Normal: {row['Both Tests Normal %']} (lower = more variety)\")\n",
    "        print(f\"   ⚠️ Both Abnormal: {row['Both Tests Abnormal %']}\")\n",
    "        print(f\"   📊 Individual Abnormal Rates: {row['Test 1 Abnormal %']} & {row['Test 2 Abnormal %']}\")\n",
    "        print(f\"   🎯 Diversity Score: {row['Diversity_Score']:.1f}/100\")\n",
    "    \n",
    "    # Show the detailed table\n",
    "    print(f\"\\n\" + \"=\"*120)\n",
    "    print(\"DETAILED CLUSTERING CANDIDATES TABLE:\")\n",
    "    clustering_display = clustering_candidates[['Test 1', 'Test 2', 'Total Patients', \n",
    "                                               'Mixed Results %', 'Both Tests Normal %', 'Both Tests Abnormal %',\n",
    "                                               'Test 1 Abnormal %', 'Test 2 Abnormal %',\n",
    "                                               'Diversity_Score']].head(10)\n",
    "    print(clustering_display.to_string(index=False))\n",
    "    \n",
    "    # Recommend the best dataset\n",
    "    best_clustering_dataset = clustering_candidates.iloc[0]\n",
    "    print(f\"\\n\" + \"🏆\" * 60)\n",
    "    print(f\"RECOMMENDED DATASET FOR CLUSTERING:\")\n",
    "    print(f\"🏆 {best_clustering_dataset['Test 1']} + {best_clustering_dataset['Test 2']}\")\n",
    "    print(f\"   👥 Sample Size: {best_clustering_dataset['Total Patients']:,} patients\")\n",
    "    print(f\"   🎭 Mixed Results: {best_clustering_dataset['Mixed Results %']} (excellent diversity)\")\n",
    "    print(f\"   ✅ Both Normal: {best_clustering_dataset['Both Tests Normal %']} (good variety)\")\n",
    "    print(f\"   ⚠️ Both Abnormal: {best_clustering_dataset['Both Tests Abnormal %']} (interesting patterns)\")\n",
    "    print(f\"   📈 Individual Abnormal Rates:\")\n",
    "    print(f\"      - {best_clustering_dataset['Test 1']}: {best_clustering_dataset['Test 1 Abnormal %']}\")\n",
    "    print(f\"      - {best_clustering_dataset['Test 2']}: {best_clustering_dataset['Test 2 Abnormal %']}\")\n",
    "    print(f\"   🎯 Diversity Score: {best_clustering_dataset['Diversity_Score']:.1f}/100\")\n",
    "    print(f\"🏆\" * 60)\n",
    "\n",
    "else:\n",
    "    print(\"❌ No datasets found meeting the strict clustering criteria.\")\n",
    "    print(\"\\nLet's relax the criteria and show the best available options:\")\n",
    "    \n",
    "    # Relax criteria and show top options by mixed results percentage\n",
    "    relaxed_clustering = clustering_df[\n",
    "        clustering_df['Total Patients'] >= 1000  # Lower minimum\n",
    "    ].sort_values('Mixed_Numeric', ascending=False)\n",
    "    \n",
    "    print(f\"\\nTOP 10 DATASETS BY MIXED RESULTS PERCENTAGE (relaxed criteria):\")\n",
    "    for i, (_, row) in enumerate(relaxed_clustering.head(10).iterrows(), 1):\n",
    "        print(f\"{i:2d}. {row['Test 1']} + {row['Test 2']}\")\n",
    "        print(f\"    👥 {row['Total Patients']:,} patients | Mixed: {row['Mixed Results %']} | Both Normal: {row['Both Tests Normal %']}\")\n",
    "\n",
    "# Show why clustering needs diversity\n",
    "print(f\"\\n\" + \"💡\" * 50)\n",
    "print(f\"WHY CLUSTERING NEEDS DIVERSE DATASETS:\")\n",
    "print(\"-\" * 70)\n",
    "print(\"✅ GOOD for clustering:\")\n",
    "print(\"   - High Mixed Results % (40-70%): Creates natural patient groups\")\n",
    "print(\"   - Balanced abnormal rates (20-80%): Allows meaningful clusters\")\n",
    "print(\"   - Moderate Both Normal % (20-60%): Ensures variety in patient profiles\")\n",
    "print()\n",
    "print(\"❌ BAD for clustering:\")\n",
    "print(\"   - Very high Both Normal % (>80%): All patients look similar\")\n",
    "print(\"   - Very low Mixed Results % (<20%): Not enough pattern diversity\")\n",
    "print(\"   - Extreme abnormal rates (0-10% or 90-100%): One-sided distributions\")\n",
    "\n",
    "# Additional analysis: Show clustering potential by outcome patterns\n",
    "print(f\"\\n\" + \"📊\" * 50)\n",
    "print(f\"CLUSTERING POTENTIAL ANALYSIS:\")\n",
    "print(\"-\" * 70)\n",
    "\n",
    "if len(clustering_candidates) > 0:\n",
    "    top_3_clustering = clustering_candidates.head(3)\n",
    "    \n",
    "    print(\"Top 3 datasets show excellent clustering potential:\")\n",
    "    for i, (_, row) in enumerate(top_3_clustering.iterrows(), 1):\n",
    "        print(f\"\\n{i}. {row['Test 1']} + {row['Test 2']}\")\n",
    "        \n",
    "        # Explain why this is good for clustering\n",
    "        mixed_pct = row['Mixed_Numeric']\n",
    "        both_normal_pct = row['Both_Normal_Numeric']\n",
    "        both_abnormal_pct = row['Both_Abnormal_Numeric']\n",
    "        \n",
    "        print(f\"   🎭 Diversity Analysis:\")\n",
    "        print(f\"      - {mixed_pct:.1f}% patients have mixed results → Creates boundary clusters\")\n",
    "        print(f\"      - {both_normal_pct:.1f}% patients are both normal → Forms healthy cluster\")\n",
    "        print(f\"      - {both_abnormal_pct:.1f}% patients are both abnormal → Forms high-risk cluster\")\n",
    "        \n",
    "        # Predict cluster types\n",
    "        print(f\"   🎯 Expected Cluster Types:\")\n",
    "        if both_normal_pct > 15:\n",
    "            print(f\"      ✅ Healthy Cluster: ~{both_normal_pct:.0f}% of patients\")\n",
    "        if both_abnormal_pct > 15:\n",
    "            print(f\"      🚨 High-Risk Cluster: ~{both_abnormal_pct:.0f}% of patients\")\n",
    "        if mixed_pct > 30:\n",
    "            print(f\"      ⚖️ Mixed-Risk Clusters: ~{mixed_pct:.0f}% of patients (2-3 sub-clusters)\")\n",
    "\n",
    "print(f\"\\n✅ CLUSTERING ANALYSIS COMPLETE!\")\n",
    "print(f\"📈 Use the recommended dataset for clustering to discover natural patient health groups.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "72ae2843",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "🎯 BEST DATASETS FOR ASSOCIATION RULE MINING\n",
      "================================================================================\n",
      "Found 7 datasets meeting association rule mining criteria:\n",
      "- Minimum 1,500 patients\n",
      "- At least 15% both abnormal (for strong rules)\n",
      "- At least 25% mixed results (for rule diversity)\n",
      "- At most 75% both normal (to avoid trivial rules)\n",
      "\n",
      "================================================================================\n",
      "TOP ASSOCIATION RULE MINING DATASETS (sorted by association score):\n",
      "----------------------------------------------------------------------\n",
      "\n",
      "1. HbA1c + Serum Creatinine\n",
      "   👥 Total Patients: 1,633\n",
      "   🔗 Both Abnormal: 28.2% (strong rules: If Test1 abnormal → Test2 abnormal)\n",
      "   🎭 Mixed Results: 58.8% (rule diversity)\n",
      "   ✅ Both Normal: 13.0% (baseline)\n",
      "   📊 Individual Abnormal Rates: 83.5% & 35.5%\n",
      "   🎯 Association Score: 49.1/100\n",
      "   💡 Potential Rules:\n",
      "      - If HbA1c abnormal → Serum Creatinine abnormal (confidence: ~33.8%)\n",
      "      - If Serum Creatinine abnormal → HbA1c abnormal (confidence: ~79.4%)\n",
      "\n",
      "2. Serum Triglycerides + Serum LDL Cholesterol\n",
      "   👥 Total Patients: 1,903\n",
      "   🔗 Both Abnormal: 39.9% (strong rules: If Test1 abnormal → Test2 abnormal)\n",
      "   🎭 Mixed Results: 40.4% (rule diversity)\n",
      "   ✅ Both Normal: 19.7% (baseline)\n",
      "   📊 Individual Abnormal Rates: 57.4% & 68.6%\n",
      "   🎯 Association Score: 48.1/100\n",
      "   💡 Potential Rules:\n",
      "      - If Serum Triglycerides abnormal → Serum LDL Cholesterol abnormal (confidence: ~69.5%)\n",
      "      - If Serum LDL Cholesterol abnormal → Serum Triglycerides abnormal (confidence: ~58.2%)\n",
      "\n",
      "3. Serum HDL Cholesterol + Serum LDL Cholesterol\n",
      "   👥 Total Patients: 1,602\n",
      "   🔗 Both Abnormal: 23.6% (strong rules: If Test1 abnormal → Test2 abnormal)\n",
      "   🎭 Mixed Results: 57.4% (rule diversity)\n",
      "   ✅ Both Normal: 19.0% (baseline)\n",
      "   📊 Individual Abnormal Rates: 37.9% & 68.7%\n",
      "   🎯 Association Score: 45.2/100\n",
      "   💡 Potential Rules:\n",
      "      - If Serum HDL Cholesterol abnormal → Serum LDL Cholesterol abnormal (confidence: ~62.3%)\n",
      "      - If Serum LDL Cholesterol abnormal → Serum HDL Cholesterol abnormal (confidence: ~34.4%)\n",
      "\n",
      "4. Blood Urea Nitrogen + Serum Creatinine\n",
      "   👥 Total Patients: 2,870\n",
      "   🔗 Both Abnormal: 18.6% (strong rules: If Test1 abnormal → Test2 abnormal)\n",
      "   🎭 Mixed Results: 62.7% (rule diversity)\n",
      "   ✅ Both Normal: 18.6% (baseline)\n",
      "   📊 Individual Abnormal Rates: 68.8% & 36.1%\n",
      "   🎯 Association Score: 44.4/100\n",
      "   💡 Potential Rules:\n",
      "\n",
      "5. HbA1c + TSH\n",
      "   👥 Total Patients: 1,538\n",
      "   🔗 Both Abnormal: 20.5% (strong rules: If Test1 abnormal → Test2 abnormal)\n",
      "   🎭 Mixed Results: 58.6% (rule diversity)\n",
      "   ✅ Both Normal: 20.9% (baseline)\n",
      "   📊 Individual Abnormal Rates: 76.6% & 32.6%\n",
      "   🎯 Association Score: 43.6/100\n",
      "   💡 Potential Rules:\n",
      "      - If HbA1c abnormal → TSH abnormal (confidence: ~26.8%)\n",
      "      - If TSH abnormal → HbA1c abnormal (confidence: ~62.9%)\n",
      "\n",
      "6. TSH + Vitamin D3\n",
      "   👥 Total Patients: 2,610\n",
      "   🔗 Both Abnormal: 15.4% (strong rules: If Test1 abnormal → Test2 abnormal)\n",
      "   🎭 Mixed Results: 63.3% (rule diversity)\n",
      "   ✅ Both Normal: 21.3% (baseline)\n",
      "   📊 Individual Abnormal Rates: 28.1% & 72.2%\n",
      "   🎯 Association Score: 42.4/100\n",
      "   💡 Potential Rules:\n",
      "\n",
      "7. Serum Triglycerides + Serum HDL Cholesterol\n",
      "   👥 Total Patients: 1,580\n",
      "   🔗 Both Abnormal: 26.0% (strong rules: If Test1 abnormal → Test2 abnormal)\n",
      "   🎭 Mixed Results: 36.6% (rule diversity)\n",
      "   ✅ Both Normal: 37.4% (baseline)\n",
      "   📊 Individual Abnormal Rates: 57.1% & 38.0%\n",
      "   🎯 Association Score: 36.5/100\n",
      "   💡 Potential Rules:\n",
      "      - If Serum Triglycerides abnormal → Serum HDL Cholesterol abnormal (confidence: ~45.5%)\n",
      "      - If Serum HDL Cholesterol abnormal → Serum Triglycerides abnormal (confidence: ~68.4%)\n",
      "\n",
      "==================================================================================================================================\n",
      "DETAILED ASSOCIATION RULE MINING CANDIDATES TABLE:\n",
      "               Test 1                Test 2  Total Patients Both Tests Abnormal % Mixed Results % Both Tests Normal % Test 1 Abnormal % Test 2 Abnormal %  Association_Score\n",
      "                HbA1c      Serum Creatinine            1633                 28.2%           58.8%               13.0%             83.5%             35.5%              49.14\n",
      "  Serum Triglycerides Serum LDL Cholesterol            1903                 39.9%           40.4%               19.7%             57.4%             68.6%              48.13\n",
      "Serum HDL Cholesterol Serum LDL Cholesterol            1602                 23.6%           57.4%               19.0%             37.9%             68.7%              45.22\n",
      "  Blood Urea Nitrogen      Serum Creatinine            2870                 18.6%           62.7%               18.6%             68.8%             36.1%              44.39\n",
      "                HbA1c                   TSH            1538                 20.5%           58.6%               20.9%             76.6%             32.6%              43.65\n",
      "                  TSH            Vitamin D3            2610                 15.4%           63.3%               21.3%             28.1%             72.2%              42.43\n",
      "  Serum Triglycerides Serum HDL Cholesterol            1580                 26.0%           36.6%               37.4%             57.1%             38.0%              36.50\n",
      "\n",
      "🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆\n",
      "RECOMMENDED DATASET FOR ASSOCIATION RULE MINING:\n",
      "🏆 HbA1c + Serum Creatinine\n",
      "   👥 Sample Size: 1,633 patients\n",
      "   🔗 Both Abnormal: 28.2% (excellent for strong rules)\n",
      "   🎭 Mixed Results: 58.8% (good rule diversity)\n",
      "   ✅ Both Normal: 13.0% (reasonable baseline)\n",
      "   📈 Individual Abnormal Rates:\n",
      "      - HbA1c: 83.5%\n",
      "      - Serum Creatinine: 35.5%\n",
      "   🎯 Association Score: 49.1/100\n",
      "\n",
      "   🔍 EXPECTED ASSOCIATION RULES:\n",
      "      Rule 1: HbA1c abnormal → Serum Creatinine abnormal\n",
      "         Support: 28.2% | Confidence: 33.8% | Lift: 95.13\n",
      "      Rule 2: Serum Creatinine abnormal → HbA1c abnormal\n",
      "         Support: 28.2% | Confidence: 79.4% | Lift: 95.13\n",
      "🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆🏆\n",
      "\n",
      "💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡💡\n",
      "WHY ASSOCIATION RULE MINING NEEDS SPECIFIC PATTERNS:\n",
      "--------------------------------------------------------------------------------\n",
      "✅ GOOD for association rules:\n",
      "   - High Both Abnormal % (20-40%): Creates strong 'If-Then' rules\n",
      "   - Moderate Mixed Results % (25-60%): Provides rule diversity\n",
      "   - Balanced individual abnormal rates: Enables bidirectional rules\n",
      "\n",
      "❌ BAD for association rules:\n",
      "   - Very low Both Abnormal % (<10%): No meaningful associations\n",
      "   - Very high Both Normal % (>80%): Only trivial rules\n",
      "   - Extreme individual rates (0-5% or 95-100%): One-sided patterns\n",
      "\n",
      "📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋📋\n",
      "ASSOCIATION RULE POTENTIAL ANALYSIS:\n",
      "--------------------------------------------------------------------------------\n",
      "Top 3 datasets show excellent association rule potential:\n",
      "\n",
      "1. HbA1c + Serum Creatinine\n",
      "   📊 Rule Potential:\n",
      "      - Strong Rules: 28.2% patients show both abnormal patterns\n",
      "      - Rule Diversity: 58.8% patients show mixed patterns\n",
      "      - Baseline Rules: 13.0% patients show both normal patterns\n",
      "   🔥 Expected Strong Rules (High Confidence):\n",
      "      - 33.8% of HbA1c abnormal cases also have Serum Creatinine abnormal\n",
      "      - 79.4% of Serum Creatinine abnormal cases also have HbA1c abnormal\n",
      "   ⚖️ Expected Moderate Rules (Medium Confidence):\n",
      "      - Various combinations of normal/abnormal patterns\n",
      "      - Useful for understanding partial risk factors\n",
      "\n",
      "2. Serum Triglycerides + Serum LDL Cholesterol\n",
      "   📊 Rule Potential:\n",
      "      - Strong Rules: 39.9% patients show both abnormal patterns\n",
      "      - Rule Diversity: 40.4% patients show mixed patterns\n",
      "      - Baseline Rules: 19.7% patients show both normal patterns\n",
      "   🔥 Expected Strong Rules (High Confidence):\n",
      "      - 69.5% of Serum Triglycerides abnormal cases also have Serum LDL Cholesterol abnormal\n",
      "      - 58.2% of Serum LDL Cholesterol abnormal cases also have Serum Triglycerides abnormal\n",
      "   ⚖️ Expected Moderate Rules (Medium Confidence):\n",
      "      - Various combinations of normal/abnormal patterns\n",
      "      - Useful for understanding partial risk factors\n",
      "\n",
      "3. Serum HDL Cholesterol + Serum LDL Cholesterol\n",
      "   📊 Rule Potential:\n",
      "      - Strong Rules: 23.6% patients show both abnormal patterns\n",
      "      - Rule Diversity: 57.4% patients show mixed patterns\n",
      "      - Baseline Rules: 19.0% patients show both normal patterns\n",
      "   ⚖️ Expected Moderate Rules (Medium Confidence):\n",
      "      - Various combinations of normal/abnormal patterns\n",
      "      - Useful for understanding partial risk factors\n",
      "\n",
      "📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈\n",
      "ASSOCIATION RULE METRICS SUMMARY:\n",
      "--------------------------------------------------------------------------------\n",
      "                             Test Combination Sample Size Support (Both Abnormal) Confidence T1→T2 Confidence T2→T1 Association Score\n",
      "                     HbA1c + Serum Creatinine       1,633                   28.2%            33.8%            79.4%              49.1\n",
      "  Serum Triglycerides + Serum LDL Cholesterol       1,903                   39.9%            69.5%            58.2%              48.1\n",
      "Serum HDL Cholesterol + Serum LDL Cholesterol       1,602                   23.6%            62.3%            34.4%              45.2\n",
      "       Blood Urea Nitrogen + Serum Creatinine       2,870                   18.6%            27.0%            51.5%              44.4\n",
      "                                  HbA1c + TSH       1,538                   20.5%            26.8%            62.9%              43.6\n",
      "\n",
      "✅ ASSOCIATION RULE MINING ANALYSIS COMPLETE!\n",
      "🔗 Use the recommended dataset to discover meaningful 'If-Then' health patterns.\n",
      "📊 Higher association scores indicate better potential for finding strong, actionable rules.\n"
     ]
    }
   ],
   "source": [
    "# Sort and filter enhanced_summary_df to find the best datasets for association rule mining\n",
    "\n",
    "print(\"🎯 BEST DATASETS FOR ASSOCIATION RULE MINING\")\n",
    "print(\"=\"*80)\n",
    "\n",
    "# Convert percentage columns to numeric for association analysis\n",
    "association_df = enhanced_summary_df_sorted.copy()\n",
    "\n",
    "# Define criteria for good association rule mining datasets\n",
    "min_patients_association = 1500  # Minimum sample size for statistical significance\n",
    "min_both_abnormal = 15  # Minimum \"both abnormal\" percentage for meaningful rules\n",
    "min_mixed_results = 25  # Minimum mixed results for rule diversity\n",
    "max_both_normal = 75   # Maximum \"both normal\" to ensure interesting patterns\n",
    "\n",
    "# Filter datasets that meet association rule mining criteria\n",
    "association_candidates = association_df[\n",
    "    (association_df['Total Patients'] >= min_patients_association) &\n",
    "    (association_df['Both_Abnormal_Numeric'] >= min_both_abnormal) &\n",
    "    (association_df['Mixed_Numeric'] >= min_mixed_results) &\n",
    "    (association_df['Both_Normal_Numeric'] <= max_both_normal)\n",
    "].copy()\n",
    "\n",
    "# Calculate an \"association score\" - higher both abnormal and mixed results are better\n",
    "association_candidates['Association_Score'] = (\n",
    "    association_candidates['Both_Abnormal_Numeric'] * 0.5 +  # 50% weight for both abnormal (main rules)\n",
    "    association_candidates['Mixed_Numeric'] * 0.3 +           # 30% weight for mixed results (rule diversity)\n",
    "    (100 - association_candidates['Both_Normal_Numeric']) * 0.2  # 20% weight for avoiding too much normal\n",
    ")\n",
    "\n",
    "# Sort by association score (higher is better) and then by total patients (higher is better)\n",
    "association_candidates = association_candidates.sort_values(\n",
    "    ['Association_Score', 'Total Patients'], \n",
    "    ascending=[False, False]\n",
    ")\n",
    "\n",
    "print(f\"Found {len(association_candidates)} datasets meeting association rule mining criteria:\")\n",
    "print(f\"- Minimum {min_patients_association:,} patients\")\n",
    "print(f\"- At least {min_both_abnormal}% both abnormal (for strong rules)\")\n",
    "print(f\"- At least {min_mixed_results}% mixed results (for rule diversity)\")\n",
    "print(f\"- At most {max_both_normal}% both normal (to avoid trivial rules)\")\n",
    "print(\"\\n\" + \"=\"*80)\n",
    "\n",
    "if len(association_candidates) > 0:\n",
    "    # Display the top association candidates\n",
    "    print(\"TOP ASSOCIATION RULE MINING DATASETS (sorted by association score):\")\n",
    "    print(\"-\" * 70)\n",
    "    \n",
    "    for i, (_, row) in enumerate(association_candidates.head(10).iterrows(), 1):\n",
    "        print(f\"\\n{i}. {row['Test 1']} + {row['Test 2']}\")\n",
    "        print(f\"   👥 Total Patients: {row['Total Patients']:,}\")\n",
    "        print(f\"   🔗 Both Abnormal: {row['Both Tests Abnormal %']} (strong rules: If Test1 abnormal → Test2 abnormal)\")\n",
    "        print(f\"   🎭 Mixed Results: {row['Mixed Results %']} (rule diversity)\")\n",
    "        print(f\"   ✅ Both Normal: {row['Both Tests Normal %']} (baseline)\")\n",
    "        print(f\"   📊 Individual Abnormal Rates: {row['Test 1 Abnormal %']} & {row['Test 2 Abnormal %']}\")\n",
    "        print(f\"   🎯 Association Score: {row['Association_Score']:.1f}/100\")\n",
    "        \n",
    "        # Explain potential rules\n",
    "        both_abnormal = row['Both_Abnormal_Numeric']\n",
    "        test1_abnormal = row['Test1_Abnormal_Numeric']\n",
    "        test2_abnormal = row['Test2_Abnormal_Numeric']\n",
    "        \n",
    "        print(f\"   💡 Potential Rules:\")\n",
    "        if both_abnormal > 20:\n",
    "            confidence_1_to_2 = (both_abnormal / test1_abnormal * 100) if test1_abnormal > 0 else 0\n",
    "            confidence_2_to_1 = (both_abnormal / test2_abnormal * 100) if test2_abnormal > 0 else 0\n",
    "            print(f\"      - If {row['Test 1']} abnormal → {row['Test 2']} abnormal (confidence: ~{confidence_1_to_2:.1f}%)\")\n",
    "            print(f\"      - If {row['Test 2']} abnormal → {row['Test 1']} abnormal (confidence: ~{confidence_2_to_1:.1f}%)\")\n",
    "    \n",
    "    # Show the detailed table\n",
    "    print(f\"\\n\" + \"=\"*130)\n",
    "    print(\"DETAILED ASSOCIATION RULE MINING CANDIDATES TABLE:\")\n",
    "    association_display = association_candidates[['Test 1', 'Test 2', 'Total Patients', \n",
    "                                                 'Both Tests Abnormal %', 'Mixed Results %', 'Both Tests Normal %',\n",
    "                                                 'Test 1 Abnormal %', 'Test 2 Abnormal %',\n",
    "                                                 'Association_Score']].head(10)\n",
    "    print(association_display.to_string(index=False))\n",
    "    \n",
    "    # Recommend the best dataset\n",
    "    best_association_dataset = association_candidates.iloc[0]\n",
    "    print(f\"\\n\" + \"🏆\" * 70)\n",
    "    print(f\"RECOMMENDED DATASET FOR ASSOCIATION RULE MINING:\")\n",
    "    print(f\"🏆 {best_association_dataset['Test 1']} + {best_association_dataset['Test 2']}\")\n",
    "    print(f\"   👥 Sample Size: {best_association_dataset['Total Patients']:,} patients\")\n",
    "    print(f\"   🔗 Both Abnormal: {best_association_dataset['Both Tests Abnormal %']} (excellent for strong rules)\")\n",
    "    print(f\"   🎭 Mixed Results: {best_association_dataset['Mixed Results %']} (good rule diversity)\")\n",
    "    print(f\"   ✅ Both Normal: {best_association_dataset['Both Tests Normal %']} (reasonable baseline)\")\n",
    "    print(f\"   📈 Individual Abnormal Rates:\")\n",
    "    print(f\"      - {best_association_dataset['Test 1']}: {best_association_dataset['Test 1 Abnormal %']}\")\n",
    "    print(f\"      - {best_association_dataset['Test 2']}: {best_association_dataset['Test 2 Abnormal %']}\")\n",
    "    print(f\"   🎯 Association Score: {best_association_dataset['Association_Score']:.1f}/100\")\n",
    "    \n",
    "    # Detailed rule analysis for the best dataset\n",
    "    print(f\"\\n   🔍 EXPECTED ASSOCIATION RULES:\")\n",
    "    both_abnormal = best_association_dataset['Both_Abnormal_Numeric']\n",
    "    test1_abnormal = best_association_dataset['Test1_Abnormal_Numeric']\n",
    "    test2_abnormal = best_association_dataset['Test2_Abnormal_Numeric']\n",
    "    both_normal = best_association_dataset['Both_Normal_Numeric']\n",
    "    \n",
    "    # Calculate rule metrics\n",
    "    support_both_abnormal = both_abnormal / 100\n",
    "    confidence_1_to_2 = (both_abnormal / test1_abnormal * 100) if test1_abnormal > 0 else 0\n",
    "    confidence_2_to_1 = (both_abnormal / test2_abnormal * 100) if test2_abnormal > 0 else 0\n",
    "    lift_1_to_2 = (confidence_1_to_2 / test2_abnormal * 100) if test2_abnormal > 0 else 0\n",
    "    lift_2_to_1 = (confidence_2_to_1 / test1_abnormal * 100) if test1_abnormal > 0 else 0\n",
    "    \n",
    "    print(f\"      Rule 1: {best_association_dataset['Test 1']} abnormal → {best_association_dataset['Test 2']} abnormal\")\n",
    "    print(f\"         Support: {both_abnormal:.1f}% | Confidence: {confidence_1_to_2:.1f}% | Lift: {lift_1_to_2:.2f}\")\n",
    "    print(f\"      Rule 2: {best_association_dataset['Test 2']} abnormal → {best_association_dataset['Test 1']} abnormal\")\n",
    "    print(f\"         Support: {both_abnormal:.1f}% | Confidence: {confidence_2_to_1:.1f}% | Lift: {lift_2_to_1:.2f}\")\n",
    "    \n",
    "    if both_normal > 15:\n",
    "        print(f\"      Rule 3: {best_association_dataset['Test 1']} normal → {best_association_dataset['Test 2']} normal\")\n",
    "        print(f\"         Support: {both_normal:.1f}% | Confidence: ~{(both_normal/(100-test1_abnormal)*100):.1f}%\")\n",
    "    \n",
    "    print(f\"🏆\" * 70)\n",
    "\n",
    "else:\n",
    "    print(\"❌ No datasets found meeting the strict association rule mining criteria.\")\n",
    "    print(\"\\nLet's relax the criteria and show the best available options:\")\n",
    "    \n",
    "    # Relax criteria and show top options by both abnormal percentage\n",
    "    relaxed_association = association_df[\n",
    "        association_df['Total Patients'] >= 1000  # Lower minimum\n",
    "    ].sort_values('Both_Abnormal_Numeric', ascending=False)\n",
    "    \n",
    "    print(f\"\\nTOP 10 DATASETS BY BOTH ABNORMAL PERCENTAGE (relaxed criteria):\")\n",
    "    for i, (_, row) in enumerate(relaxed_association.head(10).iterrows(), 1):\n",
    "        print(f\"{i:2d}. {row['Test 1']} + {row['Test 2']}\")\n",
    "        print(f\"    👥 {row['Total Patients']:,} patients | Both Abnormal: {row['Both Tests Abnormal %']} | Mixed: {row['Mixed Results %']}\")\n",
    "\n",
    "# Show why association rule mining needs specific patterns\n",
    "print(f\"\\n\" + \"💡\" * 60)\n",
    "print(f\"WHY ASSOCIATION RULE MINING NEEDS SPECIFIC PATTERNS:\")\n",
    "print(\"-\" * 80)\n",
    "print(\"✅ GOOD for association rules:\")\n",
    "print(\"   - High Both Abnormal % (20-40%): Creates strong 'If-Then' rules\")\n",
    "print(\"   - Moderate Mixed Results % (25-60%): Provides rule diversity\")\n",
    "print(\"   - Balanced individual abnormal rates: Enables bidirectional rules\")\n",
    "print()\n",
    "print(\"❌ BAD for association rules:\")\n",
    "print(\"   - Very low Both Abnormal % (<10%): No meaningful associations\")\n",
    "print(\"   - Very high Both Normal % (>80%): Only trivial rules\")\n",
    "print(\"   - Extreme individual rates (0-5% or 95-100%): One-sided patterns\")\n",
    "\n",
    "# Additional analysis: Show rule potential for top candidates\n",
    "print(f\"\\n\" + \"📋\" * 60)\n",
    "print(f\"ASSOCIATION RULE POTENTIAL ANALYSIS:\")\n",
    "print(\"-\" * 80)\n",
    "\n",
    "if len(association_candidates) > 0:\n",
    "    top_3_association = association_candidates.head(3)\n",
    "    \n",
    "    print(\"Top 3 datasets show excellent association rule potential:\")\n",
    "    for i, (_, row) in enumerate(top_3_association.iterrows(), 1):\n",
    "        print(f\"\\n{i}. {row['Test 1']} + {row['Test 2']}\")\n",
    "        \n",
    "        # Calculate detailed rule metrics\n",
    "        both_abnormal = row['Both_Abnormal_Numeric']\n",
    "        test1_abnormal = row['Test1_Abnormal_Numeric']\n",
    "        test2_abnormal = row['Test2_Abnormal_Numeric']\n",
    "        both_normal = row['Both_Normal_Numeric']\n",
    "        mixed = row['Mixed_Numeric']\n",
    "        \n",
    "        print(f\"   📊 Rule Potential:\")\n",
    "        print(f\"      - Strong Rules: {both_abnormal:.1f}% patients show both abnormal patterns\")\n",
    "        print(f\"      - Rule Diversity: {mixed:.1f}% patients show mixed patterns\")\n",
    "        print(f\"      - Baseline Rules: {both_normal:.1f}% patients show both normal patterns\")\n",
    "        \n",
    "        # Expected rule strength\n",
    "        if both_abnormal > 25:\n",
    "            print(f\"   🔥 Expected Strong Rules (High Confidence):\")\n",
    "            confidence_1_to_2 = (both_abnormal / test1_abnormal * 100) if test1_abnormal > 0 else 0\n",
    "            confidence_2_to_1 = (both_abnormal / test2_abnormal * 100) if test2_abnormal > 0 else 0\n",
    "            print(f\"      - {confidence_1_to_2:.1f}% of {row['Test 1']} abnormal cases also have {row['Test 2']} abnormal\")\n",
    "            print(f\"      - {confidence_2_to_1:.1f}% of {row['Test 2']} abnormal cases also have {row['Test 1']} abnormal\")\n",
    "        \n",
    "        if mixed > 40:\n",
    "            print(f\"   ⚖️ Expected Moderate Rules (Medium Confidence):\")\n",
    "            print(f\"      - Various combinations of normal/abnormal patterns\")\n",
    "            print(f\"      - Useful for understanding partial risk factors\")\n",
    "\n",
    "# Summary table with rule metrics\n",
    "print(f\"\\n\" + \"📈\" * 60)\n",
    "print(f\"ASSOCIATION RULE METRICS SUMMARY:\")\n",
    "print(\"-\" * 80)\n",
    "\n",
    "if len(association_candidates) > 0:\n",
    "    rule_metrics_data = []\n",
    "    for _, row in association_candidates.head(5).iterrows():\n",
    "        both_abnormal = row['Both_Abnormal_Numeric']\n",
    "        test1_abnormal = row['Test1_Abnormal_Numeric']\n",
    "        test2_abnormal = row['Test2_Abnormal_Numeric']\n",
    "        \n",
    "        confidence_1_to_2 = (both_abnormal / test1_abnormal * 100) if test1_abnormal > 0 else 0\n",
    "        confidence_2_to_1 = (both_abnormal / test2_abnormal * 100) if test2_abnormal > 0 else 0\n",
    "        \n",
    "        rule_metrics_data.append({\n",
    "            'Test Combination': f\"{row['Test 1']} + {row['Test 2']}\",\n",
    "            'Sample Size': f\"{row['Total Patients']:,}\",\n",
    "            'Support (Both Abnormal)': f\"{both_abnormal:.1f}%\",\n",
    "            'Confidence T1→T2': f\"{confidence_1_to_2:.1f}%\",\n",
    "            'Confidence T2→T1': f\"{confidence_2_to_1:.1f}%\",\n",
    "            'Association Score': f\"{row['Association_Score']:.1f}\"\n",
    "        })\n",
    "    \n",
    "    rule_metrics_df = pd.DataFrame(rule_metrics_data)\n",
    "    print(rule_metrics_df.to_string(index=False))\n",
    "\n",
    "print(f\"\\n✅ ASSOCIATION RULE MINING ANALYSIS COMPLETE!\")\n",
    "print(f\"🔗 Use the recommended dataset to discover meaningful 'If-Then' health patterns.\")\n",
    "print(f\"📊 Higher association scores indicate better potential for finding strong, actionable rules.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "c630f8c0",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Export the candidate datasets to CSV files\n",
    "classification_candidates.to_csv(\"model_data_insight/classification_candidates.csv\", index=False)\n",
    "clustering_candidates.to_csv(\"model_data_insight/clustering_candidates.csv\", index=False)\n",
    "association_candidates.to_csv(\"model_data_insight/association_candidates.csv\", index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "15ba9a5f",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
